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NOMENCLATURE 
Table 1. This table lists the used abbreviations of this work and gives their respective descriptions. For genes from 
the C. glutamicum ATCC 13032 genome, the cg numbers are derived from the 
https://coryneregnet.compbio.sdu.dk/v6/index.html database (last access: 28-06-2018). 
 
Abbreviation Description 
% (v v-1) Volume per volume percent 
% (w v-1) Weight per volume percent 
 Extinction coefficient 
µ Growth rate or micro (in 
combination with SI units) 
2×YT 2x yeast tryptone 
2-PG 2-phosphoglycerate 
3-PG 3-phosphoglycerate 
5’-ProFAR 1-(5-phosphoribosyl)-5-
[(5-phosphoribosylamino) 
methylideneamino] imidazole-4 
carboxamide 
6PG DH Phosphogluconate dehydrogenase 
A Specific enzyme activity 
a.o. Among others 
AA Amino acid 
ABC ATP-binding cassette 
aceA Isocitrate lyase (encoding gene, 
cg2560) 
aceB Malate synthase (encoding gene; 
cg2559) 
Acetyl CoA Acetyl coenzyme A 
ack Acetate kinase (encoding gene, 
cg3047) 
ADP Adenosine diphosphate 
AdSucc Adenylosuccinate 
AHAS Acetohydroxy acid synthase 
Abbreviation Description 
AICAR 5-aminoimidazole-4-carboxamide 
ribonucleotide 
AIR 5-Aminoimidazole ribotide 
ALE Adaptive laboratory evolution 
AMP Adenosine monophosphate 
asp L-Aspartate 
AspA Aspartate ammonia-lyase 
aspA Aspartate ammonia-lyase (encoding 
gene; cg1697) 
AspB Aspartate aminotransferase 
aspB Aspartate aminotransferase 
(encoding gene; cg0294) 
ATP Adenosine triphosphate 
B. subtilis Bacillus subtilis 
BenR Bacterial regulatory protein 
benR Bacterial regulatory protein 
(encoding gene, cg2641) 
BHI Brain heart infusion 
BHIS BHI medium supplemented with 
sorbitol 
BLAST Basic local alignment search tool 
bp Base pair 
BSA Bovine serum albumin 
c Concentration 
C. glutamicum Corynebacterium glutamicum 
C. jeikeium Corynebacterium jeikeium 
 XV 
 
Abbreviation Description 
C1 One carbon, in combination with 
unit or metabolism 
CDW Cell dry weight 
CeBiTec Center for Biotechnology, Bielefeld 
University 
cg0617 Potential formate dehydrogenase 
(encoding gene) 
CGXIIN/E/R Minimal media 
cis- Referring to cis-trans isomerism, 
meaning “this side of” 
COG Clusters of orthologous categories 
DAD Diode array detector 
DECHEMA Deutsche Gesellschaft für 
chemisches Apparatewesen, 
Chemische Technik und 
Biotechnologie e.V. 
dH2O Deionized water 
DHAP Dihydroxyacetone phosphate 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DNAP DNA-polymerase 
DO Dissolved oxygen concentration 
DTT Dithiotreitol 
E. coli Escherichia coli 
e.g. Exempli gratia (for example) 
EC Energy charge 
EDTA Ethylenediamine tetraacetic acid 
EF-TU Elongation factor TU 
EMS Ethyl methanesulfonate 
et al. Et aliae (and others) 
F 6-P Fructose 6-phosphate 
F-1,6-Bis-P Fructose-1,6-bisphosphate 
FACS Fluorescence activated cell sorting 
FAICAR 5-formamidoimidazole-4-
carboxamide ribotide 
FC Fold change 
FBA Flux balance analysis 
FDH Formate dehydrogenase 
fdhD Putative formate dehydrogenase 
(encoding gene, cg0616) 
fdhF Formate dehydrogenase (encoding 
gene, cg0618) 
fGAM 5’phosphoribosylformylglycine 
amidine 
fGAR phosphoribosyl-N-
formylglcineamide 
Abbreviation Description 
FID Flame ionization detector 
FLD Fluorescence detector 
Fmoc 9-Fluorenylmethoxy-carbonyl 
chloride 
FNR Fachagentur Nachwachsende 
Rohstoffe e.V. 
fTHF 10-Formyltetrahydrofolate 
fum Fumarate 
g Gram 
G6P Glucose 6-phosphate 
G6P DH Glucose 6-phosphate dehydrogenase 
GA3P Glyceraldehyde 3-phosphate 
GA3P-DH Glyceraldehyde 3-phosphate 
dehydrogenase 
gapA Glyceraldehyde 3-phosphate 
dehydrogenase (encoding gene, 
cg1791) 
GAR Glycineamide ribonucleotide 
GCV Glycine cleavage system 
gcvPTH GCV (encoding genes) from 
C. jeikeium 
Gdh L-Glutamate dehydrogenase 
gdh L-Glutamate dehydrogenase 
(encoding gene, cg2280) 
GDP Guanosine diphosphate 
GTP Guanosine triphosphate 
GlgE Potential maltosyltransferase 
glgE Potential maltosyltransferase 
(encoding gene, cg1382) 
Gln L-glutamine 
gltA citrate synthase (encoding gene, 
cg0949) 
glu L-Glutamate 
Gly / Gly Glycine 
glyA Serine hydroxymethyltransferase 
(encoding gene, cg1133) 
GMP guanosine monophosphate 
gnd 6-Phosphogluconate dehydrogenase 
(encoding gene, cg1643) 
h Hours 
his / His L-Histidine 
HisA 5’ProFAR isomerase 
hisA 5’ProFAR isomerase (encoding 
gene, cg2299) 
HisB Imidazoleglycerol phosphate 
dehydratase 
 XVI 
 
Abbreviation Description 
hisB imidazoleglycerol phosphate 
dehydratase (encoding gene, cg2303) 
HisC Histidinol phosphate 
aminotransferase 
hisC Histidinol phosphate 
aminotransferase (encoding gene, 
cg2304) 
HisD Histidinol dehydrogenase 
hisD Histidinol dehydrogenase (encoding 
gene, cg2305) 
HisE Phosphoribosyl-ATP 
pyrophosphatase 
hisE Phosphoribosyl-ATP 
pyrophosphatase (encoding gene, 
cg1699) 
HisF Synthase SU of IGP synthase 
hisF Synthase SU of IGP synthase 
(encoding gene, cg2297) 
HisG ATP phosphoribosyltransferase 
hisG ATP phosphoribosyltransferase 
(encoding gene, cg1698) 
HisH Glutaminase SU of IGP synthase 
hisH Glutaminase SU of IGP synthase 
(encoding gene, cg2300) 
HisI Phosphoribosyl-AMP 
cyclohydrolase 
hisI phosphoribosyl-AMP 
cyclohydrolase (encoding gene, 
2296) 
HisN Histidinol-phosphate phosphatase 
hisN Histidinol-phosphate phosphatase 
(encoding gene, cg0910) 
Hisol L-histidinol 
Hol-P L-histidinol phosphate 
HPLC High performance liquid 
chromatography 
HTH Helix-turn-helix 
i.e. Id est (that is) 
IAP Imidazole-acetole phosphate 
IBVT Institute of Biochemical 
Engineering, University of Stuttgart 
ICD Isocitrate dehydrogenase 
icd Isocitrate dehydrogenase (encoding 
gene; cg0766) 
ICL Isocitrate lyase 
IGP Imidazole-glycerol phosphate 
ilvC Acetohydroxyacid isomeroreductase 
(encoding gene, cg1437) 
ilvE Transaminase B (encoding gene, 
cg2418) 
Abbreviation Description 
IMP Inosine monophosphate 
ivlB Acetolactate synthase large SU 
(encoding gene, cg1435) 
ivlN Acetolactate synthase small SU 
(encoding gene, cg1436) 
Kan Kanamycin 
KM Michaelis Menten constant 
L Liter 
LC Liquid chromatography 
lipA Lipoyl synthase (encoding gene) 
from C. jeikeium 
lipB Lipoyl transferase (encoding gene) 
from C. jeikeium 
LuxR LuxR-type DNA-binding HTH 
domain 
m Meter or milli (in combination with 
SI units) 
M Molar (mol L-1) 
MerR MerR-type DNA-binding HTH 
domain 
MGE Metabolic engineering to guide 
evolution 
min Minutes 
MOPS 3-(N-morpholino) propane sulphonic 
acid 
mRNA Messenger RNA 
MS Mass spectrometry or malate 
synthase 
mTHF 5,10-Methylenetetrahydrofolate 
n Amount of substance 
n Nano (in combination with SI units) 
N Rotational speed 
N5-CAIR 5’-Phosphoribosyl-4-carboxy-5-
aminoimidazole 
NAD+ Nicotinamide adenine dinucleotide 
(oxidized) 
NADH Nicotinamide adenine dinucleotide 
(reduced) 
NADP+ Nicotinamide adenine dinucleotide 
phosphate (oxidized) 
NADPH Nicotinamide adenine dinucleotide 
phosphate (reduced) 
nt Nucleotide 
NTG N-methyl-N’-nitro-N-
nitrosoguanidine 
o- Ortho- 
o/n Overnight 
ORF Open reading frame 
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Abbreviation Description 
oriV Origin of vegetative replication 
P Promoter (with subscript giving the 
respective gene) 
P Product (superscript) 
PCA Protocatechuate or perchloric acid 
PCk Phosphoenolpyruvate carboxykinase 
pck Phosphoenolpyruvate carboxykinase 
(encoding gene, cg3169) 
PCR Polymerase chain reaction 
PCx Pyruvate carboxylase 
PDHC Pyruvate dehydrogenase complex 
PEP Phosphoenolpyruvate 
PEPCk PEP carboxykinase 
PEPCx PEP carboxylase 
PFK 6-Phosphofructokinase 
pfk 6-Phosphofructokinase (encoding 
gene, cg1409) 
PGI Phosphoglucoisomerase 
pgi Phosphoglucoisomerase (encoding 
gene, cg0973) 
pgl 6-Phosphogluconolactonase 
(encoding gene, cg1780) 
Pgm Phosphoglucomutase 
pgm Phosphoglucomutase (encoding 
gene, cg2800) 
Pi inorganic phosphate 
pKa Logarithmic acid dissociation 
constant 
pos. Position 
pp. Pages 
ppc Phosphoenolpyruvate carboxylase 
(encoding gene, cg1787) 
PPi inorganic diphosphate 
PPP Pentose phosphate pathway 
PRA phosphoribosylamine 
PR-AMP phosphoribosyl-AMP 
PR-ATP phosphoribosyl-ATP 
PRFAR 5-[(5-Phospho-1-deoxyribulos-1-
ylamino)methylideneamino]-1-(5-
phosphoribosyl) imidazole-4-
carboxamid 
PRPP Phosphoribosyl pyrophosphate 
prsA PRPP synthetase (encoding gene, 
cg1075) 
PrsA PRPP synthetase, also ribose-
phosphate diphosphokinase 
Abbreviation Description 
pta Phosphate transacetylase (encoding 
gene, cg3048) 
PTS Phosphotransferase system 
ptsF Fructose/mannitol-specific transport 
protein of PTS (encoding gene, 
cg2120) 
PtsF Phosphotransferase system for 
fructose 
ptsG Glucose-specific enzyme II BC 
component of PTS (encoding gene, 
cg1537) 
PtsG Phosphotransferase system for 
glucose 
PurA Adenylosuccinate synthase 
purA Adenylosuccinate synthase 
(encoding gene, cg3063) 
PurB Adenylosuccinate lyase 
purB Adenylosuccinate lyase (encoding 
gene, cg2876) 
PurC Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
purC Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
(encoding gene, cg2874) 
PurD PRA-glycine ligase 
purD PRA-glycine ligase (encoding gene, 
cg2878) 
PurE Phosphoribosylaminoimidazole 
mutase 
purE Phosphoribosylaminoimidazole 
mutase (encoding gene, cg0820) 
PurF Amidophosphoribosyltransferase 
purF Amidophosphoribosyltransferase 
(encoding gene, cg2857) 
PurH Bifunctional AICAR 
formyltransferase / IMP 
cyclohydrolase 
purH Bifunctional AICAR 
formyltransferase / IMP 
cyclohydrolase (encoding gene, 
cg0984) 
PurK Phosphoribosylaminoimidazole 
carboxylase 
purK Phosphoribosylaminoimidazole 
carboxylase (encoding gene, cg0816) 
PurL Phosphoribosylformylglycinamide 
synthase 
purL Phosphoribosylformylglycinamide 
synthase (encoding gene, cg2862) 
PurM Phosphoribosyl-
formylglycinamidine cycloligase 
purM Phosphoribosyl-
formylglycinamidine cycloligase 
(encoding gene, cg2856) 
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Abbreviation Description 
PurN Phosphoribosylglycinamide 
formyltransferase, fTHF-dependent 
purN Phosphoribosylglycinamide 
formyltransferase (encoding gene, 
cg0983) 
PurT Putative phosphoribosylglycinamide 
formyltransferase, formate-
dependent 
purT Putative phosphoribosylglycinamide 
formyltransferase, formate-
dependent (encoding gene, cg3054) 
PurU Potential fTHF deformylase 
purU Potential fTHF deformylase 
(encoding gene, cg0457) 
pyc Pyruvate carboxylase (encoding 
gene, cg0791) 
PyrE Orotate phosphoribosyltransferase 
pyre Orotate phosphoribosyltransferase 
gene (encoding cg3071) 
qP Biomass specific product formation 
rate 
qS Biomass specific substrate uptake 
rate 
Q-TOF Quadrupole time-of-flight 
R Resistant (superscript) 
R5P Ribose 5-phosphate 
R2 Coefficient of determination 
ramA Regulator of acetate metabolism A 
LuxR-type (encoding gene, cg2831) 
ramB Regulator of acetate metabolism B 
MerR-type (encoding gene, cg0444) 
rcf Relative centrifugal force 
RNA Ribonucleic acid 
Rpi Phosphopentose isomerase 
rpi Phosphopentose isomerase 
(encoding gene, cg2658) 
rpm Revolutions per minute 
RT Room temperature  
s Seconds (SI-unit) 
S Substrate (subscript) 
S. cerevisiae Saccharomyces cerevisiae 
S. 
typhimurium 
Salmonella enterica serovar 
Typhimurium 
sacB Levansucrase (gene) 
SAICAR Phosphoribosyl-aminoimidazole-
succinocarboxamide 
SD Standard deviation 
sdaA L-Serine dehydratase (encoding gene 
cg1852) 
Abbreviation Description 
L-SerDH L-Serine dehydratase 
SHMT L-serine hydroxymethyltransferase 
SNP Single nucleotide polymorphism 
sp. Species 
SU Subunit 
T Temperature or terminator (with 
subscript giving the respective gene) 
t Time 
TAE Tris-acetate and EDTA 
TBAS Tetrabutylammonium hydrogen 
sulfate 
TCA Tricarboxylic acid cycle 
TES Trace element solution 
Tet Tetracycline 
THF Tetrahydrofolate 
Tkt Transketolase 
tkt Transketolase (encoding gene, 
cg1774) 
trpD Anthranilate 
phosphoribosyltransferase (encoding 
gene, cg3361) 
TrpD Anthranilate 
phosphoribosyltransferase 
TrrnB Terminator of the E. coli rrnB 
operon 
tuf Elongation factor EF-TU (encoding 
gene, cg0587) 
UMP Uridine monophosphate 
UV Ultraviolet 
V Volume 
VAAM Vereinigung für Allgemeine und 
Angewandte Mikrobiologie 
Val L-Valine 
vs. Versus 
vvm Volume per volume per minute 
WGS Whole genome sequencing 
WT Wild type 
X Biomass (superscript) 
XMP Xanthosine monophosphate 
yCO2 Exhaust gas CO2 part 
yO2 Exhaust gas O2 part 
YP/Sgly Product/substrate yield for glycine 
YP/Shis Product/substrate yield for 
L-histidine 
YX/S Biomass/substrate yield 
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Abbreviation Description 
ZMP Other name for AICAR 
ZTP 5-amino-4-imidazolecarboxamide 
riboside 5triphosphate 
zwf SU of the glucose 6-phosphate 
dehydrogenase (encoding gene, 
cg1778) 
α CDW/OD600 correlation coefficient 
α-KG α-ketoglutarate 
Δ Delta (indicating gene deletions) 
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SUMMARY 
Corynebacterium glutamicum is an established industrial host for large scale fermentations of 
several different products, most famously the amino acids L-glutamate and L-lysine. Its in-depth 
investigated metabolism is a driving force that enables synthesis of a wide range of products 
and constitutes a basis for the substitution of established petroleum-based processes by 
microbial fermentation processes with C. glutamicum as host. This work expands and 
consolidates the spectrum of C. glutamicum products by focusing on the two amino acids 
L-histidine (PART I) and L-valine (PART II). 
PART I. In the first part of this thesis, C. glutamicum was engineered in a modularized 
metabolic engineering approach with LC/MS-QToF based systems metabolic profiling (SMP) 
and Flux Balance Analysis (FBA) for production of the amino acid L-histidine. This constitutes 
the first holistic, systems-based approach to develop L-histidine producing strains with 
C. glutamicum. Initially, L-histidine biosynthesis was tailored by introduction of a mutated 
variant of ATP phosphoribosyltransferase, the first enzyme in the pathway, which was released 
from feedback inhibition by L-histidine. Replacement of native promoters in front of the four 
operons containing L-histidine genes and of one internal promoter by stronger ones enabled the 
resulting strain C. glutamicum HIS7 to achieve a product yield of 0.066 ± 0.003 mol L-histidine 
per mol glucose. The strain additionally secreted equimolar amounts of glycine. HPLC analysis 
revealed heavily decreased intracellular adenylate concentrations as low as 6.6 ± 0.3 µmol ATP 
gCDW-1, 1.8 ± 0.1 µmol ADP gCDW-1, and AMP concentrations being below the detection limit 
of the applied system, compared to the C. glutamicum wildtype strain where adenylate 
concentrations were 15.7 ± 0.4 µmol ATP gCDW-1, 6.0 ± 0.6 µmol ADP gCDW-1, and 
2.1 ± 0.8 µmol AMP gCDW-1. Despite the adenylate energy charge was stable. FBA identified 
ATP regeneration, required as energy source and as L-histidine backbone donor, as a crucial 
step for L-histidine production. Moreover, SMP of the engineered strains identified strong 
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intracellular accumulations of inosine monophosphate (IMP; 43× increased peak intensities) 
and adenylosuccinate (2× increased peak intensities) compared to the WT, which were solved 
by plasmid-based overproduction of the purine biosynthesis enzymes PurA and PurB. The 
resulting strain C. glutamicum HIS8 did not improve the product yield but readjusted the 
intracellular IMP, adenylosuccinate, and ATP levels to WT level and reinforced the intrinsic 
low ATP regeneration capacity to maintain a balanced energy state of the cell. Furthermore, 
SMP in C. glutamicum HIS8 indicated limitations in the supply with C1 units essentially 
required for purine biosynthesis. Additional plasmid based production of the glycine cleavage 
(GCV) system from C. jeikeium accounted for the increased need for C1 units and increased the 
yield to 0.086 ± 0.001 mol L-histidine per mol glucose. Finally, to increase phosphoribosyl 
pyrophosphate availability, we rerouted the carbon flux towards the oxidative pentose 
phosphate pathway by replacing the native translational start codon ATG of the 
phosphoglucoisomerase to GTG. This final strain C. glutamicum HIS10 showed a further 
increased product yield of 0.093 ± 0.003 mol L-histidine per mol glucose. In addition to these 
strains, several further strains were generated, focussing on pentose phosphate pathway and 
purine biosynthesis genes/enzymes, and characterized that might help unravelling efficient 
L-histidine overproduction with C. glutamicum. Selected strains were then used to establish a 
seed train for preliminary bioprocess studies in different laboratory scales in glass and steel tank 
reactors. These studies comprised investigations of the influencing factors pH, oxygen supply, 
and medium composition and provide the basis for future investigations.  
PART II. In the second part of this work, we developed an evolutionary approach and evolved 
C. glutamicum strains that were suitable for L-valine production. Evolutionary approaches are 
often undirected and mutagen-based and result in strains with hundreds of mutations. We here 
developed and applied Metabolic engineering to Guide Evolution (MGE), an evolutionary 
approach enabling the identification of new targets to improve microbial producer strains. MGE 
is based on the idea to impair the cell`s metabolism by metabolic engineering, thereby 
generating guided evolutionary pressure. It consists of three distinct phases: (i) metabolic 
engineering to create the evolutionary pressure on the applied strain followed by (ii) a 
cultivation phase with growth as straightforward screening indicator for the evolutionary event, 
and (iii) comparative whole genome sequencing (WGS), to identify mutations in the evolved 
strains, which are eventually re-engineered for verification. Applying MGE, we evolved the 
PEP and pyruvate carboxylase deficient strain C. glutamicum Δppc Δpyc to grow on glucose as 
substrate with rates up to 0.31 ± 0.02 h-1 which corresponds to 80% of the growth rate of the 
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wildtype strain. The intersection of the mutations identified by WGS revealed isocitrate 
dehydrogenase (ICD) as consistent target in three independently evolved mutants. Upon re 
engineering in C. glutamicum Δppc Δpyc, the identified mutations led to diminished ICD 
activities (10%, 29%, and 55% of the native enzyme) and activated the glyoxylate shunt 
replenishing oxaloacetate required for growth. This manifested in isocitrate lyase activities of 
0.33 ± 0.06, 0.32 ± 0.05, and 0.53 ± 0.07 U (mg protein)-1 and malate synthase activites of and 
0.44 ± 0.07, 0.42 ± 0.08, and 0.39 ± 0.03 U (mg protein)-1, both inactive in C. glutamicum WT 
under the tested conditions. SMP analysis showed that the pools of citrate (fold 
change[FC]+12.1), isocitrate (FC+6.4), cis-aconitate (FC+13.2), and L-valine (FC+1.9) were 
significantly higher compared to C. glutamicum WT. As an alternative to existing L-valine 
producer strains based on inactivated or attenuated pyruvate dehydrogenase complex, we finally 
engineered the PEP and pyruvate carboxylase deficient C. glutamicum strains with identified 
ICD mutations for L-valine production by overexpression of the L-valine biosynthesis genes. 
Among them, C. glutamicum Δppc Δpyc ICDG407S (pJC4ilvBNCE) produced up to 8.9 ± 
0.4 g L-valine L-1, with a product yield of 0.22 ± 0.01 g L-valine per g glucose. By applying 
MGE, we evolved a PEPCx- and PCx-deficient strain to grow on a glycolytic substrate and 
identified an alternative mode for L-valine production with C. glutamicum that represents a 
suitable alternative to already existing production strains.  
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ZUSAMMENFASSUNG 
Corynebacterium glutamicum ist ein bewährter Wirtsorganismus der Industrie für großskalige 
Fermentationen zur Herstellung diverser Produkte, darunter die Aminosäuren L-Glutamat und 
L-Lysin. Der detailliert untersuchte Metabolismus stellt eine treibende Kraft dar, die die 
Synthese einer breiten Palette an Produkten, die von industriellem Interesse sind, ermöglicht. 
Auf dieser Basis ist es möglich Erdöl-basierte Verfahren durch mikrobielle 
Fermentationsprozesse mit C. glutamicum als Wirt zu ersetzen. Die in der vorliegenden Arbeit 
präsentierten Ergebnisse festigen und erweitern das Spektrum der Produkte, das mit 
C. glutamicum synthetisierbar ist. Der Fokus liegt hierbei auf den beiden Aminosäuren 
L-Histidin (PART I) und L-Valin (PART II). 
PART I. Im ersten Teil der vorliegenden Arbeit wurde C. glutamicum in einem modularisierten 
Metabolic Engineering-Ansatz mit Unterstützung einer LC/MS-QToF Plattform (Systems 
metabolic profiling) und Flux Balance Analysis (FBA) für die Produktion von L-Histidin 
optimiert. Dies stellt den ersten holistischen und systembasierten Ansatz dar, L-Histidin-
produzierende Stämme mit C. glutamicum als Basis zu erzeugen. In einem ersten Schritt wurde 
die L-Histidinbiosynthese durch die Implementierung einer mutierten Variante der 
ATP-Phosphoribosyl-Transferase, dem ersten Enzym in der L-Histidinbiosynthese, verbessert, 
indem dieses von der Enzymhemmung durch L-Histidin befreit wurde. Der Austausch der 
nativen Promotoren der vier Operons, die L-Histidingene enthalten, sowie der Austausch eines 
internen Promotors durch stärkere Promotoren, führte zu einem Produktertrag von 
0.066 ± 0.003 mol L-Histidin pro mol Glucose im resultierenden Stamm C. glutamicum HIS7. 
Zusätzlich zum Produkt L-Histidin sekretierte dieser Stamm äquimolare Mengen an Glycin. 
Mittels HPLC-Analyse konnte gezeigt werden, dass die intrazellulären Konzentrationen der 
Adenylate in den erzeugten Stämmen deutlich niedriger waren, als im Ausgangsstamm. Dies 
spiegelte sich in den niedrigeren Werten von 6.6 ± 0.3 µmol ATP gCDW-1 und 1.8 ± 0.1 µmol 
ADP gCDW-1 wider. Darüber hinaus lagen die Konzentrationen von AMP in allen L-Histidin-
produzierenden Stämmen unterhalb des Detektionslimits des eingesetzten Systems. Trotz der 
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veränderten absoluten Werte der Adenylate blieb der Wert für die Energieladung (Energy 
charge) stabil. Erstellte FBAs identifizierten die Regeneration von ATP, welches sowohl 
verantwortlich für die Bereitstellung von Energie, als auch des Kohlenstoffgerüsts in der ersten 
Reaktion der Histidinbiosynthese ist, als einen wichtigen Schritt der L-Histidinproduktion. 
Durchgeführtes SMP der Produktionsstämme identifizierte deutliche intrazelluläre 
Akkumulationen von Inosinmonophosphat (IMP; 43-fach erhöhte peak intensitites) und 
Addenylosuccinat (2-fach erhöhte peak intensitites), im Vergleich zum C. glutamicum WT. 
Diese Akkumulationen konnten durch die homologe plasmidbasierte Überproduktion der 
Enzyme PurA und PurB aus der Purinbiosynthese gelöst werden. Der daraus resultierende 
Stamm C. glutamicum HIS8 zeigte keinen höheren Produktertrag, er wies jedoch ähnliche 
Konzentrationen der Metabolite IMP und Adenylosuccinat wie der C. glutamicum WT auf, 
sowie eine erhöhte ATP-Konzentration, was auf eine Verstärkung der zuvor schwachen 
Kapazität zur ATP-Regeneration hindeutet, um so einen ausgeglichenen energetischen Zustand 
der Zelle unter den Produktionsbedingungen zu gewährleisten. SMP in C. glutamicum HIS8 
deutete weitere Limitierungen in der Versorgung mit C1-Körpern an, die zwingend für die 
Purinbiosynthese benötgt werden. Um dem entgegen zu wirken, wurde das heterologe glycine 
cleavage (GCV) System aus C. jeikeium mittels eines weiteren Plasmids produziert, was den 
Produktertrag auf 0.086 ± 0.001 mol L-Histidin pro mol Glucose steigerte. Um die 
Verfügbarkeit des Vorläufermoleküls Phosphoribosylpyrophosphat zu verbessern, wurde 
zusätzlich der Kohlenstofffluss in Richtung des oxidativen Zweigs des Pentosephosphatwegs 
verbessert, indem das native Startcodon der Glucose-6-Phosphat-Isomerase von ATG zu GTG 
getauscht wurde. Der resultierende Stamm C. glutamicum HIS10 zeigte einen gesteigerten 
Produktertrag von 0.093 ± 0.003 mol L-Histidin pro mol Glucose. Zusätzlich zu diesen 
Stämmen, wurden weitere Stämme erstellt und charakterisiert, die unter anderem 
Veränderungen im Pentosephosphatweg und der Purinbiosynthese aufweisen. Das dadurch 
erhaltene Wissen kann in künftigen Experimenten eine weitere Steigerung der 
L-Histidinproduktion mit C. glutamicum ermöglichen. Ausgewählte Stämme wurden dazu 
eingesetzt, eine Animpfschiene für vorläufige Bioprozesstudien in Glas- und Stahlreaktoren 
(0,2 – 10 L Arbeitsvolumen) zu etablieren. In diesen Studien, welche die Basis für künftige 
Bioprozessstudien bilden, wurden die Einflussfaktoren pH-Wert, Sauerstoffversorgung und 
Medienzusammensetzung näher untersucht. 
PART II. Der zweite Teil der vorliegenden Arbeit beschäftigte sich mit der Entwicklung eines 
neuen Evolutionsansatzes, mit dessen Hilfe Stämme auf Basis von C. glutamicum erzeugt 
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werden konnten, die sich für die Produktion von L-Valin eignen. Herkömmliche 
Evolutionsansätze sind oft ungerichtet und basieren auf Mutagenen, weshalb sie häufig in einer 
Vielzahl von Mutationen im Erbgut des Ausgangsstamms resultieren. Der neu entwickelte 
Ansatz mit dem Namen Metabolic Engineering to Guide Evolution (MGE) wird hier ein 
Evolutionsansatz präsentiert, der die Identifikation von neuen Angriffspunkten und die 
Verbesserung mikrobieller Produktionssysteme ermöglicht. MGE basiert auf der Idee den 
Metabolismus der Zelle durch Deletionen mittels Metabolic Engineering zu beeinträchtigen, 
um so gezielt Evolutionsdruck zu erzeugen.  MGE besteht aus den nachfolgenden drei Phasen: 
(i) die Anwendung von Metabolic Engineering um Evolutionsdruck zu erzeugen, gefolgt von 
(ii) einer Kultivierungsphase, in der das Wachstum als simpler Indikator für eine erfolgte 
Evolution fungiert, und (iii) vergleichendes Whole Genome Sequencing (WGS), um 
Mutationen im Genom der evolvierten Stämme im Vergleich zum Wildtyp-Stamm zu 
identifizieren. Dies ermöglicht den Transfer der auf diesem Weg identifizierten Mutationen in 
den Ausgangsstamm und eine anschließende Evaluierung der Mutationen. Durch die 
Anwendung von MGE konnte der Stamm C. glutamicum Δppc Δpyc, welcher Deletionen der 
Gene, die für die Pyruvat- und Phosphoenolpyruvatcarboxylase kodieren, enthält, evolvieren, 
sodass dieser mit Glucose als einziger Kohlenstoffquelle wachsen konnte. Die Wachstumsrate 
des resultierenden Stamms betrug 0.31 ± 0.02 h-1, was 80% der Wachstumsrate des 
C. glutamicum WT entspricht. Die Schnittmenge der Mutationen, die durch WGS identifiziert 
werden konnten, zeigte die Isocitratdehydrogenase (ICD) als gemeinsames Ziel in den drei 
evolvierten Stämmen. Die ICD-Mutationen führten nach Einbringung in den Ausgangsstamm 
C. glutamicum Δppc Δpyc zu geringeren Aktivitäten der ICD (10%, 29% und 55% des nativen 
Enzyms) und aktivierten den Glyoxylatzyklus, der Oxalessigsäure für das Wachstum 
bereitstellte. Die Aktivierung des Glyoxylatzyklus zeigte sich in detektierbaren Aktivitäten der 
Isocitratlyase von 0.33 ± 0.06, 0.32 ± 0.05 und 0.53 ± 0.07 U (mg Protein)-1 und der 
Malatsynthase von 0.44 ± 0.07, 0.42 ± 0.08 und 0.39 ± 0.03 U (mg Protein)-1. Für beide 
Enzyme ist bekannt, dass sie inaktiv in C. glutamicum WT bei den hier getesteten Bedingungen 
sind. Die Analyse mittels SMP zeigte, dass die intrazellulären Pools von Citrat (fold 
change[FC]+12.1), Isocitrat (FC+6.4), cis-Aconitat (FC+13.2) und L-Valin (FC+1.9) im 
Vergleich zu C. glutamicum WT deutlich erhöht waren. Schließlich wurden die erstellten 
Stämme für die Produktion der Aminosäure L-Valin eingesetzt, um als Alternative zu den 
verfügbaren Valinproduzenten, die auf einer Inaktivierung oder Abschwächung des 
Pyruvatdehydrogenasekomplexes basieren, zu fungieren. Um den Kohlenstofffluss in Richtung 
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L-Valinbiosynthese zu verstärken, wurde das Plasmid pJC4ilvBNCE eingesetzt, das die 
wichtigen Gene zur Valinproduktion enthält. Unter den Produzenten zeigte 
C. glutamicum Δppc Δpyc ICDG407S (pJC4ilvBNCE) die höchste Produkkonzentration mit 
8.9 ± 0.4 g L-Valin L-1, was einem Produktertrag von 0.22 ± 0.01 g L-Valin pro g Glucose 
entspricht. Durch die erfolgreiche Anwendung von MGE, konnte ein Stamm mit Deletionen 
der Gene, die für die Pyruvat- und Phosphoenolpyruvatcarboxylase kodieren, evolviert werden. 
Dieser Stamm konnte mit Glucose als einziger Kohlenstoffquelle wachsen. MGE ermöglichte 
darüber hinaus die Identifizierung eines neuartigen Modus für die Produktion von L-Valin mit 
C. glutamicum, welcher auf ICD Mutationen basiert und eine geeignete Alternative zu bereits 
bestehenden Produktionsweisen repräsentiert.  
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CHAPTER 1: INTRODUCTION 
 General introduction 
 Industrial biotechnology 
Biotechnology in general is defined as a broad area of science that investigates living systems 
and the catalysts performing their intrinsic reactions, such as enzymes, to develop useful 
products. Biotechnology is an ancient realm and has been used and promoted by humans for 
generations, culminating in nowadays modern fields of biotechnology. These comprise major 
areas like health care (medical biotechnology), agriculture and crop production, environmental 
biotechnology, and industrial (i.e. non-food) biotechnology. Nowadays, the major areas can be 
divided in several subcategories, including blue biotechnology (marine applications), green 
biotechnology (agricultural processes), red biotechnology (medical processes), gold 
biotechnology (bioinformatics), yellow biotechnology (food production), gray biotechnology 
(environmental applications), violet biotechnology (law, ethics, and philosophy), brown 
biotechnology (Management of arid lands), dark biotechnology (warfare), and white 
biotechnology (industrial processes) (Kafarski, 2012). 
The here presented work is anchored in the field of white biotechnology, also known as 
industrial biotechnology. The term industrial biotechnology thereby means the advanced 
application of biotechnology for the sustainable processing and production of (bio)chemical 
products of a wide range. Products that might be synthesized include chemicals and 
pharmaceuticals, human and animal nutrition products, textiles, energy-related products, 
polymers, and a steadily increasing number of products from other areas. An important and 
emphasized pillar of industrial biotechnology is the factor of sustainability, which is mediated 
by the aim to substitute established (petro)chemically-based processes by enzyme- and/or 
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microorganism-based processes, with renewable (re)sources as substrates, instead of relying on 
unlasting resources, such as petroleum. These substrates might not only include sustainable and 
renewable sources, such as plant material, but can also include waste streams, such as sugar 
containing agricultural byproducts (e.g. molasses). That implies that industrial biotechnology, 
compared to petro-based processes, can not only promote resource conservation, but also 
mediates pollution prevention and cost reduction.  
The underlying principle of industrial biotechnology are processes (either via fermentation or 
an enzymatic conversion) in which substrates are used to supply microorganisms with the 
nutrients they need to grow and produce the products of desire. Major fields to establish such 
bioprocesses include metabolic engineering (to develop the producer strains), bioprocess 
engineering (to establish, maintain, and improve the bioprocess), systems biology 
(computational modelling of complex biological systems), and in an increasing manner 
synthetic biology (to create artificial biological systems with improved characteristics) 
The concept of Metabolic engineering was coined by scientists like Jay Bailey, Jay D. Keasling, 
Jens Nielsen, and Gregory Stephanopoulos and is defined as “the science of rewiring the 
metabolism of cells to enhance production of native metabolites or to endow cells with the 
ability to produce new products” (Nielsen and Keasling, 2016).  
 
 Corynebacterium glutamicum  
The here presented work relies on Corynebacterium glutamicum, a relevant industrial 
production hosts of the last decades and a model organism of industrial biotechnology. The 
organism was isolated in 1957 by Kinoshita and co-workers as Micrococcus glutamicus and 
became famous for its ability to produce larger quantities of the amino acid L-glutamate under 
biotin limited conditions (Kinoshita et al., 2004, 1958, 1957). Later, it was renamed and 
reclassified to its recent conventional name C. glutamicum and has been isolated from several 
different soil environments since then (Abe et al., 1967). It belongs to the phylum of 
Actinobacteria and to the order Actinomycetales, and thus is a close relative of other model 
organisms of microbiology/infectiology, such as C. diphtheriae, C. jeikeium, and a distant 
relative of Mycobacterium tuberculosis and Streptomyces coelicolor (Bentley et al., 2002; Cole 
et al., 1998; Hoskisson, 2018; Tauch et al., 2005). This gives rise to the opportunity to transfer 
the knowledge gained with C. glutamicum on its close and distant relatives, among them some 
with medical/clinical relevance, e.g. M. tuberculosis or C. diphtheriae. C. glutamicum is a 
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Gram-positive organism with GC-content of about 54% (Kalinowski et al., 2003). Its cell shape 
is described as coryneform (i.e. irregularly rod-shaped) and it has no flagellum, rendering it 
unable of chemotaxis. It further has been described as non-acid fast, biotin auxotrophic, 
catalase-positive, and facultatively anaerobic, meaning proliferation under anaerobic conditions 
is possible when nitrate as final electron acceptor is available (Nishimura et al., 2007) or when 
complex components are available (Michel et al., 2015). The cell wall of C. glutamicum as a 
Gram-positive organism is stable and is composed of lipophilic mycolic acids (Bayan et al., 
2003; Burkovski, 2013; Lanéelle et al., 2013; Marienfeld et al., 1997). The optimal growth 
temperature has been established to be around 30 °C and the pH optimum has been reported to 
range between 7.0 and 9.0 (Barriuso-Iglesias et al., 2008). Growth of C. glutamicum has been 
described as moderate, growing with rates of µmax of up to 0.58 h-1 and 0.46 h-1 in minimal 
medium with D-glucose as carbon source (Bäumchen et al., 2007; Grünberger et al., 2012). 
Besides glucose, C. glutamicum can take up and use several other carbon sources, including 
other sugars, e.g. fructose, sucrose, mannose, and ribose, acids, e.g. acetate, lactate, and 
pyruvate, and alcohols, e.g. ethanol (Eggeling and Bott, 2005). Interestingly, unlike other 
organisms such as E. coli, C. glutamicum shows only very few examples of catabolite 
repression (Arndt and Eikmanns, 2007; Brückner and Titgemeyer, 2002; Görke and Stülke, 
2008). 
The most commonly deployed C. glutamicum strains were termed ATCC 13032 and R and of 
both the genome sequence has been published (Ikeda and Nakagawa, 2003; Kalinowski et al., 
2003; Yang and Yang, 2017; Yukawa et al., 2007). The status as generally recognized as safe 
(GRAS) organism has opened a door for C. glutamicum to become a frequently deployed 
production host and intense investigations over several decades have generated vast knowledge 
of this organism, enabling the development of a broad range of genetic and metabolic 
engineering tools (Baritugo et al., 2018; Kirchner and Tauch, 2003; Nešvera and Pátek, 2011). 
 
 C. glutamicum – central metabolism 
Since the here presented work mainly utilizes processes with D-glucose as the sole carbon 
source, the central metabolism of C. glutamicum will be introduced in the following with a 
focus on glucose-based growth.  
When growing on the sugars glucose, fructose, or sucrose, the sugar is taken up specifically by 
the cell via a phosphoenolpyruvate (PEP) -dependent phosphotransferase system (PTS) and is, 
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during this process, subsequently phosphorylated. The PTS thereby operates by transferring a 
phosphoryl group from PEP onto the respective sugar-specific EII permease, which is catalysed 
by the PTS components EI, encoded by ptsI, and HPr, encoded by ptsH (Parche et al., 2001). 
An EII permease then transports the respective sugar into the cell, concomitantly 
phosphorylating it (Lengeler et al., 1994). For the three introduced sugars, the C. glutamicum 
genome encodes the specific EII permeases EIIGlc (encoded by ptsG), EIIFru (encoded by ptsF), 
and EIISuc (encoded by ptsS) for the uptake of glucose, fructose, and sucrose, respectively 
(Dominguez and Lindley, 1996; Kiefer et al., 2004, 2002; Moon et al., 2007, 2005).  
Glucose 6-phosphate is then either channelled into glycolysis or pentose phosphate pathway 
(PPP). Both of them have been intensively investigated in C. glutamicum with enzymatic 
studies, genetic analysis, carbon flux analysis, and genome-wide studies in the last decades and 
profound reviews are available (Blombach and Seibold, 2010; Eikmanns, 2005; Sauer and 
Eikmanns, 2005; Yokota and Lindley, 2005). 
Glucose 6-phosphate that enters the glycolytic pathway is then converted in several enzymatic 
steps to pyruvate. The overall reaction of glycolysis is 
 D-glucose + 2×NAD+ +2×ADP +2×Pi  2×pyruvate +2×NADH +2×H+ +2×ATP +2×H2O, 
showing glycolysis’ main functions besides supplying precursors for anabolism: converting the 
free energy released by the oxidation steps from glucose to pyruvate to generate the high energy 
compounds ATP and reduced NADH (Yokota and Lindley, 2005).  
The PPP is separated into two parts (for an overview see Eggeling and Bott, 2005 and Yokota 
and Lindley, 2005). The first one is the oxidative branch, where glucose-phosphate stepwise is 
converted towards ribulose 5-phosphate and reducing equivalents in the form of NADPH are 
generated. These serve as reducing power for reductive reactions for the synthesis of cellular 
building blocks. Glucose 6-phosphate is converted to 6-phosphogluconolactone via the 
NADPH-generating reaction of the glucose 6-phosphate dehydrogenase (G6P DH, encoded by 
zwf  and opcA) in a first step, which is then further converted to 6-phosphogluconate via the 
reaction of the 6-phosphogluconolactonase (encoded by pgl). Another NADPH-generating 
reaction, namely the 6-phosphogluconate dehydrogenase (6PG DH, encoded by gnd), then 
converts 6-phosphogluconate to ribulose 5-phosphate (Moritz et al., 2000), which is then 
converted to ribose 5-phosphate via the phosphopentose isomerase (encoded by rpi). Following 
this, the reaction of the PRPP synthetase takes place, converting ribose 5-phosphate to the 
crucial L-histidine precursor PRPP (see 1.2.2 L-HISTIDINE biosynthesis – structure and 
regulation, p.11). 
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In the second part of the PPP, the non-oxidative (reductive) branch, interconversions of five 
carbon sugars is conducted, to generate ribose 5-phosphate (for e.g. nucleic acid synthesis) and 
erythrose 4-phosphate (for e.g. aromatic amino acids synthesis). Important enzymes that 
catalyse the underlying reactions comprise transaldolase (Tal, encoded by tal) and transketolase 
(Tkt, encoded by tkt). The latter reshuffles the excess of phosphorylated sugars that originates 
in the PPP into glycolysis. Tkt mediates two reactions: (i) xylulose 5-phosphate + 
ribose 5-phosphate ↔ sedoheptulose 7-phosphate + glyceraldehyde 3-phosphate and (ii) 
xylulose 5-phosphate + erythrose 4-phosphate ↔ fructose 6-phosphate + 
glyceraldehyde 3-phosphate.  
The overall reaction considering both the oxidative and the non-oxidative part of the PPP thus 
is 3×glucose 6-phosphate + 6×NADP+ + 3×H2O  2×fructose 6-phosphate + 
glyceraldehyde 3-phosphate + 6×NADPH + 6×H+ + 3×CO2. 
The ratio in which glycolysis and PPP are supplied with carbon depends on different factors. It 
has been shown that under aerobic growth conditions about 69% of the carbon is channelled in 
the PPP (Bartek et al., 2011). However, when the growth conditions proceed anaerobically, the 
PPP is close to inactive with only about 5% of carbon being channelled into PPP (Radoš et al., 
2014).  
The pyruvate that is generated in glycolysis is further converted via the pyruvate dehydrogenase 
complex (PDHC), a multi-enzyme complex consisting of the subunits pyruvate decarboxylase 
(E1), dihydrolipoamide acyltransferase (E2), and lipoamide dehydrogenase (E3). This complex 
catalyses the oxidative decarboxylation of pyruvate to acetyl-coenzyme A (CoA), subsequently 
generating NADH from NAD+ (Eikmanns and Blombach, 2014). The PDHC has been 
identified and deployed as an attractive target for metabolic engineering with focus on different 
products in C. glutamicum, among these L-valine 
The acetyl-CoA that is generated via the PDHC is then further converted in the tricarboxylic 
acid (TCA) cycle and completely oxidised to CO2 (Bott and Eikmanns, 2013). It is active 
regardless of the carbon source and supplies the cell with energy in the form of ATP and 
reducing equivalents in the form of NADH and NADPH. The TCA is a highly dynamic cycle 
of metabolite conversions, which adjusts its enzymatic activities according to the environmental 
situation, e.g. according to available carbon source(s). Its overall reaction in C. glutamicum is 
given by Acetyl-CoA + NAD+ + NADP+ + 2×MQ + ADP + Pi + 2×H2O  
2×CO2 + NADH + NADPH + 2×MQH2 + ATP + CoA-SH. One of TCA cycle’s tasks is the 
provision of metabolites for the several biosynthetic pathways. These intermediates are 
 6 
 
regularly withdrawn from the cycle, requiring frequent replenishment. This task is taken over 
by the anaplerotic reactions around the PEP-pyruvate-oxaloacetate node (Sauer and Eikmanns, 
2005) and will be discussed in detail below (1.3.3 Anaplerotic reactions in C. glutamicum, 
p.30).  
 
 C. glutamicum as industrial host 
Owing to its ability to produce larger quantities of the amino acid L-glutamate combined with 
increasing interest in monosodium glutamate (MSG) in the food culture of Japan, 
C. glutamicum got special attention (Scanning electron microscopy pricture shown in Fig. 
1, p.7). Despite L-glutamate being a non-essential amino acid for humans, the rise of its 
industrial production is strongly connected with the fact that it binds to umami (one of the five 
basic tastes, besides sour, sweet, bitter, and salty) receptors and is able to intensify the flavour 
of foods (Löliger, 2000; Yamaguchi, 1991). The development of the MSG industry, especially 
in Japan, continues until today and L-glutamate is produced with C. glutamicum in quantities 
of up to 3 million tonnes per year in 2015 (Ajinomoto Co., 2016). Besides L-glutamate, 
C. glutamicum has been intensively exploited for production of L-lysine, with quantities of 
above 2 million tonnes per year (Ajinomoto Co., 2016). Global players like Ajinomoto Co. 
(https://www.ajinomoto.com/) and Evonik Industries AG (https://corporate.evonik.de/de/) are 
participating in this field. 
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Meanwhile, despite still being especially famous for L-glutamate and L-lysine production, the 
portfolio of amino acids that C. glutamicum can produce has been expanded drastically, 
spanning almost all 20 proteinogenic amino acids. Besides the mentioned L-glutamate and 
L-lysine, studies (only a small selection of the available studies is given) for producing the 
following L-amino acids are available: L-alanine (Jojima et al., 2010), L-arginine (Jensen et al., 
2015; Park et al., 2014), L-aspartate (Kalinowski et al., 2003), L-cysteine (Joo et al., 2017), 
L-glutamine (Liu et al., 2008), L-histidine (Kulis-Horn et al., 2015), L-isoleucine (Vogt et al., 
2014b), L-leucine (Vogt et al., 2014a), L-methionine (Ying Li et al., 2016), L-phenylalanine 
(Zhang et al., 2015) , L-proline (Jensen et al., 2015), L-serine (Zhang et al., 2018), L-threonine 
(Wei et al., 2018), L-tryptophan (Ikeda and Katsumata, 1999), L-tyrosine (Ikeda and Katsumata, 
1992), and L-valine (Oldiges et al., 2014).  
Besides the proteinogenic amino acids, C. glutamicum has also been engineered to produce 
non-proteinogenic amino acids, such as L-ornithine and L-citrulline (Hwang et al., 2008; 
Jensen et al., 2015) and D-amino acids, such as D-serine and D-lysine (Stäbler et al., 2011).  
Despite being particularly established as amino acids producer, C. glutamicum has been 
engineered to produce a wide range of products besides amino acids. Among these are 
Fig. 1. Scanning electron microscopy pictures of C. glutamicum growing on different sorts of starch. Kindly 
provided by Tobias Hahn (University of Ulm), unpublished. 
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organic acids, such as pyruvate (Wieschalka et al., 2012), succinate (Litsanov et al., 2013), 
α-ketoglutarate (Li et al., 2016), 2-ketoisovalerate (Krause et al., 2010), and 2-ketoisocaproate 
(Bückle-Vallant et al., 2013), alcohols, such as ethanol (Jojima et al., 2014), isobutanol 
(Blombach et al., 2011), and 1,2-propanediol (Siebert and Wendisch, 2015), vitamins, such as 
pantothenate (Hüser et al., 2005),  
The development of C. glutamicum to a production host being able to synthesize such a wide 
range of products is tightly connected with the steady increase of available metabolic 
engineering and systems biology tools (Nielsen and Keasling, 2016; Yadav et al., 2012) to 
targeted tailor C. glutamicum towards a certain product or group of products (a.k.a. platform 
organism). Further product groups comprise carotenoids, such as decaprenoxanthin and 
sarcinaxanthin (Heider et al., 2014), diamines, such as cadaverine (Mimitsuka et al., 2007) and 
putrescine (Nguyen et al., 2015), fatty acids (Takeno et al., 2013), and polymers and 
polymer-connected SUs, such as poly(3-hydroxybutyrate) (Jo et al., 2009) and 5-aminovaleric 
acid (Shin et al., 2016). Beyond these, the portfolio of C. glutamicum expands further in 
different product categories, including further natural and non-natural products (Becker and 
Wittmann, 2015, 2012; Heider and Wendisch, 2015) 
The fact that C. glutamicum has been employed for the heterologous production of 
pharmaceutically relevant proteins (Freudl, 2017), finally emphasizes its relevance for 
industrial biotechnology.  
As mentioned before, one of industrial biotechnology’s advantages compared to competing 
petroleum-based processes, is the drawing on renewable resources as substrates for the 
microbial processes. However, these substrates often are rather heterologous than homologous 
substrates, making it in certain cases difficult to serve as fermentation substrates. Thus, 
production hosts are required to grow on a wide range of substrates, expanding from sugars 
over organic acids to alcohols. C. glutamicum has not only been engineered towards a wide 
product spectrum, but also towards a wide spectrum of substrates it can grow on, accounting 
the different available heterologous substrates originating from agricultural waste streams 
(Dahod et al., 2010; Mussatto et al., 2012). Besides the standardly used carbon source D-glucose 
(Pfeifer et al., 2017), C. glutamicum natively is able to grow on a variety of carbon sources, 
such as fructose (Kiefer et al., 2002), sucrose (Dominguez and Lindley, 1996), ribose 
(Wendisch, 2003), acetate (Gerstmeir et al., 2003), lactate (Bäumchen et al., 2007), mannose 
(Sasaki et al., 2011), ethanol (Arndt et al., 2008), and many more (for an overview see Eggeling 
and Bott, 2005). 
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Beyond natural substrates, the substrate spectrum of C. glutamicum has been expanded by 
metabolic engineering towards growth on non-native carbon sources, including arabinose 
(Kawaguchi et al., 2008), xylose (Buschke et al., 2013), starch (Seibold et al., 2006), galactose 
(Barrett et al., 2004), cellobiose (Adachi et al., 2013), and glycerol (Rittmann et al., 2008). In 
addition to the here listed substrates, pathways for many more have been implemented in 
C. glutamicum and the list is steadily increasing (Becker and Wittmann, 2015; Blombach and 
Seibold, 2010).  
 Introduction PART I 
 L-Histidine  
Histidine exists as its two enantiomers L- and D-histidine, although the D-variant is 
physiologically irrelevant and is only accessible by chemical synthesis. Therefore, whenever 
the term histidine is used in this work, it relates to the L-enantiomer. Histidine was discovered 
in the late 19th century by Kossel and Hedin simultaneously (Vickery and Leavenworth, 1928) 
and the L-enantiomer is nowadays categorized as an essential amino acid for human infants and 
adults, belonging to the 20 standard proteinogenic amino acids (Kopple and Swendseid, 1975). 
Histidine contains an α-amino group, which is protonated under physiological conditions, a 
carboxylic acid group, which is deprotonated under physiological conditions, and an imidazole 
side chain, which is partially protonated under physiological conditions, classifying it as 
positively charged amino acid under these conditions (Nelson and Cox, 2009). Histidine as only 
representative of the 20 proteinogenic amino acids can switch between the protonated and 
unprotonated state due to the pKa of about 6 of its imidazole group (Nelson and Cox, 2009).  
These characteristics enable histidine to be a common ligand in metalloproteins and play an 
important role if the catalytic triad in several enzymes, underlining its physiologically 
prominent role (Liao et al., 2013; Polgár, 2005; Rebek, 1990). Histidine is connected to several 
diseases and exceeding physiological levels of histidine in humans was demonstrated to be 
connected to mutations in histidase. This disorder is formerly known as histidinemia, a benign 
inborn error of metabolism (Auerbach et al., 1962; Kawai et al., 2005).  
Furthermore, histamine is produced from histidine by a single enzymatic step catalysed by 
histidine decarboxylase (Shahid et al., 2009). Histamine is a biogenic amine, which is known 
to play an important role in regulating human immune response and has been shown to be linked 
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to several allergic disorders, such as hay fever, allergic rhinitis, and urticaria (O’Mahony et al., 
2011; Parsons and Ganellin, 2006).  
Histidine has been reported to have several interesting effects, underlining its applicability in 
the medical and pharmaceutical sector: it has been shown to suppress inflammation and mediate 
insulin resistance (Feng et al., 2013), exhibit anti-inflammatory effect in monocytic leukemia 
and coronary arterial endothelial cells (Hasegawa et al., 2011; Hasegawa et al., 2012), to exhibit 
antioxidant properties by scavenging oxygen radicals (Wade and Tucker, 1998), to be effective 
against obesity in women (DiNicolantonio et al., 2018; Du et al., 2017), to potentially have 
beneficial effects against chronic cerebral hypoperfusion (Song et al., 2018), and to be 
connected with lowering blood pressure (Tuttle et al., 2012). Recently, it was reported that a 
diet rich in L-histidine is connected to increasing efficiency of the cancer treatment with the 
anti-cancer drug methotrexate, which was ascribed to histidine degradation (Frezza, 2018; 
Kanarek et al., 2018). 
Beyond the medical sector, potential applications were suggested for the feed sector. Histidine 
supplementation was able to prevent cataract development in atlantic salmon (Waagbø et al., 
2010). Further, histidine supplementation increased the formation of the histidine-containing 
dipeptides carnosine an anserine in the muscles of broilers, two metabolites that are connected 
to increased shelf-life, stability, and higher antioxidation capacity (Haug et al., 2008; Park et 
al., 2013).  
In the food sector, L-histidine monochloride is already available as food supplementation 
product for health and muscle development, e.g. as used in body building 
(https://www.lambertshealthcare.co.uk/l-histidine-hcl-500mg-p8313/; last access 25-07.2018; 
https://www.bulkpowders.co.uk/histidine.html; last access 25-07.2018). 
The physiological degradation of histidine is accomplished by an enzymatic system entitled 
histidine utilization (HUT) system, which is present in several prokaryotic and eukaryotic 
representatives and converts histidine to ammonia and L-glutamate (Bender, 2012). 
Interestingly, a HUT system is not encoded in the C. glutamicum genome, in contrast to the 
genomes of several other industrially relevant bacteria, such as Pseudomonas putida and 
Bacillus subtilis (Bender, 2012), which represents an advantage with respect to L-histidine 
production. 
The Food and Nutrition Board (FNB) of the US Institute of Medicine has determined the 
recommended dietary allowance for L-histidine to be 14 mg per kg body weight per day for 
adults (https://www.nap.edu/read/10490/chapter/12, last access 25-07-2018). The World 
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Health Organisiation (WHO) suggested a daily requirement for adults to be 12 mg per kg 
(Wade and Tucker, 1998).  
 
 L-Histidine biosynthesis – structure and regulation 
The biosynthetic pathway of the α-amino acid L-histidine has been investigated in prokaryotic 
representatives intensely during the past decades. These investigations mainly focused on the 
species Salmonella enterica serovar Typhimurium (S. typhimurium) and E. coli and several 
profound reviews are available on the molecular evolution of the pathway, structure and 
organisation of the participating genes and enzymes, and the underlying regulatory mechanisms 
(Alifano et al., 1996; Fani et al., 1995; Winkler and Ramos-Montañez, 2009). Besides bacteria, 
histidine biosynthesis has also been intensely studied in archaea (Fondi et al., 2009) and plants 
(Ingle, 2011).  
Histidine biosynthesis has been a model pathway for studies of the relationship between the 
connections of carbon flux through a metabolic pathway and the regulatory component 
controlling the genes, gene products, and enzymes that are responsible for this flow. The role 
as a model pathway manifests for example in the contribution of the histidine pathway in 
understanding the mechanisms of basic regulation of biosynthetic pathways, such as feedback 
inhibition (of ATP phosphoribosyltransferase to L-histidine), the energy charge, and settings of 
enzyme levels. The histidine biosynthesis pathway contains several unusual and interesting 
metabolites and enzymatic steps and it is connected to several different other biosynthetic 
pathways, such as purine and thiamine biosynthesis (1.2.5 L-HISTIDINE related pathways, p.21). 
Fundamental concepts of nowadays microbial physiology were investigated with the model 
pathway of histidine biosynthesis, such as the operon theory (e.g. Ames et al., 1961) or 
attenuation as a regulatory mechanism (Kasai, 1974) were first termed in relation to the 
histidine biosynthesis in S. typhimurium (Alifano et al., 1996). Description, investigation, and 
modification of the L-histidine biosynthesis in prokaryotic representatives has come a long way 
and since there is also valuable data published for the  L-histidine biosynthesis in 
C. glutamicum, the following overview will mainly utilize these findings if not indicated 
otherwise (Kulis-Horn et al., 2014). Despite the basic L-histidine biosynthesis is the same in all 
living organisms, subtleties can vary strongly between different genera (Alifano et al., 1996).  
In C. glutamicum, the biosynthetic L-histidine pathway consists of ten consecutive steps, 
starting with phosphoribosyl pyrophosphate (PRPP) and ATP as the two precursors for the first 
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reaction step (Fig. 2, p.13). Interestingly, PRPP is an important intermediate in several other 
pathways (reviewed in Hove-Jensen et al., 2016). The first step is catalysed by the ATP 
phosphoribosyltransferase HisG (encoded by hisG), which condensates ATP and PRPP to 
phosphoribosyl-ATP (PR-ATP), releasing pyrophosphate (PPi). The ATP 
phosphoribosyltransferase has been shown to be the target of a potent allosteric feedback 
inhibition by L-histidine, which was investigated in detail in different organisms, among others 
in Mycobacterium tuberculosis, a close relative of C. glutamicum (Cho et al., 2003; Mizukami 
et al., 1994; Pacholarz et al., 2017; Pedreño et al., 2012). This feedback inhibition is of crucial 
importance, since it prevents the waste of the precursor molecules ATP and PRPP (Fig. 2, p.13). 
The enzyme in C. glutamicum has been characterized in detail and was shown to have a specific 
enzyme activity of 2.19 µmol min-1 mg-1 and Michaelis constants (Km) of 0.08 mM for PRPP 
and 0.22 mM for ATP in glucose grown cells (Zhang et al., 2012), reflecting values obtained in 
M. tuberculosis, where Km values are 0.26 mM for ATP and 0.05 mM for PRPP (Pedreño et al., 
2012), and E. coli, where  Km values are 0.80 mM for ATP and 0.11 mM for PRPP (Tébar and 
Ballesteros, 1976). The second step is then performed by PR-ATP pyrophosphatase (HisE, 
encoded by hisE), an irreversible hydrolysis yielding phosphoribosyl-AMP (PR-AMP). Then, 
the purine ring of PR-AMP is opened by the action of the PR-AMP cyclohydrolase (HisI, 
encoded by hisI), releasing 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino) 
methylideneamino] imidazole-4 carboxamide (5’ProFAR). The fourth step is an internal redox 
reaction catalysed by 5’ProFAR isomerase (HisA, encoded by hisA), converting 5’ProFAR to 
5-[(5-phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-phosphoribosyl)imidazole-
4-carboxamide (PRFAR). 
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Fig. 2. Overview of the L-histidine biosynthetic pathway in C. glutamicum. Abbreviations: PRPP, 
phosphoribosyl pyrophosphate; ATP; adenosine triphosphate; PPi, pyrophosphate; PR-ATP, phosphoribosyl-
ATP; PR-AMP, phosphoribosyl-AMP; 5′ProFAR, 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] imidazole-4 carboxamide; PRFAR, 5-[(5-phospho-1-deoxyribulos-
1-ylamino)methylideneamino]-1-(5-phosphoribosyl)imidazole-4-carboxamide; IGP, imidazole-glycerol 
phosphate; AICAR, 1-(5′-phosphoribosyl)-5-amino-4-imidazolecarboxamide;IAP, imidazole-acetol 
phosphate; Hol-P, L-histidinol phosphate; Pi, phosphate; NAD+, oxidized nicotinamide adenine dinucleotide; 
NADH, reduced nicotinamide adenine dinucleotide; HisG, ATP phosphoribosyltransferase; HisE, 
phosphoribosyl-ATP pyrophosphatase; HisI, phosphoribosyl-AMP cyclohydrolase; HisA, 5′ProFAR 
isomerase; HisF, synthase SU of IGP synthase; HisH, glutaminase SU of IGP synthase; HisB, 
imidazoleglycerol-phosphate dehydratase; HisC, histidinol-phosphate aminotransferase; HisN, histidinol-
phosphate phosphatase; HisD, histidinol dehydrogenase. Taken from Kulis-Horn et al., 2014. 
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The following step is performed by the imidazoleglycerol-phosphate synthase (IGP-synthase; 
HisFH, consisting of a synthase SU HisF and a glutaminase SU HisH; encoded by hisF and 
hisH, respectively). The roles of these two SUs in C. glutamicum has not yet been fully 
elucidated, however the gene product of hisH has been proven to be dispensable for histidine 
formation (in contrast to hisA,B,C,D,E,F,G,I) in C. glutamicum and plasmid based expression 
of hisF was shown to be able to complement both, a deletion of hisF and of hisH, respectively 
(Kulis-Horn et al., 2014). This reaction constitutes a link between the biosynthetic pathways of 
purines and histidine and results in two products, firstly IGP, which is channelled further 
towards L-histidine, and 1-(5′-phosphoribosyl)-5-amino-4-imidazolecarboxamide (AICAR), 
which is further converted in the de novo part of the purine biosynthesis. The sixth step in the 
histidine pathway is catalysed by the IGP dehydratase (HisB, encoded by hisB), which 
dehydrates IGP to the enol, which is then ketonized non-enzymatically to imidazole-acetol 
phosphate (IAP). IAP is then transaminated to L-histidinol phosphate (Hol-P) by 
histidinol-phosphate aminotransferase (HisC, encoded by hisC), using L-glutamine as amino 
donor and pyridoxal 5’-phosphate as cofactor (Marienhagen et al., 2008). The eighth step is 
catalysed by histidinol-phosphate phosphatase (HisN, encoded by hisN) that dephosphorylates 
Hol-P to L-histidinol (Mormann et al., 2006). Besides hisH, hisN is the only histidine gene in 
C. glutamicum that does not lead to a complete auxotrophy for histidine (Kulis-Horn et al., 
2017, 2014). It has been shown that gene cg0911, encoding an enzyme with Hol-P phosphatase 
activity, can at least partially compensate a hisN deletion. Interestingly, cg0911 is part of one 
of the histidine operons in C. glutamicum (Fig. 3, p.15; Kulis-Horn et al., 2017). The final two 
steps of the L-histidine biosynthesis are then performed by the histidinol dehydrogenase (HisD, 
encoded by hisD), which first oxidizes L-histidinol to L-histidinal and further to L-histidine. 
HisD performs both reaction steps to prevent the instable L-histidinal intermediate from 
decomposing (Görisch and Hölke, 1985). During this reaction, two molecules of NAD+ are 
reduced. 
Based on a genome-scale model, one mol of L-histidine requires 9.4 mol ATP (Kulis-Horn et 
al., 2014). This value represents the third highest ATP demand of all 20 proteinogenic amno 
acids, only exceeded by those for L-arginine and L-tryptophan with 12.0 and 13.0 mol ATP per 
mol L-histidine, respectively (Kulis-Horn et al., 2014). One must keep in mind that the 
acquiration of the ATP backbone and its implementation into the first intermediate of the 
L-histidine biosynthesis is a unique feature of this reaction (see above) and does not occur in 
other amino acid biosynthesis pathways. In order to prevent energy loss, the histidine 
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biosynthesis requires stricr regulation. This regulation is not only mediated by a potent feedback 
inhibition of the ATP phosphoribosyltransferase by L-histidine, but also by transcriptional and 
translational mechanisms. On the transcriptional level, it has been demonstrated that operons 
hisE, hisH, and hisD are under positive control of the stringent response (Brockmann-Gretza 
and Kalinowski, 2006; Kulis-Horn et al., 2014). In C. glutamicum AS019, the 5’ untranslated 
region (5‘UTR) of the was demonstrated to be involved in transcriptional control of the 
respective operon (Jung et al., 2010). This regulation has not yet been confirmed for the shorter 
5’UTR of the hisD operon in C. glutamicum ATCC 13032, however a translational control 
mechanism of this region was suggested (Kulis-Horn et al., 2014).  
 
 Genomic organisation of the histidine genes 
The genomic organisation of the histidine genes in C. glutamicum ATCC 13032 has been 
investigated in detail and the following overview relies on published data if not indicated 
otherwise (Kulis-Horn et al., 2014). In C. glutamicum ATCC 13032 the histidine genes are 
organized in four operons, namely hisE-hisG, cg0911-hisN, hisH-hisA-impA-hisF-hisI-cg2294, 
and hisD-hisC-hisB-cg2302-cg2301 (Fig. 3, p.16) All histidine genes, except for hisH, have 
been shown to cause histidine auxotrophies upon deletion (hisN deletion leads to a strongly 
reduced growth). Apparently, these four transcriptional units not only contain histidine genes, 
but also protein-coding genes of other function (Fig. 3, p.16). Among these are cg2294, cg2301, 
and cg2302, whose functions have not yet been elucidated. Genes impA and cg0911 show high 
sequence similarities to hisN and might be connected to the strongly reduced growth phenotype 
of a ΔhisN strain. The operons containing cg0911 and hisH are transcribed as leaderless 
transcripts, meaning the transcription start is identical with the translation start, a rarely found 
phenomenon in Actinobacteria where about 20% of the genes are transcribed as leaderless 
transcripts (Zheng et al., 2011). The four operons are controlled by four primary promoters 
(PhisD, PhisH, Pcg0911, and PhisE) and by four internal promoters (PhisB, PhisA, PhisF, and PhisN), the 
latter potentially reinforcing the expression of distal genes in larger operons to compensate for 
natural polarity or allowing temporary expression of certain genes of an operon (Alifano et al., 
1996).  
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 Production of L-histidine  
Due to its properties, L-histidine is an attractive amino acid for the production in an industrial 
scale. Traditionally, L-histidine has been obtained via hydrolysis from proteins (Ikeda, 2003) or 
via the Strecker synthesis, a series of chemical reactions that synthesize an amino acid from an 
aldehyde or ketone (Harada, 1963; Shibasaki et al., 2008). With an increasing requirement for 
L-histidine due to its potential applications and the availability of techniques and methods to 
develop microbial producers, fermentation processes for the industrial scale production of 
L-histidine became interesting. In 2003, an estimated 400 t per year of L-histidine were 
produced annually via industrial fermentation processes, mainly applying C. glutamicum 
strains (in the past partially designated as Brevibacterium flavum) (Ikeda, 2003; Ivanov et al., 
2013). 
Examples for L-histidine producing strains in the literature are rare and solely focus on 
prokaryotic representatives. Despite investigations concerning elucidation of the L-histidine 
Fig. 3. Overview of the operons containing histidine biosynthetic pathway genes in C. glutamicum. 
Abbreviation: P, promoter. The ruler indicates the absolute position within the genome of C. glutamicum
ATCC 13032. Modified after Kulis-Horn et al., 2014. 
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biosynthetic pathways were mainly carried out in S. typhimurium, literature about L-histidine 
producer strains mainly focused on C. glutamicum (and related strains) and E. coli. 
The classical L-histidine producing strains were obtained in the 1970s by mutagenizing 
C. glutamicum strains with NTG and focused on selecting mutants resistant to L-histidine 
analogues, such as 1,2,4-triazoelalanine and 2-thiazolealanine (Araki et al., 1974; Araki and 
Nakayama, 1971), investigations on the ATP phosphoribosyltransferase (Araki and Nakayama, 
1974), and selecting for resistance markers for metabolites originating from histidine connected 
pathways, e.g. purines and pyrimidines (Araki et al., 1974). In further experiments, the 
production of L-histidinol from sugars by L-histidine auxotrophic strains of C. glutamicum 
(Araki and Nakayama, 1975) and related strains (Kubota et al., 1971) were investigated. Both 
produced quantities of L-histidinol, which were further converted to L-histidine by 
co-cultivating the L-histidinol producers either with E. coli or C. glutamicum strains, 
respectively (Araki and Nakayama, 1975; Kubota et al., 1971). In another approach, the ATP 
phosphoribosyltransferase from C. glutamicum was mutagenized with NTG and the 
plasmid-based overexpression of the resulting enzyme led to the accumulation of significant 
amounts of L-histidine upon fermentation with a mutagenized strain as host (Mizukami et al., 
1994).  
The invention and development of increasingly sophisticated techniques shifted the 
construction of microbial L-histidine producers from untargeted, mutagenesis approaches 
towards more targeted metabolic engineering approaches, with the ATP 
phosphoribosyltransferase and its feedback inhibition by L-histidine being in the focus. In an 
approach applying site directed mutagenesis, the enzyme was released from its feedback 
inhibition and the respective strain produced small amounts of L-histidine (Zhang et al., 2012). 
Another study of the ATP phosphoribosyltransferase comprising random mutagenesis and 
rational enzyme design underlined the potential of this target for L-histidine production 
(Kulis-Horn et al., 2015). Further metabolic engineering approaches in C. glutamicum 
comprised replacing the promoter of the gene hisD combined with the plasmid-based 
overexpression of genes hisE and hisG, which enabled production of L-histidine (Cheng et al., 
2013).  
Besides C. glutamicum strains, L-histidine production has also been investigated in E. coli, 
where the influence of the PRPP synthetase was studied. Mutant variants of the enzyme 
resistant to purine nucleotides were shown to be effective in L-histidine production (Klyachko 
et al., 2004b). Also, the overexpression of the purH gene, encoding the bifunctional 
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AICAR transformylase / IMP cyclohydrolase in E. coli has been reported to be beneficial for 
L-histidine production (Klyachko et al., 2004a). In a targeted metabolic engineering approach 
with E. coli the histidine feedback inhibition of ATP phosphoribosyltransferase was eliminated, 
an attenuator region was deleted, and the gene encoding the purine biosynthesis regulator 
protein PurR was deleted (Doroshenko et al., 2013). In a recent study with E. coli, the negative 
influence of AICAR on the ATP phosphoribosyltransferase was shown and construction of a 
strain overexpressing genes purA and purH led to improved AICAR to AMP recycling. 
Additional deletion of the pitA gene, encoding a transport system for inorganic phosphate, 
further proved beneficial for L-histidine production (Malykh et al., 2018). Other species that 
have been deployed for L-histidine production comprise Serratia marcescens and 
Streptomyces coelicolor via classical NTG treatment (Korajlija and Delíc, 1977). Beyond that, 
L-histidine production has been reported for regulatory mutants of B. subtilits (Jensen, 1969) 
and S. typhimurium (Sheppard, 1964), which were shown to excrete L-histidine into the 
medium. 
Besides strain engineering, there are also studies on improving bioprocesses for L-histidine 
production available. Developed strategies with L-histidine producing C. glutamicum strains 
comprise establishment of a fed-batch process with optimized feed strategies, investigating 
boundary control of the growth rate, and proposing a separated growth and production phase 
for the process (Chim-Anage et al., 1991). The deployed carbon source for L-histidine 
production was investigated by using a metabolic flux pattern approach to evaluate glucose and 
acetate as substrates (Shimizu et al., 2002).  
The manageable amount of available data for strains capable of L-histidine production indicates 
that the potential of this field has not yet been exploited. However, it also indicates the 
complexity of constructing microbial L-histidine producers.  
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Fig. 4. Overview of the central carbon metabolism of C. glutamicum with focus on the histidine 
biosynthesis and the related pathways. Abbreviations: 2PG, 2-phosphoglycerate; 3PG, 3-
phosphoglycerate; 5’-ProFAR, 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino) methylideneamino] 
imidazole-4 carboxamide; α KG, α-ketoglutarate; ADP, adenosine diphosphate; AdSucc, 
adenylosuccinate; AICAR, 1-(5′-phosphoribosyl)-5-amino-4-imidazolecarboxamide; AIR, 5-
aminoimidazole ribotide; AMP, adenosine monophosphate; asp; L-aspartate; ATP, adenosine 
triphosphate; fTHF, 10-formyltetrahydrofolate; F-1,6-Bis-P, fructose-1,6-bisphosphate; F6P, fructose 6-
phosphate; FAICAR, 5-formamidoimidazole-4-carboxamide ribotide; fGAM, 5’phosphoribosylformyl-
glycineamidine; fGAR, phosphoribosyl-N-formylglcineamide; fum, fumarate; G6P, glucose 6-phosphate; 
GA3P, glyceraldehyde 3-phosphate; GAR, glycineamide ribonucleotide; GCV, glycine cleavage system; 
gln, L-glutamine; glu, L-glutamate; GMP, guanosine monophosphate; HisA, 5’ProFAR isomerase; HisB, 
imidazoleglycerol phosphate dehydratase; HisC, histidinol phosphate aminotransferase; HisD, histidinol 
dehydrogenase; HisE, phosphoribosyl-ATP pyrophosphatase; HisF, synthase subunit of IGP synthase; 
HisG, ATP phosphoribosyltransferase; HisH, glutaminase subunit of IGP synthase; 
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Legend Fig. 4. continued: HisI, phosphoribosyl-AMP cyclohydrolase; HisN, histidinol-phosphate 
phosphatase; Hol-P, L-histidinol phosphate; IAP, imidazole-acetole phosphate; IGP, imidazole-
glycerol phosphate; IMP, inosine monophosphate; mTHF, 5,10-methylenetetrahydrofolate; N5-CAIR, 
5’-phosphoribosyl-4-carboxy-5-aminoimidazole; NAD+/NADH, oxidized/reduced nicotine amide 
dinucleotide; NADP+/NADPH, oxidized/reduced nicotine amide dinucleotide phosphate; Pgi, 
phosphoglucoisomerase; Pi/PPi, inorganic phosphate/diphosphate; Pgm, phosphoglucomutase; PR-
AMP, phosphoribosyl-AMP; PR-ATP, phosphoribosyl-ATP; PRA, phosphoribosylamine; PRFAR, 5-
[(5-phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-phosphoribosyl) imidazole-4-
carboxamid; PRPP, phosphoribosyl pyrophosphate; PtsG, phospoenolpyruvate-dependent 
phosphotransferase system for glucose; PurA, adenylosuccinate synthase; PurB, adenylosuccinate 
lyase; PurC, phosphoribosylaminoimidazole-succinocarboxamide synthase; PurD, PRA-glycine 
ligase; PurE, phosphoribosylainoimidazole mutase; PurF, amidophosphoribosyltransferase; PurH, 
bifunctional AICAR formyltransferase / IMP cyclohydrolase; PurK, phosphoribosylainoimidazole 
carboxylase; PurL, phosphoribosylformylglycinamide synthase; PurM, 
phosphoribosylformylglycinamidine cycloligase; PurN, phosphoribosylglycinamide 
formyltransferase; R5P, ribose 5-phosphate; SAICAR, phosphoribosyl-
aminoimidazolesuccinocarboxamide; SHMT, serine hydroxymethyltransferase; TCA, tricarboxylic 
acid cycle; THF, tetrahydrofolate. Taken from Schwentner et al., 2019. 
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 L-Histidine related pathways 
The histidine biosynthesis is only partly a linear pathway and bears several connections to other 
biosynthetic pathways that must be considered with respect to L-histidine overproduction (Fig. 
4, p.19). PRPP, one of the histidine precursor molecules is also an important intermediate and 
cofactor of other biosynthetic pathways in bacteria (reviewed in Hove-Jensen et al., 2016), such 
as de novo purine biosynthesis (Jensen et al., 2008; Zhang et al., 2008), pyrimidine biosynthesis 
(Turnbough and Switzer, 2008), L-tryptophan (Sprenger, 2007), nicotineamide adenine 
dinucleotides (Begley et al., 2001; Foster and Moat, 1980), and arabinogalactan, an important 
component of the cell wall of Corynebacteria (Alderwick et al., 2006). For an overview see 
Fig. 5 on page 22. These pathways will be introduced in appropriate depth in the following with 
their greater or lesser connection(s) to the L-histidine pathway and their potential significance 
for L-histidine overproduction.  
The most obvious connection of the L-histidine pathway is with the purine biosynthesis, due 
to a) the common precursor molecule PRPP, b) the common precursor molecule ATP, and c) 
AICAR as connecting molecule, being produced in one and further metabolized in the other 
pathway. The purine biosynthesis has been studied intensively in E. coli, where eleven 
enzymatic steps are needed to synthesize inosine monophosphate (IMP) from PRPP, while five 
molecules of ATP are consumed (Mueller et al., 1994; Zhang et al., 2008). The following 
overview uses the available reviews as basis (Brown et al., 2011; Jensen et al., 2008; 
Wyngaarden, 1976; Zhang et al., 2008). The complete pathway of purine biosynthesis can be 
separated in two coherent parts. In the first part, the de novo purine biosynthesis, the purine 
ring of inosine monophosphate (IMP), the endproduct of the de novo part, is generated by a 
stepwise addition of small molecules to the precursor PRPP. In the first step, 
amidophosphoribosyltransferase (PurF, encoded by purF) generates 5’phosphoribosylamine 
(PRA) by transferring an amino group from L-glutamine onto PRPP, simultaneously releasing 
pyrophosphate. PurF has been investigated in different organisms, mainly E. coli and 
B. subtilis, and was shown to be the target of a complex allosteric inhibition by the nucleotides 
AMP, ADP, GMP, and GDP in a synergistic manner (Chen et al., 1997; Zalkin, 1983; Zhou et 
al., 1994). PRA is further converted in the second step to glycineamide ribonucleotide (GAR), 
which is catalysed by the phosphoribosylamine-glycine ligase (PurD, encoded by purD) using 
glycine and ATP and releasing ADP and inorganic phosphate (Pi). The third enzymatic reaction 
is performed by phosphoribosylglycineamide formyltransferase (PurN, encoded by purN) and 
yields phosphoribosyl-N-formylglycineamide (FGAR). This reaction is one of the two (the 
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other being the tenth step by PurH) N10-formyltetrahydrofolate (fTHF) dependent reactions of 
the de novo purine biosynthesis, thus connecting purine biosynthesis with the one carbon (C1) 
metabolism (Fig. 4, p.19). In the fourth step, FGAR is converted to 
5’-phosphoribosylformylglycineamide (FGAM) by phosphoribosylformylglycineamide 
synthase (PurL, encoded by purL), requiring ATP and L-glutamine as cofactors and releasing 
L-glutamate, ADP, and Pi. FGAM is converted to aminoimidazole ribotide (AIR) in the fifth 
step by the AIR synthetase (PurM, encoded by purM), utilizing ATP and releasing ADP, Pi, 
and H2O. AIR is then converted in two steps to 5’phosphoribosyl-4-carboxy-5-aminoimidazole 
(CAIR) via N5-carboxyaminoimidazole ribonucleotide (N5-CAIR), catalysed by the N5-
carboxyaminoimidatole ribonucleotide synthetase (PurK, encoded by purK), requiring ATP and 
HCO3-, and by the N5-carboxyaminoimidatole ribonucleotide mutase (PurE, encoded by purE). 
Despite the purine biosynthesis is conserved among all realms of life, this reaction cascade may 
differ between organisms and since data for C. glutamicum have not yet been conducted, the 
here presented sequence is given for E. coli (Brown et al., 2011; Zhang et al., 2008). Besides 
for PurK, AIR is also a substrate for the hydroxymethyl pyrimidine synthase, the first enzyme 
in the biosynthetic pathway of thiamine (Du et al., 2011; Leonardi and Roach, 2004). The eighth 
step of the purine biosynthesis is catalysed by phosphoribosylaminoimidazole 
Ribose 5-P PRPP
Purine 
biosynthesis
Pyrimidine 
biosynthesis
L-Histidine
biosynthesis
L-Tryptophan 
biosynthesis
Nicotineamide
coenzyme
biosynthesis
Arabinogalactan
(30-40%)
(30-40%)
( <1%)
( 10-15%)
( 10-15%)
Fig. 5. Simplified overview of the utilization of phosphoribosyl pyrophosphate (PRPP) in C. glutamicum. 
Percentages in parentheses indicate the percentage of total used PRPP for E. coli and S. enterica in a minimal 
medium with glucose. Modified after Jensen et al., 2008 
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succinocarboxamide synthase (PurC, encoded by purC), which requires L-aspartate and ATP 
as cofactor and generates phosphoribosylaminoimidazolesuccinocarboxamide (SAICAR), 
ADP, and Pi. Then, adenylosuccinate lyase (PurB, encoded by purB) cleaves SAICAR to 
5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and fumarate. The generated 
fumarate is further converted in the TCA cycle, whereas AICAR is used as substrate for the 
bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase / inosine 
monophosphate cyclohydrolase (PurH, encoded by purH) in the tenth step of the purine 
pathway and 5-formamidoimidazole-4-carboxamide ribotide (FAICAR) is generated. Just as 
the third step of the pathway, the tenth step requires fTHF as cofactor and connects purine 
biosynthesis with C1 metabolism (Fig. 4, p.19). PurH then also catalyses the last step to produce 
inosine monophosphate (IMP) from FAICAR, releasing H2O.  
IMP marks the endpoint of the de novo part of the purine biosynthesis. It is a versatile precursor 
molecule for several different nucleobases, nucleosides, and nucleotides and the gateway for 
the salvage purine biosynthesis (Jensen et al., 2008; Murray, 1971; Peifer et al., 2012). In the 
salvage part, nucleobases and nucleosides are recovered from the degraded RNA and DNA. 
These salvage nucleobases and nucleosides might then be reconverted back to nucleotides 
(Jensen et al., 2008). With special importance for this work, one reaction IMP is undergoing is 
catalysed by adenylosuccinate synthetase (PurA, encoded by purA). This reaction requires 
guanosine triphosphate (GTP) as energy donor and L-aspartate, releasing guanosine 
diphosphate (GDP), Pi, and adenylosuccinate. Adenylosuccinate is then further converted to 
AMP via PurB, which also performs the ninth step of the de novo purine synthesis, again 
cleaving fumarate.  
As described above, the de novo part of the purine biosynthesis comprises two reaction steps 
that require fTHF as donor of C1 units in the form of a formyl group (Fig. 4, p.19). These 
molecules are part of the one carbon metabolism constituted by different tetrahydrofolate 
(THF) species that form a complex network of C1 group donors (Arinze, 2005). Folate 
(vitamin B9) serves as basis molecule and can bond with any of the C1 fragments in its 
completely reduced form as THF. The C1 fragments represent different oxidation states of the 
carbon atom and are metabolically interconvertible (Arinze, 2005). The C1 metabolism, its 
complex network, and the underlying regulatory mechanisms have been investigated in several 
species, such as E. coli (Harvey and Dev, 1975; Meedel and Pizer, 1974) and 
Saccharomyces cerevisiae (Piper et al., 2000). In C. glutamicum the main source for the 
generation of THF molecules loaded with a C1 unit that might be interconverted to other THF 
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species, appears to be the reaction of the serine hydroxymethyltransferase (SHMT, encoded by 
glyA) that converts L-serine to glycine and simultaneously loads a methylene group onto THF 
to yield N5,N10-methylene THF (mTHF), requiring pyridoxyl phosphate as cofactor (Lai et al., 
2012; Schweitzer et al., 2009; Simic et al., 2002; Stolz et al., 2007). The mTHF originating 
from the SHMT reaction is then convertible to other THF species, such as N10-formyl THF 
(fTHF). This most likely happens via a two step reaction: mTHF is oxidized to 
N5,N10-methenyl THF and then via a cyclohydrolase reaction to fTHF (Arinze, 2005). The 
generated fTHF molecules serve as formyl group donors in the de novo purine biosynthesis. 
In other organisms, among them also bacteria, such as E. coli (Okamura-Ikeda et al., 1993; 
Stauffer et al., 1986) or Streptomyces griseus (Tezuka and Ohnishi, 2014), the glycine cleavage 
(GCV) system is a further source for the generation of loaded THF species (Fig. 10, p.99). The 
GCV system is a multienzyme system that performs the reversible oxidation of glycine to CO2 
and ammonia, simultaneously generating mTHF from THF and NADH from NAD+ (Kikuchi 
et al., 2008; Okamura-Ikeda et al., 1993). In E. coli, it consists of the four proteins P- (glycine 
dehydrogenase), H- (interacts with all other components), T- (aminomethyltransferase), and 
L-protein (dihydrolipoyl dehydrogenase) and has been characterized thoroughly 
(Okamura-Ikeda et al., 1993; Stauffer et al., 1986). However, a GCV system is not encoded in 
the genome of C. glutamicum. 
Besides its role as starter molecule for the purine biosynthesis, PRPP is also required as cofactor 
in the pyrimidine biosynthesis pathway (Fig. 5, p.22). Beginning with L-glutamine, which is 
converted to carbamylphosphate, the pyrimidines uridine and cytidine nucleosides are 
generated (Turnbough and Switzer, 2008). Within this biosynthetic pathway, the reaction of 
orotate phosphoribosyltransferase (PyrE, encoded by pyrE) requires PRPP as cofactor to 
generate orotidine 5’-monophosphate from orotate. 
PRPP is also required in the biosynthesis of the α-amino acid L-tryptophan (Fig. 5, p.22).  
Originating from chorismate, the second step of the biosynthesis is performed by the 
anthranilate phosphoribosyltransferase (TrpD, encoded by trpD), converting anthranilate to 
phosphoribosylanthranilate, consuming PRPP and releasing PPi (Lambrecht and Downs, 2013; 
O’Gara and Dunican, 1995). 
The de novo biosynthesis of nicotineamide dinucleotides comprises one enzymatic reaction 
that involves PRPP as cofactor (Foster and Moat, 1980). Namely, in C. glutamicum the 
quinolinate phosphoribosyltransferase (NadC, encoded by nadC) is converting quinolinate to 
nicotinate mononucleotide consuming PRPP and releasing PPi and CO2 (Teramoto et al., 2010).  
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Additionally, PRPP was shown to be consumed for the synthesis of arabinogalactan, a 
macromolecule that connects mycolic acids to peptidoglycan in the cell wall matrix of 
Corynebacterianeae, among them C. glutamicum (Alderwick et al., 2006).  
In how far these PRPP consuming enzymatic steps interfere with the allocation of PRPP as 
precursor for the overproduction of L-histidine can only be speculated. Data are available for 
E. coli and S. enterica (Fig. 5, p.22), where the purine and pyrimidine biosynthesis each 
consume about 30-40% of the total intracellular PRPP amount, L-histidine and L-tryptophan 
biosynthesis consume each 10-15%, and the NAD de novo biosynthesis requires below 1% 
(Jensen et al., 2008). Since microbial arabinogalactan occurs only in species belonging to the 
order Actinomycetales suborder Corynebacterianeae (Alderwick et al., 2006), including 
well-known genera such as Mycobacterium and Corynebacterium, data is lacking to assess the 
amount of PRPP that is required for its synthesis. However, the proportions of pyrimidine and 
purine biosyntheses are far above the proportion of the L-histidine biosynthesis. This mediates 
insights in the amounts of carbon that are directed towards the respective PRPP consuming 
pathways. 
  
 Energy metabolism 
The fundamental chemical requirements of a cell are primary biosynthetic intermediates, 
energy, and reducing power (Atkinson and Fall, 1967). Since C. glutamicum is a 
chemoorganotrophic organism, it relies on the energy potential of redox reactions as energy 
source and on organic compounds as electron donors and carbon sources. Its metabolism 
consists of a part in which energy is generated and of a biosynthetic part where cell components 
are synthesized and transported. The connection of the energy generating part and the 
biosynthetic part is accomplished, among others, by the nucleotides of the adenylate pool.  
Nucleotides are essential components of all living organisms, constituting the building blocks 
for the nucleic acids, RNA and DNA, and serve as cofactors in sugar and lipid metabolism, 
polyamine biosynthesis, and others (Jensen et al., 2008). Nucleotides are either found as ribo- or 
as deoxyribonucleotides and occur as mono-, di-, or triphosphates. In many bacteria, the three 
adenylates ATP, ADP, and AMP are the prevalent nucleotide species and the role of ATP in 
the energy metabolism is established. It is the principal molecule of storing and transferring 
energy and as such required in biosynthetic pathways, for maintaining transmembrane 
gradients, and for such crucial procedures as cell division and movement. The biological 
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potential energy that is stored in ATP (30.5 kJ mol-1) is utilized by all these reactions and the 
enzymatic hydrolysis of ATP generates ADP and Pi (Hara and Kondo, 2015). ADP and Pi are 
regenerated to ATP in bacteria in two ways: either by substrate level phosphorylation or by 
oxidative phosphorylation (Hara and Kondo, 2015; Zhou et al., 2009).  
For human cells, it was shown that about 90% of the intracellular ATP is produced by 
phosphorylation of ADP by ATP synthase (De la Fuente et al., 2014). 
Absolute concentrations of intracellular nucleotides in S. enterica were determined to be 
3000 µM ATP, 250 µM ADP, and 100 µM AMP, whereas other triphosphate nucleotides are 
far below these numbers, with 900 µM GTP, 500 µM CTP, and 900 µM UTP (Bochner and 
Ames, 1982; Jensen et al., 2008). In E. coli, intracellular concentrations of the adenylate species 
have been determined to be 9.6 × 10-3 mol ATP L-1, 5.6 × 10-4 mol ADP L-1, and 2.8 × 10-4 mol 
AMP L-1 (Bennett et al., 2009). A common property of the nucleotides is the N-glycosyl bond 
that links the nucleobase to the pentose phosphate moiety, formed by a 
phosphoribosyltransferase from PRPP and a nitrogenous base (Jensen et al., 2008). The 
ribonucleotides are first produced as nucleoside monophosphates and then further converted to 
the respective di- and triphosphates by nucleoside mono- and diphosphate kinases (Jensen et 
al., 2008).  
The energy charge (EC) was introduced in 1967 by Atkinson and co-workers as a measure of 
the cells energetic state and a fundamental metabolic control parameter (Atkinson and Walton, 
1967). Its formula is defined as (ATP+0.5ADP)/(ATP+ADP+AMP) and uses the intracellular 
concentrations of the adenylates (Atkinson and Walton, 1967). The EC, by definition, varies 
between values of 0 and 1 and is numerically equal to half the average number of the 
anhydride-bound phosphate groups per adenosine moiety (Atkinson and Walton, 1967). 
Typical reported values for EC are between 0.8 – 0.9 in E. coli during exponential growth under 
aerobic conditions, which declines to around 0.5 when cells are starving carbon and in the 
stationary growth phase (Chapman et al., 1971; Franzen and Binkley, 1961). In 
Bacillus megaterium, metabolizing cells were shown to have ECs around 0.8, whereas in 
spores, the resting states of several bacteria, the EC declined to < 0.1 (Setlow and Kornberg, 
1970). These findings can also be transferred to all sorts of cells, among these also eukaryotic 
species like S. cerevisiae, where the EC during exponential growth was reported to be 
0.84 – 0.93 (Betz and Moore, 1967). An overview of ECs of species from all realms of life is 
given in Chapman et al., 1971. Generally spoken, an intact EC in metabolizing cells revolves 
around a value of 0.85 (Chapman et al., 1971).  
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Since ATP and the EC are such important factors for the performance of biotechnological 
producer strains and processes, they have been targeted with different strategies, which were 
reviewed in detail (Hara and Kondo, 2015; Zhou et al., 2009) and comprise metabolic 
engineering strategies, such as manipulating NADH availability, manipulation of the electron 
transfer chain, manipulating the regulation of oxygen supply and the proton gradient, or 
bioprocess strategies, such as enhancing the substrate utilization and the cells resistance against 
environmental stresses. 
 
 Motivation 
Utilization and administration of L-histidine has been proven to be beneficial in several 
financially important sectors, such as the medical (DiNicolantonio et al., 2018; Du et al., 2017) 
and animal feed (Haug et al., 2008; Park et al., 2013) sectors. Due to its versatile applicability, 
increasing amounts of L-histidine can be expected to be required on the worldwide market. 
Despite global players like Ajinomoto Co. and DAESANG Corp. are running microbial 
bioprocesses to produce L-histidine, a glimpse in scientific literature about microbial L-histidine 
production reveals that this field is a relatively small area and has not been fully exploited. Most 
available works, especially the ones applying C. glutamicum as host, focus on mutagenesis 
approaches (see 1.2.4 Production of L-HISTIDINE, p.16) and a holistic, system-wide approach 
with this objective has not yet been tackled. The motivation for this work therefore was the 
construction of L-histidine producing mutants with C. glutamicum as host in a system-wide 
manner and establishing a bioprocess for the microbial production of L-histidine. Available data 
of published L-histidine producer strains based on different bacteria, such as E. coli, 
C. glutamicum, or S. coelicolor show very limited L-histidine yields, which at least partially can 
be attributed to the sophisticated and ATP intense L-histidine biosynthesis. The tightly regulated 
L-histidine biosynthesis is intertwined with several other pathways (see 1.2.5 L-HISTIDINE 
related pathways, p. 21) and efficient tackling of optimized overproduction requires the 
application of novel strategies to reach the demanding underlying economic standards. The 
experiments conducted in this work focused on gaining access to the complex L-histidine 
biosynthesis through the development of recombinant C. glutamicum producer strains. These 
demands were encountered with a combined approach of rational strain engineering (including 
modularized tackling of important metabolic pathways), with a sophisticated comparative 
metabolomics approach, entitled Systems Metabolic Profiling (conducted by André Feith, 
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IBVT, University of Stuttgart), with Flux Balance Analysis (conducted by André Feith, IBVT, 
University of Stuttgart), and with the subsequent development and implementation of 
preliminary bioprocess studies. 
 
 Introduction PART II 
 Evolution approaches 
Nowadays, sophisticated metabolic engineering and synthetic biology approaches combined 
with new omics technologies and computational approaches are powerful tools to identify, 
modulate, and improve producer strains. However, these combined rational approaches 
sometimes are limited or impracticable. This holds especially true for organisms outside of the 
model organisms such as E. coli or S. cerevisiae, where knowledge of the metabolism and its 
regulation mechanisms is scarce. Thus, (directed) evolution approaches can be expedient where 
knowledge-based strain/protein engineering finds its limits.  
The underlying principle of all evolutionary approaches is the acceleration of evolution, i.e. 
increasing mutation rates to generate genetic variety. In the classical way, this was achieved by 
mutagenizing cells with mutagenizing agents or radiation, such as N-methyl-N’-nitro-N-
nitrosoguanidine (NTG) or ultraviolet (UV) light (Burns et al., 1986; Delić et al., 1970; Foster, 
1991) evolution could be accelerated, thus creating genetic diversity in large libraries of mutants 
(Doudney and Young, 1962). The application of mutagenizing agents however is an undirected 
process where large numbers of mutations are introduced at random positions in the genome 
what brings several disadvantages with it, e.g. strain instability. 
The introduction of directed evolution approaches in the early 1990s enabled more focused, 
user-defined evolution procedures, which are established nowadays in protein and metabolic 
engineering (Cobb et al., 2013a; Zhou and Alper, 2018). Generally, directed evolution imitates 
and accelerates the natural evolution process by increasing the mutation rate and screening rate 
of desired variants (Kumar and Singh, 2013; Zhu et al., 2018). These directed evolution 
approaches include sophisticated methods, such as error-prone PCR (Cadwell and Joyce, 1992), 
random insertion/deletion mutagenesis (Murakami et al., 2002), or saturation mutagenesis 
(Myers et al., 1985) and might be combined with the application of structural analogues to 
overcome feedback inhibition (Araki et al., 1974), but are also based on DNA recombination 
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methods, such as DNA shuffling (Stemmer, 1994) or multiplex automated genome engineering 
(Wang et al., 2009). An example of a directed evolution approach is given in Fig. 6 on page 29. 
Like classical random mutagenesis, directed evolution approaches in metabolic engineering aim 
to identify new (non-rational) targets to improve a variety of traits resulting in improved 
producer strains and rely on the creation of large pools of genetic diversity, which require 
efficient screening approaches to identify clones with the desired phenotype (Cobb et al., 
2013b). The decades of development of such methods led to increasingly larger mutant library 
sizes, recent approaches reaching numbers of up to 1010 clones (Zhou and Alper, 2018). 
However, screening (coupled with continuous evolution) of high throughput approaches 
remains a challenge (Zhou and Alper, 2018). 
 
Fig. 6. Schematic overview of typical directed evolution approaches.  
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 Screening approaches 
The field of mutagenesis / directed evolution has come a long way and development of a 
steadily increasing number of evolution methods has increased library sizes from 103 clones up 
to 1010 clones (Zhou and Alper, 2018). Having induced the genomic variation, resulting in large 
libraries, the screening part becomes increasingly challenging, since it often is time- and 
money-consuming without available adequate screening methods (Bassalo et al., 2016; Chou 
and Keasling, 2013). This limitation was partially overcome by high-throughput screening 
techniques, such as in vivo fluorescence-based biosensors, which enable in combination with 
fluorescence-activated cell sorting (FACS) or droplet-based microfluidic sorting a pre-selection 
of the mutagenized strains by translating intracellular product formation into an optical readout, 
thereby narrowing down the entirety of mutagenized cells that needed to be screened (Agresti 
et al., 2010; Dietrich et al., 2010; Eggeling et al., 2015; Lin et al., 2017; Mahr et al., 2015). 
Although such methods allow the ultra-rapid screening of library sizes of up to 109 variants 
(Dietrich et al., 2010), the final identification of relevant mutations out of the mutational pool 
of the cell is still time-consuming since it requires laborious re-engineering for verification. 
This especially holds true in case of random mutagenesis, which yields large numbers of 
mutations per cell.  
 Anaplerotic reactions in C. glutamicum 
A vital part of the central carbon metabolism of C. glutamicum is represented by the circular 
network of the anaplerotic reactions around the PEP-pyruvate-oxaloacetate-malate node (Sauer 
and Eikmanns, 2005). This circular network comprises specific carboxylation and 
decarboxylation reactions thus constituting a link between glycolysis and TCA cycle. This link 
is needed since intermediates of the TCA are constantly withdrawn for biosynthesis and thus 
anaplerotic reactions replenish this gap of TCA intermediates by using C3 units (PEP and 
pyruvate). On the other side, anaplerotic reactions are also the starting point of the 
gluconeogenesis, where C4 (oxaloacetate and malate) units are decarboxylated. Through this 
linkage, anaplerotic reactions have been shown to have great influences on TCA and glycolysis 
derived products in C. glutamicum, such as L-lysine and L-glutamate (Shirai et al., 2007; Yokota 
et al., 2017).  
In C. glutamicum, the anaplerotic reactions comprise at least five reactions (Fig. 7, p.32), two 
of them fixating and incorporating CO2/HCO3-, three of them producing CO2: 
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a) Pyruvate carboxylase (PCx, encoded by pyc), converting pyruvate to oxaloacetate by an 
ATP-dependent carboxylation reaction. The enzyme requires biotin for the reaction 
(Peters-Wendisch et al., 1998). 
b) PEP carboxylase (PEPCx, encoded by ppc), catalysing the irreversible formation of 
oxaloacetate from PEP, fixating CO2 and releasing Pi (Peters-Wendisch et al., 1993). 
c) PEP carboxykinase (PEPCk, encoded by pck), performing the GTP-dependent 
decarboxylation of oxaloacetate to PEP, releasing CO2 (Jetten and Sinskey, 1993; 
Riedel et al., 2001). 
d) Oxaloacetate decarboxylase (ODx, encoded by odx), performing the irreversible 
decarboxylation of oxaloacetate to pyruvate and CO2 (Klaffl and Eikmanns, 2010). 
e) Malic enzyme (MalE, encoded by malE), reversibly decarboxylating malate to pyruvate 
in an NADP+-dependent manner, producing NADPH and CO2 (Gourdon et al., 2000). 
 
Compared with other organisms, the presence of both a PEPCx and a PCx is a special feature 
of C. glutamicum. The situation is different in other bacteria, e.g. in B. subtilis solely a PCx and 
in E. coli solely a PEPCx is present (Sauer and Eikmanns, 2005).  
 
 32 
 
 Glyoxylate shunt in C. glutamicum 
When C. glutamicum is growing on substrates that enter the central carbon metabolism on the 
level of acetyl-CoA, such as acetate, fatty acids, or ethanol, the glyoxylate cycle (glyoxylate 
shunt) fulfils the task of replenishing the TCA cycle, i.e. providing oxaloacetate as acceptor 
molecule for acetyl-CoA to form citrate (Fig. 7, p.32). The glyoxylate cycle consists of five of 
the eight reactions of the TCA cycle and bypasses the two decarboxylating reactions of ICD 
and 2-oxoglutarate dehydrogenase complex, enabling net acquisition of carbon, which is 
impossible by serving the TCA under glycolytic conditions (Bott, 2007; Bott and Eikmanns, 
2013). By this way, the glyoxylate cycle results in the net formation of one molecule of malate 
from two molecules of acetyl-CoA (Gerstmeir et al., 2003). With an active glyoxylate shunt, 
the carbon flux is diverted at the level of isocitrate, where it is either metabolised by the reaction 
Fig. 7. Schematic overview of the anaplerotic reactions around the PEP-pyruvate-oxaloacetate node and 
the L-valine biosynthesis in C. glutamicum. Abbreviations: AHAIR, acetohydroxyacid isomeroreductase; 
AHAS, acetohydroxyacid synthase; CoA, coenzyme A; DHAD, dihydroxyacid dehydratase; G6P, glucose 
6 phosphate; Glyoxyl., glyoxylate; ICD, isocitrate dehydrogenase; ICL, isocitrate lyase; MalE, malic 
enzyme; MS, malate synthase; ODx, oxaloacetate decarboxylase; PCx, pyruvate carboxylase; PEP, 
phosphoenolpyruvate; PEPCk, PEP carboxykinase; PEPCx, PEP carboxylase; PPP, pentose phosphate 
pathway; TA, transaminase B. Taken from Schwentner et al., 2018. 
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of isocitrate lyase (ICL, encoded by aceA) or by isocitrate dehydrogenase (ICD, encoded by 
icd) (Fig. 7, p.32). 
ICD is participating in the TCA cycle and competes for isocitrate as substrate with ICL 
(Wendisch et al., 2000). ICD performs the decarboxylation reaction of isocitrate to 
2-oxoglutarate (α-ketoglutarate), simultaneously generating NADPH and has been reported to 
have a specific enzyme activity of 1 U mg protein-1, independent of the carbon source and the 
growth phase (Eikmanns et al., 1995). The affinity of ICD towards isocitrate was determined 
to be strong (Km = 12 µM) (Eikmanns et al., 1995). 
ICL on the other hand, is the first of the two glyoxylate shunt enzymes, malate synthase (MS, 
encoded by aceB) is the second one. Both enzymes have been characterized in detail in 
C. glutamicum. The ICL catalyses the cleavage of isocitrate to glyoxylate, the key intermediate 
of the glyoxylate shunt, and succinate (Reinscheid et al., 1994a). The specific activities of the 
ICL were determined to be about 0 U mg protein-1 when glucose was the sole carbon source 
and about 2.8 U mg protein-1 when acetate was the sole carbon source, showing a tight 
regulation of the glyoxylate shunt (Reinscheid et al., 1994a; Wendisch et al., 1997). The affinity 
of ICL towards isocitrate is moderate (Km = 0.28 mM) and thus lying far below the one of ICD 
towards isocitrate (Gerstmeir et al., 2003). 
The second glyoxylate shunt enzyme MS performs the irreversible condensation reaction of 
glyoxylate with acetyl-CoA to give malate (Reinscheid et al., 1994b). For MS, similar activity 
patterns were shown as for ICL. With glucose as sole carbon source, specific MS activities were 
about 0 U mg protein-1, when acetate was the sole carbon source, specific MS activities 
increased to about 1.8 U mg protein-1 (Reinscheid et al., 1994b; Wendisch et al., 1997). 
However, when acetate is not available, the glyoxylate shunt is tightly regulated and inactive 
(Wendisch et al., 2000).  
This regulation is mediated by the regulators of acetate metabolism RamA (Cramer et al., 2006) 
and RamB (Gerstmeir et al., 2004), two global transcriptional regulatory proteins that 
participate in expression control of genes involved in acetate and ethanol metabolism, 
glycolysis, gluconeogenesis, and lactate metabolism, amongst others (Auchter et al., 2011). 
With respect to the glyoxylate shunt, RamA has been demonstrated to act as positive regulator 
of the glyoxylate genes aceA and aceB, and of the acetate activating genes ack (encoding acetate 
kinase) and pta (encoding phosphotransacetylase) (Cramer et al., 2006; Shah et al., 2018). An 
overview of the RamA regulon is provided by Shah et al., 2018. RamA has further been 
demonstrated to negatively auto-regulate its own expression through binding to the identified 
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RamA binding motif, located in the promoter region of the ramA gene (Cramer and Eikmanns, 
2007). 
RamB, on the other side, was shown to be present in higher amounts when glucose was the sole 
carbon source, compared to acetate as sole source (Cramer et al., 2007). Both RamA and RamB 
bind to the ramB promoter region and ramB expression is negatively controlled by RamB and 
positively by RamA (carbon source dependent) (Cramer et al., 2007). This leaves the role of a 
RamB dependent repression of aceA and aceB in absence of acetate. 
However, effector molecules of RamA and RamB are still unknown and have yet to be revealed 
(Shah et al., 2018).  
The glyoxylate shunt with its participating genes/enzymes and their regulation machanisms 
represent interesting targets for metabolic engineering approaches, not only for TCA derived 
products and not only in C. glutamicum. Examples thereof are the production of succinate 
(Litsanov et al., 2012; Zhu et al., 2014), L-lysine (Kim et al., 1997), or α-ketoglutarate (Jo et al., 
2012) with C. glutamicum and production of 5-aminolevulinic acid (Noh et al., 2017) or 
glycolate (Liu et al., 2018) with E. coli.  
 L-Valine production 
The application of C. glutamicum for production of the α-amino acid L-valine has been pursued 
for years and several profound reviews on this topic are available, whereof the following 
overview makes use of (Lee et al., 2009; Oldiges et al., 2014; Wang et al., 2018). L-Valine is 
one of the three branched chain amino acids and has been described as an essential amino acid 
for humans (Oldiges et al., 2014). L-Valine is already applied in diverse sectors, such as food, 
feed, pharmaceutical, and cosmetics industries (Oldiges et al., 2014). As traditional methods 
for obtaining L-valine, extraction from natural protein sources or chemical synthesis were used 
(Oldiges et al., 2014).  
The biosynthesis of L-valine, as well as of the two other branched chain amino acids L-leucine 
and L-isoleucine, in C. glutamicum originates from the central carbon metabolism intermediate 
pyruvate (Fig. 7, p.32). The first enzyme in the pathway, acetohydroxyacid synthase (AHAS, 
encoded by ilvBC) catalyses either the decarboxylation of pyruvate and either its condensation 
with another molecule of pyruvate to form acetolactate, the precursor of L-valine and L-leucine, 
or the condensation of pyruvate with 2-ketobutyrate to form acetohydroxybutyrate, the 
precursor of L-isoleucine (Elišáková et al., 2005). Control of the branched chain amino acid 
pathways is mediated by a feedback inhibition of AHAS by all of the three branched chain 
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amino acids and by expression control of the ilvBNC operon via an attenuation mechanism 
(Elišáková et al., 2005). The second step towards L-valine formation is performed by the 
acetohydroacid isomeroreductase (AHAIR, encoded by ilvC), which catalyses the isomerisation 
and reduction of acetolactate to dihydroxyisovalerate (Leyval et al., 2003). Then, dihydroxyacid 
dehydratase (DHAD, encoded by ilvD) dehydrates dihydroxyvalerate to α-ketoisovalerate. In 
the final step of L-valine biosynthesis, transaminase B (TA, encoded by ilvE) reversibly 
transfers an amino group from L-glutamate onto α-ketoisovalerate, yielding L-valine. 
Concerning metabolic engineering in C. glutamicum with the objective to overproduce 
L-valine, several strategies have been conducted. Since L-valine derives from pyruvate, most 
metabolic engineering approaches targeted the PDHC (Fig. 7, p.32), either directly or indirectly 
to improve precursor availability in the form of accumulating pyruvate (Oldiges et al., 2014). 
This was achieved by a complete inactivation or by an attenuation of the PDHC via deletion of 
the aceE gene or reduction of its promoter activity by implementing weaker promoters 
(Blombach et al., 2009, 2008, 2007; Buchholz et al., 2013). Further, by applying anaerobic 
production conditions to reduce the activity of the TCA cycle (Hasegawa et al., 2013; Hasegawa 
et al., 2012) and by inactivation or attenuation of pantothenate biosynthesis to limit CoA 
availability, which is required for acetyl-CoA formation through the PDHC (Bartek et al., 2008; 
Elišáková et al., 2005; Holátko et al., 2009; Radmacher et al., 2002). Additionally, with the 
purpose to withdraw the surplus of pyruvate towards L-valine, commonly the respective 
L-valine biosynthesis genes or mutated variants thereof have been overexpressed (Oldiges et 
al., 2014; Radmacher et al., 2002). 
 
 Motivation 
The rational design of producer strains is a relatively new field in the industrial biotechnology. 
Traditionally, producer strains have been designed and improved in an indirect manner, by 
applying mutagens that induce mutations in the genome of organisms, i.e. bacteria. Nowadays, 
available evolution approaches still apply mutagens to create genomic diversity in mutant 
libraries and by this speed up the natural process of evolution. The created mutants often bear 
hundreds of mutations in their genomes and must then be screened for the one desired mutation, 
mediating the desired phenotype. This includes laborious re-engineering and the screening 
process is often time-consuming and laborious, thus constituting a major bottleneck in the fast 
evolution of mutant strains. Additionally, evolution approaches are often applied when rational 
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strain engineering finds its limit in identifying new targets to improve producer strains. One 
prominent example for this is Adaptive Laboratory Evolution (ALE), which has also been 
applied for improving C. glutamicum strains (Mahr et al., 2015; Pfeifer et al., 2017). 
The second part of this work therefore focused on the development of an evolutionary approach 
that deliberately omits the deployment of mutagens. This approach was entitled Metabolic 
engineering to Guide Evolution (MGE) and allows the evolution of producer strains, enables 
the easy identification of the phenotype generating mutations, and facilitates the identification 
and guided evolution of novel targets to improve producer strains. With the purpose to audit 
the developed method, we evolved a strain impaired in two anaplerotic reactions as an L-valine 
producing strain, subsequently identifying a novel mode for production of this amino acid 
besides the in literature established ones. Fig. 8 on page 36 shows a comparison of MGE with 
selected other available evolutionary approaches.  
Fig. 8. Simplified schematic comparison of the principles of different evolutionary approaches, comprising 
classical mutagenesis (A), classical mutagenesis with a biosensor strain (B), and Metabolic engineering to 
Guide Evolution MGE (C). Numbers of the different steps mean: 1, inducing genomic mutations via 
mutagen; 2, isolating by plating; 3, cultivation; 4, quantification of the desired product; 5, genome 
sequencing; 6, metabolic (re-)engineering, targeted introduction of the identified mutations in a host strain; 
7, biosensor strain enabled cell sorting according to production, e.g. via FACS; 8, small scale cultivation 
and high throughput screening for increased product formation; 9, metabolic engineering to generate 
selection pressure; 10, evolutionary cultivation with growth as indicator for evolved cells. 
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CHAPTER 2: MATERIALS AND METHODS 
 Bacterial strains, plasmids, and oligonucleotides 
Table 2. A complete list of the strains constructed and/or used in this work with their names, relevant 
characteristic(s), and the source. 
Strains Relevant characteristic(s) Source 
Strains   
E. coli   
DH5α F-ϕ80lacZΔM15 Δ(lacZYA-argF)U169 endA1 recA1 hsdR17 (rK- mK+) 
supE44 thi-1 gyrA96 relA1 phoA 
 
(Hanahan, 1983) 
K-12 MG1655 Wildtype strain DSM 18039; F-, λ-, ilvG-, rfb-50, rph-1 German Collection of 
Microorganisms and Cell 
Cultures 
C. glutamicum   
WT Wildtype (WT) strain ATCC 13032 American Type Culture 
Collection 
HIS1 C. glutamicum WT with the feedback inhibition released variant 
HisGG233H-T235Q (corresponding nucleotide exchanges: ggc742cat, 
acg748cag) 
This work 
HIS2 C. glutamicum HIS1 with implementation of Ptuf in front of the operon 
hisD-hisC-hisB-cg2302-cg2301 
This work 
HIS3 C. glutamicum HIS2 with implementation of Ptuf in front of the operon 
hisH-hisA-impA-hisF-hisI-cg2294 
This work 
HIS4 C. glutamicum HIS3 with implementation of Ptuf in front of the operon 
cg0911-hisN 
This work 
HIS5 C. glutamicum HIS1 with implementation of PdapA-A16 in front of the 
operon hisE-hisG, additional exchange of the translational start codon 
from the native GTG to ATG for hisE 
This work 
HIS6 C. glutamicum HIS4 with implementation of PdapA-A16 in front of the 
operon hisE-hisG, additional exchange of the translational start codon 
from the native GTG to ATG for hisE 
This work 
HIS7 C. glutamicum HIS6 with implementation of PsodA in front of gene hisF This work 
HIS8 C. glutamicum HIS7 containing pJC4 purApurB This work 
HIS9 C. glutamicum HIS8 containing pEC-XT99A_gcv_ OP1-Cjk This work 
HIS10 C. glutamicum HIS9 with exchange of the translational start codon of 
gene pgi from ATG to GTG 
This work 
CM1 C. glutamicum HIS6 with exchange of the translational start codon of 
gene pgi from ATG to GTG 
This work 
CM2 C. glutamicum CM1 with the feedback inhibition released variant 
zwfA243T 
This work 
CM2.1 C. glutamicum CM2.1 with the feedback inhibition released variant 
gndS361F 
This work 
CM3 C. glutamicum CM1 with the feedback inhibition released variant 
prsAD122S 
This work 
HISint C. glutamicum CM1 with an additional chromosomal integration of a 
cassette consisting of PdapA-A16 hisE-hisGFB TrrnB 
This work 
PUR1 Strain CM1 with an in-frame deletion of gene purF This work 
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Strains Relevant characteristic(s) Source 
PUR2 Strain CM1 with an exchange of the translational start codon from 
GTG to TTG for gene purF 
This work 
PUR3 C. glutamicum CM1 with the feedback inhibition released variant 
purFK348Q 
This work 
PUR4 C. glutamicum CM1 containing pJC4 purH This work 
HIS7.1 C. glutamicum HIS7 with exchange of the translational start codon of 
gene pgi from ATG to GTG 
This work 
HIS7.2 C. glutamicum HIS7 with exchange of the translational start codon of 
gene gapA from ATG to TTG 
This work 
HIS7.3 C. glutamicum HIS7 with exchange of the translational start codon of 
gene pgm from ATG to TTG 
This work 
HIS9.1 C. glutamicum HIS9 with exchange of the translational start codon of 
gene gapA from ATG to TTG 
This work 
HIS9.2 C. glutamicum HIS9 with exchange of the translational start codon of 
gene pgm from ATG to TTG 
This work 
ΔpurN C. glutamicum with deletion of gene purN This work 
ΔpurN ΔfdhF C. glutamicum ΔpurN with in-frame deletion of gene fdhF This work 
ΔpurU C. glutamicum with in-frame deletion of gene purU This work 
HIS7 ΔpurU C. glutamicum HIS7 with in-frame deletion of gene purU This work 
CM1 Ptuf::rpi C. glutamicum CM1 with Ptuf promoter in front of rpi gene This work 
HIS7 
PgapA:hisEG 
C. glutamicum HIS7 with PgapA in front of hisEG instead of PdapA-A16 This work 
HIS3 Δtkt C. glutamicum HIS3 with truncated version of the tkt gene This work 
HIS4 Δtkt C. glutamicum HIS4 with truncated version of the tkt gene This work 
HIS6 Δtkt C. glutamicum HIS6 with truncated version of the tkt gene This work 
HIS6 ΔtktS C. glutamicum HIS6 with a 4 bp deletion of the spacer of gene tkt This work 
HIS6 ΔtktSRbs C. glutamicum HIS6 with a 8 bp deletion of the spacer plus RBS region 
of gene tkt 
This work 
CM1 Δcg2314 C. glutamicum CM1 with an in-frame deletion of cg2314, encoding a 
potential purine regulator 
This work 
CM1 zwfATG C. glutamicum CM1 with exchange of the translational start codon of 
gene zwf from GTG to ATG 
This work 
CM1 prsAR C. glutamicum CM1 with exchange of the native RBS of gene prsA 
against a modified variant 
This work 
HIS7 (pJC4 
hisD) 
C. glutamicum HIS7 with overexpression plasmid for gene hisD This work 
HIS7 (pJC4 
purApurB hisD) 
C. glutamicum HIS7 with overexpression plasmid for genes purA, 
purB, and hisD 
This work 
CM1 (pJC4 
purA) 
C. glutamicum CM1 with overexoression plasmid for gene purA This work 
CM1 Δpup C. glutamicum CM1 with deletion of gene pup This work 
PUR1 ΔpurD C. glutamicum PUR1 with deletion of gene purD This work 
Δppc C. glutamicum WT with deletion of the ppc gene, encoding 
posphoenolpyruvate carboxylase 
(Blombach et al., 2013) 
Δppc Δpyc C. glutamicum Δppc with additional deletion of the pyc gene, encoding 
pyruvate carboxylase 
(Schwentner et al., 2018) 
Δppc Δpyc Δpck C. glutamicum Δppc Δpyc with deletion of the pck gene, encoding 
phosphoenolpyruvate carboxykinase 
(Schwentner et al., 2018) 
Δppc Δpyc 
ICDA94D 
C. glutamicum Δppc Δpyc with point mutation A94D in isocitrate 
dehydrogenase (ICD) 
This work 
Δppc Δpyc 
ICDG407S 
C. glutamicum Δppc Δpyc with point mutation G407S in isocitrate 
dehydrogenase 
This work 
Δppc Δpyc 
ICDR453C 
C. glutamicum Δppc Δpyc with point mutation R453C in isocitrate 
dehydrogenase 
This work 
Δppc Δpyc 
ICDA94D 
(pJC4ilvBNCE) 
C. glutamicum Δppc Δpyc ICDA94D with overexpression plasmid for 
L-valine genes ilvBNCE 
This work 
Δppc Δpyc 
ICDG407S 
(pJC4ilvBNCE) 
C. glutamicum Δppc Δpyc ICDG407S with overexpression plasmid for 
L-valine genes ilvBNCE 
This work 
Δppc Δpyc 
ICDR453C 
(pJC4ilvBNCE) 
C. glutamicum Δppc Δpyc ICDR453C with overexpression plasmid for 
L-valine genes ilvBNCE 
This work 
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Table 3. A complete list of the plasmids constructed and/or used in this work with their names, relevant 
characteristic(s), and the source. 
Plasmid Relevant characteristic(s) Source 
pK19mobsacB Kmr, mobilizable (oriT), oriV (Schäfer et al., 1994) 
pK18mobsacB 
PaceE dapA-
A16 
pK18mobsacB carrying the dapA-A16 promoter (Buchholz et al., 2013) 
pK19mobsacB 
hisGFB 
pK19mobsacB carrying the nucleotide sequence of a modified hisG 
variant that encodes HisG with amino acid exchanges G233H and 
T235Q (corresponding nucleotide exchanges: ggc742cat, acg748cag) 
This work 
pK19mobsacB 
hisD-Ptuf 
pK19mobsacB carrying promoter exchange to Ptuf for operon hisD-
hisC-hisB-cg2302-cg2301 
This work 
pK19mobsacB 
hisH-Ptuf 
pK19mobsacB carrying promoter exchange to Ptuf for operon hisH-
hisA-impA-hisF-hisI- 
This work 
pK19mobsacB 
hisN-Ptuf 
pK19mobsacB carrying promoter exchange to Ptuf for operon cg0911-
hisN 
This work 
pK19mobsacB 
hisEATG-PdapA-
A16 
pK19mobsacB carrying promoter exchange to PdapA-A16 for operon 
hisE-hisG and an exchange of the translational start codon from the 
native GTG to ATG for hisE 
This work 
pK18mobsacB 
zwfA243T 
pK19mobsacB carrying the nucleotide sequence of a modified zwf 
variant that encodes a G6P DH with amino acid exchange A243T 
Evonik Industries AG 
pK19mobsacB 
gndS361F 
pK19mobsacB carrying the nucleotide sequence of a modified gnd 
variant that encodes a 6PG DH with amino acid exchange G361F 
Evonik Industries AG 
pK19mobsacB 
prsAD122S 
pK19mobsacB carrying the nucleotide sequence of a modified prsA 
variant that encodes a PRPP synthetase with amino acid exchange 
D122S 
This work 
pK19mobsacB 
int::PdapAhisEATG
hisGFB 
pK19mobsacB carrying the nucleotide sequence of a cassette 
consisting of PdapA-A16 hisEATG-hisGFB TrrnB for chromosomal 
integration between genes cg0901 and cg0902 
This work 
pK19mobsacB 
ΔpurF 
pK19mobsacB carrying an in-frame deletion of gene purF This work 
pK19mobsacB 
purFTTG 
pK19mobsacB carrying the nucleotide sequence for the exchange of 
the translational start codon of gene purF from GTG to TTG 
This work 
pK19mobsacB 
purFK348Q 
pK19mobsacB carrying the nucleotide sequence of a modified purF 
variant that encodes a amidophosphoribosyltransferase with amino 
acid exchange K348Q 
This work 
pK19mobsacB 
Δtkt 
pK19mobsacB carrying a in-frame deletion of the gene encoding 
transketolase 
This work 
pK19mobsacB 
ΔtktS 
pK19mobsacB carrying a 4 bp deletion of the spacer region of the gene 
encoding transketolase 
This work 
pK19mobsacB 
ΔtktSRbs 
pK19mobsacB carrying an 8 bp deletion of the spacer and RBS regions 
of the gene encoding transketolase 
This work 
pK19mobsacB 
zwfATG 
pK19mobsacB carrying the nucleotide sequence for the exchange of 
the translational start codon of gene zwf from GTG to ATG 
This work 
pK19mobsacB 
prsAR 
pK19mobsacB carrying the nucleotide sequence of a modified RBS of 
gene prsA 
This work 
pK19mobsacB 
prsAD136A 
pK19mobsacB carrying the nucleotide sequence of a modified prsA 
variant that encodes a PRPP synthetase with amino acid exchange 
D136A 
This work 
pK19mobsacB 
prsAR87C 
pK19mobsacB carrying the nucleotide sequence of a modified prsA 
variant that encodes a PRPP synthetase with amino acid exchange 
R87C 
This work 
pK19mobsacB 
Ptuf:rpi 
pK19mobsacB carrying promoter exchange to Ptuf for gene rpi This work 
pK19mobsacB 
Δpup 
pK19mobsacB carrying an in-frame deletion of gene pup encoding a 
prokaryotic ubiquitin-like system 
(Küberl et al., 2014) 
pK19mobsacB 
PgapA:hisEATGhis
GFB 
pK19mobsacB carrying promoter exchange to PgapA for the modified 
operon hisE-hisG 
This work 
pK19mobsacB 
Δcg1305 
pK19mobsacB carrying an in-frame deletion of gene cg1305 encoding 
a potential L-histidine transporter 
This work 
pK19mobsacB 
ΔaroP 
pK19mobsacB carrying an in-frame deletion of gene aroP encoding a 
potential L-histidine transporter 
This work 
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Plasmid Relevant characteristic(s) Source 
pK19mobsacB 
Δcg2314 
pK19mobsacB carrying an in-frame deletion of gene cg2314 encoding 
a potential purine regulator 
This work 
pK19mobsacB 
Δapt 
pK19mobsacB carrying an in-frame deletion of gene apt encoding a 
adenine pjosphoribosyltransferase 
This work 
pK19mobsacB 
aptTTG 
pK19mobsacB carrying the nucleotide sequence for the exchange of 
the translational start codon of gene apt from GTG to TTG 
This work 
pK19mobsacB 
gapATTG 
pK19mobsacB carrying the nucleotide sequence for the exchange of 
the translational start codon of gene gapA from ATG to TTG 
This work 
pK19mobsacB 
pgmTTG 
pK19mobsacB carrying the nucleotide sequence for the exchange of 
the translational start codon of gene pgm from ATG to TTG 
This work 
pK19mobsacB 
ΔpurN 
pK19mobsacB carrying an in-frame deletion of gene purN This work 
pK19mobsacB 
ΔfdhF 
pK19mobsacB carrying an in-frame deletion of gene fdhF This work 
pK19mobsacB 
ΔpurU 
pK19mobsacB carrying an in-frame deletion of gene purU This work 
pK19mobsacB 
ΔpurD 
pK19mobsacB carrying an in-frame deletion of gene purD This work 
pK19mobsacB 
Δppc 
pK19mobsacB carrying a truncated version of the ppc gene (Buchholz et al., 2013) 
pK19mobsacB 
Δpyc 
pK19mobsacB carrying a truncated version of the pyc gene (Peters-Wendisch et al., 1998) 
pK19mobsacB 
Δpck 
pK19mobsacB carrying a truncated version of the pck gene (Riedel et al., 2001) 
pK19mobsacB 
ICDA94D 
pK19mobsacB carrying the nucleotide sequence for ICD amino acid 
exchange A94D 
This work 
pK19mobsacB 
ICDG407S 
pK19mobsacB carrying the nucleotide sequence for ICD amino acid 
exchange G407S 
This work 
pK19mobsacB 
ICDR453C 
pK19mobsacB carrying the nucleotide sequence for ICD amino acid 
exchange R453C 
This work 
pJC4 Kmr (Cordes et al., 1992) 
pJC4 purA pJC4 overexpressing gene purA under control of Ptuf and TrrnB This work 
pJC4 purApurB pJC4 overexpressing genes purA and purB under control of Ptuf and 
TrrnB 
This work 
pJC4 hisD pJC4 overexpressing gene hisD under control of PsodA and TlldD This work 
pJC4 purApurB 
hisD 
pJC4 overexpressing genes purA and purB under control of Ptuf and 
TrrnB and hisD under control of PsodA and TlldD 
This work 
pJC4 purH pJC4 overexpressing gene purH under control of PsodA and TrrnB This work 
pJC4 sthA pJC4 overexpressing gene sthA from E. coli K-12 MG1655 under 
control of Ptuf 
This work 
pJC4ilvBNCE Kmr, plasmid carrying the ilvBNCE genes from C. glutamicum 
encoding the L-valine biosynthetic enzymes acetohydroxyacid 
synthase, isomeroreductase, and transaminase B 
(Radmacher et al., 2002) 
pEC-
XT99A_gcv_ 
OP1-Cjk 
IPTG-inducible overexpression plasmid for genes gcvP, gcvT, gcvH, 
lipA, and lipB from C. jeikeium, Tetr 
Evonik Industries AG 
pEKEx3 aspA pEKEx3 overexpressing gene aspA, Specr Volker Wendisch 
pEKEx3 aspB pEKEx3 overexpressing gene aspB, Specr Volker Wendisch 
Abbreviations: Kmr, kanamycin resistance gene; Specr, spectinomycin resistance gene; Tetr, tetracycline resistance gene. 
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Table 4. A complete list of the oligonucleotides used in this work including their short names, working names, 
sequences (5’ to 3’), and their purpose/characteristic(s) sorted by short name in alphabetical order. The necessary 
homologous region for isothermal assembly and classical DNA ligation has been considered. Restriction sites are 
underlined and refer to the given restriction enzymes. Respective nucleotide exchanges are indicated in bold. 
Short Name Working name Sequence 5’ to 3’ Purpose, characteristic(s) 
A94D1 icd_A94D_for
  
5’-CCGGAATTCGAACAGATCACAGAATCCAA
C -3’ 
Primer #1 for flank1 for amino acid 
exchange A94D in ICD, EcoRI site 
underlined 
A94D2 icd_A94D_2 5’- GTCCTGCAGTTCCTTAATATCAGCCTTGAG
CTGTGGAAC -3’ 
Primer #2 for flank1 for amino acid 
exchange A94D in ICD, nucleotide 
leading to amino acid exchange bold  
A94D3 icd_A94D_3 5’- GTTCCACAGCTCAAGGCTGATATTAAGGA
ACTGCAGGAC -3‘ 
Primer #1 for flank2 for amino acid 
exchange A94D in ICD, nucleotide 
leading to amino acid exchange bold 
A94D4 icd_A94D_rev 5’- CGCGGATCCGATTGGGTCGGAGACCTTCA
TC -3‘ 
Primer #2 for flank2 for amino acid 
exchange A94D in ICD, BamHI site 
underlined 
A94Dseq1 A94D_seq_1 5’- GTAGAACACTGTATTCTAG -3’ Sequencing primer to verify 
nucleotide exchange leading to A94D 
in icd by sequencing 
A94Dseq2 A94D_seq_2 5’- GAACTTCATCAGCAGCGTC-3’ Sequencing primer to verify 
nucleotide exchange leading to A94D 
in icd by sequencing 
A94Dseq3 A94D_seq_3 5’- CTCGCTGGACGCATCCTC -3’ Sequencing primer to verify 
nucleotide exchange leading to A94D 
in icd by sequencing 
ABseq1  5’- GCGATTGAAGACCGTC -3’ Sequencing primer for pJC4 purA 
purB 
ABseq2  5’- GCAATCGGCACCACCGGC -3’ Sequencing primer for pJC4 purA 
purB 
ABseq3  5’- GCCTGCATGGGACGAAG -3’ Sequencing primer for pJC4 purA 
purB 
ABseq4  5’- GTCACCGAACTGCTCAAC -3’ Sequencing primer for pJC4 purA 
purB 
ABseq5  5’- GATGGAAGCAGGATCGCG -3’ Sequencing primer for pJC4 purA 
purB 
aroP1 aroP_del1 5’- AGGTCGACTCTAGAGGATCCCCGGGAGAG
TTCACAGGTTTAAGC -3’ 
Primer #1 for flank1 for deletion of 
aroP 
aroP2 aroP_del2 5’- TATCGGCCTAGTATCAACCGTAAACCCAC 
-3’ 
Primer #2 for flank1 for deletion of 
aroP 
aroP3 aroP_del3 5’- CGGTTGATACTAGGCCGATAGAAATTATT
CTGGACGTCATG -3’ 
Primer #1 for flank2 for deletion of 
aroP 
aroP4 aroP_del4 5’- TTGTAAAACGACGGCCAGTGAATTCTGAG
CGGATCCGCGTCCG -3’ 
Primer #2 for flank2 for deletion of 
aroP 
cg0901_for cg0901_for 5’- CTTGCATGCCTGCAGGTCGACTTCTAGACC
GTTCGGCTGACTCCTTC -3’ 
Primer #1 for amplification of flank1 
for integrating hisEG cassette, XbaI 
site underlined 
cg0901_rev cg0901_rev 5’- GTGATAACTGCAGAACCAATGCATCATCA
AAAAATCCGCCGTTCCTTG -3’ 
Primer #2 for amplification of flank1 
for integrating hisEG cassette 
cg0902_for cg0902_for 5’- GTCGGTGAACGCTCTCCTACTAAGTGAGT
TTGGATGCGGAAG -3’ 
Primer #1 for amplification of flank2 
for integrating hisEG cassette 
cg0902_rev cg0902_rev 5’- GTGAATTCGAGCTCGGTACCCGGCCCGGG
CTCACTAGTACGCGGATAAATG -3’ 
Primer #2 for amplification of flank2 
for integrating hisEG cassette, XmaI 
site underlined 
cg1305-1 1305_del1 5’- CTATGACCATGATTACGCCAAGCTTCAGA
AGTATCCGCAACCC -3’ 
Primer #1 for flank1 for deletion of 
cg1305 
cg1305-2 1305_del2 5’- CGAGTCTAGACGAGATGCTGACCTCGTTT
C -3’ 
Primer #2 for flank1 for deletion of 
cg1305 
cg1305-3 1305_del3 5’- CAGCATCTCGTCTAGACTCGCACGAAAAA
GGC -3’ 
Primer #1 for flank2 for deletion of 
cg1305 
cg1305-4 1305_del4 5’- TTGTAAAACGACGGCCAGTGAATTCAGTG
GCGCCGTTGTAGCG -3’ 
Primer #2 for flank2 for deletion of 
cg1305 
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Short Name Working name Sequence 5’ to 3’ Purpose, characteristic(s) 
cg2314-1 cg2314_del1 5’- CTTGCATGCCTGCAGGTCGACtctagaGTGTT
GGTACGGATGGAGTCG -3’ 
Primer #1 for flank1 for deletion of 
cg2314 
cg2314-1 cg2314_del2 5’- GTGTGCACCTTCGGTATTTTCGACCTCATC
TACCTCTTTTTCTTAATCTCTTACATC -3’ 
Primer #2 for flank1 for deletion of 
cg2314 
cg2314-1 cg2314_del3 5’- GATGTAAGAGATTAAGAAAAAGAGGTAG
ATGAGGTCGAAAATACCGAAGGTGCACAC -3’ 
Primer #1 for flank2 for deletion of 
cg2314 
cg2314-1 cg2314_del4 5’- CTTGCGGCAGCGTGAAGCTAGCGTGGGTG
TGGTGACAGCTGCACTC -3’ 
Primer #2 for flank2 for deletion of 
cg2314 
cg2314-5 cg2314_seq1 5’- GCGTCCAGCACCGATGAG -3’ Verification of cg2314 deletion 
dapA1  5’- AACTGCAGAACCAATGCATTGGTTCTGCA
GTTATCACACCC -3’ 
Primer #1 for amplification of PdapA-
A16, NsiI site underlined  
dapA2  5’- GGGAATTCCATATGAGGCTCCTTTTAAATC
GAGCGGCTCCGGTCTTAGCTGTTAAACC -3’ 
Primer #2 for amplification of PdapA-
A16, NdeI site underlined 
fdhF1 fdhF_del1 5’- GCTAGCTAGGACCCAGACGTTGTCTGCAT
CG -3’ 
Primer #1 for flank1 for deletion of 
fdhF, NheI site underlined 
fdhF2 fdhF_del2 5’- CGGGCGCGGAAAATTCCCTGGTGTTTTTA
GGTCACAGTCTAGACCCGGCAATTGAAC -3’ 
Primer #2 for flank1 for deletion of 
fdhF 
fdhF3 fdhF_del3 5’- GTTCAATTGCCGGGTCTAGACTGTGACCT
AAAAACACCAGGGAATTTTCCGCGCCCG -3’ 
Primer #1 for flank2 for deletion of 
fdhF 
fdhF4 fdhF_del4 5’- CGCGGATCCCCGAATTTCTAGAGGCTCCT
C -3’ 
Primer #2 for flank2 for deletion of 
fdhF, BamHI site underlined 
fdhFdel1 fdhF_fw 5’- GTGCGATTCGGTACTTTGCAG -3’ Verification of fdhF deletion 
fdhFdel2 fdhF_rev 5’- CTCGTTTCTGATGATGGCTGC -3’ Verification of fdhF deletion 
G407S2 icd_G407S_2 5’- CTTCAGCCTTCTGAGCCATCAGACTAACG
TTAGGGACGGTACCCATGGTG -3’ 
Inner primer #1 for amino acid 
exchange G407S in ICD, nucleotide 
leading to amino acid exchange bold  
G407S3  icd_G407S_3
  
5’- CACCATGGGTACCGTCCCTAACGTTAGTCT
GATGGCTCAGAAGGCTGAAG -3‘ 
  
Inner primer #2 for amino acid 
exchange G407S in ICD, nucleotide 
leading to amino acid exchange bold 
gapA_seq1 gapA_fw 5’- GATCCTCAAATGACCAAG -3’ Sequencing primer for gapATTG 
gapA_seq2 gapA_seq2 5’- GCAGCGTTGATGGACTC -3’ Sequencing primer for gapATTG 
gapA_seq3 gapA_rev 5’- CAGATCGTAGTGCGAACG -3’ Sequencing primer for gapATTG 
gapA1 gapA_1 5’- CAGGAAACAGCTATGACCATGATTACGCC
AAGCTTGAAGCCTAAAAACGACCGAG -3’ 
Primer #1 for amplification of flank1 
for integrating gapATTG 
gapA2 gapA_TTG_2 5’- AACACGAATGGTCAAGTTGTGTCTCCTCT
AAAGATTGTAG -3’ 
Primer #2 for amplification of flank1 
for integrating gapATTG, nucleotide 
exchange bold 
gapA3 gapA_TTG_3 5’- TAGAGGAGACACAACTTGACCATTCGTGT
TGGTATTAACG -3’ 
Primer #1 for amplification of flank2 
for integrating gapATTG, nucleotide 
exchange bold 
gapA4 gapA_4 5’- CGGCCAGTGAATTCGAGCTCGGTACCCGG
GGATCCCATTGGTGCGAGGCAGTTGG -3’ 
Primer #2 for amplification of flank2 
for integrating gapATTG 
gcv_Cjk_Mlu
I_XbaI 
 5’- 
CAGTCTAGAACGCGTGGAACCGACCATAGGG
TCTTG-3’ 
Primer #2 for amplification of gene 
cluster gcvPTH from C. jeikeium 
genome 
gcv_Cjk_start
_EcoRV 
 5’- 
ATCGATATCCGAGAGGAGACACAACATGTCT
TCTGCAGCTACTCGC-3’ 
Primer #1 for amplification of gene 
cluster gcvPTH from C. jeikeium 
genome 
gnd_seq gnd_check 5’- GTATTGCTACCACCGGCATCG -3’ Sequencing primer for introduction of 
nucleotide exchange in gene gnd 
leading to amino acid exchange 
S361F  
gnd1 gnd_fw 5’- GGATGCTGAAACCGGCAAGC -3’ Primer #1 for introduction of 
nucleotide exchange in gene gnd 
leading to amino acid exchange 
S361F  
gnd2 gnd_rev 5’- CCGAAGAAGTCGCGCTGTCC -3’ Primer #2 for introduction of 
nucleotide exchange in gene gnd 
leading to amino acid exchange 
S361F  
hisD1  5’- CCCAAGCTTCGGTGTCGCTGAAGTTAAGT
TCTG -3’ 
Outer primer #1 for exchange of 
native promoter with Ptuf in operon 
 43 
 
Short Name Working name Sequence 5’ to 3’ Purpose, characteristic(s) 
hisD-hisC-hisB-cg2302-cg2301, 
HindIII site underlined 
hisD2  5’- CGCAGGTCAGTGACATTCAACATATGTAT
TATGCATCTCGACCACCCCAGATTTACCTG -3’ 
Inner primer #1 for exchange of 
native promoter with Ptuf in operon 
hisD-hisC-hisB-cg2302-cg2301, NdeI 
and NsiI sites underlined 
hisD3  5’- CAGGTAAATCTGGGGTGGTCGAGATGCAT
AATACATATGTTGAATGTCACTGACCTGCG -
3’ 
Inner primer #2 for exchange of 
native promoter with Ptuf in operon 
hisD-hisC-hisB-cg2302-cg2301, NdeI 
and NsiI sites underlined 
hisD4  5’- CGCGGATCCCTCATCAACACCCAAGATGG
AAC -3’ 
Outer primer #2 for exchange of 
native promoter with Ptuf in operon 
hisD-hisC-hisB-cg2302-cg2301, 
BamHI site underlined  
hisD5 hisD_fw 5’- CCTACGAAAGGATTTTTTACCCATGTTGAA
TGTCACTGACCTGCGAG -3’ 
Amplifying hisD for pJC4 purApurB 
hisD and pJC4 hisD 
hisD6 hisD_rev 5’- CTTCTCTCATCCGCCAAAACAGTTAGGCCT
CGTCGGTGGTGGGGAGG -3’ 
Amplifying hisD for pJC4 purApurB 
hisD and pJC4 hisD 
hisE1  5’- CCCAAGCTTCTGACAGAGTTGAAGGCCCT
CGAG -3’ 
Outer primer #1 for exchange of 
native promoter with PdapA-A16 and 
change of the translational start codon 
from GTG to ATG in operon hisE-
hisG, HindIII site underlined 
hisE2  5’- CGTACAGCGAGTCAAATGTCTTCATATGT
ATTATGCATCTCGGAGGATATTAGTCGAATA
ATTTC -3’ 
Inner primer #1 for exchange of 
native promoter with PdapA-A16 and 
change of the translational start codon 
from GTG to ATG in operon hisE-
hisG, NdeI and NsiI sites underlined, 
base exchange bold 
hisE3  5’- GAAATTATTCGACTAATATCCTCCGAGAT
GCATAATACATATGAAGACATTTGACTCGCT
GTACG -3’ 
Inner primer #2 for exchange of 
native promoter with PdapA-A16 and 
change of the translational start codon 
from GTG to ATG in operon hisE-
hisG, NdeI and NsiI sites underlined, 
base exchange bold 
hisE4  5’- CGCGGATCCGCAACGTAGATGGCGATATC
TTTAGG -3’ 
Outer primer #1 for exchange of 
native promoter with PdapA-A16 and 
change of the translational start codon 
from GTG to ATG in operon hisE-
hisG, BamHI site underlined 
hisEG1 hisEG_1 5’- CGCAAGCTTGCGCTACCGGGCTGGCATGT
TCG -3’ 
Primer #1 for flank1 for exchanging 
PdapA-A16 promoter against PgapA in 
modified hisEG operon, HindIII site 
underlined 
hisEG2 hisEG_2b 5’- CAAAGATTTCGCAGCAGATGCAAAATCGG
AGGATATTAGTCGAATAATTTC -3’ 
Primer #2 for flank1 for exchanging 
PdapA-A16 promoter against PgapA in 
modified hisEG operon 
hisEG3 hisEG_5b 5’- GCATTTCCTACAATCTTTAGAGGAGACAC
AACATGAAGACATTTGACTCGCTGTACG -3’ 
Primer #1 for flank2 for exchanging 
PdapA-A16 promoter against PgapA in 
modified hisEG operon 
hisEG4 hisEG_6 5’- CGCGGATCCCTTCGTGGACATCAGCCTGG 
-3’ 
Primer #2 for flank2 for exchanging 
PdapA-A16 promoter against PgapA in 
modified hisEG operon, BamHI site 
underlined 
hisEGseq1 hisEG_seq1 5’- CCTGCAGTACAGCGATATTG -3’ Sequencing primer for PgapA in front 
of modified hisEG operon 
hisEGseq2 hisEG_seq2 5’- CCTGCAGTACAGCGATATTG -3’ Sequencing primer for PgapA in front 
of modified hisEG operon 
hisEGseq3 hisEG_seq3 5’- CCTGCAGTACAGCGATATTG -3’ Sequencing primer for PgapA in front 
of modified hisEG operon 
hisF1  5’- CGCAAGCTTCTCCATGCCCATGCTGGGTA
AACGC -3’ 
Primer #1 for integration of stop 
codon and PsodA in front of hisF, 
HindIII site underlined 
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Short Name Working name Sequence 5’ to 3’ Purpose, characteristic(s) 
hisF2  5’- GTCACAAGCCCGGAATAATTGGCAGTTAT
TTACTTGTACTCCTCATTTAACG -3’ 
Primer #2 for integration of stop 
codon and PsodA in front of hisF, stop 
codon bold 
hisF3  5’- GAAACCTACGAAAGGATTTTTTACCCATG
GGCGTGGCAATTCGAGTTATTC -3’ 
Primer #5 for integration of stop 
codon and PsodA in front of hisF 
hisF4  5’- CGCGGATCCCGCCGCGCTTTGCCCACTCG
ATTGC -3’ 
Primer #6 for integration of stop 
codon and PsodA in front of hisF, 
BamHI site underlined  
hisFseq  5’- CTGACACCGAAGGCCATC -3’  
hisG1  5’- CGCGGATCCCAGCTCGATTTGGGTATCAC
CG -3’ 
Outer primer #1 for introduction of 
hisGG233H-T235Q, BamHI site 
underlined 
hisG2  5’- CCAGTTGTCGCGTGCCAGTGGGGATACCT
GTGGATGGGATAAGCCTGGGGTTACTGC -3’ 
Inner primer #1 for introduction of 
hisGG233H-T235Q, affected triplets 
underlined 
hisG3  5’- GCAGTAACCCCAGGCTTATCCCATCCACA
GGTATCCCCACTGGCACGCGACAACTGG -3’ 
Inner primer #2 for introduction of 
hisGG233H-T235Q, affected triplets 
underlined 
hisG4  5’- CGCGGATCCGTTGATGGTGGTTCGTGAGA
TTTGG -3’ 
Outer primer #2 for introduction of 
hisGG233H-T235Q, BamHI site 
underlined 
hisGseq  5’- GGTATCCATCAAGCTTGG -3’ Sequencing primer for hisGG233H-T235Q  
hisH1  5’- CCCAAGCTTCGGAGTGAAATGAGGTCCTT
GGTC -3’ 
Outer primer #1 for exchange of 
native promoter with Ptuf in operon 
hisH-hisA-impA-hisF-hisI-cg2294, 
HindIII site underlined 
hisH2  5’- GAGAAGGGCGACAGTTTTGGTCATATGTA
TTATGCATCTCCCTTCCTGAGAATGACGGCTA
GTCG -3’ 
Inner primer #1 for exchange of 
native promoter with Ptuf in operon 
hisH-hisA-impA-hisF-hisI-cg2294, 
NdeI and NsiI sites underlined 
hisH3  5’- 
CGACTAGCCGTCATTCTCAGGAAGGGAGATG
CATAATACATATGACCAAAACTGTCGCCCTTC
TC -3’ 
Inner primer #1 for exchange of 
native promoter with Ptuf in operon 
hisH-hisA-impA-hisF-hisI-cg2294, 
NdeI and NsiI sites underlined 
hisH4  5’- CGCGGATCCGCACGAAGTAGAAACGCTCA
TCAGG -3’ 
Inner primer #2 for exchange of 
native promoter with Ptuf in operon 
hisH-hisA-impA-hisF-hisI-cg2294, 
BamHI site underlined 
hisN1  5’- CCCAAGCTTCGCATGAGCATTTCAGCCCA
GTCC -3’ 
Outer primer #1 for exchange of 
native promoter with Ptuf in operon 
cg0911-hisN, HindIII site underlined 
hisN2  5’- GCTCTGGATTAGTCATGCCTTCCATATGTA
TTATGCATCTCGGTGGCGTTCTAAGAATCACA
ATCG -3’ 
Inner primer #1 for exchange of 
native promoter with Ptuf in operon 
cg0911-hisN, NdeI and NsiI sites 
underlined 
hisN3  5’- CGATTGTGATTCTTAGAACGCCACCGAGA
TGCATAATACATATGGAAGGCATGACTAATC
CAGAGC -3’ 
Inner primer #2 for exchange of 
native promoter with Ptuf in operon 
cg0911-hisN, NdeI and NsiI sites 
underlined 
hisN4  5’- 
CGCGGATCCCACCGAACCACGTATAACCCAT
GG -3’ 
Outer primer #2 for exchange of 
native promoter with Ptuf in operon 
cg0911-hisN, BamHI site underlined 
int_seq1 int_seq_1 5’- CTGGCATGCGCCACTCCG -3’ Sequencing primer for genomic 
integration of hisEG cassette 
int_seq2 int_seq_2 5’- CGGAGAGGTCTGGATTGC -3’ Sequencing primer for genomic 
integration of hisEG cassette 
int_seq3 int_seq_3 5’- GTAGAGGTATCCATCAAGC -3’ Sequencing primer for genomic 
integration of hisEG cassette 
int_seq4 int_seq_4 5’- CGTAGCGCCGATGGTAGTG -3’ Sequencing primer for genomic 
integration of hisEG cassette 
int1 PdapAhisEG_fo
r 
5’- CAAGGAACGGCGGATTTTTTGATGATGCA
TTGGTTCTGCAGTTATCAC -3’ 
Primer #1 for amplification of 
modified hisEG operon  
int2 PdapAhisEG_re
v 
5’- CTTCTCTCATCCGCCAAAACAGCTAGATG
CGGGCGATGCGG -3’ 
Primer #2 for amplification of 
modified hisEG operon 
 45 
 
Short Name Working name Sequence 5’ to 3’ Purpose, characteristic(s) 
K348Qseq1 K348Q_seq 5’- CGAAGCCCGACTTGAAATCG -3’ Sequencing primer for purFK348Q 
K348Qseq2 K348Q_seq2 5’- CTCCCAAGTTTTCGACGAAC -3’ Sequencing primer for purFK348Q 
lipB-
Cjk_start-
EcoRV 
 5’- GCGGATATCATGGGATTCCAGCAAGGC-3’ Primer #1 for amplification of gene 
cluster lipAB from C. jeikeium 
genome 
lipA-
Cjk_stop-
XbaI 
 5’- GCGTCTAGATCCTTCGCCATGGATTCAAC-
3’ 
Primer #2 for amplification of gene 
cluster lipAB from C. jeikeium 
genome 
lldD1 TlldD_hisD 5’- CCTCCCCACCACCGACGAGGCCTAAAAGT
TTCTCTCCTTAGCTATTAAAAG -3’ 
Amplifying TlldD for pJC4 purApurB 
hisD and pJC4 hisD 
lldD2 TlldD_rev 5’- CTTCACGAGGCAGACCTCAGCgctagcGATG
TCCCAAATTGAAAGTGCTG -3’ 
Amplifying TlldD for pJC4 purApurB 
hisD and pJC4 hisD 
pckdel1 pckdel1 5’- GTTGATGGATCCCAGGCTGAGTG-3’ Verification of pck deletion 
pckdel2 pckdel2 5’- GAACTGGCTGTGAACCTCTGCAG-3’ Verification of pck deletion 
PgapA1 hisEG_3b 5’- GAAATTATTCGACTAATATCCTCCGATTTT
GCATCTGCTGCGAAATCTTTG -3’ 
Primer #1 for amplification of PgapA 
PgapA2 hisEG_4b 5’- CGTACAGCGAGTCAAATGTCTTCATGTTGT
GTCTCCTCTAAAGATTGTAGGAAATGC -3’ 
Primer #2 for amplification of PgapA 
pgi1  5’- CCCAAGCTTCAGCGTTGCGTGACGCACTC
ATTG -3’ 
Outer primer #1 for introduction of 
pgiGTG, HindIII site underlined 
pgi2  5’- CCAAACCTGGGTGGTCGAAATGTCCGCCA
CGAAAACTCCTTTATTGTCG -3’ 
Inner primer #1 for introduction of 
pgiGTG, nucleotide exchange bold 
pgi3  5’- CGACAATAAAGGAGTTTTCGTGGCGGACA
TTTCGACCACCCAGGTTTGG -3’ 
Inner primer #2 for introduction of 
pgiGTG, nucleotide exchange bold 
pgi4  5’- CGCGGATCCCCAATGTTGACGATCTTCTTG
ATCG -3’ 
Outer primer #2 for introduction of 
pgiGTG, BamHI site underlined 
pgiseq  5’- CAAGCGTTGGGTTAAGGAGGA -3’ Sequencing primer for pgiGTG 
pgm_seq1 pgm_seq1 5’- CAGCCCACAGCGGTGAAG -3’ Sequencing primer for pgmTTG 
pgm_seq2 pgm_seq2 5’- AGCCACAACGTCAGCGC -3’ Sequencing primer for pgmTTG 
pgm_seq3 pgm_seq3 5’- CCAAGGATGATGCCATCG -3’ Sequencing primer for pgmTTG 
pgm1  pgm_1 5’- CAGGAAACAGCTATGACCATGATTACGCC
AAGCTTGCTCCACCGCAGAAAGCCTC -3’ 
Primer #1 for amplification of flank1 
for integrating pgmTTG 
pgm2 pgm_TTG_2 5’- GCGTTCATGTGCCAAGTTTGCTCCTTAAAA
CACCAATACTTTCTC -3’ 
Primer #2 for amplification of flank1 
for integrating pgmTTG, nucleotide 
exchange bold 
pgm3 pgm_TTG_3 5’- TTTTAAGGAGCAAACTTGGCACATGAACG
CGCCGG -3’ 
Primer #1 for amplification of flank2 
for integrating pgmTTG, nucleotide 
exchange bold 
pgm4 pgm_4 5’- CGGCCAGTGAATTCGAGCTCGGTACCCGG
GGATCCCATCACGAGGAGGGTTGTGGGATG -
3’ 
Primer #2 for amplification of flank2 
for integrating pgmTTG 
pJC4hisD1 pJC4_hisD1 5’- GCATCTTCCAGGAAATCTCCG -3’ Sequencing primer for pJC4 
purApurB hisD and pJC4 hisD 
pJC4hisD2 pJC4_hisD-seq 5’- TGTGCTTCCCATAGTGCAG -3’ Sequencing primer for pJC4 
purApurB hisD and pJC4 hisD 
pJC4hisD3 pJC4_hisD2 5’- CTCTCATCAACCGTGGCTC -3’ Sequencing primer for pJC4 
purApurB hisD and pJC4 hisD 
pK19-fw pK19-fw 5’- TAATGCAGCTGGCACGAC -3’ Sequencing primer for pK19mobsacB 
inserts 
pK19-rev pK19-rev 5’- GTAGCTGACATTCATCCG -3’ Sequencing primer for pK19mobsacB 
inserts 
prsA_seq1 prsA_seq_1 5’- GAACCGCTGCAGCACAAG -3’ Sequencing primer for prsA mutations 
prsA_seq2 prsA_seq_2 5’- GGTCGTGCGCACCCAGAACTG -3’ Sequencing primer for prsA mutations 
prsA_seq3 prsA_seq_3 5’- CACTTCTCTGCAACCTTC -3’ Sequencing primer for prsA mutations 
prsA1 prsA_for 5’- CGCAAGCTTGTCTTCGTGAACTACGACG -
3’ 
Outer primer #1 for introduction of 
prsA mutations, HindIII site 
underlined 
prsA2.1 prsA_R87C_1 5’- CGCGGTGATGCGCTTTGCGGAACCACACT
TCAAAGCGTCGATCATCAGC -3’ 
Inner primer #1 for introduction of 
prsAR87C, affected triplet underlined 
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prsA2.2 prsA_D122S_1 5’- CGGTCCGCGCCAGCGGTGAGCATGAGGGA
GGCGATGAGGCGAGCAGAAATTGGC -3’ 
Inner primer #1 for introduction of 
prsAD122S, affected triplet underlined 
prsA2.3 prsA_D136A_1 5’- CTGGATCTGATCGGTGTGCAATGCCACGG
ACACGATACGGTCCGCGC -3’ 
Inner primer #1 for introduction of 
prsAD136A, affected triplet underlined 
prsA3.1 prsA_R87C_2 5’- GCTGATGATCGACGCTTTGAAGTGTGGTT
CCGCAAAGCGCATCACCGCG -3’ 
Inner primer #2 for introduction of 
prsAR87C, affected triplet underlined 
prsA3.2 prsA_D122S_2 5’- GCCAATTTCTGCTCGCCTCATCGCCTCCCT
CATGCTCACCGCTGGCGCGGACCG -3’ 
Inner primer #2 for introduction of 
prsAD122S, affected triplet underlined 
prsA3.3 prsA_D136A_2 5’- GCGCGGACCGTATCGTGTCCGTGGCATTG
CACACCGATCAGATCCAG -3’ 
Inner primer #2 for introduction of 
prsAD136A, affected triplet underlined 
prsA4 prsA_rev 5’- GAATTCCGGCTGGGTCAGAGAACACAC -3’ Outer primer #2 for introduction of 
prsA mutations, EcoRI site underlined 
prsArbs1 prsA_1_RBS_ex 5’- CGCAAGCTTGCACCCACGGTTTCGACTCC -
3’ 
Primer #1 for flank1 for modifying 
the native RBS of prsA 
prsArbs2 prsA_2_RBS_ex 5’- GTTTCCAGTGAGCAGTCATGGTATGTCCTC
CTGCTTAGCCTTCCTGGTTGTGGACG -3’ 
Primer #2 for flank1 for modifying 
the native RBS of prsA 
prsArbs3 prsA_3_RBS_ex 5’- CGTCCACAACCAGGAAGGCTAAGCAGGA
GGACATACCATGACTGCTCACTGGAAAC -3’ 
Primer #1 for flank2 for modifying 
the native RBS of prsA 
prsArbs4 prsA_4_RBS_ex 5’- CGCGGATCCCGCAGATGTTGTCCAGGTTG 
-3’ 
Primer #2 for flank2 for modifying 
the native RBS of prsA 
pup1 dpupcheckfw 5’- TAGTGGTGGCACTTGATACG -3’ Verification primer for deletion of 
pup 
pup2 dpupcheckrev 5’- CCTGCAGTACAGCGATATTG -3’ Verification primer for deletion of 
pup 
purA1 purA_fw 5’- CGAAGTCCAGGAGGACATACAATGGCTGC
AATCGTTATTGTCGGCGCTCAATG -3’ 
Primer #1 for amplification of purA 
(cg3063) 
purA2  5’- GATCTTCTTTTTATCAGCCACTGTATGTCC
TCCTGGACTTCCTAGTTGTCAGCTAGTACG -3’ 
Primer #2 for amplification of purA 
(cg3063) 
purArev purA_rev 5’- GAAAATCTTCTCTCATCCGCCAAAACAGC
TAGTTGTCAGCTAGTACGTCATGCAG -3’ 
Cloning purA into pJC4 
purAseq pJC4_rev2 5’- GCTACGCGATTGGGTTC -3’ Cloning purA into pJC4 
purAseq2 purA_seq1 5’- GCAATCGGCACCACCGGC -3’ Cloning purA into pJC4 
purB1  5’- CGTACTAGCTGACAACTAGGAAGTCCAGG
AGGACATACAGTGGCTGATAAAAAGAAGATC 
-3’ 
Primer #1 for amplification of purB 
(cg2876) 
purB2  5’- CTTCTCTCATCCGCCAAAACAGTTAAAGA
ATCTCACCTGGTCGGTAGTC -3’ 
Primer #2 for amplification of purB 
(cg2876) 
purD1 purD_for 5’- GCGAAGCTTGCCATGGCGTTGCGGAAATC
GTAATCG -3’ 
Primer #1 for flank1 for in-frame 
deletion of purD, HindIII site 
underlined 
purD2 purD_del1 5’- GACAAGCCTATCTGCGTACTGCTTGGTTGC
ACAGTTTATCCTGCAAAAC -3’ 
Primer #2 for flank1 for in frame 
deletion of purD 
purD3 purD_del2 5’- GTTTTGCAGGATAAACTGTGCAACCAAGC
AGTACGCAGATAGGCTTGTC -3’ 
Primer #1 for flank2 for in frame 
deletion of purD 
purD4 purD_rev 5’- CGCGGATCCCCTCCAACATTTGAGCGGTT
GGCTG -3’ 
Primer #2 for flank2 for in-frame 
deletion of purD, BamHI site 
underlined 
purF1 purF_for_new 5’- ACATGCATGCGGAGCGGTGTGGATTCTCA
CG -3’ 
Primer #1 for flank1 for in-frame 
deletion of purF, PaeI site underlined 
purF10 K348Q_1 5’- GGCCAAGGCATGGTCCAGAACGCCTACGT
TGGC -3’ 
Primer #2 for flank1 for purFK348Q, 
affected triplet bold 
purF11 K348Q_2 5’- GCCAACGTAGGCGTTCTGGACCATGCCTT
GGCC -3’ 
Primer #1 for flank2 for purFK348Q, 
affected triplet bold 
purF12 purFK348Q_rev 5’- CGCGGATCCGACTCCTGCTGCTGCGTATG -
3’ 
Primer #2 for flank2 for purFK348Q, 
BamHI site underlined 
purF2 purF_del_1 5’- CAACCCCTATCGCCTACCGATCAGGTCAA
ATCGTAGTCTGTCGG -3’ 
Primer #2 for flank1 for in-frame 
deletion of purF 
purF3 purF_del_2 5’- CCGACAGACTACGATTTGACCTGATCGGT
AGGCGATAGGGGTTG -3’ 
Primer #1 for flank2 for in-frame 
deletion of purF 
purF4 purF_rev 5’- CGCGGATCCCTGCCTGGACACAGCCTTCT
GC -3’ 
Primer #2 for flank2 for in-frame 
deletion of purF, BamHI site 
underlined 
purF5 purF_for 5’- CCCAAGCTTGGAGCGGTGTGGATTCTCAC
G -3’ 
Primer #1 for flank1 for purFTTG, 
HindIII site underlined 
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purF6 purF_GtoT_2 5’- CGTGTGCTGATCAAGTAATGCCAAAGGTC
AAATCGTAGTCTGTCGG -3’ 
Primer #2 for flank1 for purFTTG, 
nucleotide exchange bold 
purF7 purF_GtoT_3 5’- CCGACAGACTACGATTTGACCTTTGGCAT
TACTTGATCAGCACACG -3’ 
Primer #1 for flank2 for purFTTG, 
nucleotide exchange bold 
purF8 purF_GtoT_4 5’- CGCGGATCCGGATCGACGAGGCCAAGTTC 
-3’ 
Primer #2 for flank2 for purFTTG, 
BamHI site underlined 
purF9 purFK348Q_for 5’- CCCAAGCTTGATTGCGGACTGGTTAC -3’ Primer #1 for flank1 for purFK348Q, 
HindIII site underlined 
purH1 purH_fw 5’- GGAAACCTACGAAAGGATTTTTTACCCAT
GAGCGATGATCGTAAGGCAATTAAAC -3’ 
Amplifying gene purH for pJC4 purH 
purH2 purH_rev 5’- CTTCTCTCATCCGCCAAAACAGTTAGTGA
GCGAAGTGTCGCGC -3’ 
Amplifying gene purH for pJC4 purH 
purHseq1 pJC4_purH1new 5’- GGTCGCCCCATTCCAGC -3’ Sequencing primer for pJC4 purH 
purHseq2 pJC4_purH2 5’- GCTTGCGTTGAGCAGATC -3’ Sequencing primer for pJC4 purH 
purN1 purN_del1 5’- GCTCTAGAGCGTCTTCAGCGTGCATTCCG -
3’ 
Primer #1 for flank1 for deletion of 
purN, XbaI site underlined 
purN2 purN_del2 5’- CCTTACGATCATCGCTCATGAAGGATAAC
AGATATGTTAACGGTCTTCGGC -3’ 
Primer #2 for flank1 for deletion of 
purN 
purN3 purN_del3 5’- GCCGAAGACCGTTAACATATCTGTTATCCT
TCATGAGCGATGATCGTAAGG -3’ 
Primer #1 for flank2 for deletion of 
purN 
purN4 purN_del4 5’- CCGGAATTCCGGTGTGGCGGAAAGCCTC -
3’ 
Primer #2 for flank2 for deletion of 
purN, EcoRI site underlined 
purNdel1 cg0982_fw 5’- GACGAAGAGGAGCATGTTG -3’ Verification of purN deletion 
purNdel2 purN_rev 5’- CAGGAATACCAAGCTCAGC -3’ Verification of purN deletion 
purU1 purU_del1 5’- CCCAAGCTTGCACCAGCAGCAATCAACG -
3’ 
Primer #1 for flank1 for deletion of 
purU, HindIII site underlined 
purU2 purU_del2 5’- GTTTAGGGTCGCGTCGAAAAGCAAAAAGC
CTCGTTGCATTCTACCCTGGAAATTTTCC -3’ 
Primer #2 for flank1 for deletion of 
purU 
purU3 purU_del3 5’- GGAAAATTTCCAGGGTAGAATGCAACGAG
GCTTTTTGCTTTTCGACGCGACCCTAAAC -3’ 
Primer #1 for flank2 for deletion of 
purU 
purU4 purU_del4 5’- CGTCTAGACTGTGGCAGATCGGAATCTAC
CTCTTCG -3’ 
Primer #2 for flank2 for deletion of 
purU, XbaI site underlined 
purUdel1 deoC_fw 5’- GAATCCTGCGACGGTGG -3’ Verification of purU deletion 
purUdel2 cg0456_rev 5’- CTACAACGACGCACTCATC -3’ Verification of purU deletion 
R453C2 icd_R453C_2 5’- GGGCATCCTTGACCTGGCATGCACACCAG
ATGTCATTTGCCTCAACGTCG -3‘ 
Primer#2 for flank1 for amino acid 
exchange R453C in ICD, nucleotide 
leading to amino acid exchange bold 
R453C3 icd_R453C_3 5’- CGACGTTGAGGCAAATGACATCTGGTGTG
CATGCCAGGTCAAGGATGCCC -3‘ 
Primer#1 for flank2 for amino acid 
exchange R453C in ICD, nucleotide 
leading to amino acid exchange bold 
RG1 icd_R453C-
G407S_for 
5’- CCGGAATTCCGTTGTGCGCGCTTACTTCG -
3’ 
Primer #1 for flank1 for amino acid 
exchange R453C and G407S in ICD, 
EcoRI site underlined 
RG2 icd_R453C-
G407S_rev 
5’- CTAGCTAGCCCTGAACCTGCTGGACGTG -3
’ 
Primer#2 for flank2 for amino acid 
exchanges R453C and G407S in ICD, 
NheI site underlined 
RGseq1 R453C-
G407S_seq_1 
5’- GAGTCCCTGGACAACGGC -3’ Sequencing primer to verify 
nucleotide exchange leading to 
G407S and R453C in icd  
RGseq2 R453C-
G407S_seq_2 
5’- GAGAGCTGGGTTGCCTC -3’ Sequencing primer to verify 
nucleotide exchange leading to 
G407S and R453C in icd  
RGseq3 R453C-
G407S_seq_3 
5’- CATCACCAACCTGCATG -3’ Sequencing primer to verify 
nucleotide exchange leading to 
G407S and R453C in icd  
rpi1 rpi_1_ptuf 5’- CGCAAGCTTGCAATCGCTATACCTACGCT
G -3’ 
Primer #1 for flank1 for exchanging 
native promoter against Ptuf in rpi, 
HindIII site underlined 
rpi2 rpi_2_ptuf 5’- CAAACTACCAGCGTTCACAAATCGCAAAA
TAGC -3’ 
Primer #2 for flank1 for exchanging 
native promoter against Ptuf in rpi 
rpi3 rpi_3_ptuf 5’- CAGGAGGACATACCATGCGCGTATACCTT
GGAGCAG -3’ 
Primer #1 for flank2 for exchanging 
native promoter against Ptuf in rpi 
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rpi4 rpi_4_ptuf 5’- CGCGAATTCGGAAAAGAACTTAACCGCCC 
-3’ 
Primer #2 for flank2 for exchanging 
native promoter against Ptuf in rpi, 
EcoRI site underlined 
rrnB1  5’- GACTACCGACCAGGTGAGATTCTTTAACT
GTTTTGGCGGATGAGAGAAG -3’ 
Primer #1 for amplification of 
terminator region of rrnB (E. coli) 
rrnB2 Trrnb_rev2 5’- CTGCAGATATCCATCACACTGGCGGCCGC
AGGAGAGCGTTCACCGACAAACAAC -3’ 
Primer #2 for amplification of 
terminator region of rrnB (E. coli), 
NotI site underlined 
rrnb3 Trrnb_purH 5’- GCGCGACACTTCGCTCACTAACTGTTTTGG
CGGATGAGAGAAG -3’ 
Amplifying TrrnB for pJC4 purH 
rrnb4 Trrnb_rev 5’- ATTTGCGGCCGCAGGAGAGCGTTCACCGA
C -3’ 
Amplifying TrrnB for pJC4 purH 
seq_int hisE4 5’- CGCGGATCCGCAACGTAGATGGCGATATC
TTTAGG -3’ 
Sequencing primer for genomic 
integration of hisEG cassette 
sodA1  5’- CGTTAAATGAGGAGTACAAGTAAATAACT
GCCAATTATTCCGGGCTTGTGAC -3’ 
Primer #3 for integration of stop 
codon and PsodA in front of hisF, stop 
codon bold 
sodA2  5’- GAATAACTCGAATTGCCACGCCCATGGGT
AAAAAATCCTTTCGTAGGTTTC -3’ 
Primer #4 for integration of stop 
codon and PsodA in front of hisF 
sodA3 PsodA_D 5’- CATCAGTGCCAACATAGTAAGCCAgtatacCT
ACTTAGCTGCCAATTATTCCG -3’ 
Amplifying PsodA for pJC  
sodA4 PsodA_hisD 5’- CTCGCAGGTCAGTGACATTCAACATGGGT
AAAAAATCCTTTCGTAGG -3’ 
Amplifying PsodA for pJC4 purApurB 
hisD and pJC4 hisD 
sodA5 PsodA_fw 5’- GCTCTAGACTACTTAGCTGCCAATTATTC -
3’ 
Amplifying PsodA for pJC4 purH 
sodA6 PsodA_purH 5’- GTTTAATTGCCTTACGATCATCGCTCATGG
GTAAAAAATCCTTTCGTAGGTTTCC -3’ 
Amplifying PsodA for pJC4 purH 
tkt 9 tkt 9 5’- CGCGGATCCCAATGACGTAGATGTGGTGG
TC -3’ 
Primer #1 for flank2 for deleting 
spacer plus RBS region of tkt gene 
tkt1 tkt 1 5’- CCCAAGCTTCTGCCTGTGACGATTCCGTTA
AAG -3’ 
Primer #1 for modifications of tkt 
gene, HindIII site underlined 
tkt2 tkt 2 5’- GGAACCAATCCATGCAAGGAACGCAGGTG
ACAGCGTCAAGGTGGTC -3’ 
Primer #2 for flank1 for truncating 
the tkt gene 
tkt3 tkt 3 5’- GACCACCTTGACGCTGTCACCTGCGTTCCT
TGCATGGATTGGTTCC -3’ 
Primer #1 for flank2 for truncating 
the tkt gene 
tkt4 tkt 4 5’- CGCGGATCCGCTGAGATTGCCGGAAGTAA
TGCG -3’ 
Primer #2 for flank2 for truncating 
the tkt gene, BamHI site underlined 
tkt5 tkt 5 5’- GACAGCGTCAAGGTGGTCAATCCTGGGTT
AAACCGGGACC -3’ 
Primer #2 for flank1 for deleting 
spacer region of tkt gene 
tkt6 tkt 6 5’- GGTCCCGGTTTAACCCAGGATTGACCACC
TTGACGCTGTC -3’ 
Primer #1 for flank2 for deleting 
spacer region of tkt gene 
tkt7 tkt 7 5’- CGCGGATCCCAATGACGTAGATGTGGTGG
TC -3’ 
Primer #2 for flank2 for deleting 
spacer and spacer plus RBS of tkt 
gene, BamHI site underlined 
tkt8 tkt 8 5’- CGCGGATCCCAATGACGTAGATGTGGTGG
TC -3’ 
Primer #2 for flank1 for deleting 
spacer plus RBS region of tkt gene 
tktseq tktfowseq 5’- CGCGGATCCCAATGACGTAGATGTGGTGG
TC -3’ 
Sequencing primer for deletions tktS 
and tktSRbs 
Trrnb_for Trrnb_for 5’- CCGCATCGCCCGCATCTAGCTGTTTTGGCG
GATGAGAGAAG -3’ 
Primer #1 for amplification of TrrnB 
terminator from E. coli  
Trrnb_rev Trrnb_rev 5’- CTTCCGCATCCAAACTCACTTAGTAGGAG
AGCGTTCACCGAC -3’ 
Primer #2 for amplification of TrrnB 
terminator from E. coli 
ttrnbpurA Trrnb_purA 5’- CATGACGTACTAGCTGACAACTAGCTGTT
TTGGCGGATGAGAGAAGATTTTCAG -3’ 
Cloning purA into pJC4 
tuf1  5’- AACTGCAGAACCAATGCATCCACAGGGTA
GCTGGTAGTTTG -3’ 
Primer #1 for amplification of Ptuf, 
NsiI site underlined 
tuf2  5’- GGGAATTCCATATGATGTCCTCCTGGACTT
CGTGGTGGC -3’ 
Primer #2 for amplification of Ptuf, 
NdeI site underlined 
tuf2_1 Ptuf_fw2 5’- GATCAGCGACGCCGCAGGGTCTAGACCAC
AGGGTAGCTGGTAGTTTGAAAATC -3’ 
Primer #1 for amplification of Ptuf, 
XbaI site underlined 
tuf2_2 Ptuf_purA 5’- CATTGAGCGCCGACAATAACGATTGCAGC
CATTGTATGTCCTCCTGGACTTCG -3’ 
Primer #2 for amplification of Ptuf 
tuf3 ptuf_fw 5’- GATTTGTGAACGCTGGTAGTTTGAAAATC
AAC -3’ 
Amplification of Ptuf 
tuf4 ptuf_rev 5’- GGTATACGCGCATGGTATGTCCTCCTGGA
CTTC -3’ 
Amplification of Ptuf 
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zwf1 zwf_fw 5’- GATCTCTAAGGTACAAGCCG -3’ Primer #1 for introduction of 
nucleotide exchange in gene zwf 
leading to amino acid exchange 
A243T 
zwf2 zwf_rev 5’- CAACTGGGCTTACTACCTGTCC -3’ Primer #2 for introduction of 
nucleotide exchange in gene zwf 
leading to amino acid exchange 
A243T 
zwf3 zwf_1_GtoA 5’- CGCAAGCTTGGCGTTGCCAACGCTCAGCG
CGC -3’ 
Primer #1 for flank1 for zwfATG, 
HindIII site underlined 
zwf4 zwf_2_GtoA 5’- CCAGCTGGAGGGGGTCGTGTTTGTGCTCA
TGATGGTAGTGTCACGATCC -3’ 
Primer #2 for flank1 for zwfATG, 
nucleotide exchange bold 
zwf5 zwf_3_GtoA 5’- GGATCGTGACACTACCATCATGAGCACAA
ACACGACCCCCTCCAGCTGG -3’ 
Primer #1 for flank2 for zwfATG, 
nucleotide exchange bold 
zwf6 zwf_4_GtoA 5’- CGCGGATCCCTTCGGTGGATTCAGCCATG
CC -3’ 
Primer #2 for flank2 for zwfATG, 
BamHI site underlined 
zwfseq zwf_check 5’- GCGGAGGTTTTATCCAATGG -3’ Sequencing primer for introduction of 
nucleotide exchange in gene zwf 
leading to amino acid exchange 
A243T 
 
 
 Chemicals, Devices, Enzymes, Kits, Materials 
 Devices and Materials 
Table 5. Complete list of devices and materials used in this work with their respective product names, distributing 
companies, purposes, and catalogue numbers.  
Product Company Purpose Cat. No. 
8-Well Comb Bio-Rad Laboratories, Inc. Agarose gel electrophoresis 1704463 
15-Well Comb Bio-Rad Laboratories, Inc. Agarose gel electrophoresis 1704465 
15-Well Comb Bio-Rad Laboratories, Inc. Agarose gel electrophoresis 1704446 
20-Well Comb Bio-Rad Laboratories, Inc. Agarose gel electrophoresis 1704447 
8-Well Comb Bio-Rad Laboratories, Inc. Agarose gel electrophoresis 1704463 
Agilent 1200 Series Agilent Technologies HPLC apparatus (amino acid 
quantification) 
 
Agilent 1200 Series Agilent Technologies HPLC apparatus (adenylate 
quantification) 
 
Agilent 1260 Series Agilent Technologies HPLC apparatus of the LC 
MS/MS Q-TOF system 
 
Agilent 6540 Accurate-Mass LC 
MS/MS Q-Tof 
Agilent Technologies LC MS/MS Q-TOF system  
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Product Company Purpose Cat. No. 
BCP-CO2 BlueSens gas sensor GmbH Exhaust gas CO2 analysis  
BCP-O2 BlueSens gas sensor GmbH Exhaust gas O2 analysis BCP-02 
Benchtop shaker AK 85 Infors AG Rotary incubation of bacterial 
cultures 
 
Centrifuge 5417 R, rotor: FA45-
30-11 
Eppendorf AG Tabletop centrifuge for 1.5 mL 
and 2 mL tubes 
 
Centrifuge 5427 R, rotor: 
FA-45-30-11 or F-35-6-30 
Eppendorf AG Tabletop centrifuge for 
centrifugation of 1.5 mL, 2 mL, 
15 mL and 50 mL reaction tubes 
and DURAN® Centrifuge Tubes 
Round Bottom  
5409000012 
Centrifuge 5804 R,  
rotor: A-4-44 or FA 45-30-11 
Eppendorf AG Tabletop centrifuge for 
centrifugation of 1.5 mL, 2 mL, 
15 mL and 50 mL reaction tubes 
5805000327 
Centrifuge MiniSpin®, rotor 
F-45-12-11 
Eppendorf AG Tabletop centrifuge for 
centrifugation of 0.2 µL, 1.5 mL 
and 2 mL reaction tubes 
5452000018 
Centrifuge Tubes Round Bottom 
(DURAN® 50× 12 ml) 
Carl-Roth GmbH CDW determination C102.1 
Electroporation cuvettes, 2 mm, 
40-400 µL 
VWR International GmbH For plasmid transformation 732-1136 
Eporator® Eppendorf AG Electroporation apparatus 4309000019 
Heating circulator JULABO USA, Inc. Water bath for several 
applications 
9352506 
High performance ZORBAX 
guard fittings kit 
Agilent Technologies HPLC hardware kit (amino acid 
quantification) 
820999-901 
InLab® Easy Mettler-Toledo GmbH pH electrode 51343010 
InPro® 3100/255 Pt100 Mettler-Toledo GmbH pH probe bioreactors 52000661 
InPro® 6800 Series O2 Sensors Mettler-Toledo GmbH DO probe 52200968 
LAS-3000 Imager (Filter: 
605DF40) 
Fujifilm Medical Systems Imaging of agarose gels at UV 
light (320 nm) 
 
Mass flow controller, 0-2 l min-1 Analyt-MTC GmbH Mass flow controller for gassing 
during 30 L cultivations 
GFC 171S 
Mass flow controller, 
0-500 ml min-1 
Analyt-MTC GmbH Mass flow controller for gassing 
during triple glass reactor 
cultivations 
GFC 171S 
MF-Millipore Membrane Filter, 
mixed cellulose esters, 
hydrophile, 0,025 µm pore size, 
13 mm 
Merck Chemicals GmbH Diafiltration VSWP01300 
Microplate, 96 well, PS Greiner Bio-One GmbH Plates for protein analytics 655101 
Nano Drop ND-1000 
Spectrophotometer 
PEQLAB Biotechnologie GmbH Quantification of purified DNA  
pH meter FiveEasy™ FE20 Mettler-Toledo GmbH pH meter reaction cup scale  
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Product Company Purpose Cat. No. 
PARAFILM® M Carl-Roth GmbH Plastic shred for pyrolysis water 
purification 
H666.1 
Power Pack P25 Biometra GmbH Power source for agarose gel 
electrophoresis 
846-040-800 
Precellys®24 Bertin Instruments Mechanical cell lysis  
Rotilabo®-syringe filters, CME, 
0.22 µm 
Carl-Roth GmbH Filters for stock solution 
sterilization 
KH54.1 
Rotilabo®-syringe filters, CME, 
0.45 µm 
Carl-Roth GmbH Filters for stock solution 
sterilization 
KH55.1 
S20 - SevenEasy™ pH Mettler-Toledo GmbH pH meter interface 51302803 
Semi-micro cuvette, acrylic Sarstedt AG & Co Photometric analysis of enzyme 
activities 
67.740 
Semi-micro cuvette, PS Sarstedt AG & Co  Photometric analysis of OD600 67.742 
SeQuant® ZIC-pHILIC Merck KGaA LC MS/MS Q-TOF  
SeQuant® ZIC-pHILIC guard 
column 
Merck KGaA LC MS/MS Q-TOF  
Sub-Cell® GT Cell, Mini-Sub® 
Cell GT Cell, Wide Mini-Sub 
Cell GT Cell 
Bio-Rad Laboratories, Inc. Several chambers for agarose gel 
electrophoresis 
 
Supelcosil LC-18-T Agilent Technologies HPLC column (adenylate 
quantification) 
 
Synergy 2 Multi-Mode Reader BioTek Instruments GmbH Protein analytics at 560 nm  
TAdvanced thermocycler Biometra GmbH Thermocycler for standard and 
colony PCR and isothermal 
assembly 
 
Ultrospec 10 Cell Density Meter 
(Amersham Biosciences) 
GE Healthcare Europe GmbH OD600 analysis  
Ultrospec™ 2100 pro 
UV/Visible spectrophotometer 
GE Healthcare Europe GmbH Photometric enzyme activity 
analysis 
 
UV Transilluminator 312 nm INTAS Science Imaging 
Instruments GmbH 
UV screen to cut out bands in 
agarose gels prior to gel elution 
 
UV Küvetten micro BRAND GMBH + CO KG UV cuvettes for MS enzyme 
assay 
 
Waters XBridge BEH Amide 
column 
Waters Corp. LC MS/MS Q-TOF  
Waters XBridge BEH Amide 
VanGuard Cartridge 
Waters Corp. LC MS/MS Q-TOF  
Watson-Marlow Cased Pump 
120U/DV 
Watson-Marlow GmbH Addition of feed, base, acid, 
STRUKTOL in reactor 
cultivations 
 
Zorbax Eclipse Plus C18 Agilent Technologies HPLC column (amino acid 
quantification) 
959990-902 
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Product Company Purpose Cat. No. 
ZORBAX Eclipse Plus C18 Agilent Technologies HPLC guard column (amino acid 
quantification) 
820950-936 
 
 Chemicals 
Table 6. Complete list of the chemicals used in this work with their distributing companies and catalogue numbers. 
Product Company Cat. No. 
Acetic acid ROTIPURAN®, 100% Carl Roth GmbH&Co. KG 3738.2 
Acetonitrile VWR International GmbH 83639 320 
Acetonitrile for LC-MS,  ≥ 99.9% Sigma-Aldrich Co. LLC. 34967 
Acetyl coenzyme A, sodium salt Sigma-Aldrich Co. LLC. A2056-5mg 
Adenine, ≥ 99 % Sigma-Aldrich Co. LLC. 01830 
Adenosine-5’-triphosphate, disodium Carl Roth GmbH&Co. KG HN35.2 
Agar-Agar, Bioscience Carl Roth GmbH&Co. KG 6494.4 
Ammonium acetate for LC-MS, ≥ 99.9% Sigma-Aldrich Co. LLC. 431311 
Ammonium formate for LC-MS,  Agilent Technologies G1946-85021 
Ammonia solution, NH3 + H2O, ≥ 25% Carl Roth GmbH&Co. KG 5460.4 
Ammonium sulphate, (NH4)2SO4, ≥ 99% Carl Roth GmbH&Co. KG 9218.5 
Aspartic acid, L-, ≥ 99% Sigma-Aldrich Co. LLC. 11190 
Bacto™ Brain Heart Infusion Becton, Dickinson and Company 237500 
Biotin, D(+)-, ≥ 98.5% Carl Roth GmbH&Co. KG 3822.1 
Biozym LE Agarose Biozym Scientific GmbH 840004 
Boric acid Merck Chemicals GmbH 1.00165.0500 
Bromophenol blue sodium salt Sigma-Aldrich Co. LLC. B8026 
Buffer solution, pH 4,00 ± 0,02 (20 °C) Carl Roth GmbH&Co. KG A517.1 
Buffer solution, pH 7,00 ± 0,02 (20 °C) Carl Roth GmbH&Co. KG P713.1 
Buffer solution, pH 9,00 ± 0,02 (20 °C) Carl Roth GmbH&Co. KG P714.3 
Calcium chloride, CaCl2, (discontinued; similar product 
#1023791000) 
Merck Chemicals GmbH 2389  
Copper(II) sulfate pentahydrate, CuSO4 · 5 H2O, ≥ 99% Sigma-Aldrich Co. LLC. 61240 
1,4-Dithriothreit, ≥ 99% Carl Roth GmbH&Co. KG 6908.2 
DMSO (dimethyl sulfoxide), 100% Thermo Fisher Scientific Inc. F-515 
Ethanol, denatured,  Carl Roth GmbH&Co. KG T171.2 
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Product Company Cat. No. 
Ethanol ROTIPURAN®, min. 99.8% Carl Roth GmbH&Co. KG 9065.1 
Ethylenediamine tetraacetic acid (EDTA) disodium salt dehydrate, 
≥ 99% 
Carl Roth GmbH&Co. KG X986.2 
Fmoc chloride Sigma-Aldrich Co. LLC. 23186 
Folic acid, 97% Sigma-Aldrich Co. LLC. 47620 
Formic acid, 85% Carl Roth GmbH&Co. KG 5355.2 
Formic acid for LC-MS, 98% Sigma-Aldrich Co. LLC. 94318-50ML-
F 
Fructose, D(-)-, ≥ 99.5% Carl Roth GmbH&Co. KG 4981.2 
GelRed Nucleic Acid Gel Stain, 10,000x in water, 0.5 mL Biotinum 41003 
GeneRuler 1 kb Plus DNA Ladder  Thermo Fisher Scientific Inc. SM1331 
Glass beads, 0.1 mm Carl Roth GmbH&Co. KG HH55.1 
Glass beads, 4 ± 0.3 mm Carl Roth GmbH&Co. KG N029.1 
Glucose, α-D(+)-, monohydrate, ≥ 99.5% Carl Roth GmbH&Co. KG 6780.3 
Glutamic acid, L-, ≥ 99% Sigma-Aldrich Co. LLC. 49450 
Glutamine, L-, ≥ 99% Sigma-Aldrich Co. LLC. 49420 
Glycerol, ≥ 98% Carl Roth GmbH&Co. KG 7530.1 
Glcine, ≥ 99% Sigma-Aldrich Co. LLC. 50049 
Hydrochloric acid, HCl, ≥ 32% Sigma-Aldrich Co. LLC. 84411 
Iron(II) sulfate heptahydrate, FeSO4 · 7 H2O, 99.0-103.4% Sigma-Aldrich Co. LLC. 31236 
Kanamycin sulphate Carl Roth GmbH&Co. KG T832 
Magnesium sulphate heptahydrate, MgSO4 · 7 H2O, ≥ 99% Carl Roth GmbH&Co. KG P027.3 
Manganese(II) sulfate monohydrate, MnSO4 · H2O, ≥ 98% Sigma-Aldrich Co. LLC. 63555 
Mercaptopropionic acid, 3-, ≥ 99% Sigma-Aldrich Co. LLC. 63768 
Methanol VWR International GmbH 20864 320 
Morpholino propane sulphonic acid, 3-N-, MOPS, PUFFERAN®, 
≥ 99.5% 
Carl Roth GmbH&Co. KG 6979.3 
Nickel(II) sulphate hexahydrate, NiSO4 · 6 H2O, ≥ 98% Carl Roth GmbH&Co. KG 7322.1 
Nicotinamide adenine dinucleotide phosphate disodium dihydrate, β-, 
NADP Na2 
GERBU Biotechnik GmbH 1014,1000 
Nicotinamide adenine dinucleotide, β-, NAD GERBU Biotechnik GmbH 1013,0001 
Perchloric acid, 70-72% Sigma-Aldrich Co. LLC. 7601-90-3 
Phosphoric acid, o-, ROTIPURAN® ≥85 % Carl Roth GmbH&Co. KG 6366.2 
Phthaldialdehyde, o- Sigma-Aldrich Co. LLC. 79760 
Ribose, D(-)-, ≥ 98% Sigma-Aldrich Co. LLC. R1757-10G-A 
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Product Company Cat. No. 
Potassium acetate, 99.0-100.5% Merck Chemicals GmbH 1048201000 
Potassium dihydrogen phosphate, KH2PO4, ≥ 98% Carl Roth GmbH&Co. KG P018.5 
Potassium hydrogen phosphate, di-, K2HPO4, anhydrous, ≥ 98% Carl Roth GmbH&Co. KG 6875.3 
Potassium hydroxide, KOH, pellets, ≥ 85% Carl Roth GmbH&Co. KG 6751.2 
Potassium Ds-threo-isocitrate monobasic, 98% Sigma-Aldrich Co. LLC. 58790 
Protocatechuic acid, PCA, 3,4-dihydroxybenzoic acid, ≥ 97% Carl Roth GmbH&Co. KG 8274.1 
Serine, L-, ≥ 99% Sigma-Aldrich Co. LLC. 84960 
Sodium azide, NaN3, ≥ 99.5% Sigma-Aldrich Co. LLC. S2002 
Sodium chloride, NaCl, > 99.8% Carl Roth GmbH&Co. KG 9265.2 
Sodium glyoxylate monohydrate, ≥ 95% Sigma-Aldrich Co. LLC. G4502 
Sodium hydroxide, NaOH, pearls, ≥ 99% Carl Roth GmbH&Co. KG 9356.2 
Sodium sulfite, ≥ 98%, anhydrous Carl Roth GmbH&Co. KG 8637.1 
Sodium tetraborate decahydrate, ≥ 99.5% Sigma-Aldrich Co. LLC. S9640 
Sorbitol, D-, ≥ 98% Carl Roth GmbH&Co. KG 6213.1 
Spectinomycin dihydrochloride pentahydrate, ≥ 98% Sigma-Aldrich Co. LLC. S9007-25G 
Struktol™ J 647, 1015 kg (m3)-1, 500 mPa s, combination of 
polyglycol ethers and aliphatic alcohols, antifoam agent fermentation 
Schill+Seilacher GmbH  
Sucrose, D(+)-, ≥ 99.5% Carl Roth GmbH&Co. KG 4621.2 
Tetrabutylammonium hydrogen sulfate, ≥ 99.5% Sigma-Aldrich Co. LLC. 86868 
Tetracycline hydrochloride,  Carl Roth GmbH&Co. KG 0237.1 
Thiamine hydrochloride, min. 98.5% Carl Roth GmbH&Co. KG T911.2 
TRIS PUFFERAN®, ≥ 99,9% Carl Roth GmbH&Co. KG 4855.2 
Tryptone Becton, Dickinson and Company 211701 
Urea, ≥ 99% Sigma-Aldrich Co. LLC. 51460 
Valine, L-, ≥ 99% Merck Chemicals GmbH 1.08495.0025 
Water HiPerSolv CHROMANORM® VWR International GmbH 83645 320 
Xylene Cyanol FF Sigma-Aldrich Co. LLC. X4126 
Yeast extract Becton, Dickinson and Company 212730 
Zinc sulfate heptahydrate, ZnSO4 · 7 H2O, 99.0-103.0% Sigma-Aldrich Co. LLC. 96501 
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 Kits 
Table 7. Complete list of the kits used in this work with their respective product names, distributing companies, 
purpose, and catalogue numbers. 
Product Company Purpose Cat. No. 
DNeasy Blood & Tissue Kit QIAGEN Chromosomal DNA Isolation 
from E. coli and C. glutamicum 
69504 
E.Z.N.A.® Plasmid Mini Kit I Omega Bio-Tek, Inc. Plasmid isolation from E. coli D6942-02 
NucleoSpin® Gel and PCR 
Clean-up 
Macherey-Nagel GmbH & Co. KG PCR clean-up and purification of 
plasmids or PCR fragments from 
agarose gels 
740.609.250 
Pierce™ BCA Protein Assay 
Kit 
Thermo Fisher Scientific Inc. Protein quantification 23227 
 
 
 Enzymes 
Table 8. Complete list of the enzymes and enzyme related buffers used in this work with their product name, 
distributing company, purposes, and catalogue number. 
Product Company Purpose Cat. No. 
PCR-related 
enzymes/buffers    
Coral Red Buffer Dye 
solution, 10x Genaxxon BioScience GmbH Dye for colony PCR M3309 
dATP Solution (100 mM) Thermo Fisher Scientific Inc. For equimolar dNTP mix for PCR R0141 
dCTP Solution (100 mM) Thermo Fisher Scientific Inc. For equimolar dNTP mix for PCR R0151 
dGTP Solution (100 mM) Thermo Fisher Scientific Inc. For equimolar dNTP mix for PCR R0161 
dTTP Solution (100 mM) Thermo Fisher Scientific Inc. For equimolar dNTP mix for PCR R0171 
PCR Buffer S complete, 10x Genaxxon BioScience GmbH Buffer for colony PCR M3454.0015 
Phusion GC Buffer, 5x Thermo Fisher Scientific Inc. Buffer for standard PCR F519 
Phusion Hot Start II HF DNA 
Polymerase, 100 U Thermo Fisher Scientific Inc. Standard polymerase used in PCR F-549S 
Taq DNA Polymerase S, 250 
Units, 5 U mL-1 Genaxxon BioScience GmbH Polymerase for colony PCR M3001.0250 
Isothermal assembly 
enzymes and buffers    
FastAP Thermosensitive 
Alkaline Phosphatase, 
1 U mL-1 
Thermo Fisher Scientific Inc. For dephosphorylation of DNA EF0654 
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Product Company Purpose Cat. No. 
T4 DNA Ligase Buffer, 10x Thermo Fisher Scientific Inc. Buffer for ligation B69 
T4 DNA Ligase, 
400,000 U mL-1 New England Biolabs For isothermal assembly mix M0202S 
T4 DNA Ligase, LC, 1 U µL-1 Thermo Fisher Scientific Inc. For ligation during plasmid cloning EL0016 
T5 Exonuclease, 
10,000 U mL-1 New England Biolabs For isothermal assembly mix M0363S 
Restriction related enzymes 
and buffers    
BamHI, 10 U mL-1 Thermo Fisher Scientific Inc. Restriction digest ER0051 
BamHI-Lsp1109I Buffer, 10x Thermo Fisher Scientific Inc. Reaction buffer B57 
Buffer B, 10x Thermo Fisher Scientific Inc. Reaction buffer BB5 
Buffer O, 10x Thermo Fisher Scientific Inc. Reaction buffer BO5 
Buffer R, 10x Thermo Fisher Scientific Inc. Reaction buffer BR5 
Buffer Tango, 10x Thermo Fisher Scientific Inc. Reaction buffer BY5 
EcoRI Buffer, 10x Thermo Fisher Scientific Inc. Restriction digest B12 
EcoRI, 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0271 
HindIII, 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0501 
NdeI, 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0581 
NheI, 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0971 
NotI, 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0591 
NsiI (Mph1103I), 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0731 
PaeI (SphI), 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0601 
XbaI, 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0681 
XmaI (Cfr9I), 10 U µL-1 Thermo Fisher Scientific Inc. Restriction digest ER0171 
Enzyme assay related 
enzymes    
Glucose 6-phosphate 
dehydrogenase / hexokinase 
Sigma-Aldrich Co. LLC. Enzymatic determination of glucose 
concentration 10737275001 
L-Lactate dehydrogenase from 
rabbit muscle 
Sigma-Aldrich Co. LLC. Enzymatic determination of ICL 
activity  
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 Media and buffer preparation 
 
For semi-solid cultivations, the medium was prepared and 18 g agar L-1 were added before 
autoclaving. 
Table 9. Composition of the 2×yeast extract tryptone (YT) complex medium (Sambrook et al., 2001). 
Component Amount 
Tryptone 16 g L-1 
Yeast extract 10 g L-1 
NaCl 5 g L-1 
 
Table 10. Composition of the Brain Heart Infusion (BHI) medium (Eggeling and Reyes, 2005). 
Component Amount 
BHI 37 g L-1 
 
Table 11. Composition and preparation of the Brain Heart Infusion Sorbitol medium (Eggeling and Reyes, 2005). 
Component Amount 
BHI 18.5 g 
ad dH2O 250 mL 
Sorbitol 45.6 g 
ad dH2O 250 mL 
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Table 12. Overview of deployed CGXII minimal media in this work. The media in the following table are hybrid 
media using distinct features of the different published CGXII media (Eikmanns et al., 1991; Keilhauer et al., 
1993). The pH of the medium was adjusted with 5 M KOH in shaking flask cultivations. In fermentations, the pH 
was adjusted after autoclaving by using 25% (v v-1) NH4OH. MgSO4, CaCl2, trace elements solution (TES; 
containing FeSO4, MnSO4, CuSO4, ZnSO4, NiCl2; Table 13, p.58), and biotin were prepared as aqueous stock 
solutions and were added sterilely after the remaining components of the medium had been autoclaved. 
 
Final concentrations 
CGXIIN CGXIIE CGXIIR Stock concentration 
(NH4)2SO4 20 g L-1 5 g L-1 20 g L-1  
Urea 5 g L-1 5 g L-1  -  
MOPS 21 g L-1 21 g L-1  -  
K2HPO4 1 g L-1 1 g L-1 1 g L-1  
KH2PO4 1 g L-1 1 g L-1 1 g L-1  
MgSO4 × 7 H2O 0.25 g L-1 0.25 g L-1 0.25 g L-1 1000× (250 g L-1) 
CaCl2 0.01 g L-1 0.01 g L-1 0.01 g L-1 1000× (10 g L-1) 
FeSO4 × 7 H2O 16.4 mg L-1 16.4 mg L-1 16.4 mg L-1  
 
 
TES 1000× 
MnSO4 × H2O 10 mg L-1 10 mg L-1 10 mg L-1 
CuSO4 × 5 H2O* 0.2 mg L-1 0.2 mg L-1 0.2 mg L-1 
ZnSO4 × 7 H2O 1 mg L-1 1 mg L-1 1 mg L-1 
NiCl2 × 6 H2O 0.02 mg L-1 0.02 mg L-1 0.02 mg L-1 
Biotin  0.2 mg L-1 0.2 mg L-1 0.2 mg L-1 1000× (200 mg L-1) 
pH 7.4 7.4 7.4  
L-glutamate / yeast 
extract - 1 mM / 0.5 g L
-1 -  
Purpose 
Cultivations of 
L-histidine producers 
(PART I) 
Cultivations of 
evolution strains 
(PART II) 
Reactor cultivations 
(PART I) 
 
  
 
Table 13. 1000× trace elements solution (TES) for the CGXII media (Table 12, p.58). The pH of the TES was 
adjusted to 1 with 32% (w v-1) HCl. 
Component Amount 
FeSO4 x 7 H2O 16.4 g L-1 
MnSO4 x H2O 10 g L-1 
CuSO4 x 5 H2O* 0.2 g L-1 
ZnSO4 x 7 H2O 1.0 g L-1 
NiCl2 x 6 H2O 0.02 g L-1 
*  original publications use water free CuSO4 (Eikmanns et al., 1991; 
Keilhauer et al., 1993) 
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Table 14. 50× Tris-acetate-EDTA (TAE) buffer. The 1× working solution was used for agarose gel electrophoresis 
and had final concentrations of 40 mM Tris-acetate and 1 mM EDTA. 
Component Amount 
Tris base 242 g 
Acetic acid 57.1 mL 
EDTA (0.5 M, pH 8.0) 100 mL 
ad dH2O 1 L 
 
Table 15. 5× Iso reaction buffer for isothermal assembly (Gibson, 2011; Gibson et al., 2009). 
Component Amount 
PEG-8000 1.5 g 
Tris-HCl (1 M, pH 7.5) 3 mL 
MgCl2 (2 M) 150 µL 
DTT (1 M) 300 µL 
dCTP (100 mM)  60 µL 
dATP (100 mM) 60 µL 
dTTP (100 mM) 60 µL 
dGTP (100 mM) 60 µL 
NAD+ (100 mM) 300 µL 
 
Table 16. Iso enzyme reagent mix for isothermal assembly, stored at -20 °C (Gibson, 2011; Gibson et al., 2009) 
Component Amount 
5× Iso reaction buffer 320 µL 
T5 Exonuclease (10 U mL-1)  0.64 µL 
T4 DNA Ligase (40 U mL-1) 160 µL 
Phusion Hot Start II HF DNA Polymerase (2 U mL-1) 20 µL 
ad dH2O 1200 µL 
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Table 17. 6× DNA loading dye for agarose gel electrophoresis (Sambrook et al., 2001). The 6× DNA loading dye 
was mixed with DNA samples, resulting in 1× working concentration. 
Component Amount 
Xylene cyanol FF 0.075 g 
Bromophenol blue 0.075 g 
Glycerol, ≥ 98 % 15 mL 
ad dH2O 50 mL 
 
Table 18. Wash buffer for the preparation of cell free lysates of C. glutamicum for enzyme measurements. The 
pH value of the buffer was adjusted to 7.4 with 32% (w v-1) HCl. 
Component Amount 
Tris-HCl (pH 7.4) 0.2 M 
 
Table 19. Lysis buffer for mechanical disruption of C. glutamicum to obtain cell free lysates. The pH value of the 
buffer was adjusted to 7.4 with 32% (w v-1) HCl. 
Component Amount 
Tris-HCl (pH 7.4) 0.1 M 
Glycerol 10 % (v v-1) 
 
Table 20. Lysis buffer for chemical disruption of C. glutamicum with perchloric acid to obtain lysates and quench 
the metabolism. The lysis buffer was chilled to -20 °C before use. 
Component Amount 
Perchloric acid (pH 7.4) 35 % (v v-1) 
EDTA 80 µM 
 
Table 21. Assay buffer for measuring glucose concentration. The pH value of the buffer was adjusted to 7.6 with 
32% (w v-1) HCl. 
Component Amount 
Tris (pH 7.6) 400 mM 
MgSO4 4 mM 
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Table 22. 2× Assay buffer for measuring enzyme activities of isocitrate dehydrogenase (Eikmanns et al., 1995). 
The pH value of the buffer was adjusted to 7.6 with 32% (w v-1) HCl. MnSO4 was added after the pH was adjusted, 
then the pH was controlled again and readjusted if needed. 
Component Amount 
Tris (pH 7.6) 100 mM 
MnSO4 × H2O 0.8 mM 
NADP × Na2 0.5 mM 
 
Table 23. 2× Assay buffer for measuring enzyme activities of isocitrate lyase (Reinscheid et al., 1994a). The pH 
value of the buffer was adjusted to 7.3 with 1 M NaOH.  
Component Amount 
MOPS-NaOH (pH 7.3) 50 mM 
Dithriothreit 5 mM 
MgCl2 15 mM 
EDTA dihydrogen, dinatrium 1 mM 
NADH × 2Na 0.2 mM 
 
Table 24. 2× Assay buffer for measuring enzyme activities of malate synthase (Reinscheid et al., 1994b). The pH 
value of the buffer was adjusted to 7.6 with 32% (w v-1) HCl.  
Component Amount 
Tris (pH 7.6) 50 mM 
MgCl2 40 mM 
Na glyoxylate × H2O 2 mM 
 
Table 25. Polar phase buffer (A) for amino acid HPLC measurements. The pH value of the buffer was set to 8.2 
with 32% (v v-1) HCl. 
Component Amount 
Na2HPO4 (pH 8.2) 10 mM 
Na2B4O7 10 mM 
NaN3 0.5 mM 
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Table 26. Nonpolar phase buffer (B) for amino acid HPLC measurements. 
Component Amount 
Methanol 45% (v v-1) 
Acetonitrile 45% (v v-1) 
ddH2O 10% (v v-1) 
 
 
Table 27. Buffer (A) for adenylate HPLC measurements. The pH was adjusted to 6.0 with 1 M KOH. 
Component Amount 
KH2PO4 0.1 M 
K2HPO4, pH 6.0 0.1 M 
Tetrabutylammonium hydrogen sulfate 4 mM 
 
 
Table 28. Buffer (B) for adenylate HPLC measurements. The pH was adjusted to 7.2 with 1 M KOH before 
methanol was added. 
Component Amount 
KH2PO4 0.1 M 
K2HPO4, pH 7.2 0.1 M 
Tetrabutylammonium hydrogen sulfate 4 mM 
Methanol 30% (v v-1) 
 
 
 
 Cultivations 
 General cultivations 
Cultivations in glass reaction tubes (DURAN®, Carl-Roth GmbH, Karlsruhe, Germany) and 
shaking flasks (500 mL narrow-neck Erlenmeyer flask with 4 baffles, DURAN®, Carl-Roth 
GmbH, Karlsruhe, Germany) were performed with a rotary shaker (Benchtop shaker AK85, 
Infors AG, Bottmingen/Basel, Switzerland) at 37 °C for E. coli and at 30 °C for C. glutamicum, 
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respectively. The general complex medium for precultivations of both E. coli and 
C. glutamicum was 2× yeast extract tryptone (YT; Table 9, p.57) medium (Sambrook et al., 
2001). For specified applications, such as preparation of electrocompetent cells or 
transformations of both E. coli or C. glutamicum, brain-heart-infusion (BHI; Table 10, p.57) or 
BHI supplemented with D-sorbitol (BHIS; Table 11, p.57; Sambrook et al., 2001) was used as 
complex medium, respectively. For semi-solid media cultivations (plating), 18 g agar L-1 were 
added to the medium.  
 Storage of bacteria 
The long-time preservation of all strains was achieved by freezing at -70 °C. For this purpose, 
5 mL 2xYT (Table 9, p.57) medium were inoculated with a single colony from semi-solid 
complex medium overnight (o/n). From this culture, 700 µL were monoseptically added to 
300 µL sterile glycerol (≥ 98 %, Carl-Roth GmbH, Karlsruhe, Germany), mixed and stored in 
a screwcap reaction tube at -70 °C. To start an experiment, the glycerol stocks were thawed on 
ice and cells material was streaked on a suitable agar plate to obtain single colonies. 
 Minimal medium 
Shaking flask cultivations of C. glutamicum were performed in CGXII medium (Table 12, 
p.58), which was modified compared to the originally published CGXII medium to match the 
specific requirements of the respective experimental setup (Eikmanns et al., 1991; Keilhauer et 
al., 1993). The used medium for PART I standardly contained 20 g (NH4)2SO4 L-1, 5 g urea L-1, 
21 g 3-morpholinopropanesulfonic acid (MOPS) L-1, 1 g K2HPO4 L-1, 1 g KH2PO4 L-1, 0.25 g 
MgSO4 L-1, 0.01 g CaCl2 L-1. Before autoclaving, the pH value of the medium was adjusted to 
7.4 with 5 M KOH and afterwards 16.4 mg FeSO4 × 7 H2O L-1, 10 mg MnSO4 × H2O L-1, 
0.2 mg CuSO4 × 5 H2O L-1, 1 mg ZnSO4 × 7 H2O L-1, 0.02 mg NiCl2 × 6 H2O L-1, and 0.2 mg 
biotin L-1 were added sterilely and the medium was named CGXIIN. For the evolutionary 
experiments, the amount of (NH4)2SO4 was reduced to 5 g L-1 (for PART II) and additionally 
supplemented with 1 g yeast extract L-1 or 1 mM L-glutamate, as indicated. It was named 
CGXIIE. For the fermentation studies, both components MOPS and urea were omitted from the 
medium, as has been done before for shaking flask experiments (Eikmanns et al., 1991), and 
the medium was named CGXIIR. 
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 Carbon sources and supplements 
Carbon sources and supplements were either prepared as aqueous solutions, which were filtered 
sterilely with a sterile filter (MF-Millipore Membrane Filter, 0.025 µm pore size; Merck 
Chemicals GmbH, Billerica, USA) and added sterilely to the autoclaved medium or weighed 
out with the remaining media components and autoclaved, as indicated. Both defined and 
complex components were used as carbon sources in the conducted experiments. For standard 
cultivations in CGXIIN or CGXIIE (Table 12, p.58), 10 g D-glucose L-1 (for PART I ) or 20 / 40 g 
D-glucose L-1 (in PART II) were added to the medium sterilely from an aqueous stock solution 
(500 g L-1) after autoclaving, as indicated, respectively. In specified experiments, 6 g D-ribose 
L-1 (600 g L-1) or 10 g D-fructose L-1 were used as carbon source from 600/500 g L-1 aqueous 
stock solution. 
Supplements (concentrations of sterile stocks are given in parentheses) included 30 mg 
protocatechuic acid L-1 (PCA, 30 g L-1), 1 / 10 mM L-glutamate (50 mM), 5 mM L-glutamine 
(50 mM), 20 mM glycine (50 mM), 20 mM L-serine (50 mM), 1 mM / 20 mM L-aspartate 
(50 mM), 5 mM adenosine triphosphate (ATP, 50 mM), 2 mM adenine (20 mM), 
50 µM thiamine (50 mM), 0.36 nM folate (3.6 nm), 1 / 10 mM formate (100 mM), 1 g / 5 g 
yeast extract L-1 (added before autoclaving), 5 g BHI L-1 (added before autoclaving). For 
strains with modifications in the tkt gene, additionally 0.5% (w v-1) potassium acetate were 
added sterilely from an aqueous stock solution (500 g L-1) to liquid and semi-solid media. 
Plasmid maintenance was ensured by applying selection pressure via addition of antibiotics 
(concentration of stock solution is given in parentheses). Therefore, 50 µg kanamycin mL-1 
(50 mg mL-1, dissolved in dH2O), 5 µg tetracycline mL-1 (50 mg mL-1, dissolved in 50% (v v-
1) ethanol), or 250 µg spectinomycin mL-1 (250 mg mL-1, dissolved in dH2O) were added 
sterilely to the medium, respectively. In case two antibiotics were necessary, concentrations 
were reduced to 12.5 µg kanamycin mL-1 and 2.5 µg tetracycline mL-1. 
 
 Shaking flask cultivations 
Standard shaking flask cultivations were performed in 500 mL glass flasks with four baffles 
(Erlenmeyer narrow-neck flask, DURAN®, asd). An overview of the seed train is given in Fig. 
9 on page 66. Experiments with C. glutamicum were initiated by streaking out cell material 
from a glycerol stock on 2×YT (Table 9, p.57) agar medium, which was incubated for 2 d at 
 65 
 
30 °C. A single colony was then inoculated in 5 mL 2×YT in a glass tube, which was incubated 
for 8 – 10 h at 30 °C. The complete cell suspension was transferred into 50 mL 2×YT in a 
500 mL baffled shaking flask with four baffles and incubated o/n (about 12 – 14 h) at 30 °C. 
The optical density at 600 nm (OD600) of this culture was measured with an Ultrospec 10 Cell 
Density Meter (GE Healthcare Europe GmbH, Freiburg, Germany), a defined amount of culture 
suspension was pelleted (4,500 × g, 10 min, room temperature [RT]) with a centrifuge 5804 R 
(rotor A4-44, Eppendorf AG, Hamburg, Germany) The supernatant was discarded properly and 
the pellet was resuspended in a defined amount of 0.9% (w v-1) NaCl solution. The main culture 
was then initiated by transferring this cell solution to the respective 50 mL of CGXIIE (Table 
12, p.58) medium, thereby inoculating it to an OD600 of about 2.0, if not indicated otherwise.  
Evolutionary cultivations were prepared as described above. Main cultures were performed 
with strains C. glutamicum Δppc Δpyc and C. glutamicum Δppc Δpyc Δpck in 500 mL glass 
flasks with four baffles (Fig. 9, p.66). Therefore, the cells were pelleted with with a centrifuge 
5804 R (rotor A4-44, Eppendorf AG, Hamburg, Germany) at 4,500 × g, 10 min, RT and the 
pellet was then resuspended in a defined amount of 0.9% (w v-1) NaCl solution, which was then 
used to inoculate the main culture to an OD600 of about 1. The CGXIIE (Table 12, p.58) medium 
contained 40 g D-glucose L-1 as carbon source. After 3 – 4 d of incubation at 30 °C, the optical 
density was determined and a defined amount of cell suspension was pelleted (4,500 × g, 
10 min, RT), the pellet was washed once with 10 mL of 0.9% (w v-1) NaCl solution, pelleted 
again and the supernatant was discarded properly. Then the pellet was resuspended in a defined 
amount of 0.9% (w v-1) NaCl solution and used to inoculate freshly prepared 50 mL of CGXIIE 
with 40 g D-glucose L-1 to an OD600 of 1. This was repeated each 3 – 4 d until a distinct increase 
in OD600 was observed, indicating one or more evolutionary event(s). To isolate, i.e. obtaining 
single colonies, of the evolved strain(s), serial dilutions spanning from 10-3 to 10-6 in 
0.9% (v v-1) NaCl were prepared of the biomass suspension and plated on both 2×YT and 
 66 
 
CGXIIE agar plates, the latter containing 10 g glucose L-1 and 1 g yeast extract L-1. The plates 
were incubated at 30 °C and checked regularly to identify faster growing colonies. The faster 
growing ones were transferred onto 2×YT agar plates and their faster growth, compared with 
the initial strain, was confirmed in subsequent growth experiments.  
 
 Triple glass reactor system 
Reactor cultivations were performed in a triple glass bioreactor system with a working volume 
of 200 mL (HWS Labortechnik, Mainz, Germany) with 200 mL CGXIIR (Table 12, p.58) 
minimal medium and 10 g D-glucose L-1. To inoculate the medium, the respective strains were 
prepared as described above (2.4.5 Shaking flask cultivations, p.64) and as shown in Fig. 9 on 
page 66. The main culture was inoculated to an OD600 of about 1.5. The monitored process 
Fig. 9. Overview of the seed trains used for bacterial cultivations in this work: standard cultivations in part I 
and part II (a.), evolutionary cultivations (b.), small scale fermentations in the glass reactor system (c.), and 
steel tank reactor cultivations (d.). Seed trains were conducted by thawing a cryo tube culture (1), stored 
at -70 °C, and streaking cell suspension on 2×YT agar medium (2). After incubation, a single colony was 
transferred from the semi solid medium into 5 mL 2×YT medium (3) and incubated. After incubation, the 
complete cell suspension from (3) was transferred into 50 mL 2×YT medium in a 500 mL baffled shaking 
flask (4). This preculture was then used to inoculate the respective 50 mL CGXII minimal medium in a 500 
mL baffled shaking flask (4.1), which was either incubated as main culture in standard growth experiments 
or from which in the case of evolutionary cultivations cell suspension was transferred regularly into fresh 
CGXII medium (5.1). In the case of fermentations, the 2×YT culture (4) was either used to inoculate the 200 
mL CGXIIR reactor medium (4.2) or in the case of STR fermentations to inoculate a further preculture of 
250 mL 2×YT medium in a 2 L baffled shaking flask (4.3). The biomass generated with this preculture (4.3) 
was then used to inoculate the STR (5.2). 
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parameters included temperature (T), dissolved oxygen concentration (DO) and pH value, 
which were monitored with probes (Mettler-Toledo GmbH, Gießen, Germany). Calibration of 
the DO probe was performed at 30 °C with two setpoints (0% and 100% of saturation). Setpoint 
one was achieved by gassing with pure N2 to reduce the DO in the medium to 0%. Setpoint 2 
was achieved by gassing with air and calibrating to 100% DO. The pH value was calibrated 
with commercial buffer solutions for pH 4 and pH 7 (ROTI®CALIPURE, Carl Roth, Karlsruhe, 
Germany). During the cultivations, the pH value was fixed to 7.4 (unless indicated otherwise) 
and controlled by addition of 10% (v v-1) o-phosphoric acid and 25% (v v-1) ammonia solution. 
When foaming occurred, foam development was counteracted by manually adding Struktol™ 
J 647 (Schill+Seilacher GmbH, Hamburg, Germany). Cultivations were performed at ambient 
pressure and the initial conditions were agitation at 100 rpm and gassing with 20 mL min-1 air 
flow (0.1 vvm). The DO level was kept above 35% by firstly increasing agitation (gradually up 
to a maximal value of 450 rpm) and secondly by increasing the gassing (gradually up to a 
maximal value of 500 mL min-1) with a mass flow controller (Analyt-MTC GmbH, Müllheim, 
Germany).  
 
 30 L stirred tank reactor cultivations 
For investigation of potential upscaling effects with L-histidine producer strains, cultivations in 
a 30 L volume steel stirred tank reactor (Bioengineering AG, Wald, Switzerland) were 
performed. To obtain sufficient amounts of biomass from the precultures, the precultivations 
were performed as described in 2.4.5 Shaking flask cultivations on page 64. With the purpose 
to generate sufficient biomass, the seed train was modified as shown in Fig. 9 on page 66 and 
as described in the following. A second preculture in 250 mL 2× YT (Table 9, p.57) medium 
in a 2 L baffled shaking flask was inoculated to an OD600 = 1.5 by using the first preculture and 
incubated o/n. To collect the biomass, the cell suspension was centrifuged (8,850 × g, 10 min, 
RT) with a centrifuge Avanti™ J-25 (rotor JA10, Beckman Coulter, Brea, USA) deploying four 
beakers à 250 mL. Pellets were resuspended in 200 mL 0.9% (w v-1) NaCl solution and the 
bioprocess was started by transferring the biosuspension to the STR, containing 40 g D-glucose 
L-1 in a working volume of 10 L CGXIIR medium (Table 12, p.58), and inoculating it to 
OD600=1.0. 
T, DO, and pH were monitored online with standard probes (Mettler-Toledo GmbH, Gießen, 
Germany). Calibration of the oxygen electrode was done externally at 30 °C at two set points 
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for the 0% DO level in dH2O containing sodium sulfite and for 100% in dH2O with aeration of 
ambient air. Calibration of the pH electrode was done in buffer solutions at pH 4.0 and pH 7.0. 
Temperature of the medium during fermentation was fixed at 30 °C and controlled via 
cooling/heating through the reactor mantle. Excessive foaming was counteracted by manually 
adding Struktol™ J 647 (Schill+Seilacher GmbH, Hamburg, Germany) when needed. Agitation 
was set between 200 and 350 rpm at the fermentation start (as indicated) by using a single six 
blade Rushton turbine and four baffles at the reactor wall. Aeration rates were set to 2.5 L min-1 
(0.25 vvm for the batch cultivation) at the fermentation start to prevent CO2 degassing and 
gradually increased (together with stirrer velocity) as required to keep the DO level above 35% 
(mass flow controller 0-2 L min-1; Analyt-MTC GmbH, Müllheim, Germany). Aeration was 
realized through a needle at the bottom of the reactor. The fermentations were run with 0.5 bar 
overpressure and the exhaust gas composition was analysed with respect to O2 and CO2 
(BlueSens gas sensor GmbH, Herten, Germany).  
For the fermentation in fed-batch mode, a fermentation in batch mode was performed as 
described above o/n. Changes included the reduction of the starting volume to 8 L and the initial 
amount of D-glucose to 20 g L-1. After the carbon source was consumed completely from the 
CGXIIR medium (Table 12, p.58), the fed-batch mode was initiated by switching on the feed. 
The feed contained 500 g D-glucose L-1 and was prepared in a baffled shaking flask with stir 
bar, which was placed on a magnetic stirrer to prevent precipitation. The initial substrate feed 
rate was calculated according to Equation 1, the volume of the feed was calculated according 
to Equation 2. The values for µ and qS were used as experimentally determined. The µ during 
the fed-batch phase was set to 0.1 h-1 by adding defined amounts of feed. 
 
Equation 1. 𝑭(𝐭) = 𝒒𝑺 × 𝑽𝟎 × 𝒄𝒙𝟎 (𝒆
µ𝒕)
𝒄𝒔𝟎
 
Equation 2. 𝑽𝑭𝒆𝒆𝒅(𝐭) =
𝒒𝑺 × 𝑽𝟎 × 𝒄𝒙𝟎 (𝒆µ𝒕ି𝟏)
𝒄𝒔𝟎 × µ
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 Molecular biological methods 
The routinely performed molecular biology methods, such as restriction digestions, DNA 
ligations, and agarose gel electrophoresis were either performed as suggested by Sambrook et 
al., 2001, or as suggested by the manufacturer. Cloned plasmids and genomic integrations were 
verified by Sanger sequencing covering the complete altered DNA region, which was 
commercially performed by GATC Biotech AG, Constance, Germany. 
 Isolation/purification of DNA 
For isolation of plasmid DNA from either E. coli or C. glutamicum, E.Z.N.A.® Plasmid Mini 
Kit I (Omega Bio-tek, Inc., Norcross, USA) was used according to the manufacturer’s 
specifications. For preparation of plasmid DNA from C. glutamicum, a pretreatment with 
lysozyme (20 mg mL-1) was performed for 60 min at 37 °C. DNA was purified after polymerase 
chain reaction (PCR) or after excision from agarose gels with NucleoSpin® Gel and PCR Clean-
up (Macherey-Nagel GmbH & Co KG, Düren, Germany) according to the manufacturer’s 
specifications. For isolation of genomic DNA from either E. coli or C. glutamicum, the DNeasy 
Blood & Tissue Kit (QIAGEN, Hilden, Germany) was used according to the manufacturer’s 
specifications. All Kits used in this work are listed in Table 7, page 55. 
 
 
 Preparation of electrocompetent cells and transformation 
E. coli 
Electrocompetent cells of E. coli DH5α were prepared as has been described before (Dower 
et al., 1988). Therefore, the strain was streaked from a glycerol stock onto a 2×YT (Table 9, 
p.57) agar plate and incubated o/n at 37 °C. A single colony was used to inoculate 5 mL of 
2×YT in a glass tube, which was incubated o/n at 37 °C. From this culture, 500 µL of cell 
suspension were then used to inoculate 250 mL 2×YT medium in a 1 L shaking flask with three 
to four baffles. Progress of the increase in OD600 was followed with an Ultrospec 10 Cell 
Density Meter (GE Healthcare Europe GmbH, Freiburg, Germany) and cells were harvested by 
centrifugation (4,500 × g, 15 min, 4 °C) when an OD600 of 0.3 – 0.5 was reached. The deployed 
centrifuge was a model 5804 R with an A-4-44 rotor (Eppendorf AG, Hamburg, Germany). The 
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supernatant was discarded properly and cells were washed with 20 mL ice cold water and then 
pelleted again. This was repeated once again with ice cold water and then two more times with 
ice cold 10% (v v-1) glycerol. Eventually, the pellet was resuspended in 0.5 mL ice cold 
10% (v v-1) glycerol, separated in 50 µL aliquots, frozen instantly in liquid N2, and stored 
at -70 °C until needed.  
Transformation of electrocompetent E. coli DH5α with purified plasmid DNA (0.5 – 1.0 µg 
of DNA), ligation, or isothermal assembly mixes was performed as has been described before 
(Dower et al., 1988). This was done in electroporation cuvettes with 2 mm gap width and 
400 µL volume (Radnor, Pennsylvania, USA) and with an Eporator® (Eppendorf, Hamburg, 
Germany). Cells and DNA were mixed, transferred into the cuvettes, and chilled for 5 min on 
ice. Then a pulse of 2.5 kV was applied (yielding time constants of about 3 – 4 ms). Cells were 
washed out of the cuvettes with 2×YT medium and regeneration was conducted in 5 mL 2×YT 
medium for 50 min at 37 °C. After this, cells were plated on 2×YT agar medium containing the 
appropriate antibiotic (for the respective plasmid) for selection pressure (Table 3, p.39) and 
incubated o/n at 37 °C. 
 
C. glutamicum 
Electrocompetent cells of C. glutamicum were prepared as has been described before (Tauch 
et al., 2002). As a general approach to prepare electrocompetent C. glutamicum, a 5 mL BHI 
(Table 10, p.57) preculture was inoculated with a single colony from a 2×YT (Table 9, p.57) 
agar plate and incubated for about 6 h at 30 °C. The complete content of this glass tube was 
then transferred into 50 mL of BHIS (Table 11, p.57) medium in a 500 mL shaking flask and 
incubated o/n. The main culture of 250 mL BHIS medium in a 1 L baffled shaking flask was 
then inoculated with 7.5 mL of the preculture and incubated to an OD600 of 2.5 (equals a 
biomass concentration of about 0.55 g CDW L-1). The cells were harvested by centrifugation 
(4,500 × g, 20 min, 4 °C; model 5804 R with an A-4-44 rotor; Eppendorf AG, Hamburg, 
Germany), the supernatant was discarded, and the pellet was washed with 100 mL ice cold 
10% (v v-1) glycerol. This was repeated three times. The final pellet was then resuspended in 
1.6 mL ice cold 10% (v v-1) glycerol, 150 µL aliquots were prepared, directly frozen in liquid 
N2, and stored at -70 °C until needed. 
For transformations with pJC4-based plasmids, a scaled-down approach of the above described 
protocol was used. For this purpose, several colonies of the same strain were transferred from 
a 2×YT agar plate into 5 mL BHI (Table 10, p.57) in a glass tube and incubated for 5 – 6 h at 
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30 °C. The content of the glass tube was transferred into a 15 mL conical centrifuge tube and 
centrifuged at 4,500 × g for 10 min at 4 °C (model 5804 R with an A-4-44 rotor (Eppendorf 
AG, Hamburg, Germany)). The supernatant was discarded, the pellet was resuspended in 1 mL 
ice cold 10% (v v-1) glycerol and transferred into a 1.5 mL reaction tube. The cells were pelleted 
(centrigufation at 4,500 × g, 10 min, 4 °C; model 5804 R with an F-45-30-11 rotor [Eppendorf 
AG, Hamburg, Germany]) and three more washing steps were performed. The final pellet was 
resuspended in 80 µL ice cold 10% (v v-1) glycerol and either directly applied for 
transformation (short time storing on ice) or frozen in liquid N2 and stored at -70 °C until 
needed. 
Transformation of C. glutamicum was performed as has been described before (Liebl et al., 
1989). For this purpose, electrocompetent cells of C. glutamicum were thawed on ice, mixed 
with the respective plasmid DNA (0.5 - 1.0 µg DNA), transferred into electroporation cuvettes 
(2 mm gap width, 400 µL volume; Radnor, Pennsylvania, USA), and chilled for 5 min on ice. 
Electroporation was performed with an Eporator® (Eppendorf, Hamburg, Germany) applying a 
pulse of 2.5 kV, yielding time constants of 4 – 5 ms. As has been described before, a heat shock 
for 6 min at 46 °C was performed in 5 mL sterile-filtered BHIS (Table 11, p.57) medium 
immediately post electroporation (van der Rest et al., 1999). For regeneration purposes, cells 
were then incubated for 50 min at 30 °C and pelleted afterwards (centrifugation at 4,500 × g for 
10 min at RT; model 5804 R with an A-4-44 rotor). The supernatant was discarded and the 
pellet was resuspended in 50 µL BHIS and plated on BHIS agar plates containing the respective 
antibiotic for selection purposes (Table 3, p.39).  
 Polymerase chain reaction 
For the amplification of DNA, the polymerase chain reaction (Mullis and Faloona, 1987; Saiki 
et al., 1988) technique was used. Reactions were performed with a Biometra TAdvanced 
thermocycler (Biometra GmbH, Göttingen, Germany). For cloning purposes, Phusion Hot Start 
II HF DNA Polymerase (Thermo Fisher Scientific Inc., Waltham, USA) was used with in-house 
designed primers (synthesized by biomers GmbH, Ulm, Germany). A protocol for the reaction 
mix and protocol is given in Table 29, page 72. To verify plasmid integrity and genomic DNA 
integration or deletion, colony PCRs with Taq DNA Polymerase S (Genaxxon BioScience 
GmbH, Ulm, Germany) were performed. DNA for colony PCRs were prepared by transferring 
a single colony into 50 µL deionized water (dH2O) and incubating for 10 min at 95 °C. Cell 
debris was cleared by centrifugation at 12,100 × g for 3 min (MiniSpin®, rotor F-45-12-11; 
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Eppendorf AG, Hamburg, Germany). Then, 10 µL of the supernatant were used as template 
DNA in the colony PCR protocol (Table 30, p.72). 
 
Table 29. Standard PCR reaction composition (A) and thermocycler program (B). The amount of template DNA 
varied for different PCR reactions. 
A DNA template  2-5 µL 
DMSO  2 µL 
Phusion Hot Start II HF 1 µL 
dNTP mix (10 mM) 5 µL 
Phusion GC Buffer (5×, + MgCl2) 10 µL 
Primer (10 pmol µL-1) 2 µL 
ad dH2O 50 µL 
 
B Denaturation 98 °C 3 min  
Denaturation 98 °C 0.25 min 
30-35 
cycles Annealing 55 °C 0.5 min 
Elongation 72 °C 20 s / kb 
Final elongation 72 °C 5 min  
Hold 4 °C ∞  
 
 
Table 30. Colony PCR reaction composition (A) and thermocycler program (B). 
A Colony DNA template 10 µL 
DMSO 1 µL 
Taq DNA Polymerase 0.5 µL 
dNTP mix (10 mM) 2.5 µL 
PCR Buffer S complete (10×) 2.5 µL 
Coral Red Buffer Dye (10×) 2.5 µL 
Primer (10 pmol µL-1) 2 µL 
dH2O 4 µL 
 
B Denaturation 95 °C 5 min  
Denaturation 95 °C 0.5 min 
30-35 
cycles Annealing 55 °C 0.5 min 
Elongation 72 °C 1 min / kb 
    
Final Elongation 72 °C 8 min  
Hold 4 °C ∞  
 
 
 
 Plasmid construction 
To construct plasmids for overexpression (pJC4-based) or genomic alterations 
(pK19mobsacB-based), either isothermal assembly or SOEing PCR & ligation were performed. 
 Isothermal assembly 
The isothermal assembly of one or more DNA fragments with the respective plasmid backbone 
was performed as has been described before and the protocol is modified after 
recommendations given in literature (Gibson, 2011; Gibson et al., 2009). DNA fragments were 
generated via PCR and a minimum of 18 bps of homologous overlap with each other or the 
plasmid backbone was calculated. The plasmid DNA was linearized with one or two restriction 
enzymes (Table 8, p.55), purified, and mixed with the DNA fragments in a defined molar ratio 
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of 1:3 to yield the DNA mix. Then, 5 µL of this DNA mix were added to an iso-enzyme-reagent 
mix (Table 16, p.59) and isothermal assembly was performed in a Biometra TAdvanced 
thermocycler (Biometra GmbH, Göttingen, Germany) at 50 °C for 60 min. The assembly mix 
was then transferred onto a filter membrane (MF-Millipore Membrane Filter, 0.025 µm pore 
size; Merck Chemicals GmbH, Billerica, USA) and filtered for 10 min against dH2O. After 
filtration, 5 µL of the isothermal assembly mix were transformed into electrocompetent 
E. coli DH5α (2.5.2 Preparation of electrocompetent cells and transformation, p.69). 
 Splicing by overlap extension PCR and ligation 
Splicing by overlap extension (SOEing) PCR was performed as has been described before 
(Horton, 1995; Horton et al., 1990). For this purpose, single amplified DNA fragments were 
generated from the respective template DNA with in-house designed primers. Homologous 
regions were designed with a minimum of 18 bps overlap. For the SOEing PCR, DNA 
fragments were deployed in a molecular ratio of 1:1 and Phusion Hot Start II HF DNA 
Polymerase (Thermo Fisher Scientific Inc., Waltham, USA) was used to amplify the extended 
product with the two outer primers (Table 4, p.41). The SOEing PCR mix was run on a 
1% (w v-1) agarose gel and bands were separated at 80-120 V. The respective band of the 
SOEing PCR product was cut out on an UV Transilluminator 312 nm (INTAS Science Imaging 
Instruments GmbH, Göttingen, Germany) and purified with NucleoSpin® Gel and PCR Clean-
up Kit (Macherey-Nagel GmbH & Co KG, Düren, Germany). The SOEing PCR product and 
the adopting plasmid DNA were digested with the two respective restriction enzymes according 
to the manufacturers specifications (Thermo Fisher Scientific Inc., Waltham, USA), purified 
after restriction digestion with NucleoSpin® Gel and PCR Clean-up Kit and ligated together 
with T4 DNA ligase (Thermo Fisher Scientific Inc., Waltham, USA) for 2 h at 22 °C. The 
ligation mix was then transferred onto a filter membrane (MF-Millipore Membrane Filter, 
0.025 µm pore size; Merck Chemicals GmbH, Billerica, USA) and filtered for 10 min against 
dH2O. 5 µL of the filtered ligation were then transformed into electrocompetent E. coli DH5α 
(2.5.2 Preparation of electrocompetent cells and transformation, p.69). 
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 Genomic alterations in C. glutamicum 
For the purpose of modifying the genome (integrations, deletions, base exchanges) of 
C. glutamicum, an already published and well established markerless system was used (Schäfer 
et al., 1994). This system is based on homologous recombination by applying the mobilizable 
and integrative vector pK19mobsacB. Originally, the vectors pK18 and pK19 were constructed 
for applications in E. coli and constitute the origin of the pK19mobsacB system for applications 
in C. glutamicum (Pridmore, 1987). These vectors were combined with the broad host-range 
transfer machinery of plasmid RP4, a kanamycin resistance cassette, and a modified sacB gene 
from B. subtilis for positive selection (Datta et al., 1971; Schäfer et al., 1994; Selbitschka et al., 
1993). With the aim to facilitate homologous recombination, the flanking regions were 
amplified via PCR with a minimum of 500 bps distance, up- and downstream of the genomic 
area that was intended to be modified. 
The pK19mobsacB derivatives intended for genomic modifications in C. glutamicum were 
cloned via isothermal assembly (2.5.5 Isothermal assembly, p.72) or SOEing PCR & ligation 
(2.5.6 Splicing by overlap extension PCR and ligation, p.73). After assembly, the constructs 
were transformed into E. coli DH5α, verified by sequencing, purified, and introduced into the 
respective C. glutamicum strain via electroporation and plating on BHIS (Table 11, p.57) agar 
plates. The sacB gene in pK19mobsacB encodes the B. subtilis levansucrase, which is 
responsible for the conversion of sucrose to levan (toxic for C. glutamicum), and thus mediates 
sucrose sensitivity. Selection was therefore carried out on 2×YT (Table 9, p.57) agar plates 
containing 100 g sucrose L-1 thus creating selection pressure to resolve the integrated plasmid 
by homologous recombination. The pK19mobsacB system does not bear an origin of replication 
(ori) for C. glutamicum and counter selection on kanamycin-containing media helps to identify 
double-crossover events that lead to chromosomal integrations of the complete plasmid. These 
colonies were discarded and the ones that were not growing on kanamycin-containing agar were 
tested in colony PCRs (Table 30, p.72) with the appropriate primers and distinguished from the 
WT. 
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 Plasmid and strain construction 
 Strain Construction – PART I 
In the following, all L-histidine producing strains that were constructed in this work will be 
described in detail. Oligonucleotides are listed in Table 4, page 41. For an overview of the strain 
database see Fig. 17 on page 115. All constructed and investigated strains are listed in Table 2 
on page 37. If not mentioned otherwise, genomic DNA of C. glutamicum ATCC 13032 (WT) 
was used as template for amplifications via PCR. The ten main strains were named 
C. glutamicum HIS1 to HIS10 and were constructed proceeding from C. glutamicum WT.  
The plasmid for exchanging the native HisG variant with the feedback-released HisGG233H-T235Q 
(Schendzielorz et al., 2014), was implemented into C. glutamicum WT by amplifying the 
flanking genomic regions of hisG up- and downstream of the mutations with primer pairs 
hisG1/hisG2 and hisG3/hisG4 (including the exchanges ggc742cat and acg748cag in hisG). 
Both PCR products were used as templates in a SOEing PCR with primer pair hisG1/hisG4. 
The SOEing product and pK19mobsacB were digested with BamHI and fused together in a 
ligation reaction to give pK19mobsacB hisGFB. This plasmid was then transformed into 
E. coli DH5α, isolated, and its sequence integrity was verified by DNA sequencing with primers 
pK19-fw and pK19-rev (GATC Biotech GmbH, Constance, Germany). The verified plasmid 
was then transformed into C. glutamicum WT. The native hisG sequence was replaced with the 
hisG sequence containing the nucleotide exchanges leading to HisGG233H-T235Q via a 
homologous recombination (2.5.7 Genomic alterations in C. glutamicum, p.74). For verification 
of the nucleotide exchanges, a PCR (Table 29, p. 72) with primer pair hisG1/hisG4 was 
performed and sent for sequencing with primer hisGseq. The resulting strain was named 
C. glutamicum HIS1. To construct plasmids for the promoter exchanges in front of the operons 
containing histidine biosynthesis genes (C. glutamicum HIS2, HIS3, HIS4, and HIS6), the 
flanking regions of the respective promoter was amplified. For the exchange of the native 
promoter of the operon hisD-hisC-hisB-cg2302-cg2301 (Fig. 3, p.16) with the strong promoter 
of the gene tuf (Ptuf), encoding the elongation factor TU, the flanking regions were amplified 
with primer pairs hisD1/hisD2 and hisD3/hisD4. The products of both PCRs were used as 
templates in a SOEing PCR with primer pair hisD1/hisD4 and the SOEing product and the 
plasmid pK19mobsacB were digested with BamHI and HindIII and ligated together to give an 
intermediate plasmid. This plasmid was transformed into E. coli DH5α, the plasmid was 
isolated and sent for sequencing with primers pK19-fw and pK19-rev. In a next step, Ptuf was 
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amplified with primer pair tuf1/tuf2 and the product and the intermediate plasmid were digested 
with NdeI and NsiI. Both were ligated to give plasmid pK19mobsacB hisD-Ptuf, which was 
transformed into E. coli DH5α, isolated and sent for sequencing with primers pK19-fw and 
pK19-rev. The verified pK19mobsacB hisD-Ptuf was transformed into C. glutamicum HIS1 and 
exchange of the native promoter region with the Ptuf promoter was again performed on basis of 
homologous recombination to yield C. glutamicum HIS2. The respective region was amplified 
with primer pair hisD1/Ptuf2 and verified by sequencing with primer hisD1. The plasmids for 
exchanging the native promoter with Ptuf for operons hisH-hisA-impA-hisF-hisI-cg2294 and 
cg0911-hisN were constructed in a similar manner. Primer pairs hisH1/hisH2 and hisH3/hisH4 
and hisN1/hisN2 and hisN3/hisN4 were used to amplify the flanking regions, respectively. 
After SOEing PCR, digestion, and ligation, plasmids were transformed into E. coli DH5α and 
prepared. In further steps, the mentioned plasmids were digested with NdeI and NsiI and fused 
with the Ptuf region. After sequencing, pK19mobsacB hisH-Ptuf was implemented in 
C. glutamicum HIS2 to yield C. glutamicum HIS3. The sequence was verified with primers 
hisH1, hisH4, tuf1, and tuf2. HIS3 served as basis for implementing Ptuf in front of cg0911-hisN 
by using pK19mobsacB hisN-Ptuf to yield C. glutamicum HIS4. HIS4 was verified with primers 
hisN1, hisN4, tuf1, and tuf2. Since we were not able to implement Ptuf for operon hisE-hisG in 
C. glutamicum HIS4, we instead used PdapA-A16 (Vašicová et al., 1999), a modified version of 
the promoter of dihydrodipicolinate synthase, which was amplified with primer pair 
dapA1/dapA2 from pK18mobsacB PaceE dapA-A16 (Buchholz et al., 2013). The flanking 
regions of the hisE-hisG promoter were amplified with primer pairs hisE1/hisE2 and 
hisE3/hisE4, a SOEing PCR was prepared with primer pair hisE1/hisE4. This product and 
pK19mobsacB were digested with BamHI and HindIII and ligated together. PdapA-A16 and this 
plasmid were digested with NdeI and NsiI and ligated together. Hence, on basis of 
C. glutamicum HIS4, C. glutamicum HIS6 was created and verified with primers hisE1, hisE4, 
dapA1, and dapA2. C. glutamicum HIS5 was created by implementing PdapA-A16 in C. 
glutamicum HIS1. To exchange the internal promoter of hisF in the operon hisH-hisA-impA-
hisF-hisI-cg2294 with the promoter of manganese superoxide dismutase (encoded by sodA), 
flanking regions and the promoter were amplified with primer pairs hisF1/hisF2, sodA1/sodA2, 
and hisF3/hisF4 and an additional stop codon (TAA) was integrated upstream of hisF. The 
SOEing PCR (with all three products as template and primer pair hisF1/hisF4) and 
pK19mobsacB were cut with HindIII and BamHI and ligated together. Integration of PsodA in 
front of hisF in strain C. glutamicum HIS6 yielded C. glutamicum HIS7, which was verified 
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with primers hisF4 and hisFseq. On basis of plasmid pJC4 (Cordes et al., 1992) we constructed 
pJC4 purA purB by amplifying Ptuf, purA, and purB with primer pairs tuf2_1/tuf2_2, 
purA1/purA2, and purB1/purB2 from the C. glutamicum genome. Furthermore, primer pair 
rrnB1/rrnB2 was used to amplify the TrrnB terminator region of the rrnB operon from the 
E. coli K-12 MG1655 genome. Isothermal assembly (2.5.5 Isothermal assembly, p.72) was 
prepared with these four DNA fragments and pJC4 (Cordes et al., 1992), which had been 
digested with XbaI and NotI before. The sequence integrity was verified with primers ABseq1–
5. The plasmid pJC4 purApurB was transformed into C. glutamicum HIS7, to create 
C. glutamicum HIS8. The overproduction plasmid for the GCV system from 
Corynebacterium jeikeium was obstained from Evonik Industries AG and was constructed as 
follows. Plasmid pEC-XT99A (Kirchner and Tauch, 2003) served as basis and was digested 
with Ecl136II and XbaI. The gene cluster gcvPTH was amplified from the C. jeikeium K411 
genome (Tauch et al., 2005) with primer pair gcv_Cjk_start_EcoRV/gcv_Cjk_MluI_XbaI and 
the resulting PCR product was digested with EcoRV and XbaI and ligated into the cut 
pEC-XT99A vector. After verification by sequencing, this intermediate plasmid served as basis 
for the second cloning step. The gene cluster lipAB was amplified from the C. jeikeium K411 
genome with primer pair lipB-Cjk_start-EcoRV/ lipA-Cjk_stop-XbaI and the PCR product was 
digested with SspI und EcoRV and ligated into the XmnI cut intermediate plasmid to give 
pEC-XT99A_gcv_OP1-Cjk, which was verified by sequencing. C. glutamicum HIS9 was 
generated by transforming plasmid pEC-XT99A_gcv_OP1-Cjk into C. glutamicum HIS8. The 
exchange of the translational start codon ATG of gene pgi to GTG (Becker et al., 2010) in 
C. glutamicum HIS10 was done with pK19mobsacB pgiGTG. For its construction, the flanking 
regions were amplified with primer pairs pgi1/pgi2 and pgi3/pgi4, containing the nucleotide 
exchange. The PCR products were used in a SOEing PCR with primer pair pgi1/pgi4. The 
SOEing PCR and the vector were digested with HindIII and BamHI and ligated together. After 
sequence verification, the plasmid was introduced into C. glutamicum HIS9, the base exchange 
was done as described above, and verified with primer pgiseq.  
Besides strains HIS1 to HIS10, the strain database was further extended with accessory strains 
(Fig. 17, p.115; Table 2, p.37). 
Plasmid pK19mobsacB pgiGTG was further used to construct strains CM1 and HIS7.1, besides 
HIS9, which was done as has been described above. Besides pgi, genes gapA and pgm were 
chosen as targets and their respective translational start codons were changed from the native 
ATGs to the rarer variants TTG. For this purpose, the respective flanking regions were 
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amplified from the C. glutamicum genome with primer pairs gapA1/gapA2, gapA3/gapA4, 
pgm1/pgm2 and pgm3/pgm4. Plasmid pK19mobsacB was restricted with HindIII and BamHI 
and purified. Together with the respective purified PCR products, it was used for isothermal 
assembly to give pK19mobsacB gapATTG and pK19mobsacB pgmTTG. Sequence integritiy was 
verified by sequencing both with pK19-fw and pK19-rev. These two plasmids were used to 
create strains HIS7.2 and HIS9.1 (for gapATTG) and HIS7.3 and HIS9.2 (for pgmTTG) and 
exchange of the respective translational start codon was done by amplifying the surrounding 
genomic region with primer pairs gapA_seq1/gapA_seq3 and pgm_seq1/pgm_seq3 and 
sequencing with primers gapA_seq2 and pgm_seq2, respectively. 
Plasmid pK18mobsacB zwfA243T was obtained from Evonik Industries AG and was used to 
introduce the amino acid exchange A243T in the G6P DH, to create strain CM2. The nucleotide 
exchange (leading to A243T) was verified by PCR with primers zwf1 and zwf2 and sequencing 
of the PCR product with primer zwfseq. Besides this amino acid exchange, the zwf gene was 
targeted with another approach. With the purpose to change the translational start codon from 
the native GTG triplet to the more common variant ATG, the flanking regions of zwf were 
amplified with primer pairs zwf3/zwf4 and zwf5/zwf6. With the two PCR products as 
templates, a SOEing PCR was performed with primer pair zwf3/zwf6. The SOEing product and 
pK19mobsacB were restricted with HindIII and BamHI, purified, and ligated together to give 
pK19mobsacB zwfATG. The resulting plasmid was sequenced with pK19-fw and pK19-rev and 
used to change the translational start codon of zwf in strain CM1. The exchange GTG to ATG 
in the resulting strain CM1 zwfATG was verified by amplifying the respective genomic region 
with primer pair zwf3/zwf6 and sequencing it with primer zwf3. 
Plasmid pK19mobsacB gndS361F was obtained from Evonik Industries AG and was used to 
introduce the amino acid exchange S361F in the 6PG DH, to create strain CM2.1. The 
nucleotide exchange (leading to S361F) was verified by PCR with primers gnd1 and gnd2 and 
sequencing of the PCR product with primer gnd_seq. 
For the construction of plasmids pK19mobsacB prsAD122S, pK19mobsacB prsAR87C, and 
pK19mobsacB prsAD136A, flanking regions of the prsA gene were amplified with primer pairs 
prsA1/prsA2.1, prsA1/prsA2.2, or prsA1/prsA2.3 and primer pairs prsA3.1/prsA4, 
prsA3.2/prsA4, or prsA3.3/prsA4. Then SOEing PCRs with primer pair prsA1/prsA4 were 
conducted with the respective PCR products from the first PCRs as templates. The three 
resulting PCR products and the vector pK19mobsacB were restricted with HindIII and EcoRI 
and ligated together. The resulting plasmid pK19mobsacB prsAD122S was sequenced with 
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primers pK19-fw and pK19-rev and used to create strain CM3. The nucleotide exchange 
leading to prsAD122S was verified by amplifying the respective genomic region with primer pair 
prsA_seq1/prsA_seq3 and sequencing this PCR product with primer prsA_seq2. Despite 
successful construction of pK19mobsacB prsAR87C and pK19mobsacB prsAD136A, these amino 
acid exchanges could not be established in the C. glutamicum genome (Table 32, p.122).  
Besides amino acid exchanges, the prsA gene was also targeted by an exchange of the native 
RBS (AGGATCCTC ) with an improved variant (AGGAGGACATACC). For this purpose, the 
flanking regions of the prsA RBS were amplified with primers containing the improved RBS 
sequence. These were prsArbs1/prsArbs2 and prsArbs3/prsArbs4. The two PCR products were 
used as templates in a SOEing PCR with primer pair prsArbs1/prsArbs4. The SOEing product 
and pK19mobsacB were restricted with HindIII and BamHI, purified, and ligated together to 
give pK19mobsacB prsAR. The resulting plasmid was sequenced with primers pK19-fw and 
pK19-rev. After implementation of the improved RBS in strain CM1, the sequence identity was 
verified by amplifying the respective genomic region with primer pair prsArbs1/prsArbs4 and 
sequencing the product with prsArbs1. The resulting strain was named CM1 prsAR. 
A second genomic integration of the hisE-hisG operon was done by constructing a 
pK19mobsacB derivative containing an integration cassette with a modified variant of this 
operon. The genomic integration site was chosen according to Lange et al., 2017, and was 
located between genes cg0901 and cg0902 (Lange et al., 2017). The flanking regions of the 
integration site were amplified with primer pairs cg0901_for/cg0901_rev and 
cg0902_for/cg0902_rev from the C. glutamicum genome. The modified hisEG operon 
(including hisEATG and hisGFB) and the PdapA-A16 promoter were amplified from genomic DNA 
of strain HIS6 with primer pair int1/int2. The Trrnb terminator was amplified with primer pair 
TrrnB_for/TrrnB_rev from genomic DNA of E. coli K-12 MG1655. Plasmid pK19mobsacB 
was restricted with XbaI and XmaI. All four products and the restricted vector were purified 
and used in a isothermal assembly reaction to give plasmid pK19mobsacB 
int::PdapAhisEATGhisGFB. Sequence integrity of this plasmid was verified with primers pK19-fw, 
int_seq1, int_seq2, int_seq3, int_seq4, and pK19-rev. Integration of the cassette into the CM1 
genome to give HISint was verified by amplifying the respective genomic region with primer 
pair int_seq1/seq_int and sequencing this product with primers int_seq1 and int_seq2.  
For the in-frame deletion of gene purF, the flanking genomic regions were amplified with 
primer pairs purF1/purF2 and purF3/purF4. Then, a SOEing PCR with both PCR products and 
primer pair purF1/purF4 was conducted. The SOEing PCR product and pK19mobsacB were 
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restricted with PaeI and BamHI and ligated together. Integrity of the sequence was verified 
with primers pK19-fw and pK19-rev. Deletion of purF was established in strain CM1 with the 
resulting plasmid pK19mobsacB ΔpurF and genomic deletion was verified with primer pair 
purF1/purF4 to create strain PUR1. On basis of strain PUR1, C. glutamicum PUR1 ΔpurD was 
constructed, with an additional deletion of the purD gene. The flanking regions of the purD 
gene was amplified with primer pairs purD1/purD2 and purD3/purD4, both products were used 
as templates in a SOEing PCR. This SOEing product and pK19mobsacB were restricted with 
HindIII and BamHI, purified and ligated together. The resulting pK19mobsacB ΔpurD plasmid 
was sequenced with primers pK19-fw and pK19-rev. The following deletion of purD was 
verified with primer pair purD1/purD4. Exchange of the translational start codon from the 
native GTG to the rarer TTG in purF was achieved by amplifying the flanking regions with 
primer pairs purF5/purF6 and purF7/purF8. These two PCR products were used as templates in 
a SOEing PCR with primer pair purF5/purF8. The SOEing product and pK19mobsacB were 
restricted with HindIII and BamHI, purified, and ligated together. The sequence integrity of the 
resulting pK19mobsacB purFTTG was verified with primers pK19-fw and pK19-rev. This 
plasmid was used to create strain PUR2 and the exchange was verified by amplifying the 
respective sequence with primers purF5/purF8 and sequencing it with purF5. The plasmid for 
integration of the nucleotide exchange leading to purFK348Q was constructed by amplifying the 
flanking regions with primer pairs purF9/purF10 and purF11/purF12. The two PCR products 
were used as templates in a SOEing PCR with primer pair purF9/purF12 and the SOEing 
product and pK19mobsacB were restricted with HindIII and BamHI, purified, and ligated 
together. Sequence integrity of pK19mobsacB purFK348Q was verified with primers pK19-fw 
and pK19-rev. In the resulting strain C. glutamicum PUR3, the nucleotide exchange was 
verified by amplifying the respective genomic area with primer pair purF9/purF12 and 
sequencing it with primers K348Qseq1 and K348Qseq2.  
Effects of modifications in transketolase availability on L-histidine production was investigated 
by implementing three different modifications in the tkt gene. For the first one, the native 
genomic tkt sequence was replaced with a truncated version. Therefore, the flanking regions of 
the tkt gene were amplified with primer pairs tkt1/tkt2 and tkt3/tkt4. A SOEing PCR was then 
performed with both PCR products and primer pair tkt1/tkt4 as templates. The SOEing product 
and pK19mobsacB were restricted with HindIII and BamHI, purified, and ligated together to 
give pK19mobsacB Δtkt. The plasmid was sequenced with primers pK19-fw and pK19-rev and 
then used to truncate the native tkt gene in strains HIS3, HIS4, and HIS6, resulting in strains 
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HIS3 Δtkt, HIS4 Δtkt, and HIS6 Δtkt. The truncation was verified with primer pair tkt1/tkt4. 
The other modifications in tkt constituted the deletion of the region consisting of spacer and 
spacer plus ribosomal binding site (RBS). The flanking regions were amplified with primer 
pairs tkt1/tkt5 and tkt6/tkt7 for deletion of the spacer and with primer pairs tkt1/tkt8 and 
tkt9/tkt7 for the spacer plus the RBS. SOEing PCRs were performed with the products from the 
preceding PCRs as templates with primer pair tkt1/tkt7. Both SOEing products and 
pK19mobsacB were each restricted with HindIII and BamHI, purified, and ligated together to 
result in pK19mobsacB ΔtktS (for deletion of the 4 bp spacer region) and pK19mobsacB ΔtktSRbs 
(for deletion of the 8 bp spacer plus RBS region). Sequence indentities were verified by 
sequencing with primers pK19-fw and pK19-rev. Both were then transformed in strain HIS6, 
creating HIS6 tktS and HIS6 tktSRbs and the respective region was amplified with primer pair 
tkt1/tkt7 for both strains. The PCR product was sequenced with primer tktseq. 
The rpi gene was targeted by exchanging the native promoter with Ptuf. This was done by 
amplifying the flanking regions with primer pairs rpi1/rpi2 and rpi3/rpi4 and the Ptuf region with 
primer pair tuf3/tuf4. All three PCR products were used as templates in a SOEing PCR with 
primer pair rpi1/rpi4. The resulting product and pK19mobsacB were restricted with HindIII and 
EcoRI, purified, and ligated together, which resulted in pK19mobsacB Ptuf:rpi, which was 
sequenced with pK19-fw and pK19-rev. The promoter exchange was done with 
pK19mobsacB Ptuf:rpi in strain CM1 and verified by amplifying the respective region with 
primer pair rpi1/rp4 and sequencing it with primer rpi1. The resulting strain was named 
CM1 Ptuf:rpi. 
The pup gene was deleted in the CM1 background with plasmid pK19mobsacB Δpup, which 
was obtained from Lothar Eggeling and Michael Bott (Forschungszentrum Jülich). The 
genomic deletion of pup in CM1 was verified by amplifying the respective genomic region with 
primer pair pup1/pup2. The resulting strain was named CM1 Δpup. 
The PdapA-A16 promoter in strain HIS7 was exchanged with the PgapA promoter with 
pK19mobsacB PgapA:hisEATGhisGFB. To construct this plasmid, the flanking regions of the 
modified hisE-hisG operon and the PgapA promoter were amplified from genomic DNA of HIS7 
with primer pairs hisEG1/hisEG2, PgapA1/PgapA2, and hisEG3/hisEG4. With all three PCR 
products a SOEing PCR was conducted with primer pair hisEG1/hisEG4, and the SOEing 
product and pK19mobsacB were restricted with HindIII and BamHI and purified. Then, 
restricted plasmid and SOEing product were ligated together, and the resulting pK19mobsacB 
PgapA:hisEATGhisGFB was sequenced with primers pK19-fw and pK19-rev. After 
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implementation in strain HIS7, resulting in HIS7 PgapA:hisEG, the promoter exchange was 
verified by amplifying the respective genomic region with primer pair hisEGseq1/hisEGseq2 
and sequencing with hisEGseq3. 
With the purpose to delete the purN gene in-frame, the flanking regions were amplified with 
primer pairs purN1/purN2 and purN3/purN4. The PCR products were used as templates in a 
SOEing PCR with primer pair purN1/purN4. This product and pK19mobsacB were restricted 
with XbaI and EcoRI, purified, and ligated together. The resulting plasmid 
pK19mobsacB ΔpurN was used to delete purN in C. glutamicum WT. The deletion was verified 
in the resulting strain C. glutamicum ΔpurN with a PCR using primer pair purNdel1/purNdel2. 
Additionally, the fdhF was deleted in strain C. glutamicum ΔpurN. This was done by 
amplifying the flanking regions of fdhF with primer pairs fdhF1/fdhF2 and fdhF3/fdhF4. By 
using both PCR products as templates in a SOEing PCR and primer pair fdhF1/fdhF4, the 
flanking regions were connected. The SOEing product and pK19mobsacB were restricted with 
enzymes NheI and BamHI, purified, and ligated together. The resulting plasmid 
pK19mobsacB ΔfdhF was sequenced with pK19-fw and pK19-rev and used to delete the fdhF 
gene in C. glutamicum ΔpurN, to give C. glutamicum ΔpurN ΔfdhF. The deletion was verified 
in a PCR with primer pair fdhFdel1/fdhFdel2. 
Furthermore, the purU gene was deleted in-frame in C. glutamicum WT and HIS7. This was 
done by amplifying the flanking regions of the purU gene with primer pairs purU1/purU2 and 
purU3/purU4. The PCR products were used as templates in a SOEing PCR with primer pair 
purU1/purU4. This SOEing product and pK19mobsacB were restricted with HindIII and XbaI, 
purified, and ligated together to give pK19mobsacB ΔpurU, whose sequence identity was 
verified with primers pK19-fw and pK19-rev. The verified plasmid was used to delete purU in 
C. glutamicum WT and HIS7, resulting in strains C. glutamicum ΔpurU and HIS7 ΔpurU. The 
deletion was verified in both strains by PCR with primers purUdel1/purUdel2.  
The two potential L-histidine import systems encoded by aroP and cg1305 were also targeted 
with in-frame deletions. Therefor, the flanking regions were amplified with primer pairs 
aroP1/aroP2, aroP3/aroP4, cg1305-1/cg1305-2, and cg1305-3/cg1305-4, respectively. Plasmid 
pK19mobsacB was restricted with HindIII and EcoRI (for aroP) and XmaI and EcoRI (for 
cg1305), and the purified and restricted plasmids were used with the respective purified PCR 
products for isothermal assemblies. Sequence identity of both resulting plasmids 
pK19mobsacB ΔaroP and pK19mobsacB Δcg1305 were verified with pK19-fw and pK19-rev. 
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The potential purine biosynthesis regulator cg2314 was deleted in strain CM1 by amplifying 
the flanking regions with primer pairs cg2314-1/cg2314-2 and cg2314-3/cg2314-4. Plasmid 
pK19mobsacB was restricted with XbaI and NheI, purified, and used together with the two 
purified flanking regions in an isothermal assembly. The resulting plasmid was sequenced 
pK19mobsacB Δcg2314 with primers pK19-fw and pK19-rev and used to delete cg2314 in 
CM1 to give CM1 Δcg2314. The genomic deletion was verified in a PCR with primer pair 
cg2314-5 and cg2314-4. 
The apt gene was targeted with an in-frame deletion and an exchange of the translational start 
codon from GTG to TTG. Therefore, the flanking regions of apt were amplified with primer 
pairs aptdel1/aptdel2, aptdel3/aptdel4, aptttg1/aptttg2, and aptttg3/aptttg4, respectively. 
Plasmid pK19mobsacB was restricted with HindIII and EcoRI for both approaches and the 
purified and restricted plasmid was used together with the respective PCR products in 
isothermal assemblies. The resulting plasmids pK19mobsacB Δapt and pK19mobsacB aptTTG 
were sequenced with primers pK19-fw and pK19-rev.  
Overexpressions gene purA was achieved with pJC4 as basis. The gene sequence and the Ptuf 
promoter were amplified from the C. glutamicum genome with primer pairs tuf2_1/tuf2_2 and 
purA1/purArev. The TrrnB terminator was amplified from the E. coli K-12 MG1655 genome 
with primer pair trrnbpurA/rrnB2. All three PCR products were fused in a SOEing PCR with 
primer pair tuf2_1/rrnB2 and purified. Plasmid pJC4 was restricted with XbaI and NotI and 
purified. The SOEing product and the restricted plasmid were used for isothermal assembly and 
the resulting plasmid pJC4 purA was sequenced with primers ABseq1, purAseq1, and 
purAseq2. Transformation into strain CM1 resulted in CM1 (pJC4 purA). 
Overexpressions of hisD was achieved by cloning the hisD sequence into pJC4 and into 
pJC4 purApurB. Therefore, PsodA was amplified with primer pair sodA3/sodA4, hisD was 
amplified with primer pair hisD5/hisD6, and the terminator of the lactate dehydrogenase gene 
lldD (cg3227), TlldD, was amplified with primer pair lldD1/lldD2. The TlldD sequence was 
deduced from Pfeifer-Sancar et al., 2013. With the three PCR products as templates a SOEing 
PCR was conducted with primer pair sodA3/lldD2 and pJC4 and pJC4 purApurB were 
restricted with Bst1107I and NheI. The purified and restricted plasmids and the purified SOEing 
product were used in isothermal assemblies to give plasmids pJC4 hisD and 
pJC4 purApurB hisD, respectively. Both plasmids were sequenced with primers pJC4hisD1, 
pJC4hisD2, and pJC4hisD3 and transformed into HIS7 to give HIS7 (pJC4 purApurB hisD) 
and HIS7 (pJC4 hisD), respectively. 
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For overexpression of purH, PsodA was amplified with primer pair sodA5/sodA6 and purH was 
amplified with primer pair purH1/purH2 from the C. glutamicum genome. TrrnB was amplified 
from the E. coli K-12 MG1655 genome with primer pair rrnb3/rrnb4. All three PCR products 
were used as templates in a SOEing PCR with primer pair sodA5/rrnb4. The resulting product 
and pJC4 were restricted with XbaI and NotI, purified, and ligated together. The resulting 
plasmid pJC4 purH was sequenced with primers purHseq1, purHseq2, and purAseq and 
transformed into CM1 to create C. glutamicum PUR4. 
 Strain Construction – PART II 
For PART II, strains with deletions of genes encoding anaplerotic enzymes were constructed 
with C. glutamicum WT as basis strain. Oligonucleotides are listed in Table 4, page 41. All 
constructed and investigated strains are listed in Table 2, page 37.  
The deletions included genes ppc, pyc, and pck, encoding the phosphoenolpyruvate 
carboxylase, the pyruvate carboxylase, and the phosphoenolpyruvate carboxykinase. The 
deletions were done via two-step homologous recombination using the respective 
pK19mobsacB derivative (Table 3, p.39) and all three deletions have been described before 
(Buchholz et al., 2013; Peters-Wendisch et al., 1998; Riedel et al., 2001). 
C. glutamicum Δppc (Blombach et al., 2013) was supplied by Bastian Blombach (University of 
Stuttgart) and served as basis for C. glutamicum Δppc Δpyc. This strain was constructed with 
pK19mobsacB Δpyc (obtained from Bernhard Eikmanns, University of Ulm) as has been 
described before (Peters-Wendisch et al., 1998). 
Strain C. glutamicum Δppc Δpyc Δpck was generated by introducing pK19mobsacB Δpck 
(obtained from Bernhard Eikmanns, University of Ulm) into strain C. glutamicum Δppc Δpyc. 
After homologous recombination, the pck deletion was verified in a PCR with primer pair 
pckdel1/pckdel2.  
The ICD mutations revealed by WGS were re-engineered into the basis strain 
C. glutamicum Δppc Δpyc. With the purpose to construct plasmids for the introduction of the 
ICD mutations, the flanking regions of the icd gene were amplified from genomic DNA of 
C. glutamicum WT by PCR with primer pairs A94D1/A94D2 and A94D3/A94D4 for amino 
acid exchange A94D, primer pairs RG1/R453C2 and R453C3/RG2 for amino acid exchange 
R453C, and primer pairs RG1/G407S2 and G407S3/RG2 for amino acid exchange G407S. The 
primers already contained the nucleotide exchanges (given in parentheses) leading to the amino 
acid exchanges A94D (SNP G to T at position 681237 in WT), R453C (SNP G to A at position 
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680161 in WT), and G407S (SNP T to C at position 680299 in WT), respectively. The two PCR 
products were fused via SOEing PCRs and the purified product was either cut with EcoRI and 
BamHI for A94D or with EcoRI and NheI for G407S and R453C, respectively. Plasmid 
pK19mobsacB was restricted either with EcoRI and BamHI or EcoRI and NheI. The restricted 
and purified SOEing products were ligated into pK19mobsacB and sequence integrity was 
verified by DNA sequencing with primers pK19-fw and pK19-rev. After establishing all three 
amino acid exchanges in C. glutamicum Δppc Δpyc, the respective genomic regions were 
amplified with primer pairs RGseq1/RGseq2 for G407S and R453C, and A94Dseq1/A94Dseq2 
for A94D, and sequenced with primers RGseq3 or A94Dseq3, respectively. This resulted in 
strains C. glutamicum Δppc Δpyc ICDA94D, C. glutamicum Δppc Δpyc ICDR453C, and 
C. glutamicum Δppc Δpyc ICDG407S. 
For L-valine production, these three strains were each transformed with the L-valine 
overproduction plasmid pJC4ilvBNCE (Radmacher et al., 2002). This resulted in strains 
C. glutamicum Δppc Δpyc ICDA94D (pJC4ilvBNCE), C. glutamicum Δppc Δpyc ICDR453C 
(pJC4ilvBNCE), and C. glutamicum Δppc Δpyc ICDG407S (pJC4ilvBNCE). 
 Disruption of C. glutamicum 
 Mechanical disruption 
Clear lysates of the respective C. glutamicum strains for enzyme assays (2.8.7 Enzyme assays, 
p.90) was obtained by harvesting cells in the exponential growth phase at an OD600 of 7 (about 
1.5 g CDW L-1). The cell suspension was centrifuged at 4,500 × g for 10 min at 4 °C (centrifuge 
5804 R, rotor: A-4-44, Eppendorf AG, Hamburg, Germany), the supernatant was discarded 
completely, and the pellet was washed once in wash buffer (0.2 M Tris-HCl pH 7.4; Table 18, 
p.60), and then resuspended in 0.4 mL lysis buffer (0.1 M Tris-HCl, 10% [v v-1] glycerol, 
pH 7.4; Table 19, p.60). This solution was then transferred into a screwcap reaction tube filled 
with 0.25 mL of glass beads (Ø 0.1 mm; Carl Roth GmbH&Co. KG). Mechanical disruption 
was performed with a Precellys®24 (Bertin Instruments, Montigny-le-Brettonneux, France) 
device at 6,500 rpm for 3×20 s intervals, intermitted by 5 min breaks, where samples were 
stored on ice. To obtain cleared lysates, the cell debris was separated by centrifugation at 
20,000 × g for 20 min at 4 °C (centrifuge 5804 R, rotor: FA 45-30-11, Eppendorf AG, 
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Hamburg, Germany). Supernatants were carefully transferred in a new reaction tube and stored 
on ice until further use (2.8.7 Enzyme assays, p.90). 
 Chemical disruption and quenching 
For HPLC analysis of the intracellular adenylates, chemical disruption and quenching of the 
metabolism of C. glutamicum was achieved with perchloric acid. The protocol was based on 
before published approaches (Cserjan-Puschmann et al., 1999; Löffler et al., 2016) and was 
modified in the following points. The respective strain was cultivated aerobically until the 
mid-exponential growth phase and cells were harvested at an OD600 of 7 (about 1.5 g CDW L-1) 
and 1 mL of cell suspension was immediately added to 250 µL of -20 °C cold lysis buffer 
(35% [v v-1] perchloric acid, 80 µM EDTA). This suspension was incubated on an overhead 
shaker with about 60 rpm at 4 °C. Then, 0.25 mL 1 M K2HPO4 followed by 0.19 mL 5 M KOH 
were added, promoting neutralization (pH 7.0). The suspension was centrifugation (20,800 × g, 
5 min, 4 °C; centrifuge 5427 R, rotor: FA 45-30-11, Eppendorf AG, Hamburg, Germany), the 
supernatant was transferred into a new reaction tube, and the pH value was verified with a 
pH-meter (pH meter FiveEasy™ FE20, Mettler-Toledo GmbH, Göppingen, Germany). When 
necessary, 5 M KOH was added in small steps until the desired pH value of 6.95 - 7.00 was 
reached. The supernatant was analysed directly or stored at -70 °C until further analysis (2.8.6 
HPLC measurements, p.89). Alterations of the volume by addition of KOH were noted and 
considered for recalculations. 
For the preparation of metabolite samples for SMP measurements (2.8.8 Systems Metabolic 
Profiling, p.91), the relevant strains were cultivated aerobically in shaking flasks to an OD600 
of 8.5 (about 1.8 g CDW L-1) for PART I or to an OD600 of 12 (about 2.5 g CDW L-1) for PART II. 
Sampling, quenching, and metabolite extraction were carried out based on a previously 
described approach (Teleki et al., 2015), including the following minor changes. 2 mL of cell 
suspension were sampled by fast centrifugation (12,100 × g, 20 s, 30 °C; centrifuge 5427 R, 
rotor: FA 45 30 11, Eppendorf, Hamburg, Germany), washed with 1.5 mL of 0.9% (w v-1) NaCl 
solution, and then centrifuged again. Immediately after centrifugation, biomass was quenched 
in liquid N2 and stored at -70 °C. Defined amounts of 250 M L-norvaline solution as internal 
standard were added to the biomass pellets to obtain an extraction concentration of 
20 g CDW L-1 for PART I. For PART II, biomass concentrations were adjusted to 30 g L-1 by 
adding defined amounts of H2O to the pellets. Immediately after addition, samples were 
preincubated for 1 min at 100 °C in a water bath, homogenized by vortexing for 20 s, and 
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incubated for either 3 min (for PART I) or 4 min (for PART II) at 100 °C in a water bath. 
Subsequently, suspensions were chilled on ice, centrifuged (20,800 × g, 10 min, 4 °C; 
centrifuge 5427 R, rotor: FA 45-30-11, Eppendorf AG, Hamburg, Germany), and supernatants 
were stored at -70 °C until needed for further analysis (2.8.8 Systems Metabolic Profiling, p.91; 
Bolten et al., 2007).  
 Analytical methods 
 Optical density 
Bacterial growth was monitored by determining the turbidity of the cell suspension at a 
wavelength of 600 nm (OD600) in polystyrolic semi-micro cuvettes (Sarstedt AG & Co. KG, 
Nümbrecht, Germany). For this purpose, a sample was taken from the cell suspension, diluted 
in 0.9% (w v-1) NaCl, and analyzed in the Ultrospec 10 Cell Density Meter (GE Healthcare 
Europe GmbH, Freiburg, Germany) in the linear range of 0.1 - 0.3. A correlation of the turbidity 
to the cell number was adopted by the correlation of an OD600 value of 1 equalling about 108 
cells. 
 Cell dry weight 
To determine the correlation between the OD600 values and their respective cell dry weight, the 
following equation (Equation 3) was used 
Equation 3. 𝐂𝐃𝐖 = 𝛂 × 𝐎𝐃𝟔𝟎𝟎 ቂ
𝐠
𝐋
ቃ 
The experimental determination of the cell dry weight was done by drying glass test tubes 
(centrifuge tubes round bottom DURAN®, 12 mL, Carl-Roth GmbH, Karlsruhe, Germany). for 
2 d at 105 °C, cooling them to RT in a desiccator, and weighing them. Then, 5 mL of 
biosuspension from several time points during the bacterial cultivation were taken and 
centrifuged at 4,000 × g for 10 min at 4 °C (centrifuge 5427 R, rotor: F-35-6-30, Eppendorf 
AG, Hamburg, Germany). The supernatant was discarded completely, the pellet was washed 
twice with 5 mL dH2O, and glass tubes including pellets were dried at 105 °C for 2 d. After 
cooling to RT in a desiccator, the dry mass of the pellet was determined by subtracting the 
weight of the empty glass tube from the weight of the filled tube. Representative correlation 
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coefficients α of CDW with OD600 were determined for C. glutamicum WT and 
C. glutamicum HIS7 in CGXIIN (Table 12, p.58) minimal medium with 10 g glucose L-1 for 
several OD600/CDW values. The common correlation coefficient α of 0.21 g L-1 was determined 
for the Ultrospec 10 Cell Density Meter (GE Healthcare Europe GmbH, Freiburg, Germany) 
and both above mentioned strains. This correlation factor was therefore used for all CDW 
calculations throughout this work. 
 Glucose concentration 
The glucose concentration was determined in cleared supernatants of several time points during 
cultivations according to Equations 2 - 4. Therefore, 1 mL of cell suspension was taken from 
the bioreactor / shaking flask and centrifuged at 12,100 × g for 5 min at RT (Centrifuge 
MiniSpin®, rotor F-45-12-11, Eppendorf AG, Hamburg, Germany). The supernatant was 
transferred in a new reaction tube and directly analysed or frozen at -20 °C until used for further 
analysis. The photometric quantification of the glucose concentration in the supernatants was 
performed in acrylic semi-micro cuvettes (Sarstedt AG & Co. KG, Nümbrecht, Germany) with 
an Ultrospec™ 2100 pro UV/Visible spectrophotometer (GE Healthcare Europe GmbH, 
Freiburg, Germany). The method was performed as has been described before (Hoffart et al., 
2017). For this purpose, 500 µL buffer (400 mM Tris, 4 mM MgSO4, pH 7.6; Table 21, p.60), 
100 µL NADP+ (4.4 mg mL-1), 100 µL ATP (9.6 mg mL-1), 190 µL dH2O, and 100 µL of the 
prediluted supernatant (concentration in the cuvette < 0.1 mM) were mixed. Then, the initial 
extinction at a wavelength of 365 nm was determined. The underlying reaction cascade was 
started by adding 10 µL glucose 6-phosphate dehydrogenase / hexokinase mix (Roche 
Diagnostics International Ltd) and incubating the reaction mix for 10 min at RT. After 
incubation, the final extinction was determined and calculation after the Lambert-Beer law was 
obtained with the following formula (Equations 4, 5, 6), considering εNADPH at 365 nm. 
Equation 4. 𝜟𝑬 =  𝜺 ×  𝒄 ×  𝒅 
Equation 5. 𝒄 = 𝜟𝑬
𝜺×𝒅
 
Equation 6. 𝜺𝑵𝑨𝑫𝑷𝑯 =  𝟑. 𝟓𝟒
𝑳
𝒎𝒎𝒐𝒍× 𝒄𝒎
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 DNA 
DNA concentrations and purity of the prepared DNA were determined with a Nano Drop 
ND-1000 spectrophotometer (PEQLAB Biotechnologie GmbH, Erlangen, Germany) according 
to the manufacturer’s instructions.  
 Proteins 
The determination of the total protein content of a sample was done in cleared lysates of 
C. glutamicum (2.7.1 Mechanical disruption, p.85) with the BCA Protein Assay Kit (Thermo 
Fisher Scientific Inc., Waltham, USA; Table 7, p.55). Quantification of the total protein content 
was accomplished by analyzing a 9-level standard calibration curve of diluted albumin (BSA; 
data not shown) at 562 nm in a Synergy 2 microplate reader (BioTek Instruments GmbH, Bad 
Friedrichshall, Germany) using 96-well plates (Greiner Bio-One GmbH, Frickenhausen, 
Germany). Samples were diluted 1:10 and 1:20 in dH2O and reactions were incubated for 
30 min at 37 °C. 
 HPLC measurements 
For all HPLC measurements HiPerSolv CHROMANORM® water (VWR, Radnor, USA) was 
used. Concentrations of amino acids in the supernatants of cultivated C. glutamicum strains 
were determined as has been described before (Buchholz et al., 2013). For this purpose, 1 mL 
of cell suspension was harvested by centrifugation (12,100 × g, 5 min, RT; Centrifuge 
MiniSpin®, rotor F-45-12-11, Eppendorf AG, Hamburg, Germany) and supernatants were used 
for further analysis. Quantification was performed with an Agilent 1200 series apparatus 
(Agilent Technologies, Santa Clara, CA, USA) equipped with an Agilent Zorbax Eclipse Plus 
C18 column (250 × 4.6 mm, 5 µm) protected by an Agilent Zorbax Eclipse Plus C18 guard 
column (12.5 × 4.6 mm, 5 µm). Fluorometric detection (excitation at 230 nm and emission at 
450 nm) was carried out after automatic precolumn derivatization with ortho-phtaldialdehyde. 
The elution buffer consisted of a polar phase buffer (A) (10 mM Na2HPO4, 10 mM Na2B4O7, 
0.5 mM NaN3, pH  8.2; Table 25, p.61) and a nonpolar phase buffer (B) (45% (v v-1) methanol, 
45% (v v-1) acetonitrile;Table 26, p.62). Quantification of the analytes was conducted by using 
200 µM L-ornithine as internal standard to correct variabilities in analytes and a seven-point 
calibration curve for each component as an external reference standard. For calibration 
purposes, the Amino Acid Standard (AAS18, Sigma-Aldrich GmbH, Taufkirchen, Germany) 
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was used, enabling the identification of the following compounds: L-alanine, L-arginine, 
L-aspartic acid, L-cysteine, L-glutamic acid, glycine, L-histidine, L-isoleucine, L-leucine, 
L-lysine, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tyrosine, and 
L-valine. 
The concentrations of the adenylates ATP and ADP were determined with an HPLC system 
(1200 series, Agilent Technologies, Santa Clara, CA, USA) equipped with a RP-C18 
(octadecyl) phase column (Supelcosil LC-18-T, 3 µm, 150 cm × 4.6 mm) and a diode array 
detector (DAD) and has been described before (Löffler et al., 2016). Samples were prepared as 
described above (2.7.2 Chemical disruption and quenching, p.86). Buffer A (0.1 M KH2PO4, 
0.1 M K2HPO4, 4 mM TBAS, pH 6.0; Table 27, p.62) and buffer B (0.1 M KH2PO4, 0.1 M 
K2HPO4, 4 mM TBAS, pH 7.2 with 30% (v v-1) methanol; Table 28, p.62) were used to 
generate a gradient (3.5 min, 0% B; 20 min, 30% B, 22 min 35% B; 40 min, 60% B; 48 min, 
100% B; 55 min, 100% B, 60 min 0% B) with a flow rate of 1 mL min-1.  
 Enzyme assays 
The specific enzyme activities of the tricarboxylic acid (TCA) cycle enzyme isocitrate 
dehydrogenase (ICD) and of the glyoxylate shunt enzymes isocitrate lyase (ICL) and malate 
synthase (MS) were determined according to published methods with slight modifications 
(Eikmanns et al., 1995; Reinscheid et al., 1994b, 1994a). To obtain cleared lysates of the 
respective strains, they were cultivated, harvested, and disrupted as described above (2.4.1 
General cultivations, p. 62; 2.7.1 Mechanical disruption, p.85).  
Specific enzyme activities of ICD, ICL, and MS were determined with an Ultrospec™ 2100 
pro UV/Visible spectrophotometer (GE Healthcare Europe GmbH, Freiburg, Germany) in 
acrylic semi-micro cuvettes (Sarstedt AG & Co. KG, Nümbrecht, Germany) or UV cuvettes 
(UV-Küvetten micro, BRAND GMBH + CO KG, Wertheim, Germany) at 30 °C. 
For ICD, the cell extracts were diluted 1:50 and 1:100 in lysis buffer (0.1 M Tris, 10% [v v-1] 
glycerol, pH 7.4; Table 19, p.60) and. 500 µL of assay buffer ICD (100 mM Tris, 0.8 mM 
MnSO4 × H2O, 0.5 mM NADP × 2 Na, pH 7.6; Table 22, p.61), 350 µL dH2O, and 100 µL 
prediluted cell extract were mixed and the initial extinction was monitored for 2 min at 30 °C 
at a wavelength of 340 nm to obtain slope 1 (S1). After 2 min, the reaction was started by adding 
50 µL 16 mM Potassium-Ds-threo-isocitrate and the extinction was monitored for 8 min to 
obtain slope 2 (S2). Both slopes were determined by linear regression. 
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Specific activities of the ICL were determined by diluting the cleared lysates 1:50 and 1:100 in 
lysis buffer (Table 19, p.60). The content of the cuvette was as follows: 500 µL assay buffer 
ICL (50 mM MOPS-NaOH, 5 mM dithiothreit, 15 mM MgCl2, 1 mM EDTA, 0.2 mM 
NADH × 2 Na, pH 7.3; Table 23, p.61), 345 µL dH2O, 5 µL L-lactate dehydrogenase from 
rabbit muscle (Sigma-Aldrich GmbH, Taufkirchen, Germany), and 100 µL prediluted lysate. 
The initial extinction was monitored for 2 min at 30 °C at a wavelength of 340 nm to obtain 
slope 1 (S1). After 2 min, the reaction was started by adding 50 µL 100 mM 
Potassium-Ds-threo-isocitrate and the extinction was monitored for 8 min to obtain slope 2 (S2). 
Both slopes were determined by linear regression. 
The MS specific activities were determined by prediluting the cleared lysates 1:20 and 1:50 in 
lysis buffer (Table 19, p.60). Since the alterations in extinction were measured at 232 nm, 
instead of the acrylic cuvettes, UV cuvettes (UV-Küvetten micro, BRAND GMBH + CO KG, 
Wertheim, Germany) were used. The cuvettes contained 250 µL assay buffer MS (50 mM Tris, 
40 mM MgCl2, 2 mM sodium glyoxylate × H2O, pH 7.6; Table 24, p.61). The initial extinction 
was monitored for 2 min at 30 °C at a wavelength of 232 nm to obtain slope 1 (S1). After 2 min, 
the reaction was started by adding 100 µL 4.8 mM acetyl coenzyme A (acetyl-COA) and the 
extinction was monitored for 8 min to obtain slope 2 (S2). Both slopes were determined by 
linear regression. 
 Systems Metabolic Profiling 
Systems Metabolic Profiling (SMP) is an LC-MS/MS Q-TOF-based metabolomics approach, 
which enables analysis of several interesting metabolites. All SMP measurements conducted 
for this work were performed by André Feith. For all LC MS/MS Q-TOF-based measurements 
HiPerSolv CHROMANORM® water (VWR, Radnor, USA) was used. Metabolite samples 
(2.7.2 Chemical disruption and quenching, p.86) were analyzed on an Agilent 1260 HPLC 
system coupled to an Agilent 6540 Accurate-Mass LC-MS/MS Q-TOF system with ESI Jet 
Stream Technology (Agilent Technologies, Santa Clara, USA). Two different hydrophilic 
interaction chromatography (HILIC) systems were used to get high metabolite coverage.  
For PART I, two different hydrophilic interaction chromatography (HILIC) systems were used 
to get high metabolite coverage. The first method was ammonium acetate based (10 mM, pH 
9.2) utilizing a SeQuant ZIC-pHILIC column (150 × 2.1 mm, 5 μm; Merck KGaA, Darmstadt, 
Germany) with guard column (Sequant ZIC-pHILIC, 20 × 2.1 mm, 5 μm; Merck KGaA, 
Darmstadt, Germany) at 40 °C, 0.2 mL min 1, and 5 μL injection volume. For details see 
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(Teleki et al., 2015). an acidic HILIC method was established using ammonium formate buffer 
(10 mM, pH 2.8) and a Waters XBridge BEH Amide column (150 × 2.1 mm, 3 5 μm; Waters 
Corp., Milford, MA, USA) coupled to a Waters XBridge BEH Amide VanGuard Cartridge (5 
× 2.1 mm, 3.5 μm; Waters Corp., Milford, MA, USA) at 35 °C / 0.2 mL min-1 / 5 μL injection 
volume. Mobile phases were composed as follows: Mobile phase A: 90% acetonitrile / 10% 
water, 10 mM ammonium formate and mobile phase B: 10% acetonitrile / 90% water, 10 mM 
ammonium formate. Both adjusted to pH 2.8 with formic acid. Gradient elution was carried out 
by the following program: Isocratic hold 0% B for 1 min, linear gradient to 62.5% B for 15 min, 
linear gradient to 100% B for 4 min, column wash at 100% B for 5 min, linear gradient to 0% 
B for 5 min and column equilibration at 0% B for 15 min. Samples were prepared in 60% (v v-1) 
acetonitrile and 10 mM ammonium acetate (pH 9.2) or ammonium formate (pH 2.8). All 
metabolite samples were separated with both HILIC methods in positive and negative MS mode 
(tuned in extended dynamic range) with following conditions: drying gas flow rate of 8 L min-1 
with a gas temperature of 325 °C, nebulizer with 40 lb per square inch gauge, sheath gas flow 
rate of 12 L min-1 and sheath gas temperature of 350 °C, capillary voltage of 4000 V and 
fragmentor voltage of 100 V. Additionally, fragmentation experiments in the targeted MS/MS 
mode were carried out to investigate and verify structure integrity of IGP, adenylosuccinate, 
SAICAR, and FGAR. For this, precursor ions [M+H] or [M-H], verified by accurate mass, were 
selected and fragmented at their characteristic retention times via collision-induced dissociation 
(CID) at 10, 20, and 30 V. Since analytical standards of those compounds were not 
commercially available or only by custom synthesis, fragmentation patterns were 
computationally evaluated with MassHunter Molecular Structure Correlator (B05.00, Agilent 
Technologies, Santa Clara, USA). By combining accurate mass and plausible fragmentation 
patterns IGP, adenylosuccinate, SAICAR, and FGAR could be identified. 
For PART II, samples were prepared in 60% (v v-1) acetonitrile and 10 mM ammonium acetate 
buffer (pH 9.2), resulting in 1:20 dilutions. 5 µL of the sample were injected onto a SeQuant® 
ZIC-pHILIC column (150 × 2.1 mm, 5 µm; Merck KGaA, Darmstadt, Germany) with guard 
column (SeQuant® ZIC-pHILIC, 20 × 2.1 mm, 5 µm; Merck KGaA, Darmstadt, Germany) at 
40 °C with a flow rate of 0.2 mL min-1. Chromatographic separation was based on a previously 
described method (Teleki et al., 2015), however adapted to a quaternary pump system. Mobile 
phases were composed as follows: Mobile phase A: 100% acetonitrile, mobile phase B: 90% 
water / 10% acetonitrile, and mobile phase C: 400 mM ammonium acetate, adjusted to pH 9.2 
with 25% (w v-1) ammonium hydroxide. Gradient elution was carried out as follows (2.5% C 
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was present at all time in the program): isocratic hold 8.2% B for 1 min, linear gradient to 74.2% 
B for 30 min, linear gradient to 96.2% B for 4 min, column wash at 96.2% B for 5 min, linear 
gradient to 8.2% B for 10 min, and column equilibration at 8.2% B for 15 min. After separation 
analytes were detected in negative MS mode (tuned in extended dynamic range) with following 
conditions: drying gas flow rate of 8 L min-1 with a gas temperature of 325 °C, nebulizer with 
40 lb per square inch gauge, sheath gas flow rate of 12 L min-1 and sheath gas temperature of 
350 °C, capillary voltage of 4000 V and fragmentor voltage of 100 V. 
 Calculations 
 Growth rates 
Growth rates (µ) in h-1 were calculated by linear regression in a semi-logarithmic fashion by 
plotting the biomass concentration (g CDW L-1) over the cultivation time. The exponential 
growth phase was determined by using a maximization of the coefficient value (R-square). This 
was done for all calculated growth rates, unless stated otherwise. In some cases, differential 
growth rates were determined, which were calculated with according to Equation 7. 
Equation 7. µ𝒅𝒊𝒇𝒇 =
𝚫𝒄𝒙
𝚫𝒕
= (𝒍𝒏 𝒄𝒙
𝟐)ି(𝐥𝐧 𝒄𝒙𝟏)
(𝒕𝟐ି𝒕𝟏)
 [𝒉ି𝟏] 
 Yields 
With the aim to thoroughly characterize the constructed strains in detail, several different yields 
were calculated. The biomass/substrate yield YX/S was calculated by linear regression via 
plotting the biomass concentration (g CDW L-1) over the respective substrate concentration 
(g glucose L-1). 
For all product/substrate yields in PART I and for some in PART II (as indicated), the product and 
byproduct yields, YP/Shis for L-histidine, YP/Sgly for glycine, and YP/Sval for L-valine were 
calculated either by plotting the product/byproduct concentration (mM or g L-1) over the 
respective substrate concentration (mM or g L-1) via linear regression.  
For some product/substrate yields in PART I (as indicated), YP/S was calculated differentially 
with values obtained after 24 h of cultivation according to Equation 8. 
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Equation 8. 𝒀𝑷/𝑺 =
𝒄𝑷
𝟐𝟒
𝒄𝑺
𝟎ି𝒄𝑺
𝟐𝟒  ቂ
𝒎𝒐𝒍
𝒎𝒐𝒍
ቃ  𝒐𝒓 ቂ𝒈
𝒈
ቃ 
 Substrate uptake and production rates 
The YX/S values and the growth rates from above (2.9.1 Growth rates, p.93; 2.9.2 Yields, p.93), 
were used to calculate the biomass specific substrate uptake rate (qS) according Equation 9, 
whereby µ is the growth rate (h-1). 
Equation 9. 𝒒𝑺 =
µ
𝒀𝑿/𝑺
 ቂ 𝒈
𝒈𝑪𝑫𝑾×𝒉
ቃ 
The YP/S values and the growth rates from above (2.9.1 Growth rates, p.93; 2.9.2 Yields, p.93), 
were used to calculate the biomass specific product formation rate according Equation 10. 
Equation 10. 𝒒𝑷 =
µ
𝒀𝑷/𝑺
 ቂ 𝒈
𝒈𝑪𝑫𝑾×𝒉
ቃ  𝒐𝒓 ቂ 𝒎𝒎𝒐𝒍
𝒈𝑪𝑫𝑾×𝒉
ቃ   
Since qP and qS values were calculated from two error-prone values, the standard errors (SE) 
for qP and qS were determined via Gaussian error propagation using the standard deviations 
(σ) according to Equation 11. The errors for the energy charges were calculated in the same 
manner. 
Equation 11. 𝑺𝑬 = ඨ൬ 𝟏
𝒀𝑿/𝑺
× 𝝈µ൰
𝟐
+ ቆµ × 𝟏
൫𝒀𝑿/𝑺൯
𝟐 × 𝝈𝒀𝑿/𝑺ቇ
𝟐
 
Statistical significances were calculated with Excel v. 2016 (Microsoft Corp., Redmond, USA) 
as independent two-sample student’s t-test to assess the equality of different datasets resulting 
from biological experiments in triplicates. The confidence interval was set to be p < 0.05 and 
when resulting values were below p, the datasets were assessed as significantly different. 
 Specific enzyme activities 
The specific enzyme activities A (U mg-1) of ICD, ICL, and MS enzymes were calculated with 
the following formula, where S1/S2 are the determined slopes (2.8.7 Enzyme assays, p.90). D 
is the dilution factor of the sample, V is the volume of the assay (V = 1 mL), ε is the extinction 
factor for the respective enzyme at the given wave length, d is the diameter of the used cuvette 
(d = 10 mm), cprotein is the protein concentration (2.8.5 Proteins, p.89) of the sample, i.e. cleared 
bacterial lysate. The used extinction factors for the calculations were εICD = 6.28 (mM cm)-1 for 
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ICD at 340 nm, εICL = 6.28 (mM cm)-1 for ICL at 340 nm, and εMS = 4.50 (mM cm)-1 for MS at 
232 nm, respectively. Specific enzyme activities were calculated according to Equation 12. 
Equation 12. 𝐀 = (𝑺𝟐ି𝑺𝟏)×𝑽
𝜺×𝒅×𝒄𝒑𝒓𝒐𝒕𝒆𝒊𝒏
 × 𝑫 ቂ 𝑼
𝒎𝒈
ቃ 
 Intracellular adenylate concentrations 
The measured concentrations of the adenylate species was related to the biomass concentration. 
This was done with the following formula, where 𝑐஺௫௉௜௡௧  is the intracellular AxP concentration 
per CDW, cAxP is the measured concentration of the respective adenylate species, cx is the 
biomass at the harvest time point, and V is the factor considering volume change during titration 
in the chemical disruption (2.7.2 Chemical disruption and quenching, p.86). The intracellular 
adenylate concentration was calculated according to Equation 13. 
Equation 13. 𝒄𝑨𝒙𝑷𝒊𝒏𝒕 =
𝒄𝑨𝒙𝑷
𝒄𝒙
× 𝑽 ቂµ𝒎𝒐𝒍 𝑨𝑻𝑷
𝒈 𝑪𝑫𝑾
ቃ 
 Energy charge 
The adenylate energy charge (EC) has been introduced as a measurement to evaluate and 
compare the energetic state(s) of cells during different phases of microbial growth. This was 
done based on the originally introduced calculations as were described before and is shown in 
Equation 14 (Atkinson, 1968; Atkinson and Walton, 1967).  
Equation 14.  𝑬𝑪 = 𝑨𝑻𝑷ା𝟎.𝟓×𝑨𝑫𝑷
𝑨𝑴𝑷ା𝑨𝑫𝑷ା𝑨𝑻𝑷
 
Owing the fact that ATP is a crucial metabolite in L-histidine production with C. glutamicum, 
the intracellular concentrations of the adenylates were measured (2.9.5 Intracellular adenylate 
concentrations, p.95) and with the obtained values, energy charges were calculated. Since the 
absolute concentrations of AMP in all surveyed L-histidine producing mutants were below the 
detection limit of the applied system (3.1.4 Intracellular ATP & ADP concentrations, p.107), 
AMP was omitted as factor in these calculations. Equation 15 was used to calculate the ECs. 
Equation 15. 𝑬𝑪 = 𝑨𝑻𝑷ା𝟎.𝟓×𝑨𝑫𝑷
𝑨𝑫𝑷ା𝑨𝑻𝑷
 
The omission of AMP from the calculations of the EC for the WT leads to a deviation of about 
9%, which was calculated for C. glutamicum WT in the exponential growth phase when AMP 
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was omitted vs. when AMP was considered (data not shown). Since the EC is a relative 
measurement and since AMP was omitted from EC calculations for all strains, the 
comparability throughout the strain database is ensured.  
 Data analysis 
 Systems Metabolic Profiling – Data analysis 
In PART I, peak picking and integration was done in MassHunter ProFinder (B08.00, Agilent 
Technologies, Santa Clara, USA) by using “batch recursive feature extraction”. Subsequently, 
statistical analysis was performed in Mass Profiler Professional (13.1.1, Agilent Technologies, 
Santa Clara, CA, USA). Significance testing was done by one-way ANOVA and p-values were 
filtered (p < 0.05). Peaks were identified by accurate mass and with a personal compound data 
library, containing retention times of authentic standards. Unidentified significant features were 
searched against the METLIN (Guijas et al., 2018) and MassBank (Horai et al., 2010) database. 
After identification, peak integration was manually curated via “batch targeted feature 
extraction”.   
In PART II, system control and acquisition were performed using MassHunter Data Acquisiton 
(B06.01, Agilent Technologies, Santa Clara, USA). Peak picking and integration was done in 
MassHunter ProFinder (B08.00, Agilent Technologies, Santa Clara, USA) by using “batch 
targeted feature extraction” with a personal compound data library, focusing on central carbon 
metabolism and amino acid biosynthesis. Statistical analysis was performed in Mass Profiler 
Professional (13.1.1, Agilent Technologies, Santa Clara, USA). Significance testing was done 
by T-test, p-values were filtered (p < 0.05), and fold changes were calculated normalized to 
C. glutamicum WT. 
 Flux balance analysis 
Flux Balance Analysis (FBA) was performed to elucidate metabolic flux distributions in 
C. glutamicum WT and to identify alterations in comparison with L-histidine producing mutants 
(PART I) and the C. glutamicum Δppc Δpyc double deletion mutant strain (PART II). (Becker et 
al., 2007). All computations were performed with MATLAB 2015b (The MathWorks, Natick, 
USA) and the COBRA Toolbox v3.0 with glpk solvers (Schellenberger et al., 2011), using the 
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genome-scale metabolic model (GEM) of C. glutamicum ATCC 13032, iCW773 (Zhang et al., 
2017).  
For PART I, the glucose uptake rate was set to 3.94 mmol gCDW-1 h-1 for all simulations 
(Blombach et al., 2013), however objective functions and constraints were changed as follows: 
a) Maximizing growth rate with no further constraints results in  = 0.36 h-1 and b) maximizing 
L-histidine production and fixing growth rate to  = 0.1 h-1 results in a yield of 
0.51 mol L-histidine mol-1 glucose. 
In PART II, the pyruvate carboxylase reaction, catalyzed by PCx, was set to irreversible, as 
opposed to be reversible in the original GEM (Jitrapakdee et al., 2008). Glucose uptake rates 
were fixed to 4.2 mmol gCDW-1 h-1 for C. glutamicum WT and C. glutamicum Δppc Δpyc 
resulting in growth rates of 0.390 h-1 and 0.389 h-1, respectively. In addition, flux values were 
constrained to zero for the phosphoenolpyruvate carboxylase (PEPCx) and pyruvate 
carboxylase reaction (PCx) when computing FBA for the double deletion strain C. glutamicum 
Δppc Δpyc. The in vivo growth rate of 0.27 h-1 could also be obtained for the C. glutamicum 
Δppc Δpyc strain by adjusting glucose uptake rate. However, this did not result in any growth 
rate dependent changes of metabolic flux distribution. 
 Genome sequencing 
The genome sequencing was performed by the Kalinowski Lab at CeBiTec, Bielefeld 
University. With the aim to identify acquired mutations during the evolutionary cultivations, 
the genomic DNA of the evolved strains was isolated with the DNeasy Blood & Tissue Kit 
(QIAGEN, Hilden, Germany; 2.5.1 Isolation/purification of DNA, p.69). An Illumina Nextera 
sequencing library was prepared according to the manufacturer's instructions and sequenced in 
a 2 × 150 bp run on a MiSeq Desktop sequencing platform. The reads were mapped to the 
reference sequence of C. glutamicum WT (Kalinowski et al., 2003) using the mapping program 
SARUMAN (Blom et al., 2011), resulting in a median coverage of the genome between 145.6 
to 172.0-fold. Single nucleotide polymorphism (SNP) identification was done using the filtering 
strategy applied by (Roetzer et al., 2013): SNPs were called for bases with at least 80% reads 
showing the alternative base with a minimum coverage of 10 reads.  
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CHAPTER 3: RESULTS 
 Results PART I 
 Modularizing the L-histidine metabolism 
With the purpose to subdivide the metabolism of C. glutamicum around the L-histidine 
biosynthesis, we classified it in four modules, allowing the separate tackling of each module on 
the one hand. On the other hand, the holistic combination of the knowledge gained in each 
module was intended to help balancing the involved pathways on each other. The four created 
modules comprised the L-histidine biosynthesis, the central carbon metabolism (including 
glycolysis and pentose phosphate pathway, PPP), the purine biosynthesis (including the de novo 
and salvage parts), and the one carbon metabolism of tetrahydrofolate (THF) species (C1 
metabolism). An overview of this modularization is given in Fig. 10 on page 99 and comprises 
the selected reactions in the above mentioned pathways with their cofactors, which are 
important for the detailed contemplation of the following results. This overview is intended to 
depict and underline the complex, intertwined embedment of the L-histidine biosynthesis in the 
complete metabolism of C. glutamicum. The following paragraphs will illuminate and discuss 
this embedment.
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Fig. 10. Overview of the modularized metabolism of C. glutamicum with focus on the histidine biosynthesis 
and the related pathways central carbon metabolism, purine biosynthesis, and one carbon metabolism. The 
glycine cleavage (GCV) system is not present in C. glutamicum WT and was heterologously produced (dark 
grey). Abbreviations: 2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; 5’-ProFAR, 1-(5-phosphoribosyl)-
5-[(5-phosphoribosylamino) methylideneamino] imidazole-4 carboxamide; α KG, α-ketoglutarate; ADP, 
adenosine diphosphate; AdSucc, adenylosuccinate; AICAR, 1-(5′-phosphoribosyl)-5-amino-4-
imidazolecarboxamide; AIR, 5-aminoimidazole ribotide; AMP, adenosine monophosphate; asp; L-aspartate; 
ATP, adenosine triphosphate; fTHF, 10-formyltetrahydrofolate; F-1,6-Bis-P, fructose-1,6-bisphosphate; F6P, 
fructose 6-phosphate; FAICAR, 5-formamidoimidazole-4-carboxamide ribotide; fGAM, 
5’phosphoribosylformyl-glycineamidine; fGAR, phosphoribosyl-N-formylglcineamide; fum, fumarate; G6P, 
glucose 6-phosphate; GA3P, glyceraldehyde 3-phosphate; GAR, glycineamide ribonucleotide; GCV, glycine 
cleavage system; gln, L-glutamine; glu, L-glutamate; GMP, guanosine monophosphate; HisA, 5’ProFAR 
isomerase; HisB, imidazoleglycerol phosphate dehydratase; HisC, histidinol phosphate aminotransferase; 
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 Flux Balance Analysis 
Flux Balance Analysis (FBA) is a mathematical approach to simulate metabolism based on 
genome-scale models of metabolic networks (Gianchandani et al., 2009; Orth et al., 2010; 
Raman and Chandra, 2009). The application of FBAs enables the prediction of systemic 
phenotypes as fluxes through a reaction network (Gianchandani et al., 2009). André Feith 
(IBVT, University of Stuttgart) conducted the following FBAs using a genome-scale metabolic 
model (GEM) of C. glutamicum ATCC 13032, iCW773 (Zhang et al., 2017). In two case 
studies, he a) maximized the growth rate of the model, including no further constraints, which 
resulted in  = 0.36 h-1 and b) maximized L-histidine production, simultaneously fixing the 
growth rate to  = 0.1 h-1, which resulted in a maximal theoretical yield of 
0.51 mol L-histidine mol-1 glucose (0.44 g L-histidine g substrate). Compared with the case 
study for growth optimization, the predicted flux distributions for the histidine optimized case 
study indicated three interesting points:  
i) In the L-histidine production scenario, the flux distribution at the junction between glycolysis 
and PPP (i.e. the reaction catalysed by the phosphoglucoisomerase) changed from a 61:38 ratio 
to a 34:66 ratio, favouring the PPP over glycolysis and directing increased amounts of carbon 
towards the L-histidine precursor PRPP, i.e. 74% increased carbon flux (Fig. 11, p.102).  
Legend Fig. 10. continued: HisD, histidinol dehydrogenase; HisE, phosphoribosyl-ATP 
pyrophosphatase; HisF, synthase subunit of IGP synthase; HisG, ATP phosphoribosyltransferase; 
HisH, glutaminase subunit of IGP synthase; HisI, phosphoribosyl-AMP cyclohydrolase; HisN, 
histidinol-phosphate phosphatase; Hol-P, L-histidinol phosphate; IAP, imidazole-acetole phosphate; 
IGP, imidazole-glycerol phosphate; IMP, inosine monophosphate; mTHF, 5,10-
methylenetetrahydrofolate; N5-CAIR, 5’-phosphoribosyl-4-carboxy-5-aminoimidazole; 
NAD+/NADH, oxidized/reduced nicotine amide dinucleotide; NADP+/NADPH, oxidized/reduced 
nicotine amide dinucleotide phosphate; Pgi, phosphoglucoisomerase; Pi/PPi, inorganic 
phosphate/diphosphate; Pgm, phosphoglucomutase; PR-AMP, phosphoribosyl-AMP; PR-ATP, 
phosphoribosyl-ATP; PRA, phosphoribosylamine; PRFAR, 5-[(5-phospho-1-deoxyribulos-1-
ylamino)methylideneamino]-1-(5-phosphoribosyl) imidazole-4-carboxamid; PRPP, phosphoribosyl 
pyrophosphate; PtsG, phospoenolpyruvate-dependent phosphotransferase system for glucose; PurA, 
adenylosuccinate synthase; PurB, adenylosuccinate lyase; PurC, phosphoribosylaminoimidazole-
succinocarboxamide synthase; PurD, PRA-glycine ligase; PurE, phosphoribosylainoimidazole mutase; 
PurF, amidophosphoribosyltransferase; PurH, bifunctional AICAR formyltransferase / IMP 
cyclohydrolase; PurK, phosphoribosylainoimidazole carboxylase; PurL, 
phosphoribosylformylglycinamide synthase; PurM, phosphoribosylformylglycinamidine cycloligase; 
PurN, phosphoribosylglycinamide formyltransferase; R5P, ribose 5-phosphate; SAICAR, 
phosphoribosyl-aminoimidazolesuccinocarboxamide; SHMT, serine hydroxymethyltransferase; TCA, 
tricarboxylic acid cycle; THF, tetrahydrofolate. Taken from Schwentner et al., 2019. 
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ii) The native ATP recyclization, i.e. conversion from AICAR to AMP/ATP is strongly 
increased in the L-histidine optimized scenario (compare reactions from AICAR towards AMP; 
Fig. 11, p.102). Hence, in addition to an increased flux through the L-histidine biosynthesis, an 
equimolar flux through the purine biosynthesis is emphasized by FBA to be a prerequisite for 
efficient L-histidine production.  
iii) Connected to that, the N10-formyl THF (fTHF) requiring reactions in the purine 
biosynthesis must be supplied with strongly enhanced pools of loaded THF molecules, which 
in the L-histidine production scenario is assured by a redistribution of the carbon flux towards 
L-serine (compare fluxes from 3PG towards Ser; Fig. 11, p.102).  
With these hints revealed by FBA in mind, we started to construct L-histidine producing strains, 
which is described in detail in the following sections. 
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 Optimizing L-histidine biosynthesis 
With the purpose to optimize the L-histidine biosynthesis pathway, several modifications in the 
operons containing genes encoding L-histidine enzymes, were introduced in the C. glutamicum 
genome. These modifications are shown in Fig. 12 on page 104. 
In. a first step, we targeted the ATP phosphoribosyltransferase (HisG), which has been reported 
before for several organisms (Cho et al., 2003; Pedreño et al., 2012; 
Fig. 11. Flux Balance Analysis (FBA) of a growth optimized (white boxes, upper case) and a L-histidine 
optimized (white boxes, lower case) strain of C. glutamicum. Results are depicted in a schematic overview of 
the metabolism with focus on the L-histidine biosynthesis and the connected pathways of central carbon 
metabolism, purine biosynthesis, and one carbon metabolism. White boxes contain fluxes for the growth 
optimized strain (upper case) and for the L-histidine optimized strain (lower case) and are given in %. Boxes 
with dashed lines show the carbon flux towards biomass formation. Abbreviations: 3PG, 3-phosphoglycerate; 
AdSucc, adenylosuccinate; AICAR, 1-(5′-phosphoribosyl)-5-amino-4-imidazolecarboxamide; AMP, 
adenosine monophosphate; ATP, adenosine triphosphate; bios., biosynthesis; F6P, fructose 6 phosphate; 
FAICAR, 5-formamidoimidazole-4-carboxamide ribotide; fTHF, 10-formyltetrahydrofolate; G3P, 
glyceraldehyde 3 phosphate; G6P, glucose 6-phosphate; Gly, glycine; IGP, imidazole-glycerol phosphate; 
IMP, inosine monophosphate; mTHF, 5,10-methylenetetrahydrofolate; PPP, pentose phosphate pathway; 
PRPP, phosphoribosyl pyrophosphate; R5P, ribose 5 phosphate; Ser, L-serine; TCA, tricarboxylic acid cycle. 
Figure prepared by André Feith. Taken from Schwentner et al., 2019. 
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Tébar and Ballesteros, 1976), including C. glutamicum (Araki and Nakayama, 1974), to be 
under control of a strong feedback inhibition by the end product of the pathway, L-histidine. 
Therefore, we aimed to release HisG from its feedback inhibition, which was done by 
introducing the feedback inhibition released variant HisGG233H-T235Q into C. glutamicum WT, 
i.e. introducing the respective nucleotide exchanges (2.6.1 Strain Construction – PART I, p.75) 
in the C. glutamicum genome (Schendzielorz et al., 2014). It has been shown before, that the 
HisGG233H-T235Q variant solely is able to cause the excretion of small amounts of L-histidine into 
the medium (Schendzielorz et al., 2014). The resulting strain C. glutamicum HIS1 indeed 
showed accumulation of L-histidine in the culture supernatant and had a product substrate yield 
(YP/Shis) of 0.015 ± 0.003 mol histidine mol-1 glucose (Fig. 13, p.106; Table 31, p.120). 
Compared to C. glutamicum WT, the growth rate µ of C. glutamicum HIS1 decreased from 
0.38 ± 0.01 h-1 to 0.32 ± 0.01 h-1, whereas the biomass substrate yield (YX/S) remained similar 
with 0.45 ± 0.01 g biomass g-1 substrate, compared to 0.46 ± 0.02 g biomass g-1 substrate of 
C. glutamicum WT. Beyond this, HIS1 produced glycine as main byproduct besides L-histidine 
with a YP/Sgly of 0.021 ± 0.003 mol glycine mol-1 glucose (Fig. 13, p.106). At this point, the 
metabolic state of strain C. glutamicum HIS1 was analysed in detail by applying Systems 
Metabolic Profiling (SMP; 2.8.8 Systems Metabolic Profiling, p.91), which revealed increased 
intracellular peak intensities of D-erythro-1 (imidazole-4-yl)glycerol 3-phosphate (IGP; about 
18×) and L-histidinol (about 275×), compared to C. glutamicum WT (detailed results see 
3.1.9 Systems Metabolic Profiling, p.112). To enable sufficient amounts of enzymes throughout 
all of the L-histidine pathway, i.e. guaranteeing balanced enzymatic activities of all histidine 
enzymes, and to prevent accumulations of potentially inhibiting metabolites, we proceeded by 
exchanging the native promoters of all four canonical operons containing L-histidine genes 
against stronger ones (compare Fig. 3, p.16 and Fig. 12, p.104). This was done in a first step 
for the hisD-hisC-hisB-cg2302-cg2301 operon, where the native promoter sequence was 
replaced with the promoter of elongation factor TU (encoded by tuf), named Ptuf. 
Concomitantly, the sequence in front of the hisD gene, which mediates a T-box mediated 
attenuation mechanism controlling the transcription of this operon, was eliminated (Jung et al., 
2010; Kulis-Horn et al., 2014). The resulting strain C. glutamicum HIS2 showed similar YP/Shis, 
µ, YX/S, and YP/Sgly with 0.013 ± 0.001 mol L-histidine mol-1 glucose, 0.32 ± 0.01 h-1, 
0.48 ± 0.01 g biomass g-1 substrate, and 0.021 ± 0.01 mol glycine mol-1 substrate, respectively 
(Fig. 13, p.106). In a similar manner, the native promoters of operons hisH-hisA-impA-hisF-
hisI-cg2294 and cg0911-hisN were replaced with Ptuf. However, the performance characteristics 
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of the resulting strains C. glutamicum HIS3 and HIS4 remained constant, with YP/Shis of 
0.013 ± 0.002 and 0.012 ± 0.001 mol L-histidine mol-1 glucose, growth rates of 0.33 ± 0.01 and 
0.31 ± 0.01 h-1, YX/S of 0.50 ± 0.02 and 0.45 ± 0.01 g biomass g-1 glucose, and YP/Sgly of 
0.019 ± 0.001 and 0.017 ± 0.001 mol glycine mol-1 glucose, respectively (Fig. 13, p.106). HisG 
has been reported as being the rate-limiting step in the L-histidine biosynthesis (Mizukami et 
al., 1994). Therefore, we aimed at replacing the fourth and last remaining native promoter of a 
histidine operon, which contains genes hisE and hisG. After several unsuccessful attempts of 
replacing the native promoter of the hisEG operon with Ptuf or PsodA, the promoter of manganese 
superoxide dismutase, encoded by sodA (data not shown), we instead implemented PdapA-A16, a 
mutated variant of the promoter of dihydrodipicolinate synthase, encoded by dapA (Vašicová 
et al., 1999). Simultaneously, the native translational start codon GTG of gene hisE was 
replaced by the more common start codon ATG, to ensure stronger translation efficiency. This 
has been shown for several genes before to be a potent tool to improve/decrease translation 
Fig. 12. Modifications in the operons containing L-histidine biosynthetic pathway genes in C. glutamicum. 
Black circles and crosses indicate where modifications were introduced in the C. glutamicum genome. 
Detailed explanations for the modifications is described in 2.6.1 Strain Construction – PART I, page 75. 
Abbreviations: P, promoter. The ruler indicates the absolute position within the genome of C. glutamicum
ATCC 13032. Compare with Fig. 3 on page 16. Taken from Schwentner et al., 2019. 
 105 
 
efficiency (Becker et al., 2010; Kim et al., 2014; Li et al., 2016; Schneider et al., 2012). The 
resulting strain C. glutamicum HIS6 showed improved production behaviour with a YP/Shis of 
0.065 ± 0.004 mol L-histidine mol-1 glucose, µ of 0.26 ± 0.02 h-1, YX/S of 0.39 ± 0.05 g biomass 
g-1 glucose, and YP/Sgly of 0.072 ± 0.004 mol glycine mol-1 glucose (Fig. 13, p.106). 
To reassure the necessity of overexpression of all L-histidine genes, we constructed strain 
C. glutamicum HIS5, which bears the hisEG modifications of C. glutamicum HIS6, i.e. the 
HisGG233H-T235Q variant, exchange of the translational start codon from GTG to ATG in hisE, 
and exchange of the native promoter by PdapA-A16. However, this strain does not have Ptuf in front 
of the remaining three L-histidine operons (compare Fig. 12, p.104), thus only overexpressing 
genes hisE and hisG. C. glutamicum HIS5 showed a YP/Shis of 0.039 ± 0.001 mol L-histidine 
mol-1glucose, classifying it between C. glutamicum HIS4 and HIS6, and thus justifying the 
overexpression of the remaining L-histidine genes with focus on L-histidine production.  
As a further measurement, we implemented PsodA internally inside operon hisH-hisA-impA-
hisF-hisI-cg2294, directly in front of the hisF gene and introduced and additional artificial stop 
codon upstream of PsodA. The rationale here was to ensure adequate activities of the enzymes 
encoded by genes hisF and hisI, which are arranged at the end of a relatively long operon with 
> 4000 bp (Fig. 12, p.104; Kulis-Horn et al., 2014).  
The resulting strain C. glutamicum HIS7 showed similar characteristics compared to HIS6, 
with a YP/Shis of 0.066 ± 0.003 mol L-histidine mol-1 glucose, µ of 0.28 ± 0.01 h-1, YX/S of 
0.42 ± 0.02 g biomass g-1 glucose, and YP/Sgly of 0.073 ± 0.002 mol glycine mol-1 glucose. 
However, by implementing the internal PsodA, intracellular peak intensities of IGP and 
L-histidinol in C. glutamicum HIS7 were decreased by 88% and 91% compared to 
C. glutamicum HIS1, approaching wildtype like levels and thus re-balancing the connected 
purine biosynthetic pathway (Fig. 16, p.114). Detailed presentation of the metabolomics data is 
given in 3.1.9 Systems Metabolic Profiling on page 112.  
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 Intracellular ATP & ADP concentrations 
The tight connection of the biosynthesis pathways for L-histidine and purines manifests a.o. in 
the form of ATP, as the backbone donor in the HisG-catalysed reaction, and in AICAR, as 
L-histidine side product and reshuffling molecule for the purine biosynthesis (Fig. 10, p.99). 
Overproducing L-histidine thus represents a direct intervention in energy metabolism, i.e. 
purine biosynthesis, and since ATP a.o. is an endproduct of this pathway, cross effects cannot 
be ruled out per se. For this reason, the effect of L-histidine overproductionin the form of 
overexpression of one or more L-histidine genes, on the intracellular pools of the three 
adenylates ATP, ADP, and AMP was investigated in more detail. Therefore, intracellular 
concentrations thereof were determined in strains C. glutamicum HIS1 – HIS7 via cell 
disruption and quenching of the metabolism with perchloric acid (2.7.2 Chemical disruption 
and quenching, p.86).  
For the reference strain C. glutamicum WT, intracellular concentrations of 
15.7 ± 0.4 µmol ATP gCDW-1, 6.0 ± 0.6 µmol ADP gCDW-1 (Fig. 14, p.108), and 
2.1 ± 0.8 µmol AMP gCDW-1 were detected when cells were harvested and quenched in the 
exponential growth phase. This changed, when C. glutamicum WT was quenched in the 
stationary growth phase. Here, AMP was the predominating adenylate species with 
17.0 ± 2.4 µmol AMP gCDW-1, followed by 12.9 ± 3.4 µmol ADP gCDW-1, and 
1.4 ± 0.3 µmol ATP gCDW-1 (data not shown). 
For the L-histidine producing strains, cells were quenched in the exponential growth phase. 
Concentrations of AMP were found to be below the detection limit of the applied system in 
strains C. glutamicum HIS1 – HIS7 (< 300 nm) and were only measurable in 
C. glutamicum WT (data not shown).  
In contrast to AMP, ATP and ADP concentrations were traceable in the quenched cell extracts 
of strains C. glutamicum HIS1 – HIS7 and according to the detected concentrations, the 
mentioned strains can be divided in two groups (Fig. 14, p.108). Compared to 
C. glutamicum WT, the first group (C. glutamicum HIS1 – HIS4) exhibited solely diminished 
ADP levels, showing about half of the concentration of C. glutamicum WT, whereas ATP levels 
remained stable (Fig. 14, p.108). In contrast to that, the second group 
(C. glutamicum HIS5 - HIS7) exhibited similarly diminished ADP levels compared to 
C. glutamicum WT, however beyond this also ATP levels were strongly affected, showing 
concentrations as low as 6.6 ± 0.3 µmol ATP gCDW-1 and 1.8 ± 0.1 µmol ADP gCDW-1 in 
C. glutamicum HIS5 (Fig. 14, p.108). Strikingly, ATP levels were only affected in strains where 
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the native promoter of the hisEG operon had been exchanged with PdapA-A16. As mentioned 
above, intracellular AMP levels were below the detection limit of the applied HPLC system, 
and it thus can be concluded that AMP concentrations in strains C. glutammicum HIS1 - HIS7 
were significantly below the concentrations of C. glutamicum WT.  
 
 Energy charges 
The energy charge (EC) has been introduced as a measurement for the energetic state of cells 
and as a tool to assess cell fitness (Atkinson, 1968; Atkinson and Walton, 1967). The equation 
for calculating the EC comprises the intracellular concentrations of ATP, ADP, and AMP 
(2.9.6 Energy charge, p.95). Since AMP concentrations were below the detection limit of the 
applied HPLC system (2.9.6 Energy charge, p.95), we proceeded by calculating the EC by 
omitting AMP. Interestingly, despite the absolute intracellular concentrations of ATP and ADP 
were affected strongly in strains C. glutamicum HIS1 - HIS7, the ECs are not affected at all 
(Fig. 15, p.109). All strains showed very similar ECs compared with C. glutamicum WT 
(0.89 ± 0.04). This indicates that the EC as a critical value is kept stable despite the absolute 
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Fig. 14. Intracellular ATP and ADP concentrations during the exponential growth phase for strains 
C. glutamicum HIS1 to HIS7 with C. glutamicum WT as reference, as determined via quenching with 
perchloric acid and HPLC analysis. Intracellular ATP and ADP contents are given in µmol gCDW-1
and are shown in dark grey and white, respectively. 
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ATP, ADP, and AMP concentrations might vary strongly. Compared to the EC of 0.89 ± 0.04 
obtained in the exponential growth phase for C. glutamicum WT, the value of the EC 
determined in the stationary phase was strongly decreased to 0.25 ± 0.03 (data not shown). ECs 
of the producer strains were not determined during stationary phase. 
 
 Overcoming limitations in ATP recyclization  
At this point, the combined results of FBA (3.1.2 Flux Balance Analysis, p.100), indicating the 
requirement for an equimolar flux through the purine biosynthesis, and of intracellular ATP 
measurements (3.1.4 Intracellular ATP & ADP concentrations, p.107), showing that 
intracellular ATP levels are strongly diminished, pointed towards an increased need for ATP 
recyclization, i.e. AICAR to AMP/ATP conversion. To support this hypothesis, we aimed at 
gaining a more holistic overview of the strains optimized in histidine biosynthesis. Therefore, 
we performed Systems Metabolic Profiling (SMP) of strain C. glutamicum HIS7 and identified 
strongly increased intracellular pool sizes of inosine monophosphate (IMP) and 
adenylosuccinate (for detailed results see 3.2.10 Systems Metabolic Profiling, p.154; Fig. 16, 
p.114). Tackling these accumulations and enabling balanced fluxes throughout the L-histidine 
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Fig. 15. Energy charges (ECs) of strains C. glutamicum HIS1 to HIS7. ECs have been calculated 
without considering AMP, since AMP concentrations in the L-histidine producing strains were 
below the detection limit of the applied HPLC system (2.9.6 Energy charge, p.95). Experiments 
were performed in at least triplicates and standard deviations are given as error bars. 
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connected pathways was done by overexpressing genes purA (cg3063) and purB (cg2876), 
encoding the IMP and adenylosuccinate utilizing enzymes adenylosuccinate synthetase and an 
adenylosuccinate lyase (Fig. 10, p.99). This was achieved by amplifying purA and purB from 
the genome of C. glutamicum WT and cloning both in the medium copy number plasmid pJC4 
under control of promoter Ptuf and terminator TrrnB, respectively. The idea behind a combined 
overexpression of genes purA and purB was to firstly solve the IMP/adenylosuccinate 
accumulation and its potentially adverse intracellular effects and secondly to boost the 
re-cyclization of ATP. The plasmid pJC4purApurB was introduced into strain 
C. glutamicum HIS7, and the resulting strain C. glutamicum HIS8 was characterized. 
Surprisingly, C. glutamicum HIS8 showed a lower YP/Shis of 0.054 ± 0.002 mol L-histidine 
mol-1 glucose compared to C. glutamicum HIS7 (Fig. 13, p.106). The growth rate remained 
stable with 0.29 ± 0.01 h-1 and the biomass substrate yield increased slightly to 0.46 ± 0.02 
g biomass g-1 glucose. Accordingly, with the decreased L-histidine yield, the glycine yield 
decreased to 0.056 ± 0.001 mol glycine mol-1 glucose (Fig. 13, p.106). 
To classify and to reassure the efficacy of the invasion into the energy metabolism (i.e. purine 
biosynthesis) of the cell by overexpressing purA and purB, we again performed SMP. 
Comparison of the metabolomes of strains C. glutamicum HIS7 and HIS8 showed that upon 
introduction of pJC4purApurB the intracellular peak intensities of IMP and adenylosuccinate 
were decreased to wildtype-like levels (Fig. 16, p.114). Additionally, intracellular peak 
intensities of ATP and ADP were restored to 111% and 96% of the C. glutamicum WT levels 
(Fig. 16, p.114). These findings indicate that despite the YP/Shis was decreased in strain 
C. glutamicum HIS8 compared to HIS7, the accumulations of IMP and adenylosuccinate were 
re-diminished and the decreased ATP levels could be re-increased. Since the blockages of IMP 
and/or adenylosuccinate accumulations and ATP re-cyclization were solved properly, it seemed 
to be most likely that a further limitation that is connected to the highly interlinked L-histidine 
biosynthesis occurred and superimposed the rearranged ones. 
 Reinforcing the native C1 supply 
The pathway of one-carbon metabolism is a cycle that provides tetrahydrofolate (THF) species 
as donors of C1 units for several enzymatic reactions, by reshuffling and regenerating them 
(1.2.5 L-HISTIDINE related pathways, p.21). The donation of C1 units is crucial for the synthesis 
of several metabolites, a.o. for the purine nucleotides and glycine (Sah et al., 2015). As a 
relevant example, the de novo purine biosynthesis requires the supply of two molecules fTHF 
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as cofactors for reaction steps three (PurN) and ten (PurH). In several organisms, one of the 
major sources for the generation of C1 units of the THF cycle is the reaction catalysed by the 
serine hydroxymethyltransferase (SHMT), converting L-serine to glycine and simultaneously 
generating 5,10-methylenetetrahydrofolate (mTHF). Interestingly, this fact is also reflected in 
the FBA with L-histidine overproducing scenario in C. glutamicum, where the flux distribution 
towards glycine was increased (11% to 33%) in a similar manner compared with the distribution 
towards histidine biosynthesis (5% to 52%) (3.1.2 Flux Balance Analysis, p.100). Furthermore, 
glycine was experimentally identified as main byproduct being inevitably present in equimolar 
amounts to L-histidine throughout the generated strain database (3.1.12 Byproduct formation, 
p.124). Additionally, the SMP data for strain C. glutamicum HIS8 showed a strong increase of 
the intracellular peak intensities of AICAR (+158%), compared to strain HIS7 (3.1.9 Systems 
Metabolic Profiling, p.112). Interestingly, the peak intensities of AICAR increased even 
further, despite having solved the IMP/adenylosuccinate accumulations. This shows that the 
accumulation of AICAR was not due to limited ATP recyclization, but instead might be a 
problem of cofactor availability. Since one of the two reactions that are required to convert 
AICAR to IMP is dependent on fTHF, we aimed to improve the fTHF supply. Thus, we 
identified the glycine cleavage (GCV) system as a solution approach. The GCV system is a 
multi-enzyme complex converting glycine to CO2 and NH3, simultaneously loading THF with 
a C1 unit, yielding mTHF, and reducing NAD+ to NADH (Fujiwara et al., 1984; Kikuchi et al., 
2008). The GCV system from C. jeikeium, a close relative of C. glutamicum, was overproduced 
via a plasmid-based approach with pEC-XT99A_gcv_ OP1-Cjk (obtained from Andrea Hüser, 
Evonik Industries AG). This was done to i) eradicate glycine as main byproduct, which has 
been shown to exhibit adverse effects through above physiological intra- and extracellular 
concentrations (Hishinuma et al., 1969; Minami et al., 2004), and ii) to supply the cell with 
additional loaded C1 units in the form of mTHF (Fig. 10, p.99). Therefore, pEC-XT99A_gcv_ 
OP1-Cjk was transformed into strain C. glutamicum HIS8, resulting in C. glutamicum HIS9. 
C. glutamicum HIS9 showed improved L-histidine production with a YP/Shis of 0.086 ± 0.001 
mol histidine mol-1 glucose, a µ of 0.22 ± 0.01 h-1, and a YX/S of 0.35 ± 0.01 g biomass 
g-1 glucose (Fig. 13, p.106). The determined glycine concentrations in the medium were 
negligible (data not shown) and thus YP/Sgly was not calculated. Eradication of glycine in the 
medium proved the functionality and activity of the GCV system.  
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 Directing carbon towards L-histidine precursors 
With a rational, purpose-driven approach combined with the indication of the FBA (L-histidine 
production scenario), the junction of glycolysis and PPP was identified as an additional target 
for improving strain C. glutamicum HIS9 (3.1.2 Flux Balance Analysis, p.100). Thus, 
C. glutamicum HIS9 was engineered to direct increased amounts of carbon towards the crucial 
L-histidine precursor PRPP. This was done by changing the native translational start codon 
ATG of the pgi (cg0973) gene, encoding the glucose 6-phosphate isomerase (Pgi), to the rarer 
variant GTG (Pfeifer-Sancar et al., 2013). This has been shown before in C. glutamicum to 
decrease the overall activity of the Pgi enzyme and therefore channelling increased amounts of 
carbon into the oxidative part of the PPP (Becker et al., 2010, 2009). The generated strain 
C. glutamicum HIS10 showed an improved product yield of 0.093 ± 0.001 mol L-histidine 
mol-1 glucose, while maintaining stable growth rate and biomass substrate yield (Fig. 
13, p.106).  
 Systems Metabolic Profiling 
Systems Metabolic Profiling (SMP) is an LC MS/MS Q-TOF-based approach to identify and 
comparatively analyse peak intensities of intracellular metabolites. This method was developed 
and tested by André Feith (IBVT, University of Stuttgart), who provided metabolome data for 
this work (2.8.8 Systems Metabolic Profiling, p.91). Despite results of SMP experiments are 
incorporated in the above sections, they will be presented in detail in this section. 
Strains C. glutamicum HIS1, and HIS6 – HIS10, were cultivated and quenched in the 
mid-exponential growth phase (2.7.2 Chemical disruption and quenching, p.86). The cleared 
and quenched lysates were then measured on a LC MS/MS Q-TOF system (2.8.8 Systems 
Metabolic Profiling, p.91) and analysed appropriately (2.10.1 Systems Metabolic Profiling – Data 
analysis, p.96). Results will not be described in all detail, however the main results from the 
SMP measurements will be summarized in the following lines.  
Upon introduction of the feedback released HisG variant, C. glutamicum HIS1 showed altered 
intracellular peak intensities of several metabolites compared to C. glutamicum WT. Among 
these, D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate (IGP), product of the fifth reaction step 
in the L-histidine biosynthesis, and L-histidinol, product of the eighth reaction step, were the 
most prominent ones and resulted in 18× and 275× fold increased intracellular peak intensities 
(Fig. 16, p.114). Decreased intracellular peak intensities of the TCA cycle (derived) 
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intermediates α-ketoglutarate, malate, and L-aspartate and slightly increased intensities of the 
PPP intermediate 6-phosphogluconate indicate that carbon is withdrawn towards the 
biosynthesis pathways of L-histidine and purines, favouring the oxidative PPP. 
The histidine biosynthesis optimized strains C. glutamicum HIS6 and HIS7 show, compared to 
C. glutamicum HIS1, relaxed peak intensities of IGP and L-histidinol, indicating that 
overexpression of all L-histidine genes efficiently balanced the histidine pathway (Fig. 16, 
p.114). Further, they show a drastic increase in inosine monophosphate (IMP) peak intensities 
(43× higher than C. glutamicum WT), suggesting limitations in the purine biosynthesis. The 
oxidative part of PPP is further arrogated, which is indicated by the further increasing 
6-phosphogluconate peak intensities. 
By the overexpression of genes purA and purB in C. glutamicum HIS8 (3.1.6 Overcoming 
limitations in ATP recyclization, p.109) as reaction to the increased IMP peak intensities, they 
were re-adjusted to C. glutamicum WT like levels. Additionally, ADP and ATP were 
re-increased to about WT like levels. SMP further revealed strongly increased AICAR peak 
intensitites in C. glutamicum HIS8 compared to C. glutamicum WT and C. glutamicum HIS7. 
As a reaction to the increased AICAR peak intensities in C. glutamicum HIS8, the heterologous 
overproduction of the GCV system from C. jeikeium in C. glutamicum HIS9 (3.1.7 Reinforcing 
the native C1 supply, p.110) re-decreased the AICAR peak intensities (reduction of 73% 
compared to C. glutamicum HIS8). 
The final strain C. glutamicum HIS10 still showed slightly increased peak intensities for 
AICAR and additionally for FGAR and L-serine, which might be tackled in future experiments 
and will be discussed below. 
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Fig. 16. Systems Metabolic Profiling (SMP) of selected L-histidine producing strains. Results are depicted in 
a schematic overview of the metabolism with focus on the L histidine biosynthesis and the connected central 
carbon metabolism, purine biosynthesis, and one carbon metabolism. Selected metabolites originating from 
these pathways are given as bar diagrams showing intracellular peak intensities. Bars show results for strains 
C. glutamicum WT (WT), HIS1, HIS6, HIS7, HIS8, HIS9, and HIS10, from left to right, respectively. 
Abbreviations: 3PG, 3-phosphoglycerate; AKG, α-ketoglutarate; ADP, adenosine diphosphate; AdSucc, 
adenylosuccinate; AICAR, 1-(5′-phosphoribosyl)-5-amino-4-imidazolecarboxamide; AMP, adenosine 
monophosphate; ATP, adenosine triphosphate; bios., biosynthesis; C1, one carbon metabolism; FGAR, 
phosphoribosyl-N-formylglcineamide; G6P, glucose 6-phosphate; Hisol, L-histidinol; IGP, imidazole-
glycerol phosphate; IMP, inosine monophosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; Pyr, 
pyruvate; PRPP, phosphoribosyl pyrophosphate; SAICAR, phosphoribosyl-
aminoimidazolesuccinocarboxamide. Figure prepared by André Feith. Taken from Schwentner et al., 
2019. 
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 Extending the strain database 
In addition to strains C. glutamicum HIS1 to HIS10, further strains were constructed to extend 
the strain database and to gain a broader knowledge on the intertwined pathways that are 
connected to the L-histidine biosynthesis. These strains did not necessarily provide improved 
histidine yields, they however might provide deeper insights into specific issues, which in the 
future might ultimately lead to higher yields or at least form a foundation to that. 
These strains are quoted in Table 31 on page 120, with their respective growth rates, biomass 
substrate yields, and histidine and glycine yields. An overview of the modular structure of the 
strain database and how the strains are based on each other is shown in Fig. 17 on page 115. 
After having constructed strain C. glutamicum HIS6, with optimized L-histidine biosynthesis 
pathway, the focus was set on the module of the central carbon metabolism (i.e. glycolysis 
and PPP), where the translational start codon of the pgi gene was changed from the native ATG 
to the rarer variant GTG. The resulting strain was named C. glutamicum CM1 (CM for central 
WT
HIS1
HIS2
HIS3
HIS4
HIS6
HIS7
HIS8
HIS9
HIS10
HIS5
CM1
CM2
CM2.1
PUR4
PUR3
PUR2
PUR1
HIS9.2HIS9.1
CM3
HIS7.3
HIS7.2
HIS7.1
HISint
Fig. 17. Overview of the modular strain database. Strain names are given as short forms of the full strain 
names. For strain explanations see Table 2 on page 37, for strain characteristics see Table 31 on page 120. 
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carbon metabolism) and showed only slightly altered characteristics (i.e. µ, YX/S, YP/Shis, YP/Sgly) 
compared to its basis C. glutamicum HIS6. This strain was used a.o. for supplementation studies 
(3.1.14 Supplementation experiments, p.127) and as a basis for extensive further metabolic 
engineering studies (see following paragraphs). 
Due to the potential overstressing of the oxidative part of the PPP, which provides PRPP as 
L-histidine precursor, and a subsequent increased generation of NADPH (Fig. 10, p.99), the 
introduction of the published amino acid exchange A243T for the glucose 6-phosphate 
dehydrogenase (G6P DH) was considered (Georgi et al., 2005). Based on C. glutamicum CM1, 
strain C. glutamicum CM2 was constructed, which contains the respective nucleotide exchange 
in the zwf (cg1778) gene, leading to a mutated variant of the G6P DH that is less sensitive to 
allosteric inhibition by NADPH (Georgi et al., 2005; Moritz et al., 2000). C. glutamicum CM2 
had a higher YP/Shis, it however had a lower growth rate and strongly diminished biomass 
substrate yield (Table 31, p.120). With the success of the zwfA243T variant, we proceeded by 
implementing a feedback insensitive variant of the 6-phosphogluconate dehydrogenase 
(6PG DH), encoded by gnd (cg1643) that catalyzes the following reaction. Therefore, the 
nucleotide exchange of gndS361F was introduced into the native gnd gene, leading to a 6PG DH 
variant that is less sensitive to allosteric control by fructose-1,6-bisphosphate, glyceraldehyde 
3-phosphate, PRPP, ATP, and NADPH (Ohnishi et al., 2005). Based on C. glutamicum CM2, 
the resulting gnd-modified strain C. glutamicum CM2.1 showed a lower YP/Shis and a lower 
growth rate.  
Another target in the PPP besides zwf and gnd was the gene prsA (cg1075), encoding the PRPP 
synthetase. It has been described before that this enzyme is the target of allosteric inhibition by 
mainly ADP, and to lower extents to guanosine diphosphate (GDP), and uridine monophosphate 
(UMP), in several organisms, a.o. Bacillus subtilis, Salmonella typhimurium, and E. coli 
(Eriksen et al., 2000; Gibson et al., 1982; Hove-Jensen et al., 1986). In addition to these 
publications, there is a patent available, where an amino acid exchange in the PRPP synthetase 
is described, leading to a mutated variant of the PRPP synthetase in E. coli that is less sensitive 
to allosteric inhibition by ADP, which might be harnessed for L-histidine production (Klyachko 
et al., 2004b). We transferred this amino acid exchange onto the C. glutamicum PrsA enzyme 
resulting in the genetic variant prsAD122S (data not shown). The nucleotide exchange leading to 
PrsAD122S was introduced in C. glutamicum CM1 and resulted in strain C. glutamicum CM3. 
Despite the growth rate and the biomass substrate yield of this strain were similar to those of 
the progenitor strain, it had higher YP/Shis and YP/Sgly with 0.076 ± 0.002 mol L-histidine 
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mol-1 glucose and 0.093 ± 0.002 mol glycine mol-1 glucose, respectively (Table 31, p.120), 
showing the potential of the PrsAD122S variant. 
Based on C. glutamicum CM1, one further modification concerning the histidine biosynthesis 
was investigated. It has been shown e.g. for L-lysine overproducing strains of C. glutamicum 
that additional chromosomal copies of important genes (with respect to the desired product) can 
improve the product yield (Becker et al., 2011). In this line of thinking, we aimed at 
implementing an additional copy of the modified hisE-hisG operon (HisGG233H-T235Q variant, 
translational start codon GTG to ATG in hisE, and PdapA-A16 in front of hisE) into the 
chromosome of C. glutamicum CM1. The resulting strain C. glutamicum HISint showed similar 
growth rate and YP/Sgly compared with its basis, however YX/S and YP/Shis decreased to 
0.33 ± 0.06 g biomass g-1 substrate and 0.063 ± 0.003 mol histidine mol-1 glucose, respectively 
(Table 31, p.120), indicating that additional copies of the hisE-hisG operon are adverse for 
L-histidine production at this point of strain construction. 
Beyond the central carbon metabolism, the purine biosynthesis was considered as important 
factor for improving YP/Shis. As a first target, the first enzyme of the purine biosynthetic pathway 
amidophosphoribosyltransferase PurF (encoded by purF [cg2857]) was identified. This enzyme 
competes with a.o. HisG for PRPP as substrate (Fig. 5, p.22) and has been shown to be target 
of allosteric feedback inhibition by purine nucleotides in E. coli and B. subtilis 
(Chen et al., 1997; Zhang et al., 2008; Zhou et al., 1994). With the purF gene as target for 
metabolic engineering, we tested three different modifications. The first one was an in-frame 
deletion of purF, which was performed in strain C. glutamicum CM1. The resulting strain 
C. glutamicum PUR1 (for purine biosynthesis) had a strongly diminished growth rate resulting 
in 0.12 ± 0.01 h-1 and YX/S with 0.18 ± 0.01 g biomass g-1 substrate (Table 31, p.120). It further 
showed lower YP/Shis and YP/Sgly, compared to C. glutamicum CM1, producing 0.059 ± 0.004 
mol L-histidine mol-1 glucose and 0.062 ± 0.003 mol glycine mol-1 glucose, respectively, 
indicating the crucial role of the purF gene product for the integrity of the cell’s (energy) 
metabolism. Since the product yield was only decreased mildly, despite the very low growth 
rate and biomass substrate yield, we considered PurF as an interesting target. Instead of 
abolishing the enzymatic activity of PurF by deleting the encoding gene, we attempted to 
decrease it in a more sensitive way. Thus, we changed the translational start codon from the 
native GTG triplet to the rarer variant TTG (Becker et al., 2010, 2009; 
Pfeifer-Sancar et al., 2013). Interestingly, the resulting strain C. glutamicum PUR2 showed 
very similar characteristics like C. glutamicum PUR1, with µ = 0.12 ± 0.01 h-1, 
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YX/S = 0.16 ± 0.04 g biomass g-1 substrate, YP/Shis = 0.060 ± 0.002 mol L-histidine mol-1 
glucose and YP/Sgly = 0.068 ± 0.001 mol glycine mol-1 glucose (Table 31, p.120). The similar 
effects of ΔpurF and purFTTG indicate that i) C. glutamicum can grow without the purF gene 
and ii) that the TTG exchange has the same effects as a complete deletion of purF. However, 
both modifications seem not to be suitable for L-histidine production with C. glutamicum in this 
manner.  
As the third modification concerning PurF, we introduced an amino acid exchange that was 
described as releasing PurF partially from its allosteric inhibition by AMP and GMP in E. coli 
and C. glutamicum (Matsui et al., 2001; Peifer et al., 2012; Shimaoka et al., 2007). The idea 
behind this step was to reveal the effects of improved purine biosynthesis fluxes on L-histidine 
production. The resulting strain C. glutamicum PUR3 showed decreased characteristics 
compared to its basis C. glutamicum CM1, resulting in µ = 0.21 ± 0.01 h-1, 
YX/S = 0.37 ± 0.01 g biomass g-1 substrate, YP/Shis = 0.055 ± 0.003 mol L-histidine 
mol-1 glucose and YP/Sgly = 0.067 ± 0.003 mol glycine mol-1 glucose (Table 31, p.120). 
As another target in the purine biosynthesis besides PurF, the bifunctional enzyme PurH, with 
functionalities as AICAR formyltransferase and IMP cyclohydrolase (encoded by purH 
[cg0984]) was chosen (Fig. 10, p.99). This enzyme catalyses the reaction steps ten and eleven 
in the purine biosynthesis and is responsible for processing the AICAR moiety originating from 
step five of the L-histidine biosynthesis. Since amounts of AICAR coming from the L-histidine 
pathway most likely are increased in L-histidine overproducing strains, we aimed to withdraw 
this surplus by overexpressing the purH gene. This was done by cloning the native purH gene 
into pJC4 under control of the strong promoter PsodA. The plasmid pJC4-purH was introduced 
into C. glutamicum CM1 and resulted in strain C. glutamicum PUR4 (Fig. 17, p.115). 
C. glutamicum PUR4 showed improved YP/Shis with 0.075 ± 0.005 mol L-histidine 
mol-1 glucose and YP/Sgly with 0.081 ± 0.006 mol glycine mol-1 glucose. The growth rate and 
YX/S decreased slightly to 0.19 ± 0.04 h-1 and 0.41 ± 0.03 g biomass g-1 substrate, respectively. 
These characteristics indicate the potential of a purH overexpression for L-histidine production 
and might be considered for future strain construction. 
In module glycolysis, we wanted to test if different points of vantage in this module enable a 
targeted redirection of carbon fluxes. Three different sites of modification were identified, 
amongst which the pgiGTG modification (leading to CM1; see above) was the first one. 
C. glutamicum HIS7 was used as the basis, and in a first step pgiGTG was implemented in this 
strain to yield C. glutamicum HIS7.1 (Fig. 17, p.115). As described above, the attenuation of 
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the G6P DH activity mediated by pgiGTG was intended to direct increased amounts of carbon 
towards PRPP. Eventually, C. glutamicum HIS7.1 showed very similar characteristics 
compared to its basis, resulting in a growth rate of 0.26 ± 0.01 h-1, YX/S of 0.44 ± 0.03 g biomass 
g-1 substrate, YP/Shis of 0.064 ± 0.004 mol L-histidine mol-1 glucose, and YP/Sgly of 0.078 ± 0.004 
mol glycine mol-1 glucose (Table 31, p.120). As an alternative to the pgi-modification and as 
the second target in the glycolysis on basis of C. glutamicum HIS7, the gene gapA (cg1791), 
encoding the glyceraldehyde 3-phosphate dehydrogenase (GA3P DH), was modified 
(Fig. 10, p.99; Eikmanns, 1992). In the same manner as for pgi and purF before, we exchanged 
the native translational start codon of the gapA gene from ATG to TTG, to weaken the 
GA3P DH activity, thereby directing increased carbon fluxes towards the non-oxidative part of 
the PPP and eventually to PRPP. The resulting strain C. glutamicum HIS7.2 had similar growth 
rate (0.24 ± 0.01 h-1) and YX/S (0.40 ± 0.01 g biomass g-1 substrate) and increased L-histidine 
and glycine yields (0.072 ± 0.005 mol L-histidine mol-1 glucose, 0.079 ± 0.003 mol glycine 
mol-1 glucose), indicating that carbon is directing towards PRPP rather through the 
non-oxidative part of PPP instead of the oxidative part and indicating potential of the gapATTG 
modification for L-histidine production (Table 31, p.120). The phosphoglucomutase (Pgm), 
encoded by pgm (cg2800), was chosen, since a change of the translational start codon from the 
native ATG to TTG and the putatively connected decrease of the enzymatic activity of Pgm 
should enable a backlog of carbon into glycolysis/PPP, despite enabling supply of carbon for 
the crucial SHMT reactions for mTHF generation (Fig. 10, p.99). The resulting strain 
C. glutamicum HIS7.3 had very similar characteristics compared with C. glutamicum HIS7, 
resulting in µ = 0.24 ± 0.01 h-1, YX/S = 0.41 ± 0.04 g biomass g-1 substrate, 
YP/Shis = 0.064 ± 0.002 mol histidine mol-1 glucose and YP/Sgly = 0.073 ± 0.001 mol glycine 
mol-1 glucose (Table 31, p.120). This result indicates either that the pgmTTG modification was 
not strict enough or that the Pgm is not an ideal target for L-histidine production.  
To re-evaluate the three modifications of the central carbon metabolism in a strain that was 
released from the IMP/adenylosuccinate accumulation (3.1.6 Overcoming limitations in ATP 
recyclization, p.109), we implemented them into strain C. glutamicum HIS9. Interestingly, not 
gapATTG was the most potent one in this background, but pgiGTG led to a better performance, 
yielding strain C. glutamicum HIS10 (3.1.8 Directing carbon towards L-HISTIDINE precursors, 
p.112 and Table 31, p.120). Compared with C. glutamicum HIS9, both HIS9.1 (with gapATTG) 
and HIS9.2 (with pgmTTG) each showed a stable growth rate (0.22 ± 0.01 and 0.22 ± 0.01 h-1) 
and a stable YX/S (0.32 ± 0.01 and 0.35 ± 0.06 g biomass g-1 substrate). However, the 
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L-histidine yields were decreased to 0.076 ± 0.008 and 0.081 ± 0.003 mol L-histidine 
mol-1 glucose, respectively (Table 31, p.120).  
 
 A versatile toolbox enables deeper insights 
Due to the highly dynamic and intertwined character of the L-histidine biosynthesis, it is not 
necessarily given that a certain modification that in the first place proves adverse (i.e. no 
improvement of YP/Shis), still is adverse when a blockage is uncovered. With the following 
“toolbox” that comprises several pK19mobsacB- and pJC4/pEKEx3-based plasmids, a fast and 
reliable testing of the effects constituted by the respective plasmid, is enabled as soon as a 
different flux distribution is achieved. The “toolbox” includes mainly plasmids that did not 
constitute positive effects on YP/Shis in several strain backgrounds or were not implementable in 
the applied strain basis. However, these constructs might be used for future works and might 
achieve improvements under the then applied conditions. A list of these plasmids, and if 
applicable results of their implementation, is given in Table 32 on page 122. The following 
section will briefly summarize the most relevant results of the toolbox plasmids. 
As has been suggested before (Ikeda et al., 1999, 1998; Kamada et al., 2001), gene tkt (encoding 
transketolase) might play an important role for L-histidine production, since it is not elucidated 
in detail if the carbon flux towards PRPP is channelled through the oxidative or the 
non-oxidative part of PPP. We chose the tkt as target and since promoter engineering (due to 
the tkt gene being part of the operon tkt-tal-zwf-opcA-pgl; Kim et al., 2014) and engineering 
translation initiation (due to the native translational start codon being TTG) were not feasible, 
we engineered the native RBS. Three approaches were followed, including truncation of the tkt 
gene, deletion of the spacer region of tkt (4 bp deletion), and deletion of the extended RBS 
region of tkt (8 bp deletion). Despite supplementing with potassium acetate, the tkt modified 
strains showed no positive effect in growth experiments. 
In E. coli, the purine regulatory protein PurR has been targeted in a metabolic engineering 
approach and was deleted from the genome of an L-histidine producing mutant, which led to 
increased biomass production while maintaining L-histidine production 
(Doroshenko et al., 2013). Since there is no gene encoding a PurR regulator annotated in the 
C. glutamicum genome, we performed BLAST analysis (data not shown) to identify potential 
purine regulators in C. glutamicum. Therefore, the nucleotide sequences from the genes 
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encoding the PurR proteins of . subtilis, E. coli, and Lactococcus lactis were obtained (from 
https://www.ncbi.nlm.nih.gov/; last access 15-08-2018) and the C. glutamicum genome was 
searched for homologous sequences. By this, we identified the following genes (annotations 
from https://coryneregnet.compbio.sdu.dk/v6/index.html; last access 15-08-2018), encoding 
(potential) regulatory proteins, given in declining order of amino acid sequence similarity to 
the E. coli PurR protein (amino acid sequence similarity given in parentheses): 
cg0210 (29%), cg2314 (27%), cg1410 (25%) annotated as rbsR (LacI-family transcriptional 
regulator), cg2242 (23%), cg2910 (23%) annotated as ipsA (transcriptional regulator, LacI 
family), and cg0221 (20%). Since we were not able to construct a cg0210 deletion plasmid (data 
not shown), we continued by deleting cg2314 in C. glutamicum CM1, which had no effect on 
the growth phenotype and production behaviour of the resulting strain (Table 32, p.122). The 
remaining potential regulatory proteins might be considered for further studies concerning 
purine regulators in C. glutamicum. 
The prokaryotic ubiquitin like protein (Pup, encoded by pup) has been shown to target proteins 
for further degradation in the proteasome in mycobacteria (Burns et al., 2009; 
Pearce et al., 2008). Despite not possessing a proteasome, C. glutamicum Pup targets proteins, 
which are potentially degradet or modified in a so far unknown manner (Küberl et al., 2014). 
Among these pupylated proteins are two enzymes of the L-histidine pathway, namely HisC and 
HisD (Küberl et al., 2014). To avoid potential cross effects of the pupylation machinery on 
L-histidine enyzmes, we deleted the pup gene in C. glutamicum CM1. The resulting strain 
however showed no effect on the investigated parameters (Table 32, p.122). 
The remaining chromosomal- and plasmid-based modifications are given in Table 32 on 
page 122 and their effects are described by the following abbreviations: not implementable, 
meaning either the plasmid could not be constructed or the respective modification could not 
be chromosomally integrated with the constructed plasmid; not (yet) tested, meaning the 
plasmid has been successfully constructed but due to time / priority reasons the modification 
has not yet been evaluated; tested and no (phenotypic) effect, meaning the plasmid / 
chromosomal modification has been implemented but did not constitute any effect on the 
investigated parameters growth, growth rate, YX/S, YP/Shis, and YP/Sgly. 
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 Byproduct formation 
The L-histidine producing strains were analysed for production of L-histidine, which was 
qualified and quantified. However, as it is a common phenomenon with producer strains of all 
varieties (a.o. amino acid producers), not only the desired product is excreted into the medium, 
but also one or more byproducts might occur (Ma et al., 2017; Zhu et al., 2014). The 
predominating byprodut here was glycine, which was detected in the medium of several strains 
of the database, including strains C. glutamicum HIS1 to HIS7 (Fig. 13, p.106). Interestingly, 
the amount of glycine was about equimolar with the main product L-histidine in these strains, 
leading to a strong correlation between YP/Shis and YP/Sgly (Fig. 18, p.124).  
Besides glycine, further byproducts were detected in minimal amounts in the supernatant. These 
included exemplarily for C. glutamicum HIS10 after 24 h of cultivation:  
L-glutamate (max. 0.4 mM), L-serine (max. 0.2 mM), L-arginine (max. 0.1 mM), L-alanine 
(max. 0.1 mM), L-lysine (max. 1 mM). For some of these amino acids, concentrations in the 
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Fig. 18. Correlation of the product substrate yields (mol mol-1) for L-histidine (YP/Shis) and glycine (YP/Sgly) 
of strains C. glutamicum HIS1 to HIS7 from the strain database, including C. glutamicum WT. Given 
product substrate yields (open circles) are mean values calculated from at least three independent 
experiments. Taken from Schwentner et al., 2019. 
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medium were lower after 30 h than after 24 h, indicating their re-uptake and degradation, i.e. 
for L-glutamate. For further improvements of YP/Shis, prevention of formation of the detected 
and other, potentially undetected, byproducts might prevent loss of carbon. 
 
 Studies on purine reactions requiring fTHF 
The purine biosynthesis strongly relies on the supply with C1 units, since the reaction steps 
three and ten, which are catalysed by PurN and PurH, both require fTHF as cofactor 
(Fig. 10, p.99; Zhang et al., 2008). As glycine as the inevitable byproduct indicates, the SHMT 
reaction is the major source to supply these C1 units in the form of mTHF (Schirch et al., 1985; 
Stolz et al., 2007). With the idea in mind to examine, in how far the de novo part of the purine 
biosynthesis can be released from its dependency on fTHF, we conducted preliminary 
experiments in the C. glutamicum WT background. Besides PurN, the ATCC 13032 genome 
contains a second gene encoding a phosphoribosylglycineamide formyltransferase, which is 
annotated as PurT, encoded by purT (cg3054) (derived from 
https://coryneregnet.compbio.sdu.dk/v6/index.html). Interestingly PurT catalyses the third 
reaction step of the purine biosynthesis with formate as C1 group donor, instead of using fTHF. 
Thus, we in-frame deleted the purN (cg0983) gene from the C. glutamicum genome to see if 
PurT can compensate a purN deletion. The resulting strain C. glutamicum ΔpurN showed 
strongly impaired growth in shaking flask cultivations compared to C. glutamicum WT (Fig. 
19, p.126), indicating that PurT is not able to compensate the purN deletion. 
The PurT reaction was further supported by supplementing 10 mM formate, 0.74 mM adenine, 
or a combination of both supplements, resulting in elevated growth behaviour, despite being far 
from WT-like growth behaviour (Fig. 19, p.126). With the aim to increase the intracellularly 
available formate, the formate dehydrogenase FDH, encoded by genes fdhD (cg0616), cg0617, 
and fdhF (cg0618), was identified as target. This enzyme is known to catalyse the oxidation of 
formate to CO2 and it has been shown before for C. glutamicum that deletion of fdhF prevents 
formate utilization (Witthoff et al., 2012). Thus, fdhF was deleted in-frame in strain 
C. glutamicum ΔpurN and cultivations of the resulting C. glutamicum ΔpurN ΔfdhF showed 
that fdhF deletion was not able to revert the heavy growth defect of C. glutamicum ΔpurN. 
Since C. glutamicum WT was not able to grow with purN and/or fdhF deletions, we 
relinquished to test these modifications in a strain with L-histidine production brackground. 
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The detachment from the dependency on fTHF of the PurN reaction did not work and thus we 
switched to a different approach: Elimination of potential fTHF-consuming reactions to 
increase the intracellular fTHF supply for the PurN reaction. It has been shown before that the 
gene product of purU (cg0457), a fTHF deformylase, in E. coli constitutes the major source of 
formate for the PurT reaction by degrading fTHF (Nagy et al., 1993). Therefore, the purU gene 
was deleted in-frame in C. glutamicum WT and in HIS7 to prevent potential fTHF degradation. 
In both strains, no phenotypic effect on growth rate and biomass substrate yields was observable 
upon purU deletion, respectively (data not shown). Furthermore, no effect of purU deletion on 
YP/Shis in C. glutamicum HIS7 was observed (data not shown). 
Fig. 19. Shaking flask cultivations of C. glutamicum ΔpurN and C. glutamicum ΔpurN ΔfdhF with different 
supplementations (10 mM formate, 0.74 mM adenine, or a combination of both), including C. glutamicum
WT as a reference. Abbreviations: +f, medium contained formate; +a, medium contained adenine. 
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 Supplementation experiments 
In further experiments, selected strains of the strain database (Fig. 17, p.115) were cultivated 
with a wide range of supplements, focusing on cofactors of the L-histidine connected pathways. 
These included e.g. amino acids, vitamins, and complex components. The following section 
describes the idea behind each tested supplement and explains the results that are given in Table 
33 on page 129 in a compact form. The results are shown in positive or negative percentages 
(representing improvement or decline, respectively) for the four characteristics growth rate, 
YX/S, YP/Shis, and YP/Sgly compared to the cultivations w/o supplementation. 
Since we suspected limitations in the purine biosynthesis, we supplemented each cofactor of 
the de novo part of this pathway separately. L-glutamine is the cofactor in enzymatic steps one 
(PurF) and four (PurL) of the purine biosynthesis and in step five (HisF/HisH) of the L-histidine 
biosynthesis. Thus, we supplemented C. glutamicum CM2 with L-glutamine, which resulted in 
a slight increase of the growth rate, YP/Shis was not affected. We proceeded by supplementing 
C. glutamicum CM1 with glycine, the cofactor of the second step in purine biosynthesis (PurD). 
This had a slight effect on YP/Shis, which decreased by about 7%. For the purpose to increase 
the intracellular fTHF (needed in purine steps three and ten) pool, folate was supplemented to 
C. glutamicum CM1. Folate supplementation showed no effect on the four characteristics of 
CM1. Reaction steps four, five, and six of the purine biosynthesis (PurM, L, K) require ATP as 
energy donor. Thus, C. glutamicum CM2 was supplemented with ATP, resulting in an increase 
of µ by 42%, however YP/Shis and YP/Sgly slightly decreased by 6% and 10%, respectivel, 
indicating that the ATP surplus is used for faster growth instead of increased product formation. 
Step eight of the purine pathway requires L-aspartate as cofactor, which was supplemented 
(20 mM) to C. glutamicum CM1. This resulted in an increase of the growth rate (35%) and 
decreases of YP/Shis and YP/Sgly by 15% and 13%, respectively. When the concentration of the 
supplemented L-aspartate was reduced (1 mM), no effect on the four characteristics was 
observed. Further considering purine biosynthesis, we supplemented C. glutamicum CM1 with 
thiamine, a vitamin whose biosynthesis pathway requires AIR, the product of the PurM reaction 
(Fig. 4, p.19; Begley et al., 2012; Jurgenson et al., 2009). However, in C. glutamicum CM1, 
thiamine showed no effect. Supplementation of C. glutamicum PUR1 and PUR3 showed only 
an effect on YP/Shis (+9%) of the latter one. The purine modified C. glutamicum PUR2 with 
potentially decreased PurF activity was further supplemented with adenine (and a combination 
of adenine and thiamine), the nucleobase of adenylate nucleotides and nicotinamide adenine 
dinucleotides, to see if the strongly affected purine biosynthesis in this strain might be sustained 
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in this way. Experiments showed that adenine and adenine plus thiamine were able to support 
growth rates (+52% for both) and biomass substrate yields (+155% and +140%), however, 
YP/Shis were not affected. 
In further experiments, we focused on supporting the enhanced requirement of C1 units. To 
supply the C1 metabolism of C. glutamicum CM1, L-serine was supplied but showed no effect. 
Only when C. glutamicum CM1 was supplied with L-aspartate in addition to L-serine, an effect 
on growth rate (+30%), YP/Shis (-19%) and YP/Sgly (-13%) was detected. However, this most 
likely can be attributed to the effect of L-aspartate (see above). Further, formate was supplied 
in different concentrations to C. glutamicum CM1 to support the PurT catalysed 
fTHF-independent (and formate-dependent) reaction, thus potentially supporting the PurN 
catalysed fTHF-dependent reaction (3.1.13 Studies on purine reactions requiring fTHF, p.125). 
However, formate supplementations showed no effect.  
Since protocatechuate (PCA) is a routinely used supplement in cultivations with C. glutamicum, 
we examined its effect on C. glutamicum CM1. It was shown before that addition of the 
iron-complexing compound can mediate accelerated and stable growth of C. glutamicum in 
synthetic media, such as CGXII (Liebl et al., 1989; Unthan et al., 2014). PCA in cultivations 
with C. glutamicum CM1 however did neither increase growth rate nor YP/Shis. 
Complex media or addition of complex components to synthetic media are well known of being 
able to support growth of the host strain or to enable increased product formation 
(Hahn-Hägerdal et al., 2005; Hoffart et al., 2017; Zhang et al., 2003). Thus, strain 
C. glutamicum CM2 was supplemented in shaking flask experiments with one of the two 
complex components brain-heart-infusion (BHI) or yeast extract (YE), respectively. 
Interestingly, both components were able to increase growth rates (+163% and +308%, 
respectively), failed however in supporting YP/Shis (-11% and -8%, respectively).  
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 Redox balance 
The metabolic cofactors and reducing equivalents NADH and NADPH play important roles in 
a wide variety of cellular processes. Imbalances in the NADPH pool of C. glutamicum have 
been shown to be adverse for product formation in certain cases and balancing these pools 
increased product formation, e.g. in L-arginine production with C. glutamicum 
(Park et al., 2014). A major cellular source in C. glutamicum for the generation of the reducing 
equivalent NADPH under glycolytic conditions are the two initial reactions of the oxidative 
part of the PPP, constituted by the G6P DH and the 6PG DH, and others, such as the reactions 
of isocitrate dehydrogenase and malic enzyme (Spaans et al., 2015). All these reactions in 
C. glutamicum use NADP+ as a cofactor and reduce it to NADPH, which is needed as reducing 
equivalent for several reductive biosynthetic reactions (Moritz et al., 2000). The modification 
of the redox pool constituted by NADPH has been studied intensively, especially in the case of 
industrial producer strains, since several products require increased provision of NADPH 
(Lee et al., 2013; Papagianni, 2012). Such a product with relevance to C. glutamicum is 
L-lysine, whose biosynthesis requires 4 mol of NADPH for the generation of 1 mol L-lysine 
(Kiefer et al., 2004; Takeno et al., 2010) and thus efforts have been made to increase NADPH 
supply (Becker et al., 2005; Bommareddy et al., 2014; Georgi et al., 2005; Takeno et al., 2010).  
L-Histidine, on the other side, is a product that theoretically generates increased amounts of 
NADPH, meaning by providing increased amounts of the L-histidine precursor PRPP, the 
oxidative part of the PPP is overused, compared to growth of C. glutamicum WT (Fig. 10, p.99). 
However, the metabolic model (Zhang et al., 2017) used for FBA (3.1.2 Flux Balance Analysis, 
p.100) did not indicate any imbalances connected with increased formation of NADPH in the 
L-histidine overproduction study (personal communication with André Feith, IBVT, University 
of Stuttgart). For the purpose to investigate the redox state of the L-histidine producing strains, 
we constructed a multi-copy plasmid based on pJC4, expressing the sthA gene from 
E. coli K-12 MG1655 under control of Ptuf. The sthA gene encodes a soluble transhydrogenase 
from E. coli, which can transfer reducing equivalents between NAD+ and NADP+ 
(Boonstra et al., 1999; Cao et al., 2011; Sauer et al., 2004). This hydrogenase has been applied 
successfully for balancing NAD/NADP ratios in producer strains before (Jan et al., 2013; 
Sánchez et al., 2008). The plasmid pJC4 sthA was introduced in strains C. glutamicum HIS6 
and CM1 and the resulting strains were cultivated and characterised. Since both strains showed 
strongly impaired growth and very low YP/Shis, we concluded that expression of sthA from 
E. coli is not beneficial for L-histidine production at this point of the strain construction. It 
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however remains to be elucidated if the soluble transhydrogenase from E. coli is produced 
functionally in C. glutamicum from the pJC4 plasmid. 
 Alternative carbon source(s) 
The L-histidine biosynthesis pathway precursor molecule PRPP originates from the PPP and 
chemically is a C5 sugar phosphate. Thus, D-ribose (i.e. ribose 5-phosphate) suggested itself to 
be tested as an alternative carbon source to glucose, due to its spatiotemporal proximity to the 
L-histidine biosynthesis, compared to glucose (Fig. 4, p.19). Additionally, C. glutamicum has 
been shown to be able to grow on D-ribose as sole carbon source (Blombach and Seibold, 2010; 
Wendisch, 2003). Therefore, strains C. glutamicum HIS7 and CM2 were cultivated in CGXIIN 
supplemented with 12 g D-ribose L-1. Where C. glutamicum WT was able to grow 
(µ = 0.22 ± 0.02 h-1), both C. glutamicum HIS7 and CM2 surprisingly showed no growth. We 
proceeded by cultivating C. glutamicum CM2 with a mixture of 6 g D-ribose L-1 and 
5 g glucose L-1, where it was able to grow (µ = 0.20 ± 0.02 h-1). Since the ribose concentration 
was not determined, the YP/Shis and YP/Sgly were not available. However, C. glutamicum CM2 
with mixed glucose and ribose substrates excreted 4.8 ± 0.4 mM L-histidine and 5.6 ± 0.4 mM 
glycine into the medium after 30 h of cultivation, which equals approximately what 
C. glutamicum CM2 excreted when growing on glucose as sole carbon source (data not shown). 
However, despite not being able to grow (and produce) on D-ribose as sole carbon source, 
C. glutamicum CM2 takes up, metabolizes, and produces L-histidine from D-ribose when 
glucose is simultaneously present. 
 
 MGE – Decoupling purine biosynthesis from L-histidine biosynthesis 
In a evolutionary approach, we aimed at decoupling the two tightly interlinked pathways of 
purine biosynthesis and L-histidine biosynthesis (1.2.5 L-HISTIDINE related pathways, p.21). 
The method chosen for this task, Metabolic engineering to Guide Evolution (MGE), is 
described in PART II of this work in detail (3.2 Results PART II – Metabolic engineering to guide 
evolution, p.142). The principle idea for this experiment was to switch off a part of the de novo 
purine biosynthesis, namely the reactions originating from PurF and ending with PurB, yielding 
the purine intermediate AICAR (Fig. 10, p.99). This metabolically expensive part of the de novo 
purine biosynthesis consists of nine enzymatic reactions that require five molecules of ATP and 
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several other cometabolites, such as L-glutamine, fTHF, and L-aspartate (Fig. 10, p.99). By 
shutting down this part of the metabolism and by trying to evolve a cell that can grow without 
using this branch of the purine pathway and instead coupling the L-histidine biosynthesis to the 
generation of required purine intermediates in the form of AICAR, we hoped to boost the 
L-histidine production in C. glutamicum.  
In a first MGE experiment, C. glutamicum PUR1 with in-frame deleted purF gene was 
cultivated in CGXIIE with 20 g glucose L-1 and 1 g yeast extract L-1 and regularly transferred 
into fresh medium. After about 14 d of continuous cultivation with intermitted transfers, 
evolutionary events occurred in three independent MGE approaches in parallel, which were 
identified by strongly increased biomass formation (data not shown). The faster growing strains 
were isolated and their cultivation showed that the growth rates were the same as for the basis 
strain (µ = 0.1 h-1 for all). However, the three evolved strains showed increased biomass 
formation after 24 h, reaching above 200% increased biomass concentrations (data not shown). 
To reveal the underlying mutations, we sequenced genes that encode potential isoenzymes. 
Such a potential isoenzyme for amidophosphoribosyltransferase PurF is the anthranilate 
phosphoribosyltransferase (TrpD, encoded by trpD), which has been connected to this 
circumstance before in S. enterica (Lambrecht and Downs, 2013; Ramos et al., 2008). 
Surprisingly, we found an intact trpD gene, however, sequencing of the trp operon revealed 
single nucleotide polymorphisms (SNPs) in the trpCF gene, encoding the the bifunctional 
indole-3-glycerol-phosphate synthase (TrpC)/ phosphoribosylanthranilate isomerase (TrpF) in 
two of the evolved strains (Ikeda, 2006). The first SNP resulted in an isoleucine to threonine 
exchange (I422T), the other in a tryptophan to arginine exchange (W405R), both manifesting 
in the trpF encoded part of the enzyme. It was shown in E. coli that a trpF deletion can be 
compensated by a secondary function of PurF (Patrick and Matsumura, 2008). It appears that 
in the presented case, it was vice versa.  
Since MGE of C. glutamicum PUR1 resulted in evolved strains that were able to evolve a 
potential isoenzyme of PurF, we additionally deleted gene purD, catalysing the PurF following 
reaction to ensure inhibited flux through the de novo purine branch (Fig. 10, p.99). As 
C. glutamicum PUR1 before, the newly constructed C. glutamicum PUR1 ΔpurD was deployed 
in an MGE approach using CGXIIE with 20 g glucose L-1 and 1 g yeast extract L-1 and was 
regularly transferred into fresh medium. However, after 90 d of consecutively passaging, the 
strain showed no increasing biomass formation, meaning no evolutionary event could be 
observed in three independent cultivations. 
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 Preliminary Fermentation studies 
For each producer strain with the potential to be used as host strain in industrial scale production 
processes, the transfer from a laboratory scale over a pilot scale towards an industrial scale are 
critical steps and eventually determine the implementability of a strain 
(Delvigne and Noorman, 2017; Reisman, 1993; Thiry and Cingolani, 2002). The suitability of 
C. glutamicum for the large-scale production of industrially relevant products in general as a 
production host is out of question, since several established processes are based on this 
organism. Especially the processes for amino acid production, e.g. L-glutamate, L-lysine, and 
L-methionene are economically lucrative (Becker and Wittmann, 2012; Ikeda, 2003; 
Wendisch et al., 2016). It is a well-known phenomenon that producer strains, despite 
performing well in a laboratory scale, fail to deliver the same or similar performances in a 
bigger scale (Delvigne et al., 2017; Gonçalves et al., 2014). With the purpose to anticipate such 
issues, we conducted preliminary fermentation studies with selected strains of the strain 
database of L-histidine producing mutants (Fig. 17, p.115). These experiments were intended 
to reveal potentially emerging critical points for scale-up experiments in future projects. 
However, one needs to keep in mind that all conducted fermentation experiments were 
performed as single experiments and in order to confirm the obtained results, repetitions are 
urgently needed. The purpose of the subsequently presented experiments was to gain swift 
insights in potential issues connected with scale-up, allowing the opportunity to counteract such 
potential issues during strain construction. 
A 1. Glass reactor system 
With the purpose to investigate the growth and production behaviour of L-histidine producing 
strains in bioreactor systems and compare these to the standardly used shaking flask system, 
selected strains were cultivated in a glass reactor system (2.4.6 Triple glass reactor system, 
p.66). All results of fermentations in this system are summarized in Table 34 on page 134. 
Comparison between shaking flask and fermentation cultivations. Strains 
C. glutamicum HIS7 and C. glutamicum CM2 were chosen as a basis for the fermentation 
experiments in the small-scale bioreactor system. Both were cultivated in a laboratory scale 
fermentation with a working volume of 200 mL in the fermentation minimal medium (CGXIIR; 
Table 12, p.58).  
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The results showed that the growth rate of both C. glutamicum HIS7 and CM2 increased from 
0.28 h-1 and 0.19 h-1 in shaking flasks to 0.31 h-1 and 0.26 h-1 in the reactor system, respectively. 
Interestingly, the YX/S of C. glutamicum HIS7 remained stable (0.42 ± 0.02 vs. 
0.41 g biomass g-1 substrate), whereas the YX/S of C. glutamicum CM2 strongly increased 
during fermentation from 0.25 ± 0.02 to 0.44 g biomass g-1 substrate (compare Table 31, p.120, 
and Table 34, p.134). Compared to the shaking flask cultivations, the growth profile of both 
strains was continuously exponential until the glucose was completely consumed. In the 
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shaking flask cultivations, this was different. Here, the growth profile was characterized by a 
first phase of exponential growth, which then slowed down and slowly approached a maximal 
biomass concentration, instead of a wildtype-like exponential growth until reaching the 
stationary phase (exemplarily shown for C. glutamicum CM2; Fig. 33, p.231).  
The YP/Shis in contrast to the growth rate decreased in both strains from 0.066 ± 0.003 to 0.035 
mol L-histidine mol-1 glucose for C. glutamicum HIS7 and from 0.079 ± 0.003 to 
0.057 mol L-histidine mol-1 glucose for C. glutamicum CM2, respectively. The same holds true 
for YP/Sgly, which decreased from 0.073 ± 0.002 to 0.038 mol glycine mol-1 glucose for 
C. glutamicum HIS7 and from 0.098 ± 0.003 to 0.058 mol glycine mol-1 glucose for 
C. glutamicum CM2, respectively. These results indicate (i) that the scaling-up from shaking 
flasks to a small-scale fermentations holds challenges, which need to be considered preferably 
early on in strain construction. And (ii), glycine remains an equimolar byproduct to L-histidine, 
as was observed in the shaking flask cultivations (Table 31, p.120 and Fig. 18, p.124).  
Mimicking shaking flask cultivations in small-scale fermentations: medium composition. 
With the purpose to investigate the differences in YP/Shis between shaking flask and reactor 
cultivations in more detail, the media compositions were examined in more detail. Since the 
fermentation medium CGXIIR (Table 12, p.58) compared to CGXIIN (standardly used in 
shaking flask cultivations) lacks the two components urea and 3-(N-morpholino) 
propanesulfonic acid (MOPS), we performed reactor cultivations and added these components 
separately (C. glutamicum HIS7) and combined (C. glutamicum CM2) to the medium to 
investigate if these components are responsible for the decreased YP/Shis in shaking flask 
cultivations compared to the initially conducted reactor cultivations. These reactor cultivations 
resulted in similar growth rates, biomass substrate yields, and product yields for 
C. glutamicum HIS7 compared to small scale reactor cultivations in CGXIIR medium (Table 
34, p.134). Preliminary experiments for cultivations of C. glutamicum CM2 in reactor 
cultivations using the shaking flask medium (including urea and MOPS) indicate similar 
circumstances. The decrease of the YP/Shis here needs closer investigations, however. 
Mimicking shaking flask cultivations in small-scale fermentations: pH. Besides the 
differences in the composition of the medium, there are further factors that behave differently 
in reactor and shaking flask cultivations, e.g. the absolute value of the pH and its progress over 
the cultivation time. While the pH value in reactor cultivations is fixed to a certain value (by 
adding acid/base), constituting the optimal value for the deployed organism, shaking flask 
cultivations show a gradient of pH values ranging from the starting value of 7.4 to a maximal 
 136 
 
value of 8.6 (after 24 h) over the cultivation duration (Fig. 34, p.229; Follmann et al., 2009; 
Lange et al., 2018). Thus, we disabled the standardly used automated pH regulation (with 10% 
H3PO4 and 25% NH4OH; 2.4.6 Triple glass reactor system, p.66) and cultivated 
C. glutamicum CM2 in CGXIIN medium. In this scenario, the pH steadily increased to a 
maximal value of 8.79, which was reached after about 10 h of cultivation and slowly 
re-decreased to about 8.60 after 24 h, exceeding the maximal pH value of the shaking flask 
cultivations (Fig. 34, p.231). The growth rate and the YX/S of C. glutamicum CM2 both strongly 
decreased to 0.21 h-1 and 0.27 g biomass g-1 substrate, compared to the cultivation with active 
pH regulation. Interestingly, YP/Shis (and YP/Sgly) increased to 0.052 mol L-histidine mol-1 
glucose (and 0.069 mol glycine mol-1 glucose), indicating that the pH unregulated process 
promotes increased formation or export of L-histidine and underlining an important role of the 
extracellular pH for further fermentation cultivations. 
We proceeded by cultivating C. glutamicum CM2 at different fixed pH values, including 6.25, 
8.0, and 8.25, and compared results to standard cultivations at a fixed pH of 7.4 (see above). 
When cultivated at a pH of 6.25, the growth rate slightly increased to 0.30 h-1 and the YX/S 
remained stable with 0.44 g biomass g-1 substrate. However, YP/Shis and YP/Sgly decreased to 
0.042 mol L-histidine mol-1 glucose and 0.055 mol glycine mol-1 glucose, respectively, 
indicating that slightly acidic fermentation conditions might have adverse effects for L-histidine 
production with C. glutamicum. Next, C. glutamicum CM2 was cultivated with a fixed pH 
value of 8.0 and under this condition, performed better than at pH 6.25. Despite the growth rate 
strongly decreased to 0.17 h-1, YX/S, YP/Shis, and YP/Sgly remained stable compared to pH 7.4, 
resulting in 0.47 g biomass g-1 substrate, 0.053 mol L-histidine mol-1 glucose and 
0.065 mol glycine mol-1 glucose. When cultivated at pH 8.25, the growth and production 
behaviour of C. glutamicum CM2 decreased strongly. The growth rate was below 0.1 h-1, the 
YX/S was below 0.1 g biomass g-1 substrate, and YP/Shis and YP/Sgly were not calculated due to 
the low extracellular concentrations of L-histidine and glycine, respectively. Despite the pH 
values in shaking flask cultivations increased above values of 8.6 (Fig. 34, p.231), it seems that 
the starting phase of the cultivation (at about pH 7.4) where C. glutamicum starts to build 
biomass is important to bear the burden of increased pH values in a later phase of cultivation. 
Mimicking shaking flask cultivations in small-scale fermentations: oxygen limitation. 
Beyond the mentioned differences, shaking flask cultivations in general differ from reactor 
cultivations in the option of controlled aeration. For aerobic cultivations, oxygen needs to be 
transferred from the gas phase into the liquid phase. In aerobic bioreactor cultivations this is 
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actively facilitated via aeration through sterile filters and controlling air bubble sizes with frits. 
The simpler shaking flask system on the other hand relies on passive aeration via natural oxygen 
transfer at the interface of liquid and gas phases, which might be increased by using baffled 
flasks. Despite its many advantages e.g. for fast screening of producer strains, it is known that 
oxygen limitations in the shaking flask system occur and probabilities of these increase with 
increasing biomass concentrations (Klöckner and Büchs, 2012; Lange et al., 2018; 
Losen et al., 2004; McDaniel and Bailey, 1969). For the purpose to investigate if these potential 
limitations in the shaking flask system have impacts on the L-histidine producing strains, we 
conducted small-scale fermentations with strain C. glutamicum CM2 and induced oxygen 
limitations after 4, 6, and 8 h of cultivation time. This was done by restricting the velocity of 
the stirrer and the aeration to fixed values (100 rpm, 0.1 vvm) after 4, 6, or 8 h of cultivation to 
decrease the pO2 in a controlled manner. Results showed that compared with the fermentations 
with controlled oxygen supply, the limitations did not lead to significantly different values for 
growth rates and biomass substrate yields. With an oxygen limitation after 4 h of cultivation, 
C. glutamicum CM2 showed a slightly decreased growth rate, whereas with an oxygen 
limitation after 8 h it had an increased YX/S of 0.52 g biomass g-1 substrate. The YP/Shis and 
YP/Sgly in all three scenarios decreased strongly to 0.034, 0.029, and 0.023 mol L-histidine mol-1 
glucose and 0.038, 0.034, and 0.030 mol glycine mol-1, indicating that the cells need an optimal 
oxygen supply for L-histidine production. However, since these are results from mostly 
preliminary single experiments, repetitions are urgently needed to substantiate these first 
findings. 
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A 2. STR batch fermentation 
With the purpose to conduct initial and preliminary fermentation studies in increasingly larger 
volumes, the process was transferred from the glass reactor system with 200 mL working 
volume to a stirred tank steel reactor (STR) with a working volume of 30 L (2.4.7 30 L stirred 
tank reactor cultivations, p.67). To generate sufficient amounts of biomass, the seed train was 
modified (Fig. 9, p.66) and 10 L CGXIIR medium were inoculated with C. glutamicum CM2 in 
the STR. In a first study, C. glutamicum CM2 performed poor and showed a growth rate of 
< 0.1 h-1 and YX/S of <0.1 g biomass g-1 substrate (data not shown). We monitored growth for 
8 h, where the strain had accumulated 0.67 g biomass L-1 (from the initial 0.27 g biomass L-1). 
Since protocatechuic acid (PCA) is known to be a crucial supplement for reactor cultivations in 
certain scenarios with C. glutamicum (personal communication with Bastian Blombach, 
Michaela Graf; both IBVT, University of Stuttgart), 30 mg L-1 were added sterilely to the 
medium. Indeed, the cells showed increasing differential growth rates after addition of PCA 
Fig. 20. Representative stirred tank reactor fermentation in batch mode of strain C. glutamicum CM2 in 
10 L working volume in CGXIIR medium with 30 mg protocatechuate L-1 and 45 g glucose L-1. (A) biomass 
concentration (filled circles) and glucose concentration (open circles), (B) process data velocity of the stirrer 
(black line) and aeration with sterile air (grey line), (C) amino acid concentrations for L-histidine (black 
triangles) and glycine (white triangles), (D) proportion of the exhaust gas in percentage for O2 (black line) 
and CO2 (grey line). 
 139 
 
and the strain increased its biomass significantly to 17.6 g biomass L-1 after 22 h of cultivation 
(data not shown). Thus,PCA was identified as an essential ingredient for bioreactor cultivations 
with the L-histidine producing C. glutamicum CM2 in scales above 200 mL working volume.   
A further bioreactor cultivation was conducted and C. glutamicum CM2 was cultivated with 
the same conditions as before, with the difference that PCA was included in all applied minimal 
media (seed train and main culture). When PCA was present, C. glutamicum CM2 grew 
exponentially with a growth rate of 0.29 h-1 and had a YX/S of 0.39 g biomass g-1 substrate. The 
YP/Shis, and YP/Sgly decreased compared to the standard cultivation conditions in shaking flasks 
(Table 31, p.120) and in the small-scale fermentations in glass reactors (Table 34, p.134), to 
0.025 mol L-histidine mol-1 glucose and 0.035 mol glycine mol-1 glucose, respectively. Despite 
YP/Shis was in the end diminished compared to cultivations in shaking flasks and small-scale 
fermentations, the strain showed exponential growth (with PCA) until it reached the stationary 
phase, consumed the glucose steadily and showed no strain instabilities, at least in this scenario 
(Fig. 20, p.138). 
 
A 3. STR fed-batch fermentation 
In a final reactor cultivation, we performed a preliminary fed-batch fermentation with a starting 
volume of 8 L in the 30 L stirred STR with C. glutamicum CM2. The required biomass for the 
fed-batch mode was generated with a batch fermentation, which was run o/n with the same 
conditions as used above, with slight changes (A 2 STR batch fermentation, p.138). As soon as 
the initially supplied 20 g glucose L-1 in the medium were consumed, the fed-batch mode was 
initiated and the growth rate of C. glutamicum CM2 was adjusted to µ = 0.1 h-1 by adding 
defined amounts of glucose feed (Fig. 21, p.141). At the end of the batch phase, 
C. glutamicum CM2 had reached a biomass concentration of 9.2 g biomass L-1, which 
corresponds to a YX/S of 0.43 g biomass g-1 substrate. It had grown with a growth rate of 
0.26 h-1, similar to the small-scale fermentations (Table 34, p.134). During the batch phase, 
C. glutamicum CM2 had excreted 2.48 mM L-histidine and 3.37 mM glycine into the medium, 
resulting in YP/Shis and YP/Sgly of 0.022 mol L-histidine mol-1 glucose and 0.029 mol glycine 
mol-1 glucose. 
C. glutamicum CM2 had consumed the initial 20 g glucose L-1 in the o/n batch phase after about 
13 h of process duration (Fig. 21A, p.141). At this point, the process was switched to fed-batch 
mode, where µ was set to be 0.1 h-1. The overall growth rate during the fed-batch phase 
ultimately was about 0.09 h-1, slightly below the intended µ (data not shown). 
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The bioprocess was aborted after about 28 h, after the oxygen content in the exhaust gas started 
to increase significantly (data not shown) and after glucose concentration in the medium started 
to increase drastically (Fig. 21A, p.141) after about 22.3 h. Both findings indicate that one of 
the medium components was limiting at this point, since glucose was present in excess. 
However, medium components were not fed, which might be considered for future fermentation 
studies. The extension of the fed-batch process after glucose in the medium and oxygen in the 
exhaust gas increased, was performed to investigate whether C. glutamicum CM2 under these 
conditions also produced L-histidine one of the medium components limited, as was observed 
in the shaking flask cultivations when glucose limited (data not shown). Indeed, 
C. glutamicum CM2 kept producing L-histidine (and glycine) after one ore more components 
limited, between hours 22.3 and about 26 h (Fig. 21B, p.141). 
During the fed-batch phase a maximal CDW of 25.6 g biomass L-1 was reached after about 25 h 
of cultivation. The substrate specific biomass yield and the glucose uptake rate were 
0.89 g biomass g-1 substrate and 0.90 g substrate g-1 biomass h-1. YP/Shis was 0.014 mol 
histidine mol-1 glucose.  
The batch and fed-batch phases combined resulted in 2.6 g histidine L-1 and in 1.4 g glycine as 
main byproduct. Interestingly, 86% of L-histidine were produced in the fed-batch phase, 
whereas only 64% of biomass were built. YP/Shis was 30% lower in the fed-batch phase 
compared to the batch phase.  
Between about 18 h and 22 h of cultivation, there is an increase in L-histidine and glycine 
production (Fig. 21B, p.141). In this phase, YP/ was 0.022 mol L-histidine mol-1 glucose. The 
process data show an upregulation of the stirrer speed to maintain the DO level above a critical 
value of 35% (Fig. 21C, p.141). After about 12 h of cultivation at the end of the batch phase, 
strong foaming occurred, which most likely resulted in accumulation of the base NH4OH on 
top of the foam layer. Manual addition of antifoam destroyed the accumulated foam. However, 
the accumulated base led to an increase of the pH to about 8.7 (data not shown). We 
counteracted this by adding 20 mL 10% (v v-1) phosphoric acid followed by 20 mL 80% (v v-1) 
phosphoric acid, readjusting the pH to 7.4. Determination of the anorganic phosphate in the 
medium revealed that due to the addition of phosphoric acid, phosphate was not the growth 
limiting component in the medium (data not shown). 
 141 
 
 
 
  
Fig. 21. Fed-batch fermentation of strain C. glutamicum CM2 in a stirred tank steel reactor with 8 L 
starting volume of CGXIIR medium with 30 mg protocatechuate -11 and 20 g glucose L-1 starting 
concentration. First about 13 h show fermentation in batch mode, then the fed-batch was switched on and 
defined amounts of glucose were added to the medium. (A) biomass concentration (filled circles) and 
glucose concentration (open circles), (B) amino acid concentrations for L-histidine (black triangles) and 
glycine (white triangles), (C) process data velocity of the stirrer (black line) and oxygen partial pressure 
(grey line), (D) actual feed addition during the fed-batch phase of the fermentation (black line) and 
calculated feed addition (grey line). The dashed line indicates the start of the fed-batch mode, i.e. when 
the feed was switched on. 
 142 
 
 Results PART II – Metabolic engineering to guide evolution 
 Idea 
The ideas behind the development of an evolutionary method in addition to the multiple 
available evolutionary approaches, such as adaptive laboratory evolution (ALE) or directed 
evolution was  
i) to develop an evolutionary approach that yields only a minimal set of mutational background, 
thus enabling simple screening for the desired mutations and  
ii) to create a novel metabolic mode for production of L-valine with this evolutionary approach. 
This novel metabolic mode was intended to expand the the available modes for L-valine 
production, which classically focus on inactiving or attenuating the pyruvate dehydrogenase 
complex (PDHC; Blombach et al., 2009, 2008, 2007; Buchholz et al., 2013; 
Oldiges et al., 2014). Therefore, in a first step, we applied metabolic engineering and 
inactivated PEPCx and PCx enzymes with the aim to increase carbon fluxes over the PDHC 
thereby supplying increased amounts of pyruvate, which might then be drawn towards L-valine 
(Fig. 7, p.32). Strain C. glutamicum Δppc Δppc constituted the basis for the evolutionary 
approach. 
 Flux Balance Analysis 
We intended to construct a double deletion mutant strain with deletions of the genes ppc, 
encoding PEP carboxylase, and pyc, encoding pyruvate carboxylase, to harness the potentially 
higher flux over the PDHC for L-valine production. However, the double deletion mutant had 
been described before as being unable to grow on glucose as sole carbon source (Peters-
Wendisch et al., 1998). Therefore, in a first step, André Feith (IBVT, University of Stuttgart) 
conducted a Flux balance analysis (FBA) with a recently published model of C. glutamicum 
(Zhang et al., 2017). This was done to predict compensatory flux distributions that might enable 
the growth of C. glutamicum Δppc Δpyc on glucose, as a potential result of an evolutionary 
experiment (Fig. 22, p.143).  
In the C. glutamicum WT scenario, the FBA predicted a µ of 0.39 h-1, which fits the 
experimental data quite well (compare Table 36, p.151). FBA further predicted a flux 
distribution between PPP and glycolysis of 39:60 for C. glutamicum WT and no flux into the 
glyoxylate shunt during growth on glucose (Fig. 22A, p.143), as is known from experimental 
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data, since the glyoxylate shunt enzymes isocitrate lyase (ICL) and malate synthase (MS) are 
inactive on glucose as sole carbon source (Wendisch et al., 2000).  
In contrast to that, the flux distributions changed when the two anaplerotic reactions of PEPCx 
and PCx were deleted from the model (Fig. 22B, p.143). Here, the glyoxylate shunt became 
active with a split ratio of 23:26 between the ICD and ICL reactions, resulting in an identical µ 
compared to C. glutamicum WT. Furthermore, the flux distribution between PPP and glycolysis 
changed to 54:45, favouring the NADPH-forming reactions in the PPP as compensation for the 
diminished flux through the NADPH-forming ICD reaction.  
In sum, the FBA predicted that growth of a C. glutamicum Δppc Δpyc mutant should be feasible 
on glucose as sole carbon source, when the glyoxylate shunt is activated. 
 Metabolic engineering of the anaplerotic reactions 
With the result from the FBA indicating that a C. glutamicum mutant with deficiencies in the 
PCx and PEPCx reactions might potentially be able to grow on glucose, we constructed the 
A B 
Fig. 22. Carbon flux distribution in C. glutamicum WT (A) and C. glutamicum Δppc Δpyc (B) during growth 
on glucose as predicted by Flux Balance Analysis (FBA). Grey numbers give the respective carbon fluxes 
towards biomass. Abbreviations: 3PG, 3-Phosphoglycerate; Acetyl-CoA, acetyl coenzyme A; F6P, Fructose 
6-phosphate; G6P, Glucose 6-phosphate; Glyoxyl., Glyoxylate; PEP, Phosphoenolpyruvate. Results obtained 
from André Feith, figure prepared by myself and taken from Schwentner et al., 2018. 
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basis strain for the evolutionary approach C. glutamicum Δppc Δpyc. In addition to 
C. glutamicum Δppc Δpyc, we constructed C. glutamicum Δppc Δpyc Δpck, based on the afore 
mentioned strain, with an additional deletion of the pck gene, encoding PEP carboxykinase. In 
general, the PEPCk reaction is a gluconeogenic enzyme and directed towards pyruvate 
generation, rather than consumption (Riedel et al., 2001). It however has been demonstrated 
that PEPCk activity in C. glutamicum during growth on glucose is present (Riedel et al., 2001) 
and that the PEPCk reaction is reversible in principle (Jetten and Sinskey, 1993; 
Klaffl et al., 2013). Thus, by deploying a PEPCk deficient strain in the evolutionary approach, 
PEPCk should be omitted as potential target acquiring mutations.  
Firstly, the growth behaviour of both basis strains C. glutamicum Δppc Δpyc and 
C. glutamicum Δppc Δpyc Δpck was monitored in shaking flask experiments in CGXIIE (Table 
12, p.58) medium w/o yeast extract or L-glutamate with 20 g glucose L-1, where none of the two 
strains was able to grow (data not shown). We proceeded by cultivating 
C. glutamicum Δppc Δpyc and C. glutamicum Δppc Δpyc Δpck in CGXIIE medium, containing 
20 g glucose L-1 and 1 g yeast extract L-1. Compared with the growth of C. glutamicum WT 
(growth rate 0.39 ± 0.01 h-1), both C. glutamicum Δppc Δpyc and 
C. glutamicum Δppc Δpyc Δpck, showed strong growth deficits, as was expected (Fig. 
23, p.144). However, addition of 1 g yeast extract L-1 into the medium enabled minimal growth, 
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Fig. 23. Shaking flask cultivations of strains C. glutamicum WT (circles), C. glutamicum Δppc Δpyc
(triangles), and C. glutamicum Δppc Δpyc Δpck (squares) in CGXIIE minimal medium with 20 g glucose L-1
and 1 g yeast extract L-1. Experiments were performed in triplicates and error bars show standard deviation. 
Figure taken from Schwentner et al., 2018 
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which is considered as prerequisite for an evolutionary approach relying on growth, i.e. 
increasing biomass concentration, as the screening indicator. In CGXIIE medium w/o 
yeast extract, neither C. glutamicum Δppc Δpyc nor C. glutamicum Δppc Δpyc Δpck showed 
an increase in biomass concentration at all (data not shown). 
 Evolutionary Approach 
Both strains C. glutamicum Δppc Δpyc and C. glutamicum Δppc Δpyc Δpck were deployed in 
evolutionary experiments in CGXIIE minimal medium with 40 g glucose L-1, inoculated and 
incubated for 3-4 days, and then transferred into fresh medium (Fig. 24, p.145; 2.4.5 Shaking 
flask cultivations, p.64). The evolutionary cultures were monitored each day for increasing 
biomass, simply by observing the density of the biosuspension. Increased biomass formation 
indicating an evolutionary event was observed two times independently for strain 
C. glutamicum Δppc Δpyc after 14 and 15 days (exemplarily shown for one culture in Fig. 
24, p.145), and once for strain C. glutamicum Δppc Δpyc Δpck after 33 days. 
Fig. 24. Exemplary growth profile of C. glutamicum Δppc Δpyc in CGXIIE medium with 40 g glucose L-1 and 
1 g yeast extract L-1 during the shaking flask cultivations of the evolutionary experiment. Arrows indicate 
transfers of biomass into fresh CGXIIE medium. Figure taken from Schwentner et al., 2018. 
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 Evolved Strains 
Of each shaking flask containing evolved cultures, cell suspension was plated in serial dilutions 
on semi-solid complex and minimal medium (CGXIIE) with the aim to identify faster growing 
cells, i.e. colonies, and extract them from the mixed culture containing the initial strains 
C. glutamicum Δppc Δpyc or C. glutamicum Δppc Δpyc Δpck. The agar plates were incubated 
for 1-3 days and examined regularly to identify faster growing colonies. The fastest growing 
ones were isolated and characterized in shaking flask cultivations with CGXIIE containing 
20 g glucose L-1 and 1 g yeast extract L-1. The two evolved strains proceeding from 
C. glutamicum Δppc Δpyc were named Evo1.1 and Evo1.2 and showed distinctly faster growth 
compared to the initial strain (Fig. 25, p.146), with growth rates of 0.23 ± 0.01 h-1 and 
0.22 ± 0.01 h-1, respectively (compare Table 36, p.151). The evolved strain proceeding from 
C. glutamicum Δppc Δpyc Δpck was named Evo2 and showed a distinctly lower growth rate of 
0.08 ± 0.01 h-1, compared with Evo1.1 and Evo 1.2. However, the growth of Evo2 was indeed 
enhanced compared to the initial strain (compare Table 36, p.151).  
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Fig. 25. Shaking flask cultivations of the evolved strains C. glutamicum Δppc Δpyc Evo1.1 (circles), 
C. glutamicum Δppc Δpyc Evo1.2 (triangles), and C. glutamicum Δppc Δpyc Δpck Evo2 (squares) obtained 
from the evolutionary experiments. Cultivations were performed in CGXIIE minimal medium with 
20 g glucose L-1 and 1 g yeast extract L-1. Experiments were performed in triplicates and error bars show 
standard deviation. Figure taken from Schwentner et al., 2018 
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 Whole genome sequencing and mutational intersection 
With the evolved and verified strains in hands, it remained to elucidate what enables the faster 
growth of the evolved strains. With the purpose to identify chromosomal alterations as an 
outcome of the evolutionary experiment, the genomic DNA of strains Evo1.1, Evo1.2, and Evo2 
was extracted and analysed at the Center for Biotechnology (CeBiTec), Bielefeld University, 
in the working group of Prof. J. Kalinowski (Microbial Genomics and Biotechnology). Whole 
genome sequencing (WGS) was performed with C. glutamicum WT as basis of comparison to 
identify the genomic alterations of strains Evo1.1, Evo1.2, and Evo2. As a result, three 
alterations in two of the evolved strains (Evo1.1 and Evo2) and six alterations in one evolved 
strain (Evo1.2) were identified (for a complete overview of the genomic alterations see Table 
35, p.148). These alterations comprise several single nucleotide polymorphisms (SNPs), 
synonymous as well as nonsynonymous SNPs, a nucleotide insertion, and a deletion of 12 bps. 
From this pool of mutations, we built the mutational intersection of the three evolved strains 
and visualized it in a Venn-diagram (Fig. 26, p.149). The result of the mutational intersection 
showed that only one target gene was mutationally affected in all three strains, which was the 
icd gene (cg0766), encoding the isocitrate dehydrogenase (ICD). The SNPs T to C 
(pos. 680299) in Evo1.1, G to A (pos. 680161) in Evo1.2, and G to T (pos. 681237) in Evo2 in 
the icd gene constituted nonsynonymous missense SNPs led to the three amino acid exchanges 
A94D, R453C, and G407S in the ICD enzyme, respectively, and were named ICDA94D, 
ICDR453C, and ICDG407S. The genome positions given refer to the genome sequence of 
Kalinowski et al., 2003. Other mutational targets comprised PtsF (cg2120) and BenR (cg2641) 
in Evo1.1, cg0466, GlgE (cg1382), PtsF (cg2120), BenR (cg2641), and an ABC-type sugar 
transport system ATPase component (cg2708) in Evo1.2, and GlgE (cg1382) and cg1793 in 
Evo2 (Table 35, p.148).  
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Since the ptsF gene was affected by mutations in strains Evo1.1 and Evo1.2, both strains were 
cultivated in CGXIIE minimal medium with fructose instead of glucose. Here, both strains 
showed impaired growth compared to growth on glucose (data not shown) other than 
C. glutamicum WT, which is able to grow on fructose as sole carbon source 
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(Dominguez et al., 1998, 1997). This indicates that the mutations in the ptsF gene indeed affect 
the PtsF protein in Evo1.1 and Evo1.2.  
 
 Re-engineering 
Having identified icd as the sole mutational intersection, we proceeded by re-engineering the 
three nucleotide exchanges into C. glutamicum Δppc Δpyc, resulting in the re-engineered 
strains C. glutamicum Δppc Δpyc ICDA94D, C. glutamicum Δppc Δpyc ICDR453C, and 
C. glutamicum Δppc Δpyc ICDG407S. With the aim to confirm the ICD mutations as definitive 
factor for the enhanced growth of the evolved strains, the re-engineered strains were cultivated 
in CGXIIE minimal medium containing 20 g glucose L-1 and 1 g yeast extract L-1 (Fig. 
27, p.150). C. glutamicum Δppc Δpyc ICDA94D, C. glutamicum Δppc Δpyc ICDR453C, and 
C. glutamicum Δppc Δpyc ICDG407S showed growth rates of 0.24 ± 0.03 h-1, 0.22 ± 0.01 h-1, and 
0.31 ± 0.02 h-1, respectively, accounting to 62%, 56%, and 80% of the growth rate of 
C. glutamicum WT (Table 36, p.151).  
Fig. 26. Venn-diagram showing the mutational background of the evolved strains C. glutamicum Δppc Δpyc 
Evo1.1, C. glutamicum Δppc Δpyc Evo1.2, and C. glutamicum Δppc Δpyc Δpck Evo2. Genomic targets that 
were altered compared to the genome of C. glutamicum WT were revealed by (comparative) whole genome 
sequencing and are given as cg numbers (according to https://coryneregnet.compbio.sdu.dk/v6/index.html; 
last access 15-06-2018). WGS unveiled gene cg0766 (icd, encoding isocitrate dehydrogenase) as mutational 
intersection, i.e. only consistent target in all three evolved strains. For an overview of all targets of the 
evolutionary approach see Table 35 on page 148. Figure taken from Schwentner et al., 2018.  
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Under these conditions, substrate specific biomass yields slightly decreased to 0.56 ± 0.03, 
0.56 ± 0.02, and 0.55 ± 0.03 g biomass per g substrate, respectively, compared to 0.60 ± 0.01 
g biomass per g substrate of C. glutamicum WT (Table 36, p.151).  
Biomass specific glucose consumption rates qS decreased from 0.64 ± 0.01 g glucose per 
g biomass per h for C. glutamicum WT to 0.43 ± 0.05, 0.40 ± 0.02, and 0.56 ± 0.04 g glucose 
per g biomass per h in C. glutamicum Δppc Δpyc ICDA94D, C. glutamicum Δppc Δpyc 
ICDR453C, and C. glutamicum Δppc Δpyc ICDG407S (Table 36, p.151). By re-engineering the 
ICD mutations into the initial strain C. glutamicum Δppc Δpyc, we created a strain that is 
deficient in the reactions catalysed by PCx and PEPCx and despite this can grow on the 
glycolytic substrate glucose. ICD mutations were identified as the one factor enhancing the 
growth phenotype of the initial strain and enabled the evolved strains to grow, where 
C. glutamicum Δppc Δpyc was not able to.  
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Fig. 27. Shaking flask cultivations of the re-engineered strains C. glutamicum Δppc Δpyc ICDA94D (A), 
C. glutamicum Δppc Δpyc ICDR453C (B), and C. glutamicum Δppc Δpyc ICDG407S (C) in CGXIIE 
minimal medium with 20 g glucose L-1 and 1 g yeast extract L-1. Filled circles represent biomass 
formation, empty circles represent glucose concentration. Experiments were performed in triplicates 
and error bars show standard deviation. Figure taken from Schwentner et al., 2018. 
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 Media investigations 
In further experiments, we investigated the requirements of the re-engineered strains concerning 
media composition in more detail. Therefore, yeast extract, which enabled minimal growth of 
the initial strain C. glutamicum Δppc Δpyc (3.2.3 Metabolic engineering of the anaplerotic 
reactions, p.143), was omitted from the CGXIIE medium. Interestingly, none of the 
re-engineered strains was able to grow in this environment, indicating that evolution strongly 
selects according to surrounding conditions (data not shown; Nevo, 2011), since Evo1.1, 
Evo1.2, and Evo2 had evolved in the presence of yeast extract. To see whether the yeast extract 
complex component could be replaced by a more defined component, we supplemented the 
CGXIIE medium (w/o yeast extract) with 1 mM or 10 mM L-glutamate. This was intended to 
enable the re-engineered strains to take up L-glutamate, incorporate carbon into the TCA cycle 
via the reaction of gdh (cg2280) encoded L-glutamate dehydrogenase (Gdh), and potentially 
close their oxaloacetate-forming gap due to the deletions of ppc and pyc. Both 1 mM (Fig. 
28, p.152) and 10 mM (data not shown) of supplemented L-glutamate were able to mediate 
growth of the re-engineered strains. Exemplarily, the consumption of 1 mM L-glutamate was 
monitored for C. glutamicum Δppc Δpyc ICDG407S, which had consumed all present 
L-glutamate in the medium post 8 h of cultivation start (data not shown). Further, it continued 
to grow after depletion of L-glutamate and showed an overall growth rate of 0.27 ± 0.01 h-1, 
which corresponds to 87% compared to conditions with yeast extract. The other two 
Table 36. Overview of growth rates, substrate specific biomass yields, and biomass specific substrate 
uptake ratess of C. glutamicum WT, the initial strains for the evolutionary experiment, and the 
re-engineered strains in CGXIIE medium with 20 g glucose L-1 and 1 g yeast extract L-1. 
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re-engineered strains, C. glutamicum Δppc Δpyc ZICDA94D and C. glutamicum Δppc Δpyc 
ICDR453C, showed growth rates of 0.24 ± 0.01 h-1 and 0.26 ± 0.01 h-1 in the presence of 1 mM 
L-glutamate, which corresponds to 100% and 118% compared to when supplemented with 
yeast extract, respectively.  
 ICD mutations impair ICD activities 
After having verified ICD mutations as growth-enabling factors of the re-engineered strains on 
glucose and having identified L-glutamate as required supplement, we proceeded by 
investigating the effects of the ICD mutations in more detail. Therefore, the specific ICD 
enzyme activities (2.8.7 Enzyme assays, p.90) of all three ICD variants were measured. This 
was done by generating cell-free lysates of strains C. glutamicum Δppc Δpyc ICDA94D, 
C. glutamicum Δppc Δpyc ICDR453C, C. glutamicum Δppc Δpyc ICDG407S, and 
C. glutamicum WT, grown in CGXIIE with 20 g glucose L-1 and 1 mM L-glutamate.  
The three ICD variants ICDA94D, ICDR453C, and ICDG407S showed specific ICD activities of 
0.11 ± 0.01, 0.31 ± 0.03, and 0.58 ± 0.06 U (mg protein)-1, accounting to about 10%, 29%, and 
55% of the specific ICD activity of the wildtype enzyme, respectively (Fig. 29, p.153). The 
measurement of the specific enzyme activities of the ICD variants, ICDA94D, ICDR453C, and 
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Fig. 28. Shaking flask cultivations of the re engineered strains C. glutamicum Δppc Δpyc ICDA94D 
(triangles), C. glutamicum Δppc Δpyc ICDR453C (squares), and C. glutamicum Δppc Δpyc ICDG407S 
(circles) in CGXIIE minimal medium with 20 g glucose L-1 and 1 mM L-glutamate, instead of 
yeast extract. Experiments were performed in triplicates and error bars show standard deviation. Figure 
taken from Schwentner et al., 2018. 
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ICDG407S, showed that the specific activities of the mutated variants was significantly lower 
than the one of the native enzyme. 
Since the FBA (3.2.2 Flux Balance Analysis, p.142) predicted that growth of the double deletion 
mutant C. glutamicum Δppc Δpyc on glucose in principle is possible, but that activation of the 
glyoxylate shunt - i.e. presence of enzymatic activities of ICL and MS – is needed, we 
proceeded by investigating activities of these enzymes. Lysates were prepared as described for 
ICD and measurements showed that in glucose-grown C. glutamicum WT specific activities of 
ICL and MS were negligible, resulting in 0.03 ± 0.05 and below 0.01 U (mg protein)-1 specific 
activity (Fig. 29, p.153). It is known that both enzymes are typically inactive when 
C. glutamicum is growing on glucose as sole carbon source (Wendisch et al., 2000, 1997). In 
contrast, specific ICL and MS activities in the re-engineered strains were significantly higher 
than in C. glutamicum WT, reaching 0.33 ± 0.06, 0.32 ± 0.05, and 0.53 ± 0.07 U (mg protein)-1 
for ICL and 0.44 ± 0.07, 0.42 ± 0.08, and 0.39 ± 0.03 U (mg protein)-1 for MS in 
C. glutamicum Δppc Δpyc ICDA94D, C. glutamicum Δppc Δpyc ICDR453C, and C. glutamicum 
Δppc Δpyc ICDG407S, respectively (Fig. 29, p.153). Thus, ICD mutations indeed activated the 
glyoxylate shunt, manifesting in ICL and MS activity. 
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Fig. 29. Specific enzyme activities of isocitrate dehydrogenase (black bars), isocitrate lyase (gray bars), 
and malate synthase (white bars) in strains C. glutamicum WT, C. glutamicum Δppc Δpyc ICDA94D, 
C. glutamicum Δppc Δpyc ICDG407S, and C. glutamicum Δppc Δpyc ICDR453C. All experiments were 
performed in triplicates and error bars show standard deviation. Figure taken from Schwentner et al., 
2018. 
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 Systems Metabolic Profiling 
With the purpose to gain a more detailed insight into the metabolic state of the re-engineered 
mutants, André Feith (IBVT, Univeristy of Stuttgart) exemplarily performed a comparative 
metabolome analysis, entitled SMP (2.8.8 Systems Metabolic Profiling, p.91), with 
C. glutamicum Δppc Δpyc ICDG407S as representative of the re-engineered strains on an 
LC-MS/MS Q-TOF system and evaluated fold changes (FCs) normalized on the metabolome 
levels of C. glutamicum WT. In four independent cultivations, 
C. glutamicum Δppc Δpyc ICDG407S showed altered intracellular pool sizes of several 
metabolites compared to C. glutamicum WT (Fig. 30, p.154). Amongst these, cis-aconitate 
(FC+13.2), citrate (FC+12.1), isocitrate (FC+6.4), and L-valine (FC+1.9) were the most 
prominent ones in relation to increased intracellular pool sizes. Several metabolites showed 
decreased intracellular pool sizes, amongst these were besides others acetyl-CoA 
(FC-0.9), -1,6-bisphosphate (FC-1.2), glucose 6-phosphate (FC-1.4), fructose, and as most 
prominent member glycerate-2/3-phosphate (FC-3.8).  
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Fig. 30. Comparative metabolomics between C. glutamicum WT and C. glutamicum Δppc Δpyc ICDG407S 
showing the identified metabolites that had increased or decreased fold changes (FCs) in the latter strain. 
Abbreviations: P, -phosphate. Results and figure obtained from André Feith. Results published 
partially in Schwentner et al., 2018. 
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 L-Valine production 
As has been intended with the deletions of genes pyc and ppc, C. glutamicum Δppc Δpyc might 
have an increased carbon flux over the PDHC and towards the TCA cycle. Such an increased 
carbon flux might be harnessed for the generation of pyruvate-derived products.  
This potentially higher PDHC flux has been indicated by the results of FBA of C. glutamicum 
Δppc Δpyc (3.2.2 Flux Balance Analysis, p.142) and our plan to apply L-valine as a product 
was further underlined by the result of the metabolomics, showing that C. glutamicum Δppc 
Δpyc ICDG407S exhibited increased intracellular pool sizes of L-valine. This indicated its 
potential as L-valine producer. Thus, we transformed the L-valine overproduction plasmid 
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Fig. 31. Shaking flask cultivations for L-valine production of strains C. glutamicum (pJC4ilvBNCE) (A), 
C. glutamicum Δppc Δpyc ICDR453C (pJC4ilvBNCE) (B), C. glutamicum Δppc Δpyc ICDA94D
(pJC4ilvBNCE) (C), and C. glutamicum Δppc Δpyc ICDG407S (pJC4ilvBNCE) (D). Filled circles represent 
biomass formation, empty triangles represent glucose concentration, and empty squares represent L-valine 
concentration. Experiments were performed in triplicates, error bars show standard deviation. Figure taken 
from Schwentner et al., 2018. 
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pJC4ilvBNCE (Radmacher et al., 2002) into C. glutamicum Δppc Δpyc ICDA94D, 
C. glutamicum Δppc Δpyc ICDR453C, and C. glutamicum Δppc Δpyc ICDG407S. Additionally, 
pJC4ilvBNCE was transformed into C. glutamicum WT, which does not excrete L-valine under 
the applied growth conditions (data not shown), to serve as a control strain. The plasmid 
pJC4ilvBNCE has been applied for L-valine production before and contains the L-valine 
biosynthesis genes ilvB (cg1435), encoding the large SU of acetohydroxyacid synthase 
(AHAS), ilvN (cg1436), encoding the small SU of AHAS, ilvC (cg1437), encoding 
acetohydroacid isomeroreductase (AHAIR), and ilvE (cg2418), encoding transaminase B (TA) 
(Fig. 7, p.31; Leyval et al., 2003; McHardy et al., 2003; Radmacher et al., 2002).  
The three re-engineered strains and C. glutamicum WT, each containing pJC4ilvBNCE, were 
cultivated in CGXIIE supplemented with 40 g glucose L-1 and 1 mM L-glutamate (Fig. 
31, p.155). Here, C. glutamicum (pJC4ilvBNCE) showed a growth rate of 0.32 ± 0.01 h-1, a YX/S 
of 0.38 ± 0.02 gCDW per g glucose and reached a maximal concentration of 2.4 ± 0.1 
g L-valine L-1 in the medium, which corresponds to a product yield of 0.05 ± 0.01 
g L-valine per g glucose. C. glutamicum Δppc Δpyc ICDR453C (pJC4ilvBNCE) showed a 
growth rate of 0.17 ± 0.01 h-1 in the first 6 h of cultivation, however, reached only a maximal 
biomass concentration of 2.6 ± 0.1 gCDW per L, and was unable to consume the glucose 
completely within 48 h of fermentation. In contrast, 
C. glutamicum Δppc Δpyc ICDA94D (pJC4ilvBNCE) and 
C. glutamicum Δppc Δpyc ICDG407S (pJC4ilvBNCE) metabolized the glucose efficiently and 
showed a growth rate of 0.20 ± 0.01 h-1 and 0.17 ± 0.01 h-1 and a YX/S of 0.30 ± 0.01 and 
0.37 ± 0.03 gCDW per g glucose, respectively. Besides L-valine, all strains secreted between 2.4 
to 3.7 mM L-alanine (data not shown). C. glutamicum Δppc Δpyc ICDA94D (pJC4ilvBNCE) and 
C. glutamicum Δppc Δpyc ICDG407S (pJC4ilvBNCE) produced maximal 8.0 ± 0.1 and 8.9 ± 0.4 
g L-valine per L, which corresponds to an overall YP/S of 0.20 ± 0.01 and 0.22 ± 0.01 
g L-valine per g glucose, respectively.  
Taken together, the re-engineered strains showed a solid L-valine production performance, 
which demonstrates their potential for further modifications. MGE thus proved to be functional 
to identify a non-rational target to improve producer strains by identifying ICD mutations as a 
novel mode for L-valine production with C. glutamicum. Table 37 on page 157, gives a brief 
comparison of the best here constructed L-valine producer strain with other, in literature 
available, L-valine producers based on C. glutamicum and E. coli. 
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Strain Titer, mM YP/S§ Fermentation Source 
C. glutamicum     
Δppc Δppc ICDG407S (pJC4ilvBNCE) 75 0.22 g g-1 Shaking flask (This work,  
Schwentner et al., 2018) 
ΔpanBC ΔilvA (pJC1ilvBNCD) 92 0.27 g g-1* Shaking flask (Radmacher et al., 2002) 
ΔilvA ΔpanB ilvNM13 (pECKAilvBNC) 130 0.38 g g-1* Shaking flask (Elišáková et al., 2005) 
ilvNM13 ΔpanB P-ilvAM1CG P-ilvDM7 
P-ilvEM6 
136 0.40 g g-1* Shaking flask (Holátko et al., 2009) 
ΔaceE Δpqo Δpgi (pJC4ilvBNCE) 410 0.49 g g-1 Fed-batch (Blombach et al., 2008) 
aceE A16 Δpqo Δppc (pJC4ilvBNCE) 738 0.36 mol mol-1 Fed-batch (Buchholz et al., 2013) 
E. coli     
VAMF (pKBRilvBNCED) 
(pTrc184ygaZHlrp) 
65 0.38 g g-1 Batch (Park et al., 2007) 
WLA (pKBRilvBNmutCED) 
(pTrc184ygaZHlrp) 
518 0.34 mol mol-1 Fed-batch (Park et al., 2011) 
§YP/S either given in g L-valine per g glucose or mol L-valine per mol glucose, as indicated. 
*neither YP/S calculation nor glucose concentration given in reference. Therefore glucose concentration was assumed to be 
40 g glucose L-1, as given in the general reference of the used CGXII medium (Keilhauer et al., 1993). Additional supplements, 
like L-isoleucine or L-valine were omitted from the calculations. YP/S, if not given in the cited publications, were calculated as 
described in the Materials and methods part of this work. Data taken from Oldiges et al., 2014 and Wang et al., 2018. 
 
Table 37. Brief comparison of selected E. coli and C. glutamicum L-valine producer strains. Table modified 
after Oldiges et al., 2014 and Wang et al., 2018. 
 158 
 
CHAPTER 4: DISCUSSION 
 Part I 
L-Histidine is an attractive amino acid for various applications in several sectors, such as feed 
supplement for salmon and chicken breeding (Han et al., 1991; Haug et al., 2008; Park et al., 
2013; Waagbø et al., 2010), food supplement (https://www.lambertshealthcare.co.uk/l-
histidine-hcl-500mg-p8313/; last access 25-07-2018; 
https://www.bulkpowders.co.uk/histidine.html; last access 25-07-2018), and medical 
applications, e.g. against obesity (Du et al., 2017; Feng et al., 2013; Keller et al., 2000; Kimura 
et al., 2013; Tuttle et al., 2012; Watanabe et al., 2008). In 2003 the annual fermentative 
production of L-histidine was estimated to be 400 t per year (Ikeda, 2003). Nowadays, 
L-histidine is produced in large scale via fermentation processes by several companies, e.g. 
Ajinomoto K.K. (https://www.ajiaminoscience.com/Products/histidine; last access 
25-07-2018) and DAESANG Corp. (http://www.businesskorea.co.kr/news 
/articleView.html?idxno=19569; last access 25-07-2018). However, current numbers for the 
annual worldwide production of L-histidine are not available. 
Most efficient producer strains that are described in scientific literature have been obtained by 
classical mutagenesis and show maximal YP/Shis values of about 0.15 - 0.20 g L-histidine per 
g substrate (Becker and Wittmann, 2012; Mizukami et al., 1994), which is about 2.5 fold lower 
than the maximum theoretical  growth coupled (μ = 0.1 h-1) yield of 0.44 g per g calculated by 
André Feith (IBVT, University of Stuttgart) in the context of the underlying project (3.1.2 Flux 
Balance Analysis, p.100). Knowledge for the targeted engineering of C. glutamicum for 
L-histidine production so far is limited on the deregulation of the biosynthesis and improving 
precursor availability (Ikeda, 2003; Kulis-Horn et al., 2015; Mizukami et al., 1994; 
Zhang et al., 2012). The moderate success to develop efficient production strains might be 
attributed to the demanding biosynthesis of L-histidine, which is reflected by its tight connection 
to the energy and C1 metabolism (1.2.5 L-HISTIDINE related pathways, p.21). 
 159 
 
Therefore, to gain a more holistic understanding in the metabolic limitations for L-histidine 
production, we performed a modularized metabolic engineering approach, including flux 
balance analysis and LC MS/MS Q-TOF based systems metabolic profiling (SMP). Especially, 
the applied untargeted metabolomics workflow proofed as effective tool to monitor intracellular 
levels of key metabolites in the engineered strain genealogy. 
In the first module, the biosynthesis pathway of L-histidine, we introduced two allele exchanges 
in the hisG gene (ggc742cat and acg748cag), entitled hisGFB, leading to amino acid exchanges 
G233H and T235Q in the native amino acid sequence of the ATP phosphoribosyltransferase 
(HisG) (Schendzielorz et al., 2014). HisG has been described in several organisms, such as 
S. typhimurium (Wainscott and Ferretti, 1978), M. tuberculosis (Pedreño et al., 2012), E. coli 
(Dall-Larsen, 1988), and C. glutamicum (Araki and Nakayama, 1974) to be the target of a 
potent feedback inhibition mediated by the endproduct of the pathway, L-histidine, 
demonstrating the universality of this principle. For S. typhimurium, a synergistic inhibition of 
HisG by guanosine tetraphosphate (ppGpp), an intermediate of the stringent response 
(Traxler et al., 2008), and L-histidine has been demonstrated (Morton and Parsons, 1977). With 
the purpose to circumvent this feedback regulation in C. glutamicum, we implemented the 
mentioned mutated HisG variant from Schendzielorz et al. and the resulting strain 
C. glutamicum HIS1 indeed produced L-histidine, with a product subtrate yield for L-histidine 
(YP/Shis) of 0.015 ± 0.003 mol L-histidine per mol glucose. Simultaneously with L-histidine, this 
strain produced glycine in about equimolar amounts, which was the main detected byproduct 
and accompanied L-histidine throughout the strain history (Table 31, p.120). The coproduction 
of glycine and L-histidine had been observed in other L-histidine producing mutants of 
C. glutamicum (Araki and Nakayama, 1971; Ishino et al., 1986) and related strains 
(Shimizu et al., 2002) before, indicating inevitability in these organisms. Most likely, the 
glycine by-production can be ascribed to the requirement of the de novo purine biosynthesis 
steps three (PurN) and ten (PurH) for each one molecule of fTHF, serving as donor of a C1 unit 
in the form of a formyl group. However, glycine by-production was not observed in L-histidine 
producing E. coli (Doroshenko et al., 2013; Malykh et al., 2018) and Streptomyces coelicolor 
(Korajlija and Delíc, 1977), showing the presence of a functional GCV system in these 
organisms, compared to C. glutamicum. It might be speculated that the presence of a GCV 
system led to the evolution of a different network and embedment of the L-histidine biosynthesis 
in these organisms.  
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The introduced modifications in strains C. glutamicum HIS1 to HIS7 concerning the L-histidine 
biosynthesis (feedback release of HisG, promoter exchanges in front of all four operons 
containing L-histidine genes, exchange of translational start codon, integration of an internal 
promoter, elimination of a potential translational regulatory domain) enabled L-histidine 
overproduction. However, the characteristics (growth rate, biomass substrate yield, product 
substrate yield of L-histidine) remained stable in strains C. glutamicum HIS1 – HIS4. As soon 
as the hisEG promoter was improved, YP/Shis increased dramatically in C. glutamicum HIS6. 
This clearly shows that in addition to the feedback release of HisG the overexpression of hisEG 
is crucial for improved YP/Shis. This is most presumably due to overexpression of hisG (since it 
encodes the first enzyme in the pathway) to initially withdraw PRPP (and ATP) precursor(s) 
into the L-histidine biosynthesis, away from the competing PRPP-consuming reactions 
(Fig. 5, p.22; Hove-Jensen et al., 2016). Overproduction of desensitized HisG variants has been 
performed before in a plasmid-based approach and was shown to be beneficial for increasing 
L-histidine production (Mizukami et al., 1994).  
The transitional strain C. glutamicum HIS5 that was solely modified in the hisEG operon 
(feedback release of HisG, promoter exchange from PhisE to PdapA-A16, exchange of translational 
start codon of hisE from GTG to ATG) was constructed to prove the necessity of overexpressing 
all L-histidine operons, i.e. genes. C. glutamicum HIS5 resulted in an intermediate YP/Shis of 
0.039 ± 0.001 mol L-histidine per mol glucose (compared to 0.012 ± 0.002 and 
0.065 ± 0.001 mol L-histidine per mol glucose of C. glutamicum HIS4 and HIS6, respectively), 
thus showing that overexpression of all L-histidine operons, i.e. genes, is beneficial for 
improving YP/Shis. To my knowledge, this has not been shown before and represents the first 
approach to improve L-histidine production with a holistic strategy considering all relevant 
genes.  
Relative metabolome measurements (entitled SMP) to determine the intracellular peak 
intensities of key metabolites showed that IGP and L-histidinol, two intermediates in L-histidine 
biosynthesis, drastically increased upon feedback release of HisG (in C. glutamicum HIS1). 
The increased IGP and L-histidinol peak intensities were re-decreased to wildtype like levels in 
C. glutamicum HIS7. In contrast, the intracellular peak intensities of L-histidine increased 
stepwise (reaching maximal levels in C. glutamicum HIS8 where intensities were 33 times 
higher compared to the WT), indicating an export limitation. Concerning export of L-histidine, 
to my knowledge no export system has been identified in C. glutamicum so far, nor in any other 
organism. Concerning L-histidine import, the gene product of gene cg1305 was proposed to be 
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involved in histidine import (Kulis-Horn et al., 2014). A strategy pursued in future experiments 
should include the deletion of potential L-histidine import systems, such as the one encoded by 
cg1305 (deletion construct available; Table 32, p.122). By this, re-import of L-histidine might 
be prevented, decreasing the high intracellular peak intensities of L-histidine detected in the 
L-histidine producing mutants and potentially easing regulatory/inhibiting effects. Positive 
effects for such a scenario were demonstrated for production of L-tryptophan with 
C. glutamicum, where the respective L-tryptophan uptake system was modified (Ikeda et al., 
1994; Ikeda and Katsumata, 1995).  
In a further approach to optimize the L-histidine biosynthesis, we implemented second copies 
of the genes hisE and hisG into the chromosome of C. glutamicum CM1, in the form of a 
modified hisEG operon (containing genes hisEATG and hisGFB) under control of PdapA and TrrnB. 
The chromosomal integration of multiple copies of the gene encoding the first enzyme of a 
pathway with the aim to withdraw carbon, has been proven beneficial for e.g. L-lysine 
production with C. glutamicum (Becker et al., 2011). However, in the case of L-histidine 
production, the introduction of a second copy of the hisEG operon did not manifest in increased 
YP/Shis, in fact it decreased YP/Shis by 7% in C. glutamicum HISint, indicating that the amount of 
carbon withdrawn into the L-histidine biosynthesis is not the limiting step in this strain. Instead, 
withdrawal of increased amounts of PRPP or ATP seemed to have adverse effects on YP/Shis, 
probably by withdrawing the precursors from other reactions. Nevertheless, implementation of 
a second hisEG copy might be expedient in strain C. glutamicum HIS10, where important 
pathways are more balanced, and should be considered for future experiments. 
The reaction catalysed by HisG withdraws one molecule of ATP from the general ATP pool of 
the cell by condensing it to PRPP (Alifano et al., 1996). With the purpose to investigate potential 
effects of this condensation, i.e. withdrawal, on the energy metabolism in an L-histidine 
overproduction scenario, we measured intracellular concentrations of the three adenylate 
species ATP, ADP, and AMP. Adenylates were quenched with perchloric acid and quantified 
via HPLC measurements and showed that intracellular concentrations of AMP in L-histidine 
producers were below the detection limit of the applied system (< 300 nM, data not shown). 
Since AMP concentrations in C. glutamicum WT were determined to be about 2.1 µmol 
AMP gCDW-1, intracellular AMP concentrations in the L-histidine producing mutants probably 
are far below the WT’s levels. 
Determination of the intracellular ADP concentrations showed that they were decreased in the 
analysed strains C. glutamicum HIS1 - HIS7 to roughly about half the value of C. glutamicum 
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WT. For the third and energy densest species, ATP, we found that overexpression of operon 
hisEG in strains C. glutamicum HIS5 – HIS7 drained ATP efficiently into L-histidine 
biosynthesis and led to strongly diminished concentrations of ATP, which was not observed 
when hisEG was not overexpressed. This effect might most likely be addressed to the 
overexpression of hisG, encoding ATP phosphoribosyltransferase, which is responsible for the 
covalent binding of ATP to PRPP, rather than to an effect mediated by hisE overexpression. 
Overexpression of the hisG gene has been shown before to be an important step in bacterial 
L-histidine production (Cheng et al., 2013; Mizukami et al., 1994; Zhang et al., 2012), but has 
not yet been connected to perturbations in the energy metabolism in C. glutamicum. However, 
HisG has been connected to perturbations in energy metabolism in S. typhimurium before, 
where low levels of HisG enzyme activity led to adenine auxotrophic mutants and reverting 
clones thereof were found to bear mutations in the hisG gene (Johnston and Roth, 1979).  
From the absolute concentrations of ATP and ADP (AMP was omitted since concentrations 
were below the detection limit) we calculated the energy charge (EC), a measure for the 
energetic state of the cell that considers the phosphate groups per adenosine moiety and thus 
the energy delivering potential of each adenylate species. Interestingly, the perturbation of the 
energy metabolism in the L-histidine producers did not manifest in altered ECs, despite the ATP 
(in some strains) and ADP (in all strains) concentrations were diminished strongly. Typical ECs 
of exponentially and aerobically growing E. coli range from about 0.80 – 0.95 and revolve in 
this range. This was studied in E. coli in detail and it was shown that the EC declined upon 
carbon starvation, i.e. in the stationary growth phase, however, it was kept stable when nitrogen 
was the limiting factor (Chapman et al., 1971). An increase in EC is connected to (i) the 
activation of enzymes that are controlling anabolic, i.e. ATP requiring, pathways, such as PRPP 
synthetase, and to (ii) the inhibition of enzymes controlling amphibolic pathways, i.e. ATP 
generating, such as PDHC and phosphofructokinase (Atkinson and Walton, 1967, 1965). It thus 
appears that control of these enzymes (and their pathways) has evolved to maintain the EC 
within tight boundaries resembling an energy buffering system (Nelson and Cox, 2009). This 
might be reflected in the here presented ECs that are kept stable despite strongly altered absolute 
concentrations of ATP, ADP, and AMP. Reported conditions that result in diminished ECs are 
connected with nutrient starvation, i.e. stationary growth phase (Strange et al., 1963) and for 
example resting states, such as sporulation (Setlow and Kornberg, 1970), small decreases in EC 
also occurred in E. coli when cells were transitioned from aerobic to anaerobic conditions 
(Chapman et al., 1971).  
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This underpins the relevance of a balanced energy state in the regulatory hierarchy of the cell 
(Atkinson, 1968; Walker-Simmons and Atkinson, 1977).  
The FBA (conducted by André Feith) already pointed to the requirement of a high ATP 
regeneration, i.e. AICAR to AMP/ATP recycling, capacity of the cell for efficient L-histidine 
production. Additionally, the SMP approach (also conducted by André Feith) finally hinted to 
PurA and/or PurB as limiting step(s), since the intracellular peak intensities of IMP and 
adenylosuccinate were strongly increased in C. glutamicum HIS6 and HIS7, compared to 
C. glutamicum WT. One of the IMP converting reactions is the one catalysed by 
adenylosuccinate synthethase (PurA, encoded by purA), which converts IMP to 
adenylosuccinate, which is then further converted to AMP by the action of adenylosuccinate 
lyase (PurB, encoded by purB). Beyond that, IMP might also be converted to xanthosine 
monophosphate (XMP), inosine, and hypoxanthine. However, intracellular accumulation of 
IMP and adenylosuccinate indicated limitations in PurA and PurB capacities. Therefore, we 
plasmid-based oxerexpressed purA and purB, which not only reduced the intracellular peak 
intensities of IMP and adenylosuccinate but also readjusted the ADP and ATP peak intensitites 
to C. glutamicum WT niveau. This demonstrated that the natural capacity of the cell is not 
suited to regenerate ATP on top of the growth demands in an L-histidine overproduction 
scenario.  
Further SMP studies in the resulting C. glutamicum HIS8 strain revealed increased peak 
intensities of AICAR compared to C. glutamicum WT. In a recent work, where E. coli was 
engineered for L-histidine production, an observed intracellular accumulation of AICAR was 
overcome by introduction of an additional copy of the purA gene into the chromosome (Malykh 
et al., 2018). Since overexpression of purA and purB positively impacted the energy state of the 
cell but did not improve YP/Shis, we speculated that the increased intracellular AICAR peak 
intensities feedback on the upper part of L-histidine biosynthesis and indicate a further 
bottleneck in the metabolism of C. glutamicum. In accordance, Malykh et al. (2018) suggested 
a competitive inhibitory influence of AICAR on HisG in E. coli. However, this regulatory effect 
has not yet been proven for C. glutamicum or other bacteria and might be different in 
Actinobacteria compared to Enterobacteria.  
AICAR (also termed ZMP) was shown to accumulate upon folate limitation and to bind to a 
specific, conserved riboswitch, which negatively controls expression of several purine genes 
(Kim et al., 2015). This riboswitch also binds 5-aminoimidazole-4-carboxamide-riboside-5-
triphosphate (ZTP), which was shown to accumulate in S. typhimurium and E. coli upon 
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artificial shortage of folates (Bochner and Ames, 1982; Rohlman and Matthews, 1990) and thus 
was proposed as an alarmone for C1 / folate shortage (Bochner and Ames, 1982). Interstingly, 
ZTP is directly synthesized in one reaction catalysed by PRPP synthetase, which transfers 
pyrophosphate onto ZMP, and not like other triphosphate ribonucleotides, whose formation is 
catalysed in two reactions by mono- and diphosphate kinases, in e.g. B. subtilis 
(Sabina et al., 1985, 1984). However, the presence of ZTP in C. glutamicum or other 
Actinobacteria is unclear and has not yet been investigated. Further, the availability of fTHF in 
S. typhimurium was connected to an influence on the mode of derepression of the L-histidine 
genes, indicating farreaching connections of the C1 metabolism and the L-histidine biosynthesis 
(Berberich et al., 1966; Petersen et al., 1976a, 1976b). In B. subtilis, folate shortage has been 
shown to initiate sporulation (Freese et al., 1979; Heinze et al., 1978).  
AICAR is converted to FAICAR and IMP, both reactions are catalysed by PurH.  As mentioned, 
the first of them depends on the crucial cofactor fTHF. Therefore, we interpreted the AICAR 
accumulations in C. glutamcium HIS8 as potential limitations in the supply with C1 units. This 
hypothesis was additionally supported by the results of FBA, proposing a requirement for 
higher flux over the serine hydroxymethyltransfere (SHMT) reaction, thereby supplying 
increased amounts of C1 units. Additionally, strains C. glutamicum HIS1 - HIS8 secreted 
glycine as inevitable equimolar byproduct to L-histidine (see above), pointing in the same 
direction, since the required fTHF for purine biosynthesis is supplied by the reaction of the 
SHMT, converting L-serine to glycine. In this reaction, THF is loaded with a C1 unit to yield 
mTHF (Green and Matthews, 2007; Huennekens, 1969; Schweitzer et al., 2009; Simic et al., 
2002). Unfortunately, the various THF-species of the C1 metabolism are not accessible with the 
applied analytical system, due to low pool sizes caused by interconversion, polyglutamylation, 
and degradation (Lu et al., 2007). However, the C1 cycle is a complex network of several 
oxidised/reduced forms of C1 units with THF as carrier molecule and has been investigated 
before for L-methionine and L-serine overproducing C. glutamicum strains (Bolten et al., 2010; 
Harvey and Dev, 1975; Krömer et al., 2006; Stolz et al., 2007). Interconversion of the different 
THF species has been elucidated in detail (Green and Matthews, 2007) and thus we speculated 
in supplying the cell with increased amounts of mTHF and rely on the interconversion potential 
of the cell. 
With this purpose, we plasmid-based overproduced a glycine cleavage (GCV) system from the 
close C. glutamicum relative C. jeikeium in C. glutamicum HIS8. Upon this, only minimal 
amounts of glycine were detectable during the cultivation (< 0.2 mM; data not shown) and were 
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eradicated from the medium at the end of the cultivation, indicating re-uptake. In combination 
with the purA and purB overexpression, overexpression of the GCV genes led to a significant 
reduction of the intracellular AICAR peak intensities in the resulting C. glutamicum HIS9 and 
a significantly increased YP/Shis. This was attributed to the combined effects of (i) balanced pool 
sizes of IMP, adenylosuccinate, AICAR, and the adenylates (due to purA/purB overexpression) 
and (ii) the eradication of glycine from the medium with the simultaneous improved supply of 
the purine biosynthesis with fTHF, enabling a higher ATP recycling capacity, i.e. AICAR to 
AMP/ATP regeneration (due to overexpression of the GCV genes). Glycine has been 
demonstrated to effectively inhibit bacterial growth above certain concentrations 
(Hammes et al., 1973; Hishinuma et al., 1969; Strominger and Birge, 1965). In several bacterial 
species, e.g. S. typhimurium, the GCV system is the main source for C1 units in vivo, however 
SHMT is the main source in vitro (Jelsbak et al., 2016). In a recent approach, a GCV system 
from E. coli has been applied in a metabolic engineering approach in C. glutamicum, where it 
enabled increased L-serine accumulation in a glyA (encoding SHMT) attenuated strain, by 
generating improved amounts of C1 units for incorporation in the purine biosynthesis (Zhang et 
al., 2018). Consistent with these data, the GCV system from C. jeikeium seems to be able to at 
least partially satisfy the need for loaded THF molecules in the here investigated L-histidine 
producing C. glutamicum. However, SMP revealed still slightly increased intracellular AICAR 
peak intesities in C. glutamicum HIS9 and HIS10. This either indicates an even higher demand 
for fTHF or points to limiting AICAR formyltransferase/IMP cyclohydrolase activity. In the 
former case, an overproduction of the SHMT (or overexpression of the coding glyA) might 
counteract the still increased intracellular peak intensities in these strains by converting the 
surplus to glycine, thereby providing increased amounts of fTHF. In the case that the AICAR 
formyltransferase/IMP cyclohydrolase constitutes a limiting factor, the overproduction of PurH 
(or overexpression of purH) might be pursued in future experiments. In fact, the plasmid-based 
overexpression of the purH gene in the C. glutamicum CM1 background (resulting in 
C. glutamicum PUR4) improved YP/Shis by 10%, indicating that increased PurH activity can 
solve AICAR accumulations and that this is beneficial for L-histidine production. Depending 
on the potency of a feedback inhibition of AICAR on HisG, as was identified in E. coli (Malykh 
et al., 2018), the balancing of still increased AICAR levels back to C. glutamicum WT niveau 
might reveal further beneficial effects on L-histidine formation in C. glutamicum HIS10. This 
might include studying the AICAR inhibition on HisG in more detail.  
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The YP/Shis was further increased by exchanging the translational start codon of pgi from the 
native ATG triplet to GTG, thereby decreasing the translational efficiency and leading to a 
decrease in enzyme activity of the phosphoglucoisomerase by about 40% (Becker et al., 2010). 
This modification has proven beneficial for production of L-lysine (Becker et al., 2010) and 
L-ornithine (Kim et al., 2014) with C. glutamicum, since it favours the pentose phosphate 
pathway (PPP) over glycolysis, thus generating increased amounts of NADPH, which are 
required for both mentioned amino acid pathways. Since pgiGTG was able to improve YP/Shis in 
the C. glutamicum HIS10 background, however not in strain C. glutamicum CM1, the increase 
in YP/Shis most likely is connected to a combination of improved PRPP precursor supply (as 
result of pgiGTG) together with the PurA/PurB and GCV overproduction background. It appears 
that in strain C. glutamicum CM1 the beneficial effect of pgiGTG was superimposed by the 
graver fTHF and IMP/adenylosuccinate limitations. To my knowledge, it has not been advised 
whether flux towards PRPP in C. glutamicum is provided via the oxidative 
(NADPH-generating) part of the PPP or via the non-oxidative part. In an inosine producing 
mutant of the close C. glutamicum relative C. ammoniagenes, zwf was interrupted in order to 
provide increased amounts of ribose 5-phosphate via the non-oxidative PPP, which led to 
decreased production of inosine (Kamada et al., 2003). Overproduction of transketolase (Tkt, 
encoded by tkt) and transaldolase could not improve production in the zwf deficient background 
(Kamada et al., 2003). In contrast to that, deletion of the tkt gene improved production of inosine 
(Kamada et al., 2001). Consistent with that, it was shown that increased activity of Tkt is 
beneficial for production of aromatic amino acids (Ikeda et al., 1999) and it was suggested that 
diminished activity or deficiency of Tkt might be beneficial for L-histidine production 
(Ikeda, 2003), requiring the same precursor as inosine production. However, several 
modifications aiming at decreasing Tkt activity (in strains C. glutamicum HIS3, HIS4, HIS6) 
including tkt deletion, deletion of the RBS, and deletion of the extended RBS did not improve 
L-histidine production. Again, these modifications might be expedient when applied in the 
C. glutamicum HIS10 background. 
Since it remained unclear to what exact extent the carbon flux towards PRPP is directed through 
the oxidative vs. the non-oxidative PPP, we constructed several mutant strains with attenuations 
most likely leading to different flux patterns. As alternative to the pgiGTG variant (described 
above), the translational start codons of the gapA (encoding glyceraldehyde 3-phosphate 
dehydrogenase) and the pgm (encoding phosphoglucomutase) genes (Omumasaba et al., 2005; 
Seibold and Eikmanns, 2013) were exchanged from the native ATG to the rare variant TTG. 
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Compared to pgiGTG, gapATTG was intended to direct carbon through the non-oxidative PPP 
towards PRPP, whereas pgmTTG was intended to retain carbon downstream of the junction 
towards the SHMT reaction, leaving sufficient carbon for C1 generation. These modifications 
were tested in different strain backgrounds. All three were introduced in the 
C. glutamicum HIS7 background, resulting in strains HIS7.1, HIS7.2, and HIS7.3. In this 
scenario, only the gapATTG exchange manifested in improved YP/Shis (+9%), whereas pgiGTG and 
pgmTTG did not improve YP/Shis. When the exchanges were implemented in the 
C. glutamicum HIS9 background, only pgiGTG improved YP/Shis (+8%), whereas gapATTG and 
pgmTTG resulted in lower YP/Shis (-11% and -6%, respectively). It seems that these different 
results in the different strain backgrounds reflect the complexity of carbon fluxes in the 
generated L-histidine production scenario. The finding that the purApurB overexpression in 
C. glutamicum HIS8 balanced the intermediates in the purine pathway and that this did not 
increase YP/Shis, whereas YP/Shis was only increased after combined overproduction of 
PurA/PurB and the GCV system indicates the complexity of limitations in L-histidine 
production. Limitations seem to superimpose each other and solving one must not necessarily 
solve a knot but rather expose further limitations. 
One of these limitations, however, is the supply with C1 units. For future experiments, the 
allocation of C1 units might be generated by attenuating or deleting the gene encoding 
L-serine dehydratase (L-serDH, encoded by sdaA), which converts L-serine to pyruvate, thus 
competing with the C1 generating SHMT for L-serine (Netzer et al., 2004). Additionally, 
cystathionine β-lyase was identified to consume L-serine (Kim et al., 2001; Netzer et al., 2004), 
however, to a lesser extent than L-serDH, which should be considered for future L-histidine 
producer strains. Generating a surplus of L-serine by supplementing the amino acid in growth 
experiments with strain C. glutamicum CM1 did not result in altered growth and production 
characteristics, despite the amino acid was consumed from the medium (data not shown), which 
has been demonstrated before, where C. glutamicum cometabolized L-serine with glucose 
(Netzer et al., 2004). As mentioned above, overexpression of glyA might be more expedient in 
this case. 
In further studies, modifications in the two PPP enzymes glucose 6-phosphate dehydrogenase 
(G6P DH, encoded by zwf) and 6-phosphogluconate dehydrogenase (6PG DH, encoded by gnd) 
were examined for their suitability for L-histidine production. It has been shown that G6P DH 
is allosterically inhibited mainly by NADPH, however, oxaloacetate, 
fructose-1,6-bisphosphate, and PRPP were also identified as inhibitors (Eggeling and Bott, 
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2005). 6PG DH was shown to be inhibited by NADPH, fructose-1,6-bisphosphate, 
ribulose 5-phosphate, glyceraldehyde 3-phosphate, and erythrose 4-phosphate (Eggeling and 
Bott, 2005). For both enzymes, desensitized variants are available in C. glutamicum, namely 
zwfA243T and gndS361F, which both have been deployed for amino acid production with the aim 
to strengthen the flux through the oxidative PPP before (Georgi et al., 2005; 
Ohnishi et al., 2005). In a sequential approach we first implemented zwfA243T, which increased 
YP/Shis in C. glutamicum CM2 compared to the parental strain by 16%. Most likely this can be 
attributed to the release from feedback inhibition of G6P DH from NADPH and PRPP, since 
by strengthening the PPP flux via pgiGTG, these two molecules are generated in increased 
amounts. The zwfA243T modification represents an interesting regulating screw to be modified 
in C. glutamicum HIS10, where energy metabolism and C1 supply are optimized. The second 
modification, gndS361F, however, did not prove beneficial, since the resulting strain 
C. glutamicum CM2.1 had 24% lower YP/Shis compared to its parental strain 
C. glutamicum CM2. It remains unclear why a combination of both desensitized variants is not 
beneficial for L-histidine production. So far, these two oxidative PPP modifications have not 
been implemented in row, wherefore a comparison is not possible.  
Besides zwf and gnd, the prsA gene, encoding the PRPP synthetase, was targeted. PRPP 
synthetase is a key enzyme since it provides PRPP for several reactions (reviewed in Hove-
Jensen et al., 2016 and Jensen et al., 2008). The C. glutamicum enzyme has not yet been 
investigated in detail, however, there are intensive data for PRPP synthetases from other 
bacteria available, such as E. coli (Hove-Jensen et al., 1986), S. typhimurium 
(Post and Switzer, 1991; Switzer and Gibson, 1978), and the C. glutamicum relative 
M. tuberculosis (Alderwick et al., 2011). PRPP synthetase transfers the diphosphoryl group 
from ATP onto ribose 5-phosphate, releasing AMP and PRPP in a Mg2+ and Pi dependent 
manner and is allosterically inhibited by ADP as the most potent allosteric inhibitor in all these 
bacterial species. PRPP synthetase obviously has the potential of a regulating screw since it 
provides the crucial L-histidine precursor PRPP. Thus, we aimed to release PRPP synthetase 
from its regulatory mechanisms. There are mutant variants of PRPP synthetase available in 
different organisms wherefrom we chose the three amino acid exchanges R78C, elevating the 
Km towards ATP and ribose 5-phosphate and reducing sensitivity for ADP inhibition , D115S, 
desensitizing PRPP synthetase against purine nucleotide inhibition, and D128A, leading to 
higher Km value towards ATP and releasing PRPP synthetase from AMP inhibition 
(Klyachko et al., 2004b). These patents applied the PRPP synthetase variants for L-histidine 
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production with Entereobacteriacea. Therefore, the amino acid exchanges were transferred 
from the E. coli enzyme onto the C. glutamicum enzyme via BLAST analysis (data not shown), 
which led to the three amino acid exchanges R87C, D122S, and D136A. After several attempts 
to implement the respective nucleotide exchanges in the prsA gene of C. glutamicum, only the 
one leading to D122S could be established, indicating that amino acids arginine at position 87 
and aspartate at position 136 are essential for PRPP synthetase functionality in C. glutamicum. 
The D122S variant was established in C. glutamicum CM1, resulting in C. glutamicum CM3, 
which had stable growth rate and biomass substrate yield and improved YP/Shis by 11%. This 
underlines the potential of PRPP synthetase as target for L-histidine production with 
C. glutamicum and mutations thereof might be introduced in C. glutamicum HIS10 with 
balanced purine and L-histidine pathways and improved C1 supply in future experiments. 
Further modifications were introduced in the purine biosynthesis with the objective to elucidate 
the potential of this pathway for increasing YP/Shis. Since PurF, the first enzyme in the purine 
pathway, competes with HisG for the common precursor PRPP, we intended to decrease the 
overall PurF activity to leave increased amounts of PRPP for the HisG reaction. Therefore, we 
pursued two approaches in which we firstly deleted the purF gene and exchanged its 
translational start codon from GTG to TTG. The resulting strains C. glutamicum PUR1 and 
PUR2 showed very similar phenotypes and were characterized by strong decreases in growth 
rate (half the one of C. glutamicum CM1) and biomass substrate yield (below half the one of 
C. glutamicum CM1). However, the YP/Shis only decreased by about 12% and 13%, respectively. 
In bacteria, an important moiety for thiamine biosynthesis originates from the purine 
intermediate AIR (Begley et al., 2012). To exclude thiamine interferences caused by modifying 
the entry flux into the purine pathway by a purF deletion/attenuation, we supplemented 
C. glutamicum PUR1 with thiamine, which was not able to compensate the growth defect. 
Supplementations of C. glutamicum PUR2 with adenine (plus thiamine) increased the growth 
rate by 52% (52%) and strongly increased biomass substrate yield by 155% (140%). However, 
no effect on YP/Shis was detected. These experiments indicate that (i) the exchange of the 
translational start codon from GTG to the rarest variant TTG in purF is an intrusion that 
resembles an in-frame deletion of the gene, heavily impacting cells, and (ii) that purF is not 
essential since C. glutamicum PUR1 can grow in minimal medium w/o supplementations. ATG 
is the most common translational start codon in C. glutamicum, being present in 72% of all 
cases, whereas GTG (21%) and TTG (7%) occur less often (Becker et al., 2010). For purF 
deletion mutants of S. typhimurium it was suggested that an alternative way to form PRA, the 
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product of PurF, exists (Downs and Roth, 1991). This potential alternative route might also 
exist in C. glutamicum. Interestingly, the supplementation of C. glutamicum PUR2 with 
adenine did not result in increased YP/Shis but increased growth rate and biomass substrate yield 
strongly, indicating that the additonal carbon provided by adenine is directly used for biomass 
formation and not for product formation. Adenine supplementation for a butanol producing 
Clostridium saccharoperbutylacetonicum strain was shown to strongly increase the growth and 
simultaneously increasing product formation (Kiyoshi et al., 2017). The third purF 
modification included the feedback released variant K348Q (K326Q in E. coli) that had been 
characterized in C. glutamicum (Peifer et al., 2012) and E. coli (Zhou et al., 1993) before. The 
mutant strain C. glutamicum purFK348Q had been deployed for IMP production and resulted in 
increased intracellular concentrations of AMP and adenine by about 25%, respectively (Peifer 
et al., 2012). The here constructed strain C. glutamicum PUR3 was characterized by a lower 
growth rate, biomass substrate yield, and YP/Shis compared to its progenitor 
C. glutamicum CM1, suggesting that the potentially increased adenine and AMP concentrations 
where not a limiting factor in this strain background. This might have to do with increased 
amounts of PRPP that are withdrawn into purine biosynthesis, instead of L-histidine 
biosynthesis and renders purFK348Q uninteresting for L-histidine production.  
Further studies in the de novo part of the purine pathway focused on the fTHF requiring 
reactions of PurN and PurH. In an attempt to circumvent the PurN reaction, the respective purN 
gene was deleted in C. glutamicum WT to investigate if PurT (performing the reaction step w/o 
fTHF, instead using formate as formyl group donor) is able to take over the PurN reaction 
(Nagy et al., 1993; Nygaard and Smith, 1993; Saxild et al., 1995). Radioactive tracing 
experiments had revealed that when both PurN and PurT are present in an organism, here in 
E. coli, the completely synthesized purine molecule in 50% of the cases contained a carbon 
atom at position C8 originating from the PurN reaction, in the other 50% of the cases it 
originated from the PurT reaction (Dev and Harvey, 1982), suggesting an even usage between 
both reactions in E. coli. 
However, the resulting strain C. glutamicum ΔpurN showed a strong growth defect in minimal 
medium. Supplementation with adenine was partially able to compensate the growth defect, 
however, failed to revert growth to C. glutamicum WT niveau. To support PurT with its 
cofactor, C. glutamicum ΔpurN was supplemented with formate, which was not able to 
compensate the strong growth defect. This either indicates that the PurT activity is too low to 
compensate a purN deletion or that formate as cofactor for PurT is limiting. In S. typhimurium 
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it had been shown that a purN deletion caused a 50% reduced in vivo multiplication rate, 
whereas a purT deletion did not (Jelsbak et al., 2016). With the purpose to increase 
intracellularly available formate, we deleted the formate dehydrogenase gene fdhF in 
C. glutamicum ΔpurN, which was shown in C. glutamicum to abolish formate dehydrogenase 
activity (Witthoff et al., 2012). Since C. glutamicum ΔpurN ΔfdhF had a similar growth 
phenotype as its parental strain, even with formate supplementation, we concluded that supply 
with the cofactor is not limiting the PurT reaction. Further studies in this direction might include 
overexpression of the PurT gene in C. glutamicum ΔpurN ΔfdhF and if feasible, apply this 
scenario in a strain with L-histidine production background. Besides PurT, another source for 
the formate dependent generation of fTHF exists in some bacteria, constituted by formate-THF 
ligase (Fhs), encoded by the fhs gene (Aluri et al., 2015; Sah et al., 2015). Both genes purT and 
fhs are anticorrelatively present in bacterial genomes, meaning only one of both is encoded in 
the vast majority of bacteria (Aluri et al., 2015). Fhs catalyses the transfer of a C1 unit from 
formate to THF, requiring ATP (Celeste et al., 2012; McGuire and Rabinowitz, 1978). A 
potential idea for further studies could be the heterologous expression of a (codon optimized) 
fhs gene in an L-histidine producer with purN deletion, to enforce the allocation of additional 
C1 units.  
Besides the PurN reaction in the third step of the purine biosynthesis, the tenth step is also fTHF 
dependent in bacteria, where the formylation of AICAR to FAICAR is catalysed by PurH 
(which also performs a cyclohydrolase reaction in step eleven). In archaea, steps ten and eleven 
in the purine biosynthesis are not mediated by one enzyme, but rather by two (reviewd in 
Brown et al., 2011). In the tenth step, the formylation of AICAR is mediated in absence of 
folates instead relying on formate as formyl group donor by an enzyme entitled PurP (Zhang et 
al., 2008) and then the cyclohydrolase reaction is performed by an enzyme entitled PurO 
(Graupner et al., 2002; Ownby et al., 2005). In the case that the supply with C1 units indeed is 
one of the limiting factors for L-histidine production in C. glutamicum, future approaches might 
include the deletion of the native purH gene in C. glutamicum and the heterologous 
(codon-optimized) expression of archaeal purO and purP genes. Cumulatively, this could be 
done on top of the deletion of purN combined with the heterologous expression of a fhs gene in 
an L-histidine production background and could enable a complete relief of the purine de novo 
biosynthesis from the SHMT (and GCV system) reactions in C. glutamicum (and 
C. glutamicum HIS10), thus decoupling L-histidine biosynthesis from L-serine/glycine, i.e. 
C1 metabolism. 
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Purine biosynthesis in E. coli is regulated by a purine regulatory protein, named PurR, that 
specifically binds to a motif in the operator region of the purF gene, repressing its expression, 
and in this way controlling the entry flux into de novo part of the purine biosynthesis, further 
autoregulating its own synthesis (He et al., 1990; Meng et al., 1990; Rolfes and Zalkin, 1988). 
Moreover, high-resolution chromatin immunoprecipitation (ChIP)–chip experiments revealed 
that genes beyond the purine pathway are regulated by PurR, e.g. genes encoding enzymes of 
the pyrimidine pathway (Cho et al., 2011). Existence of purine regulatory proteins has also been 
revealed in Gram-positive organisms, such as B. subtilis (Bera et al., 2003; Saxild et al., 2001; 
Shin et al., 1997) and Lactococcus lactis (Beyer et al., 2003; Kilstrup and Martinussen, 1998). 
Due to the interconnectivity of the purine pathway and its strong influence on energy 
metabolism and other pathways, PurR is an attractive target for strain engineering. Logically, 
PurR has been chosen as target for, e.g. riboflavin production with B. subtilis (Shi et al., 2014) 
and interestingly also for L-histidine production with E. coli (Doroshenko et al., 2013). In the 
latter case, the purR gene was deleted leading to increased biomass formation while maintaining 
stable L-histidine production (Doroshenko et al., 2013). However, a gene encoding a purine 
regulatory protein has not been identified in C. glutamicum to my knowledge. BLAST analysis 
(data not shown) with the purine regulators of B. subtilis, L. lactis, and E. coli with 
C. glutamicum regulatory proteins identified potential candidates, among them cg2314 
(annotated as transcriptional regulator, LacI family; annotation from 
https://coryneregnet.compbio.sdu.dk/v6/index.html, last access 15-08-2018). The respective 
gene was deleted in C. glutamicum CM1, but the resulting strain did not show an altered growth 
phenotype or production behaviour. The task to identify further potential purine regulators in 
C. glutamicum and exploring their potential for L-histidine production should be tackled in 
future experiments and might consider the additional identified regulatory proteins (3.1.11 A 
versatile toolbox enables deeper insights, p.121). 
The best producer strain in a laboratory scale is useless for industrial demands if it does not 
perform in a larger scale, which commonly includes the transfers to a pilot and further to an 
industrial scale (Delvigne and Noorman, 2017; Reisman, 1993; Thiry and Cingolani, 2002). 
C. glutamicum is well known as industrial production host and several processes with industrial 
scales are established, such as for the production of L-glutamate, L-lysine, and L-methionine 
(Becker and Wittmann, 2012; Ikeda, 2003; Wendisch et al., 2016). However, the phenomenon 
that production hosts show poor performances in a larger scale, despite performing well in a 
laboratory scale, is known (Delvigne and Noorman, 2017; Gonçalves et al., 2014). 
 173 
 
Since the L-histidine producers constructed in this work were standardly evaluated in a shaking 
flask approach, we transferred this process to small scale fermentations in glass reactors and 
further into medium scale steel tank reactors (STR), to enable first insights in the performance 
potential of these strains. It has to be mentioned that several conducted processes were not 
performed as triplicates, meaning that to secure the obtained results of the here presented 
preliminary experiments, they need to be replicated and reproduced in upcoming experiments. 
Nevertheless, these preliminary fermentations enabled fast insights into the performance 
characteristics of the L-histidine producers. In the standard reactor medium, CGXIIR, 
C. glutamicum HIS7 and CM2 showed increased growth rates (by 11% and 37%), whereas the 
YP/Shis of both strains decreased (by 47% and 28%) in reactor cultivations compared to shaking 
flask cultivations. The faster growth in the reactor might be attributed to the increased supply 
with oxygen, which has been shown to constitute a limiting factor in shaking flask cultivations 
(Klöckner and Büchs, 2012; Losen et al., 2004; McDaniel and Bailey, 1969). With the purpose 
to elucidate the influencing factor(s) responsible for the decreased product formation in reactor 
cultivations, we conducted experiments investigating the composition of the medium, the pH 
value, and the oxygen supply. 
Cultivations with different media compositions, including the components urea and MOPS into 
the CGXIIR reactor medium, showed that both had no influence on the examined characteristics 
growth rate, YX/S, YP/Shis, and YP/Sgly, when included as sole addition or in a combination of both 
(equalling the CGXIIN medium). Consecutively, urea and MOPS were ruled out as influencing 
factor(s) for decreased YP/Shis. Cultivations with different pH values and with disabled pH 
regulation indicated that C. glutamicum can grow and produce at pH values of 6.25 and 8.00. 
Growth was strongly affected at pH value 8.25. These findings only partially match published 
data, where stable pH homeostasis of C. glutamicum was found at pH values between 6 and 9 
(Follmann et al., 2009). The same study revelead 2.3× increased amounts of intracellular 
L-histidine in C. glutamicum grown in medium with pH 6 compared to pH 7.5 
(Follmann et al., 2009). Interstingly, the reactor cultivation performed at a fixed pH value of 
8.00 revealed a strongly diminished growth rate and however stable YP/Shis, compared to the 
standard CGXIIR cultivation with a pH value at 7.4, indicating potential applications of high 
pH values for further fermentations. Nevertheless, YP/Shis was diminished in all reactor 
cultivations in whiche the pH as influencing factor was investigated, pointing towards other 
factor(s) that are responsible for the altered behaviour in reactor cultivations vs. shaking flask 
cultivations. 
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The third investigated factor was oxygen supply, a known limiting factor in the shaking flask 
system (as mentioned above). To mimick the shaking flask cultivations, oxygen limitations 
where induced after defined time points during cultivation. However, the results showed that 
limiting the oxygen supply is not beneficial for L-histidine production at all. Despite the growth 
rate and YX/S of C. glutamicum CM2 were stable in all these experiments and resembled the 
values obtained in the standard reactor cultivation, the YP/Shis decreased significantly (as low as 
by 58%). However, it might as well be that the induced oxygen deprivations were to harsh and 
that the oxygen limitations potentially occurring in the shaking flask system are less severe and 
occur in a more fluent manner. 
The factor(s) that are responsible for the higher YP/Shis in the shaking flask system remain 
unknown and will have to be revealed in further experiments. Nevertheless, we were able to 
establish a functional seed train and first bioprocesses with selected strains of the strain database 
constructed in this work. It might as well be that the combination of these factors leads to the 
different production behaviour in the shaking flask system. 
With the knowledge of the small scale fermentations and with the established seed train as basis, 
we performed first STR fermentations in a steel tank reactor with a medium volume of 10 L 
and cultivated C. glutamicum CM2 in batch mode. Here, we identified protocatechuic acid 
(PCA) as an essential component for growth of C. glutamicum CM2 in this scenario, in contrast 
to shaking flask and small scale fermentation scales. 
Why PCA addition is required for the 10 L cultivations and not in the small scale cultivations 
remains unknown. PCA has been shown to increase growth rates in reactor cultivations, which 
was connected to the iron metabolism, however, it is not an essential component in 
C. glutamicum WT for growth in reactor cultivations (Liebl et al., 1989; Unthan et al., 2014).  
Unfortunately, fermentation data for L-histidine producing strains of C. glutamicum are lacking 
in the available literature. The available data focusing on cultivations in reaction tubes / 
shaking flasks of L-histidine producers however show that all deployed strains require 
expensive and complex components for growth and production, such as yeast and meat extract 
(Araki and Nakayama, 1974; Cheng et al., 2013; Doroshenko et al., 2013), uracil 
(Chim-Anage et al., 1991), or adenosine (Doroshenko et al., 2013; Malykh et al., 2018). Therein 
lies an advantage of the constructed strains in this work, since they do not require additional 
supplements besides glucose as carbon source in the deployed CGXII minimal medium to grow 
and produce L-histidine. Since the batch and fed-batch processes represent preliminary 
bioprocesses, they will not be discussed thoroughly. They are ment to represent a basis for 
 175 
 
potential expansion of the L-histidine project and might serve as first points of references for 
future experiments. Nevertheless, it became obvious that the strains we cultivated in 
bioprocesses were not able to achieve the same product substrate yields found in shaking flask 
cultivations. To elucidate where these differences come from and how to tackle them will 
remain tasks for future experimenters. 
Taken together, the applied interplay of strain engineering, metabolomics (SMP), and 
model-based analysis (FBA) enabled a comprehensive view on the complex metabolic network 
of the L-histidine biosynthesis. Engineering of the purine pathway identified and reinforced the 
intrinsic low ATP regeneration capacity to maintain the balanced energy state of the cell. To 
utilize the readjusted ATP levels for L-histidine production, it was essential to provide C1 units 
in adequate amounts, which was accomplished by overproduction of a GCV system. Further, 
AICAR, which seems to be a potent effector molecule to control the entry flux into L-histidine 
biosynthesis, was identified as future regulating screw. 
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 Part II 
Genetic variation i.e. the variability of an organism’s genetic information is one of biology’s 
basic principles and a source for new life forms and a major factor of influence for what is 
known as evolution in the sense of Charles Darwin. This principle has been exploited since the 
beginnings of modern biotechnology for the breeding and selection of prokaryotic and 
eukaryotic unicellular producer organisms. In the classical way, mutagenizing substances, such 
as N-methyl-N’-nitro-N-nitrosoguanidine (NTG) and ethylmethanesulfonate (EMS), or 
radiation, such as ultraviolet (UV) light, were/are used to stimulate such genetic variations in 
this way accelerating evolution (Burns et al., 1986; Delić et al., 1970; Doudney and Young, 
1962; Ekwall and Thon, 2017; Foster, 1991; Sega, 1984; van Zeeland et al., 1983). By this, the 
natural spontaneous mutation frequency (4 × 10-10 for E. coli) can be accelerated to magnitudes 
above this (Parkhomchuk et al., 2009). The creation of genetic diversity in huge libraries of 
mutants are the results of these experiments and single cells often bear up to hundreds of 
mutations after mutagenic treatment (Harper et al., 2011; Parkhomchuk et al., 2009). With the 
purpose to identify the mutations responsible for the phenotype of the mutant, e.g. improved 
concentrations of the desired product, sophisticated and often time-consuming screening 
strategies are needed (Harper et al., 2011; Zhou and Alper, 2018). These undirected and random 
mutagenesis approaches were in the last decades further developed towards more directed and 
targeted approaches, often entitled as directed evolution, due to the acceleration of the 
Darwinian principle of evolution without resorting to mutagenizing substances 
(Cobb et al., 2013b; Harper et al., 2011). Combined with new techniques of improved screening 
technologies, such as biosensor strains or high-throughput screenings, undirected and directed 
evolution approaches have made great progress (Dietrich et al., 2010; Eggeling et al., 2015; 
Lin et al., 2017; Zhou and Alper, 2018). However, most available evolution approaches create 
a variety of mutations per cell, requiring intense screenings. 
We here conceived a method we entitled Metabolic engineering to Guide Evolution (MGE) that 
relies on creating intrinsic evolutionary pressure and deliberately omits mutagenizing agents. 
By this we intended to generate a minimal set of mutations to enable a simplified identification 
of the phenotype-generating mutation(s), which is the most time-consuming and laborious step 
in evolution approaches (Harper et al., 2011). In a first step, we conceived how to generate the 
evolutionary pressure. An abundance of methods for generating genetic diversity in single cell 
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organisms is available, which comprise beyond the mentioned mutagenizing approaches also 
methods like error-prone PCR (McCullum et al., 2010; Wilson and Keefe, 2001), DNA 
shuffling (Cohen, 2001; Zhao and Arnold, 1997), sequence saturation mutagenesis (Wong et 
al., 2004), synthetic shuffling (Ness et al., 2002; Zha et al., 2008), just to name some of the 
available ones (reviewed in Kumar and Singh, 2013). These methods allow the targeted 
improvement of traits like biocatalysts (Turner, 2009), biosynthetic pathways 
(Atsumi and Liao, 2008), and regulatory networks (Yokobayashi et al., 2002). 
We here relied on the generation of an intrinsic evolutionary pressure by applying metabolic 
engineering in C. glutamicum and aimed at identifying and evolving a novel metabolic mode 
for production of L-valine. The production of L-valine with C. glutamicum has been intensively 
studied and exploited to generate producer strains (reviewed in Oldiges et al., 2014; 
Wang et al., 2018). So far, metabolic engineering of the L-valine biosynthesis in C. glutamicum 
mainly relied on redirecting carbon fluxes towards the endproduct by targeting the pyruvate 
dehydrogenase complex (PDHC), which generates acetyl-coenzyme A (acetyl-CoA) from 
pyruvate (Oldiges et al., 2014). This was either achieved by a complete inactivation or an 
attenuation of the PDHC, by deletion of the aceE gene or reduction of its promoter activity 
(Blombach et al., 2009, 2008, 2007; Buchholz et al., 2013). Further strategies comprised the 
application of anaerobic conditions to reduce tricarboxylic acid (TCA) cycle activity 
(Hasegawa et al., 2013; Satoshi Hasegawa et al., 2012) and the inactivation or attenuation of 
pantothenate biosynthesis to limit availability of coenzyme A, which is required for acetyl-CoA 
formation through the PDHC (Bartek et al., 2008; Elišáková et al., 2005; Holátko et al., 2009; 
Radmacher et al., 2002).  
With the purpose to generate a basis strain for the following evolutionary experiments, we 
created the double deletion mutant strain C. glutamicum Δppc Δpyc. By deleting the genes for 
PEP carboxylase and pyruvate carboxylase, we aimed at increasing the flux over the PDHC to 
the disadvantage of oxaloacetate formation. Generally, during growth on glycolytic substrates 
(such as the standardly used glucose), the glyoxylate shunt is inactive in C. glutamicum and the 
anaplerotic carboxylation of either PEP or pyruvate to replenish the TCA with oxaloacetate is 
mediated by PEPCx and/or PCx (Sauer and Eikmanns, 2005). In contrast to several other 
bacteria like E. coli (Morikawa et al., 1980) and Bacillus subtilis (Diesterhaft and Freese, 1973), 
C. glutamicum, possesses both a PEPCx and a PCx. Although PEPCk activity is present in 
C. glutamicum during growth on glucose (Riedel et al., 2001) and is in principle reversible 
(Jetten and Sinskey, 1993; Klaffl et al., 2013), C. glutamicum Δppc Δpyc is unable to grow on 
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glucose (Peters-Wendisch et al., 1998). However, since the PEPCk reaction has been shown to 
be bifunctional in some organisms, e.g. Alcaligenes eutrophus (Schobert and Bowien, 1984) 
and since a mutated PEPCk enabled growth of an evolved Saccharomyces cerevisiae Δpyc1 
Δpyc2 strain on glucose (Zelle et al., 2010), we additionally constructed C. glutamicum Δppc 
Δpyc Δpck as a second basis strain. This was done to avoid potentially occurring mutations in 
the pck gene during evolution, i.e. to eliminate the pck gene as evolutionary target in this 
scenario. However, mutated variants of the pck gene in the two evolved C. glutamicum 
Δppc Δpyc strains (Evo1.1 and Evo1.2) were not observed.  
Evolution strives to optimize growth, which basically restricts the outcome of evolutionary 
experiments and enables the prediction of theoretical flux distributions by FBA 
(Motter et al., 2008) or its variants such as MOMA (Segrè et al., 2002) and OptReg 
(Pharkya and Maranas, 2006). With the purpose to predict the evolvability of the constructed 
basis strains, André Feith conducted FBAs of C. glutamicum Δppc Δpyc. Therefore, the 
reactions of PEPCx and PCx were deleted from the metabolic model (Zhang et al., 2017) and 
optimized for growth. Indeed, in the here presented study, FBA predicted the most expectable 
result of the evolution, i.e. the activation of the glyoxylate shunt to compensate for the missing 
oxaloacetate-forming carboxylase reactions, thereby enabling growth of C. glutamicum 
Δppc Δpyc. Thus, our study is one of the rare examples exploiting the potential of evolution by 
constraining solutions with target-oriented metabolic engineering approaches 
(Auriol et al., 2011). 
With the anticipation that growth of C. glutamicum Δppc Δpyc in general should be possible, 
we performed preliminary growth experiments in minimal media to identify a suitable 
evolutionary environment, which potentially plays a role for the outcome of the experiment 
(Dykhuizen, 1990). In minimal medium with glucose as sole carbon source, both 
C. glutamicum Δppc Δpyc and C. glutamicum Δppc Δpyc Δpck were not able to grow, as has 
been reported before (Peters-Wendisch et al., 1998). However, when a small amount of 
yeast extract was added to the medium, at least the double deletion mutant showed minimal 
growth. It needs to be clarified in further experiments, why the triple deletion mutant showed 
stronger impaired growth compared to the double deletion mutant, since a C. glutamicum Δpck 
mutant has been reported to show no growth defect on minimal medium with glucose 
(Riedel et al., 2001). We regarded growth as prerequisite for evolutionary experiments, since 
we intended to deploy increasing biomass concentrations, i.e. reproduction, as the screening 
indicator. Having defined the boundaries of the planned scenario, we cultivated the double and 
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triple deletion mutants in minimal medium with glucose and yeast extract and transferred 
defined amounts of biomass every three to four days, respectively, to clear the medium from 
potentially growth inhibiting compounds and supply the cells with all factors needed for growth. 
Increasing biomass concentrations (as the results of evolutionary events) were observed for the 
double deletion mutant after 14 and 15 d, respectively, and for the triple deletion mutant after 
33 d. The delayed occurrence of increasing biomass concentrations for the triple deletion mutant 
compared to the double deletion mutant might reflect the stronger impaired growth of the basis 
strain. The evolved strains were isolated by plating dilutions on semi-solid agar media and 
tested for improved growth characteristics in the evolutionary medium. Evo1.1 and Evo1.2 
showed distinctly faster growth compared to their initial strain C. glutamicum Δppc Δpyc. 
Compared to Evo1.1 and Evo1.2, Evo2 showed slower growth, although it now was able to 
grow, compared to its basis strain C. glutamicum Δppc Δpyc Δpck. Having isolated the evolved 
strains and having confirmed their improved growth phenotypes, we proceeded by 
re-sequencing their genomes. This was done in a whole genome sequencing (WGS) approach 
at the CeBiTec (Bielefeld University) and allowed us to compare the genomes of 
C. glutamicum WT and the evolved strains. By deliberately omitting the application of 
mutagenic agents, the evolutionary approach resulted in a neat set of mutations per cell (as was 
intended), yielding two strains with each three mutations and one strain with six mutations 
(Table 35, p.148). These numbers are far below the numbers of mutations per single cell that 
are generated with classical evolutionary approaches, which often result in >100 mutations per 
single cell (Harper et al., 2011; Parkhomchuk et al., 2009). With this neat set of mutations, we 
built the mutational intersection of the three evolved strains to identify shared targets of the 
evolutionary approach. The mutational intersection in our case only yielded one relevant target 
that was affected by mutations in Evo1.1, Evo1.2, and Evo2, namely the icd (cg0766) gene, 
encoding the isocitrate dehydrogenase (ICD). ICD is a key enzyme of the TCA cycle, 
generating NADPH from NADP+ by oxidatively decarboxylating isocitrate to α-ketoglutarate 
and CO2, thus supporting the cell with reducing equivalents and precursors 
(Eikmanns et al., 1995). The genomic alterations (i.e. single nucleotide polymorphisms 
[SNPs]) in icd led to three amino acid exchanges in ICD, respectively. These SNPs were then 
introduced in the basis strain C. glutamicum Δppc Δpyc and resulted in three re-engineered 
strains, with the three different amino acid exchanges A94D, R453C, and G407S. With the 
purpose to understand the underlying effects of these exchanges (mutations), we measured the 
specific enzyme activities of the three ICD variants and found that all three variants showed 
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drastically lower activities than the native enzyme. It has been reported that the specific enzyme 
activity of ICD is 1 U mg-1 protein, regardless of the carbon source (Eikmanns et al., 1995; 
Wendisch et al., 1997), reflecting the value we obtained for C. glutamicum WT. In a metabolic 
engineering approach Becker et al. targeted the TCA cycle by exchanging the native 
translational start codon of ICD (ATG) with GTG, which resulted in about 70% decreased ICD 
activity and increased L-lysine production (Becker et al., 2009). However, this was correlated 
to a shift of the TCA cycle towards anaplerotic carboxylation and not to connected with a 
potential activation of the glyoxylate shunt (Becker et al., 2009). The idea that isocitrate might 
be metabolized via the glyoxylate shunt in an strain with low ICD activity, i.e. 
C. glutamicum Δicd mutant, has been mentioned before (Baumgart et al., 2011). With the 
purpose to test this hypothesis in relation to the re-engineered strains and nurtured by the FBA 
result, we measured isocitrate lyase (ICL) and malate synthase (MS) activites. Results for 
C. glutamicum WT showed that no activities for both enzymes were present in minimal 
medium with glucose (and L-glutamate). This is in accordance with published data, since it was 
shown before that ICL and MS activities are absent in C. glutamicum in glucose-based minimal 
medium (Reinscheid et al., 1994b, 1994a). In contrast, specific activities of ICL and MS were 
present in all three re-engineered strains, thus showing that ICD mutations activate the 
glyoxylate shunt. 
Besides the icd gene as shared target in the three evolved strains, mutations were found in two 
genes with yet unknown function (cg0466, cg1793) and four genes (glgE, msiK1, benR, ptsF) 
encoding enzymes of the carbohydrate metabolism. Interestingly, we found a SNP and a 12 bp 
deletion in ptsF (cg2120), encoding the fructose-specific EIIABC permease of the 
PEP-dependent phosphotransferase system for fructose (PTSFru), which had evolved 
independently. Both mutations led to a defective PTSFru, since strains Evo1.1 and Evo1.2 (in 
both ptsF was affected) showed impaired growth on fructose compared to glucose (data not 
shown). Recently, ΔpfkB-suppressor mutants were characterized with a deletion of the 
ptsF-operon gene pfkB, which regained growth on sucrose (Wang et al., 2016). Subsequently, 
they found a 12 bp deletion in ptsF, which overlaps with our identified 12 bp ptsF deletion in 
8 bp. Quantification of intracellular sugar phosphates of a sucrose grown ptsF mutant revealed 
strongly reduced levels of glucose 6-phosphate (72 %), fructose 6-phosphate (84 %) and 
fructose 1-phosphate (below detection limit) compared to the wildtype strain 
(Wang et al., 2016). Interestingly, our re-engineered strain C. glutamicum Δppc Δpyc ICDG407S 
also showed significant reduced intracellular glucose 6-phosphate (40%) and 
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fructose-1,6-bisphosphate (20%) pools compared to the wildtype strain. These sugar 
phosphates represent most relevant effector molecules regulating microbial metabolism and are 
typically present in low intracellular concentrations during growth on gluconeogenic carbon 
sources (Engels and Wendisch, 2007; Görke and Stülke, 2008). However, elevated 
transcriptional levels of genes related to acetate metabolism (e.g. aceA, aceB, pta, ack) were 
not observed in the ptsF mutant (Wang et al., 2016). This indicates a different or more complex 
regulatory pattern to explain the activation of the glyoxylate shunt during growth on glucose in 
the evolved and re-engineered C. glutamicum Δppc Δpyc strains and might be more likely 
attributed to the increased intracellular pool sizes of cis-aconitate, citrate, and isocitrate, which 
were exemplary observed in C. glutamicum Δppc Δpyc ICDG407S compared to 
C. glutamicum WT. In accordance with the results of the FBA from André Feith and the 
determination of significant ICL and MS activities in strains with reduced ICD activity, 
Baumgart et al. proposed an activation of the glyoxylate shunt in a C. glutamicum Δicd mutant 
to metabolize accumulating isocitrate from glucose (Baumgart et al., 2011). However, since the 
effector molecules or activity modulating effects of the most relevant regulators of acetate 
metabolism, RamA and RamB (Cramer et al., 2006; Gerstmeir et al., 2004; 
Teramoto et al., 2011), are still unknown and since other transcriptional regulators such as 
GlxR (Kim et al., 2004; Teramoto et al., 2011) and SugR (Engels and Wendisch, 2007; 
Gaigalat et al., 2007; Tanaka et al., 2008; Teramoto et al., 2011) are involved 
(Toyoda et al., 2013), the regulatory interplay remains puzzling and requires further 
investigation to explain the altered flux distributions in the evolved and re-engineered strains.  
All three re-engineered strains and the basis strain C. glutamicum Δppc Δpyc needed 
yeast extract for (minimal) growth in minimal medium. Interestingly, the yeast extract was 
replaceable by L-glutamate, which was used as a more defined component, compared to 
yeast extract. In our understanding, this is facilitated by the conversion of L-glutamate by the 
reaction of glutamate dehydrogenase, which (reversibly) channels the carbon from glutamate 
into the TCA cycle, in this way enabling the formation of α-ketoglutarate 
(Börmann et al., 1992). By this, α-ketoglutarate might be further converted in the TCA cycle 
thus providing initial molecules of oxaloacetate, which serve as acceptor molecules for 
acetyl-CoA, provided by the PDHC (Bott, 2007). Eventually, the lack of the two 
oxaloacetate-forming reactions of PEPCx and PCx in the basis and re-engineered strains can be 
compensated. Since the re-engineered strain had consumed all available L-glutamate after 8 h 
of cultivation and did not stop growing thereafter, we hypothesized that L-glutamate is needed 
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to kickstart the TCA cycle in absence of PEPCx and PCx. Accompanied by a decreased activity 
of the ICD enzyme (in ICDG407S) in combination with the PEPCx and PCx deficiencies, we 
observed decreased intracellular concentrations of oxaloacetate-derived products, such as 
L-aspartate, L-lysine, and L-threonine, whereas TCA intermediates upstream of the ICD reaction 
were increased, such as isocitrate, cis-aconitate, and citrate.  
For future evolutionary studies it would be interesting to use a C. glutamicum 
Δppc Δpyc ΔaceA ΔaceB deletion mutant in an MGE approach. With the additional deletions 
of the genes encoding ICL and MS, the basis strain for MGE would be deprived of the 
possibility to activate the glyoxylate shunt by acquiring glyoxylate shunt-activating mutations. 
It would be fascinating to explore if the metabolism of C. glutamicum holds ready other options 
to compensate for a combined PEPCx and PCx deficiency, besides the here acquired ICD 
mutations. Options therefor could be the evolution of a native carboxylase enzyme adopting the 
PEPCx or PCx reaction. This might be facilitated by a carboxylase that forms oxaloacetate but 
uses different substrates than PEP or pyruvate, respectively. A further evolutionary target in 
such a scenario could be a decarboxylating enzyme, which gains a mutation that reverts its 
reaction mechanism. 
A further interesting topic for future investigations concerning the re-engineered strains might 
be the evaluation of the intracellular balances of reducing equivalents, i.e. NADP+/NADPH. In 
the re-engineered strains, the carbon flux over the NADH- / NADPH-forming reactions 
catalysed by ICD and 2-oxoglutarate dehydrogenase complex is weakend due to the ICD 
mutations and thus less NADH / NADPH might be formed due to the active glyoxylate bypass.  
In several studies C. glutamicum has been engineered for production of L-valine and strains are 
readily available which operate close to the maximal theoretical yield (Blombach et al., 2008; 
Hasegawa et al., 2012). Besides the overexpression of L-valine biosynthesis genes and mutated 
variants thereof, a common feature of efficient producer strains is a direct or indirect 
inactivation or attenuation of the PDHC to improve pyruvate availability for L-valine production 
(Eikmanns and Blombach, 2014; Oldiges et al., 2014). To engineer a novel basis strain which 
does not rely on reduced or absent PDHC activity, we applied MGE to evolve C. glutamicum 
Δppc Δpyc to grow on glucose. The FBA predicted growth of the double deletion mutant by 
activation of the glyoxylate shunt and an increased flux through the PDHC compared to 
C. glutamicum WT, which might be rerouted towards L-valine. To test this hypothesis, we 
transformed the strains C. glutamicum Δppc Δpyc carrying the re-engineered icd variants with 
the plasmid pJC4ilvBNCE, which was previously applied for L-valine production with 
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C. glutamicum (Oldiges et al., 2014; Radmacher et al., 2002). C. glutamicum Δppc Δpyc 
ICDGA94D (pJC4ilvBNCE) and C. glutamicum Δppc Δpyc ICDGG407S (pJC4ilvBNCE) 
efficiently produced L-valine from glucose with product yields of 0.20 ± 0.01 and 0.22 ± 0.01 
g L-valine per g glucose, respectively, which are about 4 times higher compared to the YP/S of 
C. glutamicum (pJC4ilvBNCE). The YP/S values of the novel engineered strains compete with 
already published data for L-valine producers, which are based on reduced or absent PDHC 
activity (Buchholz et al., 2013) or on an H+-ATPase deficiency (Wada et al., 2008) but are still 
improvable. However, we here identified with modulating ICD activity an alternative mode for 
L-valine production with C. glutamicum and created the basis for further research in this 
direction. To further advance the performance of the presented strains, future work might focus 
on an adjustment of the NADPH supply, an improvement of the export capacity, or a rescue 
from feedback inhibition of acetohydroxy acid synthase (AHAS) as previously proved 
beneficial for L-valine production with C. glutamicum and E. coli (Oldiges et al., 2014; 
Park and Lee, 2010).  
After having presented and discussed the idea and results of MGE, I want to complete this 
discussion with an evaluation of MGE as method. Ultimately, MGE relies on an ancient and 
well-described evolutionary principle, which is called genetic suppression. Genetic suppression 
is a phenomenon, which reverts phenotypic effects of an already existing mutation by an 
acquired second mutation at a site distinct from the first one, and is applied to explore gene 
expression, function, and interaction (Hodgkin, 2005). Even lethal phenotypes might thus be 
rescued by either a loss-of-function or a gain-of-function mutation (Motter et al., 2008). This 
process has been described as synthetic rescue (Motter et al., 2008) and represented a driving 
force to utilize this concept for the here described method of MGE. MGE introduces targeted 
deletions, thereby generating a suboptimal metabolic state for the cell and reducing or 
abolishing growth of the microbial host with the aim to create intrinsic selection pressure. This 
eventually is supposed to guide evolution to create a new metabolic state of the cell, which is 
beneficial for the synthesis of the target molecule by optimizing precursor availability and/or 
creating an alternative metabolic mode. Typically, the evolutionary readjusted metabolism 
increases the previously low growth rate or even revives the cell. Increasing biomass 
concentrations constitute a straightforward indicator that facilitates simplified screening and 
easily identifies relevant evolving clones. The application of mutagenizing agents or radiation 
might accelerate evolution, it however potentiates the number of mutations, which requires 
laborious re-engineering to identify relevant ones (Harper et al., 2011). We deliberately omitted 
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mutagens in MGE and relied on intrinsic selection pressure created via metabolic engineering, 
which worked out and resulted in a neat set of mutations (seven genomic targets in sum, 
separated in strains with each three, three or six mutations; Table 35, p.148).  
Other evolution approaches, such as adaptive laboratory evolution (ALE), have also been 
applied with focus on improving L-valine production with C. glutamicum in combination with 
an L-valine responsive biosensor (Mahr et al., 2015). Identified genomic targets in this approach 
comprised ureD, glxR, prpD2, rpsP, and lepA (Mahr et al., 2015). 
Beyond this, parallel, independent, and timesaving evolution experiments further simplify the 
identification of relevant mutations, since they enable forming an intersection of the mutational 
pool. In our experiments this yielded one shared, i.e. relevant, target gene (icd) with three 
mutated variants, which could be swiftly re-engineered and identified as growth-mediating 
factors. Combined with the technology of comparative metabolomics, in the form of SMP, 
evolved strains could readily be screened for potential production applications. In our case, 
MGE worked out as planned and cells were indeed suitable for L-valine production, which was 
underlined by the revelation of increased intracellular L-valine pools in 
C. glutamicum Δppc Δpyc ICDGG407S. 
MGE has proven to be able to identify novel targets with the purpose to improve existing 
producer strains. This might prove exceptionally useful when rational strain design comes to its 
limits. However, applying MGE requires intense and profound knowledge of the hosts 
metabolism including underlying regulation networks and accessibility of the targeted 
genes/enzymes. It is indispensable to predict potential outcomes of an evolutionary experiment, 
which however might be encouraged by applying FBA, with the aim to evaluate the prospect 
of success prior starting. Nevertheless, a profound knowledge of the deployed methods and 
technologies, such as FBA, strain construction, and SMP, and importantly a synergy thereof is 
required from the experimenter.  
Taken together, the application of MGE identified and created a novel metabolic mode for 
L-valine production with C. glutamicum, which represents a suitable alternative to already 
existing approaches.  
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CHAPTER 6: APPENDIX 
 Supplementary results 
 Differential YP/Shis during fed-batch fermentation 
 
Fig. 32. Differential product substrate yields for L-histidine (YP/Shis) over the process time during the 
fed-batch phase of a STR fed-batch fermentation of C. glutamicum CM2. 
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 C. glutamicum CM2 shaking flask vs. reactor cultivation 
 
 pH profiles in shaking flasks and reactor cultivations 
 
Fig. 33. Comparison of growth profiles of C. glutamicum CM2 in shaking flasks (circles) and small scale 
reactor cultivations (triangles). Filled symbols represent biomass, open symbols represent glucose 
concentration. Depicted shaking flask cultivations were performed in triplicates and bars show standard 
error, for reactor cultivation one representative experiment is shown. 
Fig. 34. pH profiles in shaking flask cultivations (white circles) and in a small scale fermentation (black 
circles) with C. glutamicum CM2 w/o pH regulation. Starting values of both cultivations were in the range 
of 7.4-7.5. Shaking flask cultivations were performed in triplicate and error bars give standard deviations. 
For the small scale fermentation a representative pH profile of one cultivation is shown.  
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